data_1kjk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kjk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.61 158.65 31.38 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.651 1.567 . . . . 0.0 111.312 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 16' ' ' LEU . 58.2 Cg_endo -69.63 156.67 63.06 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.603 2.202 . . . . 0.0 112.713 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 70.84 -17.35 0.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.761 -0.587 . . . . 0.0 110.195 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 14' ' ' PRO . 3.9 tt -99.95 142.7 31.08 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.204 -0.935 . . . . 0.0 109.815 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -134.34 -177.79 4.75 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.476 0.655 . . . . 0.0 109.775 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 tt -140.0 148.88 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-O 121.376 0.607 . . . . 0.0 109.792 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -91.11 156.84 17.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.359 -0.838 . . . . 0.0 109.702 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -57.38 -14.39 4.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.463 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -88.67 -2.12 58.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 108.676 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.99 12.62 67.97 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -86.51 130.52 34.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.045 -1.268 . . . . 0.0 108.429 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -84.2 148.92 26.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 109.71 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.3 p -152.72 138.66 18.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.162 -0.961 . . . . 0.0 109.903 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -100.92 150.58 22.71 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.346 -0.846 . . . . 0.0 108.956 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -111.32 113.0 25.16 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.185 -0.947 . . . . 0.0 110.293 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.07 139.71 76.41 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 108.939 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -82.75 -10.77 10.51 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.042 1.828 . . . . 0.0 113.107 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -89.08 -38.82 14.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.784 -1.198 . . . . 0.0 109.769 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 33' ' ' LYS . 2.5 t -106.51 -11.08 16.01 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.75 -6.39 0.62 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -75.52 179.71 5.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.971 -1.311 . . . . 0.0 109.315 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 68.4 mt-10 -107.89 173.03 6.5 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.539 -0.726 . . . . 0.0 109.985 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -136.6 116.55 13.25 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.82 125.79 16.8 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 28.3 mt -110.44 -59.73 1.9 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.501 -0.999 . . . . 0.0 109.207 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.91 -176.06 35.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -93.13 7.79 42.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.15 -1.206 . . . . 0.0 109.477 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.02 101.99 13.73 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -58.77 -12.88 4.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.157 -0.964 . . . . 0.0 108.764 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -75.63 -56.8 4.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.458 -0.777 . . . . 0.0 108.97 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 89.0 mt -73.27 -34.71 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.526 -0.734 . . . . 0.0 109.596 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.57 -57.71 7.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.035 -1.041 . . . . 0.0 109.437 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 92.1 mt -54.51 -36.82 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 109.211 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -53.7 -56.81 14.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 108.938 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -62.11 -42.99 99.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.651 -0.656 . . . . 0.0 110.027 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.65 67.68 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.387 -0.82 . . . . 0.0 109.147 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.31 -48.34 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.336 -0.852 . . . . 0.0 109.919 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -61.37 -39.68 91.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.989 -1.069 . . . . 0.0 108.241 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.14 75.13 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -67.92 -33.62 75.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.421 -0.799 . . . . 0.0 109.695 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 108.824 -179.852 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -35.59 145.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.738 2.292 . . . . 0.0 112.52 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.523 ' C ' HD21 ' A' ' 15' ' ' ASN . 83.1 Cg_exo -44.43 138.5 7.45 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.079 1.852 . . . . 0.0 113.429 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.523 HD21 ' C ' ' A' ' 14' ' ' PRO . 1.4 m-80 61.04 43.38 11.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.446 -0.784 . . . . 0.0 111.63 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.5 tp -139.95 119.42 13.07 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -113.39 179.87 3.84 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.583 0.706 . . . . 0.0 110.413 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.0 tt -138.73 147.1 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-O 121.538 0.685 . . . . 0.0 109.243 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -91.48 160.12 15.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.533 -0.73 . . . . 0.0 110.352 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -61.36 -11.49 10.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.58 -0.7 . . . . 0.0 109.125 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -88.87 -1.2 57.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.029 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.77 4.99 86.92 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -86.65 135.29 33.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.11 -1.23 . . . . 0.0 108.367 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -84.37 152.53 24.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.166 -0.959 . . . . 0.0 110.16 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.437 ' SG ' ' O ' ' A' ' 25' ' ' CYS . 30.2 p -150.77 126.4 10.23 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.424 -0.797 . . . . 0.0 109.455 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -94.96 150.27 20.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.195 -0.94 . . . . 0.0 109.333 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -115.05 115.67 27.2 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.485 -0.759 . . . . 0.0 110.627 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -76.01 131.43 75.95 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 108.989 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.86 -7.69 13.33 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.022 1.815 . . . . 0.0 113.42 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -86.13 -18.16 33.05 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.646 -1.284 . . . . 0.0 108.977 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 t -130.67 -27.46 2.13 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.46 -3.52 84.63 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -75.21 -176.32 3.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.953 -1.322 . . . . 0.0 109.304 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -115.99 170.2 8.67 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.484 -0.76 . . . . 0.0 110.266 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -137.27 121.7 18.27 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.28 123.5 6.32 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.7 mt -104.79 -69.56 0.81 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.417 -1.049 . . . . 0.0 109.572 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.57 -177.92 37.67 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.413 ' HG3' HH11 ' A' ' 39' ' ' ARG . 6.9 mtm-85 -90.52 7.19 40.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.169 -1.195 . . . . 0.0 110.035 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -95.18 111.31 23.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.253 -0.904 . . . . 0.0 110.216 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.5 ' HG3' HH11 ' A' ' 41' ' ' ARG . 0.7 OUTLIER -62.63 -15.57 52.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 108.99 179.119 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -74.43 -46.67 38.48 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.85 -39.6 16.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.44 -58.16 7.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.667 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 98.7 mt -55.88 -37.56 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.942 -1.099 . . . . 0.0 109.343 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -55.97 -57.96 9.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 109.542 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -61.47 -42.71 99.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.475 -0.766 . . . . 0.0 109.911 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.32 64.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.491 -0.755 . . . . 0.0 109.542 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.47 -42.99 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.242 -0.911 . . . . 0.0 110.36 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -59.94 -32.47 70.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.039 -1.038 . . . . 0.0 108.804 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.28 -36.5 84.29 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -67.18 -37.49 83.79 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.28 -0.888 . . . . 0.0 109.873 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.8 mt . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.131 -0.981 . . . . 0.0 109.011 -179.852 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.91 161.91 43.71 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.34 2.027 . . . . 0.0 111.094 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.56 ' C ' ' H ' ' A' ' 16' ' ' LEU . 32.4 Cg_endo -62.58 165.03 16.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.35 2.034 . . . . 0.0 112.052 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 61.7 -9.35 0.08 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.654 -0.654 . . . . 0.0 110.698 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.56 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.9 tp -108.08 143.0 37.43 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.091 -1.005 . . . . 0.0 109.335 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 46.5 m-85 -136.78 -165.33 1.72 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.769 0.795 . . . . 0.0 110.052 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.5 tp -138.47 138.05 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.464 ' HE ' ' CB ' ' A' ' 23' ' ' TYR . 44.1 mtm180 -89.71 173.04 8.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.258 -0.901 . . . . 0.0 109.28 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.565 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -64.51 -20.04 65.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.113 -0.992 . . . . 0.0 109.699 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.85 3.1 55.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.001 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.93 19.82 74.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.464 ' CB ' ' HE ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -84.92 132.76 34.33 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -82.2 141.99 32.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.925 -1.109 . . . . 0.0 109.638 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.9 m -144.13 135.23 25.43 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 38.5 t80 -96.86 157.49 15.88 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.565 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 27.6 ttm180 -127.52 120.53 28.48 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.498 -0.751 . . . . 0.0 110.539 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -76.47 144.94 74.9 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.128 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.18 -13.0 7.85 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.997 1.798 . . . . 0.0 111.902 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -91.59 -36.3 13.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.282 -0.886 . . . . 0.0 110.078 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.517 ' C ' ' H ' ' A' ' 33' ' ' LYS . 27.6 p -106.2 -17.83 14.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.37 -0.831 . . . . 0.0 109.503 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.1 -8.99 0.81 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' A' ' 31' ' ' THR . 6.6 tmtt? -73.6 -174.17 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.983 -1.304 . . . . 0.0 108.232 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -128.99 161.38 30.07 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.39 -0.819 . . . . 0.0 110.51 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -119.48 137.17 53.97 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.8 120.58 5.25 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mt -102.53 -61.27 1.42 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.409 -1.054 . . . . 0.0 108.838 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.18 -170.18 32.69 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.572 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 1.2 mtm180 -95.85 11.37 33.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -1.194 . . . . 0.0 109.13 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -93.06 98.51 11.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.476 -0.765 . . . . 0.0 110.031 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -61.78 -13.13 20.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.572 -0.705 . . . . 0.0 109.163 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.408 HH11 ' HG3' ' A' ' 42' ' ' ARG . 17.3 mmm-85 -77.04 -57.12 4.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.48 -0.762 . . . . 0.0 109.591 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.5 ' N ' ' CD1' ' A' ' 43' ' ' ILE . 1.7 mp -74.42 -35.95 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.22 -0.925 . . . . 0.0 109.537 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.6 -52.98 62.16 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.162 -0.961 . . . . 0.0 109.346 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.5 mt -57.2 -41.67 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.684 -1.26 . . . . 0.0 108.554 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.9 m -57.76 -51.25 70.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 110.614 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -32.77 74.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.035 -1.041 . . . . 0.0 109.768 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.5 90.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.168 -0.957 . . . . 0.0 110.051 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.18 -56.31 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.353 -0.842 . . . . 0.0 111.007 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -56.19 -31.11 63.14 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.943 -1.098 . . . . 0.0 108.489 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.94 -38.0 82.3 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -65.6 -45.28 83.79 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.5 mt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.353 -0.842 . . . . 0.0 108.748 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 13' ' ' PRO . 40.6 mt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 12' ' ' LEU . 90.7 Cg_exo -35.41 158.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.617 2.212 . . . . 0.0 111.814 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.08 143.88 50.63 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.059 1.839 . . . . 0.0 111.265 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 65.85 29.17 10.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.602 -0.686 . . . . 0.0 109.939 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.0 tp -138.91 123.66 18.64 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 11.9 m-85 -131.1 -163.95 1.38 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.172 0.987 . . . . 0.0 111.11 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 tp -126.82 142.21 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.411 HH11 ' HG3' ' A' ' 19' ' ' ARG . 14.5 ttm-85 -88.48 161.53 16.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.162 -0.962 . . . . 0.0 109.036 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -59.26 -18.35 36.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.038 -1.039 . . . . 0.0 109.423 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -89.36 -0.33 57.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.093 -1.005 . . . . 0.0 108.722 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.36 8.41 74.57 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -86.22 142.61 28.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -1.174 . . . . 0.0 108.943 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -81.48 149.71 28.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.967 -1.083 . . . . 0.0 108.938 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 p -148.57 135.44 19.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.983 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -97.83 154.81 17.38 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -118.12 110.84 18.11 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.451 -0.781 . . . . 0.0 109.472 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.95 151.02 86.28 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.223 -0.923 . . . . 0.0 109.645 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -90.46 -23.18 0.64 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.624 2.216 . . . . 0.0 113.146 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -90.14 -26.35 20.22 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.933 -1.105 . . . . 0.0 110.346 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.543 ' C ' ' H ' ' A' ' 33' ' ' LYS . 68.1 p -105.92 -19.24 13.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.0 -1.062 . . . . 0.0 108.421 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.74 -11.23 0.63 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -75.99 -161.97 0.2 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.202 -1.176 . . . . 0.0 109.032 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 44.1 mt-10 -129.82 179.52 5.8 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.573 -0.705 . . . . 0.0 109.935 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -143.94 117.45 9.14 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.09 126.3 10.2 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt -105.97 -52.47 2.8 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.362 -1.081 . . . . 0.0 109.622 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.92 -173.07 30.52 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -97.72 8.95 43.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -1.129 . . . . 0.0 109.292 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -94.43 99.52 11.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.325 -0.859 . . . . 0.0 110.422 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -55.47 -19.61 10.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' A' ' 42' ' ' ARG . 1.1 mmt-85 -75.46 -54.09 7.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 109.237 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 78.9 mt -76.25 -36.84 30.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.688 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -58.52 8.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 50.8 mt -50.84 -39.43 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.8 -1.187 . . . . 0.0 109.176 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.06 -51.5 66.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.008 . . . . 0.0 109.499 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -62.37 -41.25 98.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 109.151 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.38 93.4 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.434 -0.792 . . . . 0.0 110.229 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.1 mt -60.46 -52.66 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.137 -0.977 . . . . 0.0 110.593 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -59.12 -30.87 68.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.875 -1.141 . . . . 0.0 108.712 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.31 93.18 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -68.05 -39.32 83.05 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.466 -0.771 . . . . 0.0 109.392 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.8 mt . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.243 -0.911 . . . . 0.0 108.831 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.1 mt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.53 160.44 39.7 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.752 1.634 . . . . 0.0 110.354 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.519 ' C ' ' H ' ' A' ' 16' ' ' LEU . 57.2 Cg_endo -67.7 171.6 11.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.31 2.007 . . . . 0.0 112.201 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 57.05 4.21 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.555 -0.716 . . . . 0.0 109.422 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' PRO . 26.1 tp -129.74 132.39 46.57 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -134.46 -163.47 1.38 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.366 -0.834 . . . . 0.0 110.339 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 tp -132.04 141.11 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -88.77 158.91 18.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.968 . . . . 0.0 109.115 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.621 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -57.4 -19.91 26.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.465 -0.772 . . . . 0.0 109.043 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.81 -2.93 58.96 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.72 10.99 71.79 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -86.61 140.23 30.04 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.231 -1.158 . . . . 0.0 108.588 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.438 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 68.4 m-85 -81.84 151.24 27.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.85 -1.156 . . . . 0.0 109.432 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.447 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 17.2 p -146.68 133.36 19.93 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.397 -0.814 . . . . 0.0 110.156 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -96.94 137.33 36.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.331 -0.855 . . . . 0.0 108.812 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -108.81 115.33 29.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.591 -0.693 . . . . 0.0 110.104 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.34 142.66 89.77 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -84.17 -8.8 9.76 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.393 2.062 . . . . 0.0 113.323 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -89.78 -24.45 21.48 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.842 -1.161 . . . . 0.0 109.987 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 -22.33 3.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.368 -0.832 . . . . 0.0 109.49 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.41 0.9 68.34 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.407 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 3.6 tmtt? -73.94 179.68 4.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.959 -1.318 . . . . 0.0 108.494 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 25.9 mt-10 -131.72 160.25 36.04 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.375 -0.828 . . . . 0.0 110.605 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -138.04 125.48 21.94 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.16 132.46 33.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.428 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.6 mt -105.09 -47.79 3.9 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.413 -1.051 . . . . 0.0 108.869 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.39 -178.98 22.8 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.181 -1.967 . . . . 0.0 108.181 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -91.55 11.03 25.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.021 -1.282 . . . . 0.0 109.371 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.34 100.72 13.25 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.933 0.873 . . . . 0.0 109.835 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.438 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 43.0 ttm180 -59.25 -20.06 51.04 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.4 0.619 . . . . 0.0 109.9 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.542 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -77.08 -49.27 15.68 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.714 0.768 . . . . 0.0 109.2 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.5 mt -75.76 -36.89 34.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.8 -55.41 26.71 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.348 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.53 -40.34 74.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.418 -0.801 . . . . 0.0 109.78 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -50.63 -51.74 46.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 108.914 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -62.53 -37.76 87.34 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.551 -0.718 . . . . 0.0 109.333 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.25 -51.91 67.81 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.497 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.61 -48.87 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.361 -0.837 . . . . 0.0 110.641 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -58.07 -44.07 87.3 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.839 -1.163 . . . . 0.0 108.145 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.54 74.05 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -69.94 -45.74 66.81 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.333 -0.855 . . . . 0.0 109.521 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.7 mt . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.085 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -40.21 157.27 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.115 1.876 . . . . 0.0 111.85 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 16' ' ' LEU . 50.5 Cg_endo -69.61 153.03 70.15 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.093 1.862 . . . . 0.0 111.767 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 69.0 -11.27 0.45 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.535 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.5 tt -97.56 142.28 29.58 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.926 -1.109 . . . . 0.0 109.664 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -136.03 -178.83 5.32 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.551 -0.718 . . . . 0.0 109.393 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.21 147.77 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.662 0.744 . . . . 0.0 109.631 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.483 HH21 ' CB ' ' A' ' 23' ' ' TYR . 15.1 ttp180 -91.31 156.32 17.88 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -59.71 -10.33 3.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.057 -1.027 . . . . 0.0 109.604 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -88.69 1.41 55.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.259 -0.901 . . . . 0.0 108.755 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.88 6.16 88.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CB ' HH21 ' A' ' 19' ' ' ARG . 3.6 m-85 -84.36 138.06 33.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.313 -1.11 . . . . 0.0 108.488 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -83.0 154.67 24.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.034 -1.041 . . . . 0.0 109.307 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 p -150.88 132.24 14.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.818 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -101.98 143.64 31.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.378 -0.826 . . . . 0.0 109.097 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -101.86 118.66 37.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.49 -0.756 . . . . 0.0 109.5 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 35' ' ' PHE . 1.9 m-20 -74.35 149.12 86.53 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.977 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.24 3.06 7.09 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.771 2.314 . . . . 0.0 113.015 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -86.48 -55.12 4.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.951 -1.093 . . . . 0.0 110.243 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.17 -18.93 9.21 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.457 -0.777 . . . . 0.0 109.807 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.32 6.76 59.78 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.051 -1.031 . . . . 0.0 110.635 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -72.25 -175.23 1.48 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.847 -1.384 . . . . 0.0 109.325 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -119.1 166.86 12.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.646 -0.659 . . . . 0.0 109.822 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.469 ' CE1' ' OD2' ' A' ' 28' ' ' ASP . 8.0 m-85 -134.77 119.2 17.9 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.14 121.75 16.83 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -104.22 -53.49 2.72 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.526 -0.985 . . . . 0.0 109.302 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.46 -177.45 28.53 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.509 -1.837 . . . . 0.0 108.509 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.408 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 1.8 mtm180 -93.92 8.47 41.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.13 -1.218 . . . . 0.0 109.422 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -94.19 102.73 14.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -60.5 -11.77 7.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.349 -0.845 . . . . 0.0 109.018 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.575 HH11 ' CG ' ' A' ' 42' ' ' ARG . 0.2 OUTLIER -75.8 -54.72 6.49 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.467 -0.771 . . . . 0.0 109.216 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.44 ' N ' ' CD1' ' A' ' 43' ' ' ILE . 1.7 mp -74.92 -37.91 42.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.614 -0.679 . . . . 0.0 109.183 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.11 -56.74 14.3 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.65 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.7 mt -55.99 -40.88 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.043 -1.036 . . . . 0.0 109.329 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.7 m -59.96 -50.73 72.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 110.477 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -32.86 74.52 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.306 -0.871 . . . . 0.0 110.018 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.97 92.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.105 -0.997 . . . . 0.0 108.961 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.1 mt -56.86 -42.2 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.441 -0.787 . . . . 0.0 110.207 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -58.19 -39.53 79.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.053 -1.029 . . . . 0.0 108.991 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.35 84.01 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -67.8 -39.26 84.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.531 -0.731 . . . . 0.0 110.419 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.004 -1.06 . . . . 0.0 109.572 -179.215 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -37.87 154.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.29 1.993 . . . . 0.0 111.892 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 16' ' ' LEU . 41.4 Cg_endo -66.68 153.61 77.37 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.377 2.051 . . . . 0.0 112.554 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 54.71 6.5 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.482 -0.761 . . . . 0.0 110.42 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.462 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.6 tt -104.61 148.01 27.0 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.19 -0.944 . . . . 0.0 109.25 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -139.1 -177.58 4.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.879 0.847 . . . . 0.0 110.331 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 tt -141.31 145.45 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.403 HH21 ' CB ' ' A' ' 23' ' ' TYR . 8.9 ttp180 -90.32 151.64 21.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.418 -0.801 . . . . 0.0 109.667 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.52 HD21 ' H ' ' A' ' 20' ' ' ASN . 1.5 m-80 -51.07 -15.86 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.444 -0.785 . . . . 0.0 109.973 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -88.69 0.89 56.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.178 -0.951 . . . . 0.0 108.845 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.69 12.18 78.19 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.403 ' CB ' HH21 ' A' ' 19' ' ' ARG . 8.0 m-85 -84.07 127.71 34.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.951 -1.323 . . . . 0.0 107.76 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -82.82 147.53 28.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.2 m -150.32 141.84 23.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.029 -1.045 . . . . 0.0 110.308 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 36.6 t80 -110.99 150.09 29.76 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.418 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 33.8 mtt180 -109.92 117.36 33.59 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.5 ' OD1' ' CD1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -75.06 131.73 78.2 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -75.22 -6.25 17.68 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.776 1.651 . . . . 0.0 112.622 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -89.1 -44.0 10.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.923 -1.11 . . . . 0.0 109.163 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.527 ' C ' ' H ' ' A' ' 33' ' ' LYS . 1.4 t -108.34 -7.4 15.9 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.289 -0.882 . . . . 0.0 108.913 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.6 -2.42 0.85 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.527 ' H ' ' C ' ' A' ' 31' ' ' THR . 3.4 mmtp -73.14 -179.94 3.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.068 -1.254 . . . . 0.0 108.857 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -105.75 171.72 7.19 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.537 -0.727 . . . . 0.0 109.951 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.5 ' CD1' ' OD1' ' A' ' 28' ' ' ASP . 14.8 m-85 -140.53 109.87 6.24 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.33 125.55 21.15 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.02 -31.37 7.65 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.55 -0.97 . . . . 0.0 109.93 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.15 -174.36 18.33 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -97.61 10.77 39.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.215 -1.168 . . . . 0.0 109.823 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -92.43 100.46 13.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.371 -0.831 . . . . 0.0 110.084 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -59.03 -16.39 18.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.515 -0.74 . . . . 0.0 109.628 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.515 HH11 ' CG ' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -76.49 -58.68 3.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.184 -0.948 . . . . 0.0 109.326 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.461 ' N ' ' CD1' ' A' ' 43' ' ' ILE . 1.7 mp -74.89 -33.1 29.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.654 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.44 77.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.765 -1.21 . . . . 0.0 109.928 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 45' ' ' ILE . 74.7 mt -59.1 -38.79 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.733 -1.23 . . . . 0.0 108.976 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.87 -63.92 0.99 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.239 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -53.05 -38.54 62.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.628 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.3 80.88 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.298 -0.877 . . . . 0.0 108.896 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.25 -44.83 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.425 -0.797 . . . . 0.0 110.8 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -57.41 -39.03 75.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 108.173 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.43 -35.77 81.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -66.86 -40.83 88.0 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.349 -0.845 . . . . 0.0 109.714 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.4 mt . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.041 -1.037 . . . . 0.0 108.477 179.635 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.6 mt . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -40.6 156.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.848 1.699 . . . . 0.0 111.336 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.75 165.2 16.57 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.946 1.764 . . . . 0.0 111.384 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.502 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 3.1 m-80 51.16 30.21 5.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.193 -0.942 . . . . 0.0 109.415 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 tt -138.28 127.51 24.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.349 -0.845 . . . . 0.0 108.793 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.11 -179.01 4.26 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.578 -0.701 . . . . 0.0 109.423 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.1 tt -140.39 150.53 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.561 -0.712 . . . . 0.0 109.299 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -91.65 152.53 20.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.168 -0.958 . . . . 0.0 109.602 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.9 -15.63 13.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 0.0 109.447 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -88.2 -1.73 58.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 108.642 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.82 9.58 65.97 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.65 129.28 34.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -1.224 . . . . 0.0 108.216 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -81.5 152.23 27.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.982 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.2 m -152.06 136.42 16.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.418 -0.801 . . . . 0.0 109.58 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 15' ' ' ASN . 81.5 t80 -105.03 137.4 42.84 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.383 -0.823 . . . . 0.0 109.083 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -103.23 113.07 26.26 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.392 -0.817 . . . . 0.0 109.682 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.13 139.9 85.25 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.275 -0.891 . . . . 0.0 110.347 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -83.5 1.4 8.98 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.479 2.12 . . . . 0.0 112.248 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -86.89 -37.0 18.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.082 -1.011 . . . . 0.0 109.88 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.1 -23.07 3.65 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.488 -0.757 . . . . 0.0 109.102 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.81 2.04 72.69 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -74.76 -164.97 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.875 -1.368 . . . . 0.0 109.777 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -129.52 171.87 12.14 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.755 0.788 . . . . 0.0 110.889 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -139.58 124.65 18.77 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.26 119.26 6.19 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.9 mt -103.8 -52.22 3.01 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.32 -1.106 . . . . 0.0 109.022 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.3 -169.09 26.46 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -97.47 11.87 35.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.288 -1.125 . . . . 0.0 109.269 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.94 106.5 18.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.367 -0.833 . . . . 0.0 110.142 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -64.43 -18.52 64.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.532 -0.73 . . . . 0.0 109.18 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.401 HH11 ' HG3' ' A' ' 42' ' ' ARG . 11.4 mmm-85 -76.84 -50.52 13.23 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.478 -0.763 . . . . 0.0 109.076 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 92.4 mt -76.12 -36.35 30.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.606 -0.684 . . . . 0.0 109.806 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.99 -52.65 58.62 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.183 -0.948 . . . . 0.0 109.823 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 45' ' ' ILE . 54.7 mt -56.14 -39.28 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.001 -1.062 . . . . 0.0 109.426 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.99 -50.87 65.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.0 109.715 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' O ' ' OE1' ' A' ' 50' ' ' GLN . 66.3 mm-40 -62.5 -39.78 94.58 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.512 -0.743 . . . . 0.0 109.656 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.43 -44.84 95.45 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.478 -0.764 . . . . 0.0 109.977 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.28 -58.41 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.217 -0.927 . . . . 0.0 111.23 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.402 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -55.73 -24.44 34.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.989 -1.069 . . . . 0.0 109.167 -178.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.57 81.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -70.58 -40.42 73.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.738 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.6 mt . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.12 -0.987 . . . . 0.0 109.236 -179.36 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.2 mt . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -37.59 158.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.447 2.098 . . . . 0.0 111.886 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.1 166.09 30.32 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.312 2.008 . . . . 0.0 111.948 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 49.48 20.94 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.919 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 tp -128.0 125.99 40.49 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -121.68 173.53 7.39 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.624 -0.672 . . . . 0.0 110.249 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.24 134.53 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.502 ' C ' ' H ' ' A' ' 21' ' ' ASN . 18.4 mtm180 -89.92 149.48 22.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.095 -1.003 . . . . 0.0 109.887 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -54.05 -8.85 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.136 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.502 ' H ' ' C ' ' A' ' 19' ' ' ARG . 88.0 m-20 -89.65 0.26 57.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.394 -0.816 . . . . 0.0 109.218 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.79 3.92 90.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -88.07 129.92 35.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.173 -1.192 . . . . 0.0 109.073 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.437 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 13.4 m-85 -84.82 156.9 21.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.461 -0.774 . . . . 0.0 108.987 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.437 ' SG ' ' O ' ' A' ' 24' ' ' TYR . 98.9 m -152.83 129.34 10.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.298 -0.877 . . . . 0.0 109.464 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -95.6 145.43 25.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.248 -0.908 . . . . 0.0 108.953 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -120.41 118.63 30.82 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.59 -0.694 . . . . 0.0 110.139 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -76.02 138.79 68.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.319 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.12 16.41 1.65 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.556 2.171 . . . . 0.0 112.896 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 -68.44 0.75 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.8 -1.188 . . . . 0.0 109.042 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.32 -19.56 13.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.307 -0.871 . . . . 0.0 109.36 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.68 17.52 23.37 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 178.84 5.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.765 -1.432 . . . . 0.0 108.977 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -126.49 164.14 21.81 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.423 -0.798 . . . . 0.0 110.443 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -134.78 133.08 39.48 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.21 131.57 10.73 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.34 -54.68 2.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.485 -1.009 . . . . 0.0 109.643 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.27 -171.46 31.54 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.91 7.66 46.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -1.201 . . . . 0.0 109.683 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -95.29 103.96 15.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.256 -0.902 . . . . 0.0 110.098 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -58.13 -18.64 26.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 108.738 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.472 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -73.46 -49.69 25.51 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.7 mt -76.89 -37.06 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.543 -0.723 . . . . 0.0 109.238 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.14 -56.56 12.21 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.854 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 88.8 mt -54.15 -35.74 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.098 -1.001 . . . . 0.0 109.351 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -56.82 -59.53 4.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.096 -1.003 . . . . 0.0 109.033 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -59.53 -42.24 91.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.37 -0.831 . . . . 0.0 109.807 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.6 -42.15 61.75 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.96 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.09 -52.49 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -60.58 -29.7 69.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.947 -1.096 . . . . 0.0 108.199 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.16 86.35 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -64.79 -36.78 85.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.412 -0.805 . . . . 0.0 109.377 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.0 mm . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 108.876 179.784 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.7 mt . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -40.78 157.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.049 1.833 . . . . 0.0 111.491 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.42 162.39 40.87 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.257 1.971 . . . . 0.0 112.143 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 52.72 27.35 5.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.469 -0.769 . . . . 0.0 110.25 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.64 148.47 47.44 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.221 -0.925 . . . . 0.0 108.81 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 22.6 m-85 -138.16 -166.85 2.05 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.115 0.96 . . . . 0.0 110.753 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.42 136.01 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 21' ' ' ASN . 26.8 ttp180 -88.62 142.25 27.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.921 -1.112 . . . . 0.0 109.424 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -50.45 -10.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.497 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.504 ' H ' ' C ' ' A' ' 19' ' ' ARG . 8.6 m120 -89.75 -0.04 57.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 109.169 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.57 5.11 87.12 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.448 ' CB ' HH21 ' A' ' 19' ' ' ARG . 3.0 m-85 -88.61 134.92 33.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.273 -1.134 . . . . 0.0 108.977 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.405 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 60.5 m-85 -84.18 147.94 27.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.927 . . . . 0.0 108.699 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 24' ' ' TYR . 83.8 m -150.62 143.03 24.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.037 -1.04 . . . . 0.0 110.044 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.436 ' CZ ' ' CB ' ' A' ' 51' ' ' ALA . 43.8 t80 -105.01 159.05 16.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.495 -0.753 . . . . 0.0 109.102 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.519 HH21 ' CD ' ' A' ' 34' ' ' GLU . 27.8 ttm180 -130.5 113.9 14.84 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.358 -0.839 . . . . 0.0 109.78 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.58 141.33 79.5 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.509 -0.744 . . . . 0.0 109.176 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -83.57 -19.82 5.04 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 121.931 1.754 . . . . 0.0 112.388 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -89.14 -26.01 21.55 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.126 -0.984 . . . . 0.0 109.491 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.551 ' C ' ' H ' ' A' ' 33' ' ' LYS . 1.9 p -107.33 -21.02 13.09 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.36 -10.43 0.66 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.551 ' H ' ' C ' ' A' ' 31' ' ' THR . 5.5 tmtt? -75.99 -179.21 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -1.232 . . . . 0.0 109.6 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.519 ' CD ' HH21 ' A' ' 27' ' ' ARG . 36.5 mt-10 -115.89 168.13 10.33 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.546 0.688 . . . . 0.0 110.291 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -135.77 121.22 19.3 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.54 124.58 6.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -105.09 -73.87 0.67 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.417 -1.049 . . . . 0.0 109.226 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 172.08 -168.55 41.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.29 0.16 45.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.269 -1.136 . . . . 0.0 109.593 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -98.36 100.1 11.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.308 -0.87 . . . . 0.0 109.748 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -54.63 -20.23 7.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.267 -0.896 . . . . 0.0 109.527 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -50.48 52.94 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.406 ' N ' ' CD1' ' A' ' 43' ' ' ILE . 1.9 mp -77.57 -34.87 20.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.82 -53.84 34.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.847 . . . . 0.0 109.781 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 73.1 mt -54.9 -35.92 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 109.232 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.22 -54.88 37.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 0.0 108.958 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.8 -39.73 95.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.529 -0.732 . . . . 0.0 109.756 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.45 81.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.486 -0.759 . . . . 0.0 109.577 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.84 -44.69 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 110.155 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -58.33 -28.9 65.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.862 -1.149 . . . . 0.0 108.519 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.436 ' CB ' ' CZ ' ' A' ' 26' ' ' TYR . . . -65.53 -35.06 79.75 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -66.89 -35.09 79.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.835 . . . . 0.0 109.473 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.485 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -35.29 154.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 122.556 2.171 . . . . 0.0 112.441 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 16' ' ' LEU . 49.6 Cg_endo -67.89 151.87 77.77 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.387 2.058 . . . . 0.0 111.75 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 62.73 -4.39 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.517 -0.739 . . . . 0.0 110.007 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.7 tt -100.15 153.61 19.11 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.172 -0.955 . . . . 0.0 109.221 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -138.03 -169.42 2.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.339 -0.85 . . . . 0.0 110.604 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.15 137.68 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.456 ' NE ' HD21 ' A' ' 21' ' ' ASN . 40.1 ttp180 -89.58 151.55 21.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.153 -0.967 . . . . 0.0 109.205 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.457 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 1.5 p30 -61.9 -9.28 6.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.107 -0.995 . . . . 0.0 109.665 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.456 HD21 ' NE ' ' A' ' 19' ' ' ARG . 74.0 m-80 -91.03 -1.51 57.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.337 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.74 3.03 77.84 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -87.87 140.17 29.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.207 -1.172 . . . . 0.0 109.106 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.494 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 55.0 m-85 -84.78 150.79 24.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 0.0 109.075 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.7 p -150.45 138.92 20.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.213 -0.93 . . . . 0.0 110.057 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -102.35 150.66 23.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.94 112.82 15.1 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.371 -0.831 . . . . 0.0 108.795 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.454 ' CB ' ' NZ ' ' A' ' 33' ' ' LYS . 11.2 t70 -73.29 129.73 85.49 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.891 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.02 17.99 0.95 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.049 1.833 . . . . 0.0 113.093 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -88.79 -65.47 1.01 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.732 -1.23 . . . . 0.0 109.294 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.04 -20.07 13.43 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.196 -0.94 . . . . 0.0 108.794 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.11 13.8 32.68 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.502 ' HD3' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -73.77 177.67 5.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.65 -1.5 . . . . 0.0 109.532 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -131.64 167.52 19.29 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.388 -0.82 . . . . 0.0 110.288 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -139.43 117.73 11.99 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.505 -0.747 . . . . 0.0 109.051 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.54 124.27 8.02 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.77 -71.48 0.72 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.312 -1.111 . . . . 0.0 109.653 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.67 -173.84 39.8 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -95.0 10.5 35.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.037 -1.272 . . . . 0.0 109.707 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.96 103.3 15.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.194 -0.941 . . . . 0.0 110.717 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.494 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 79.5 mtt180 -54.3 -19.81 6.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.362 -0.836 . . . . 0.0 108.822 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -74.04 -55.07 6.57 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.401 -0.812 . . . . 0.0 109.462 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.4 mt -80.65 -32.43 13.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.529 -0.732 . . . . 0.0 109.801 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.43 -58.46 5.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.827 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 97.9 mt -55.71 -37.21 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.302 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -53.81 -57.4 11.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.092 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -54.07 -43.85 70.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.615 -0.678 . . . . 0.0 109.6 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.31 -43.63 79.15 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.753 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.24 -41.09 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.204 -0.935 . . . . 0.0 110.646 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.65 -39.0 82.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.811 -1.181 . . . . 0.0 108.643 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.74 -35.48 80.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.573 -0.705 . . . . 0.0 109.364 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -68.38 -40.52 81.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.513 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--N 1.302 -1.46 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.686 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 13' ' ' PRO . 73.8 mt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 12' ' ' LEU . 95.4 Cg_exo -36.14 158.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 122.508 2.138 . . . . 0.0 111.779 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' A' ' 16' ' ' LEU . 56.1 Cg_endo -69.12 166.83 25.46 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.115 1.877 . . . . 0.0 111.843 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 52.27 10.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.886 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.464 ' H ' ' C ' ' A' ' 14' ' ' PRO . 34.6 tp -124.13 140.04 53.35 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -133.19 -164.81 1.53 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 122.12 0.962 . . . . 0.0 110.766 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.47 139.27 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -91.0 151.47 21.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.012 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -13.12 6.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 109.324 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -91.13 0.3 57.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.368 -0.832 . . . . 0.0 109.262 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.63 4.89 79.22 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -88.62 138.46 31.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -1.119 . . . . 0.0 109.476 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -81.24 153.81 26.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 108.752 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -149.97 124.59 9.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.056 -1.028 . . . . 0.0 110.223 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 44.1 t80 -98.23 151.03 20.89 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.437 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 59.3 mtt180 -115.88 122.54 45.66 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.995 0.902 . . . . 0.0 110.322 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.77 129.85 77.9 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.5 -6.99 16.68 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.966 1.777 . . . . 0.0 113.537 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -89.03 -29.04 19.76 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.639 -1.288 . . . . 0.0 109.12 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.7 t -118.66 -15.49 9.5 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.9 -1.8 7.54 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -74.16 179.54 4.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.015 -1.285 . . . . 0.0 109.12 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -108.44 170.67 7.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.507 -0.746 . . . . 0.0 109.806 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -140.37 118.34 11.84 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.73 123.98 14.26 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.0 mt -106.46 -55.91 2.26 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.426 -1.044 . . . . 0.0 109.527 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.24 -175.14 25.86 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -94.3 11.03 31.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.005 -1.291 . . . . 0.0 108.672 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.78 98.65 11.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.473 -0.767 . . . . 0.0 109.711 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -61.68 -13.51 23.29 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.231 -0.918 . . . . 0.0 108.985 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -72.5 -53.27 12.55 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.338 -0.851 . . . . 0.0 109.354 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 87.8 mt -79.07 -36.81 18.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.509 -0.744 . . . . 0.0 109.631 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.46 -55.97 22.61 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.231 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.2 mt -56.45 -43.54 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.782 -1.199 . . . . 0.0 108.989 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.0 m -57.61 -51.34 69.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.982 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -32.97 74.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -0.854 . . . . 0.0 109.584 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.94 -47.91 70.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.182 -0.949 . . . . 0.0 110.399 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.4 mt -57.81 -49.68 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.275 -0.891 . . . . 0.0 111.127 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -58.74 -31.25 68.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.875 -1.14 . . . . 0.0 108.862 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.56 83.27 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -68.1 -38.79 82.68 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.416 -0.802 . . . . 0.0 109.368 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.84 . . . . 0.0 108.988 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.2 mt . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.33 162.04 28.54 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.239 1.959 . . . . 0.0 111.602 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 16' ' ' LEU . 38.4 Cg_endo -65.15 169.62 11.85 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.684 2.256 . . . . 0.0 112.259 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 55.64 8.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.799 . . . . 0.0 110.07 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.0 tt -129.29 137.65 51.16 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.343 -0.848 . . . . 0.0 108.782 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -127.38 -166.59 1.62 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.678 0.751 . . . . 0.0 110.193 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -134.48 132.96 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -86.75 150.61 24.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.207 -0.933 . . . . 0.0 109.199 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.682 HD21 ' N ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -59.23 -10.6 3.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 110.014 -179.237 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.682 ' N ' HD21 ' A' ' 20' ' ' ASN . 93.8 m-20 -91.51 0.54 57.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.109 -0.994 . . . . 0.0 109.167 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.84 4.29 84.99 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -86.2 138.81 31.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -1.165 . . . . 0.0 108.725 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -83.43 150.14 26.23 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.6 p -148.85 137.14 21.01 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.847 -1.158 . . . . 0.0 110.526 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -102.09 152.49 20.93 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -127.22 116.34 20.45 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.424 -0.798 . . . . 0.0 108.88 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.81 139.61 73.82 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.03 -1.044 . . . . 0.0 109.549 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -83.34 25.31 0.69 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.121 1.88 . . . . 0.0 112.63 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -88.63 -68.13 0.79 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.919 -1.113 . . . . 0.0 108.709 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.466 ' HG1' ' N ' ' A' ' 32' ' ' GLY . 1.5 p -116.19 -25.28 7.65 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.466 ' N ' ' HG1' ' A' ' 31' ' ' THR . . . 115.88 23.0 4.44 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.469 ' H ' ' HD2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -75.45 177.96 6.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.031 -1.276 . . . . 0.0 109.103 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.44 165.3 23.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.395 -0.815 . . . . 0.0 109.621 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -135.74 115.07 12.52 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.95 119.53 6.42 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.15 -68.87 0.78 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.269 -1.136 . . . . 0.0 109.142 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.78 -165.97 38.78 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.814 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -100.7 6.27 43.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.468 -1.019 . . . . 0.0 109.312 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -94.99 98.63 10.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.343 -0.848 . . . . 0.0 110.271 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -54.9 -14.9 1.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.529 0.68 . . . . 0.0 109.291 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.527 HH11 ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -77.33 -54.77 6.06 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.355 -0.84 . . . . 0.0 109.509 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.7 mt -76.99 -32.89 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.342 -0.849 . . . . 0.0 109.658 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.71 -55.68 24.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.078 -1.014 . . . . 0.0 109.38 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mt -55.72 -39.44 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.059 -1.026 . . . . 0.0 109.254 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -51.15 -54.4 25.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.096 -1.003 . . . . 0.0 109.172 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -63.95 -41.63 97.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 0.0 109.605 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.9 -42.68 76.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.618 -0.676 . . . . 0.0 110.191 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.04 -58.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.079 -1.013 . . . . 0.0 110.911 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -58.82 -24.28 61.75 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.984 -1.073 . . . . 0.0 109.098 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.07 -35.34 80.26 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.166 -0.959 . . . . 0.0 108.445 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -67.18 -38.66 85.77 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.395 -0.816 . . . . 0.0 109.372 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.155 -0.965 . . . . 0.0 108.935 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' PRO . 72.4 mt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 12' ' ' LEU . 75.8 Cg_exo -34.94 157.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 122.555 2.17 . . . . 0.0 111.844 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.22 148.33 84.74 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.104 1.869 . . . . 0.0 111.582 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 61.88 32.63 17.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 109.929 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.0 tp -140.23 130.09 24.6 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.354 -0.841 . . . . 0.0 108.818 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -129.63 -172.32 2.73 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.717 0.77 . . . . 0.0 110.059 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.9 tt -142.94 152.04 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.398 0.618 . . . . 0.0 109.617 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 19' ' ' ARG . 19.3 ttm-85 -90.84 160.3 15.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.542 -0.724 . . . . 0.0 109.527 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -64.28 -14.75 57.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 108.994 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -90.12 -0.47 57.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.329 -0.857 . . . . 0.0 108.997 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.57 11.94 65.41 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -87.06 129.72 34.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.096 -1.237 . . . . 0.0 108.476 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.687 ' HH ' ' HE ' ' A' ' 41' ' ' ARG . 54.2 m-85 -83.11 147.91 27.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.456 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 18.7 p -150.49 131.46 14.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.099 -1.001 . . . . 0.0 109.861 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -97.21 149.35 22.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.294 -0.878 . . . . 0.0 109.286 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' A' ' 34' ' ' GLU . 25.8 ttm180 -115.93 116.58 28.21 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.341 -0.85 . . . . 0.0 110.224 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -74.27 138.28 75.17 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.455 -0.778 . . . . 0.0 108.988 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.92 -2.51 12.17 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.136 1.891 . . . . 0.0 112.516 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -88.18 -55.12 3.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.084 -1.01 . . . . 0.0 109.704 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -102.82 -1.06 30.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.41 -0.806 . . . . 0.0 109.124 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.3 4.96 2.97 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.496 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.96 179.4 3.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.157 -1.202 . . . . 0.0 109.124 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 20.8 mp0 -114.94 168.39 9.95 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.47 -0.769 . . . . 0.0 109.926 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -138.96 114.39 9.71 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.69 125.14 9.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.6 mt -105.17 -50.17 3.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.384 -1.068 . . . . 0.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.91 -155.37 26.22 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.718 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -110.53 7.08 22.43 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.435 -1.038 . . . . 0.0 109.411 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -93.09 101.86 14.17 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.345 -0.847 . . . . 0.0 110.252 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.687 ' HE ' ' HH ' ' A' ' 24' ' ' TYR . 38.1 ttm180 -58.6 -20.08 44.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.685 -0.634 . . . . 0.0 109.477 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -75.38 -52.19 11.34 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.12 -33.33 24.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.517 -0.739 . . . . 0.0 109.621 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.32 -58.82 5.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.187 -0.945 . . . . 0.0 109.517 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 50.5 mt -53.94 -36.73 31.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.075 -1.015 . . . . 0.0 109.13 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.54 -50.95 66.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 109.345 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -61.28 -40.36 93.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.482 -0.761 . . . . 0.0 109.601 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.99 -43.95 74.03 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.413 -0.804 . . . . 0.0 109.117 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.16 -46.07 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.09 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -59.1 -38.65 80.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.929 -1.107 . . . . 0.0 108.584 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.71 92.26 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -69.06 -39.08 79.33 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.45 -0.781 . . . . 0.0 109.385 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.7 mt . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.897 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 13' ' ' PRO . 39.4 mt . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 12' ' ' LEU . 98.7 Cg_exo -35.92 158.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.656 2.237 . . . . 0.0 111.737 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 16' ' ' LEU . 65.8 Cg_endo -72.63 158.87 49.99 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.352 2.035 . . . . 0.0 112.214 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 59.71 1.25 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.794 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 14' ' ' PRO . 41.5 tp -108.34 136.91 47.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -132.56 -178.49 4.95 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.961 0.886 . . . . 0.0 110.511 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.5 tt -143.09 143.59 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 -89.58 169.16 11.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.409 -0.807 . . . . 0.0 109.852 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.511 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -66.86 -12.48 59.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.573 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -88.25 -1.56 58.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.092 -1.005 . . . . 0.0 108.989 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.31 10.04 78.36 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -88.22 130.72 35.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.06 -1.259 . . . . 0.0 108.732 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.21 148.31 26.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.885 . . . . 0.0 109.789 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.432 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 20.5 p -151.32 130.02 12.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.208 -0.933 . . . . 0.0 109.547 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 48.1 t80 -95.09 162.02 13.89 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.264 -0.897 . . . . 0.0 109.218 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.531 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 28.9 ttm180 -125.78 117.69 23.94 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.518 -0.739 . . . . 0.0 109.437 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -73.22 148.73 88.88 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.381 -0.824 . . . . 0.0 109.673 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -84.6 -16.52 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.405 2.07 . . . . 0.0 112.14 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -92.18 -40.66 10.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.334 -0.854 . . . . 0.0 110.092 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.587 ' C ' ' H ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -100.49 -13.35 18.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.158 -0.964 . . . . 0.0 109.349 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.48 -7.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -75.25 -166.09 0.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.885 -1.362 . . . . 0.0 108.734 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 27' ' ' ARG . 68.1 mt-10 -129.64 169.98 14.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.438 -0.789 . . . . 0.0 110.507 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -136.55 122.03 19.51 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.13 122.73 8.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 mt -104.85 -55.52 2.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.384 -1.068 . . . . 0.0 109.632 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.1 179.45 25.91 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' A' ' 39' ' ' ARG . 2.2 mtm-85 -88.04 4.87 43.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.447 -1.031 . . . . 0.0 109.494 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 42' ' ' ARG . 7.4 m-20 -94.38 99.19 11.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 109.545 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.508 ' NH1' ' NE ' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -62.17 -8.56 5.78 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.508 ' NE ' ' NH1' ' A' ' 41' ' ' ARG . 19.6 mmt180 -72.88 -56.98 4.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 95.4 mt -77.32 -34.0 20.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.326 0.584 . . . . 0.0 109.572 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -56.81 12.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.657 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.9 mt -56.1 -37.16 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.39 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.17 -52.64 62.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.01 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -63.11 -45.8 90.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.548 -0.72 . . . . 0.0 109.742 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.18 65.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.601 -0.687 . . . . 0.0 109.806 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.3 mt -61.78 -42.34 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.068 -1.02 . . . . 0.0 110.024 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.05 -35.08 74.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.906 -1.121 . . . . 0.0 109.012 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.77 -34.43 77.89 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -69.31 -35.65 76.19 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.463 -0.773 . . . . 0.0 109.62 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.7 mt . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.35 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 49.0 mt . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.28 161.54 23.01 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.819 1.679 . . . . 0.0 111.273 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 16' ' ' LEU . 49.6 Cg_endo -67.35 155.12 71.77 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.626 2.218 . . . . 0.0 112.252 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.517 ' ND2' ' OD1' ' A' ' 52' ' ' ASN . 2.7 m-20 73.34 -15.83 0.52 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.652 -0.655 . . . . 0.0 110.193 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 14' ' ' PRO . 11.6 tp -102.21 139.52 37.71 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.098 -1.001 . . . . 0.0 109.009 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -123.68 -170.27 2.1 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.714 0.769 . . . . 0.0 109.948 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.97 133.99 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.4 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 13.1 mtm180 -91.11 152.41 20.62 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.0 -1.062 . . . . 0.0 109.906 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -58.21 -11.2 2.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 108.926 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -89.76 0.82 56.76 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.66 4.67 90.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.4 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 5.3 m-85 -86.68 131.13 34.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.259 -1.142 . . . . 0.0 108.715 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.525 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 78.4 m-85 -82.53 154.13 25.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 108.959 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -150.72 135.63 17.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.022 -1.048 . . . . 0.0 110.088 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 37.6 t80 -106.98 146.99 30.43 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.622 -0.674 . . . . 0.0 109.571 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.42 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 4.8 mtt180 -110.14 125.18 52.75 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.637 -0.664 . . . . 0.0 109.879 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 30' ' ' ARG . 44.2 t0 -79.0 112.3 26.61 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.929 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.41 0.82 0.31 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 121.399 1.399 . . . . 0.0 112.687 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.417 ' H ' ' C ' ' A' ' 28' ' ' ASP . 35.1 ttp180 -88.66 -52.04 5.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.894 -1.129 . . . . 0.0 109.741 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.94 -11.74 15.62 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.48 -0.762 . . . . 0.0 109.391 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.83 0.06 58.7 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -179.9 3.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.057 -1.261 . . . . 0.0 108.728 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -111.34 168.22 9.69 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.504 -0.748 . . . . 0.0 109.701 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -138.56 114.27 9.85 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.02 127.54 18.52 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.5 mt -107.8 -49.73 3.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.588 -0.948 . . . . 0.0 109.249 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.9 -174.28 23.22 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -91.01 11.38 23.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -1.228 . . . . 0.0 108.879 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -91.21 95.91 10.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.432 -0.792 . . . . 0.0 110.327 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 38.8 ttm180 -57.01 -19.04 16.19 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -77.0 -51.99 10.14 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.523 -0.736 . . . . 0.0 109.34 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -77.13 -31.62 18.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.64 -0.663 . . . . 0.0 109.682 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.52 -58.74 4.59 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.098 -1.001 . . . . 0.0 109.49 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.1 mt -54.22 -35.12 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.095 -1.003 . . . . 0.0 109.003 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.08 -50.77 66.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 0.0 108.968 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -61.07 -41.07 95.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.2 87.3 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.441 0.639 . . . . 0.0 109.751 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.81 -62.46 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.39 -0.819 . . . . 0.0 110.78 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -56.93 -30.01 63.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 108.683 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.61 -41.59 83.78 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.517 ' OD1' ' ND2' ' A' ' 15' ' ' ASN . 84.0 m-20 -68.97 -39.96 79.11 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.423 -0.798 . . . . 0.0 109.775 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--N 1.303 -1.429 0 O-C-N 121.207 -0.933 . . . . 0.0 108.494 -179.884 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.99 164.15 5.17 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.592 1.528 . . . . 0.0 110.986 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.93 160.95 46.22 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.526 2.151 . . . . 0.0 112.286 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 59.96 19.61 8.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 110.088 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.9 tp -133.83 118.04 17.53 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -114.71 178.44 4.28 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.383 0.611 . . . . 0.0 109.824 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 tt -141.48 148.06 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.59 -0.694 . . . . 0.0 109.552 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' A' ' 21' ' ' ASN . 22.9 ttp180 -91.01 153.35 20.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.595 -0.69 . . . . 0.0 109.58 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -56.73 -11.52 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.173 -0.954 . . . . 0.0 108.989 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 19' ' ' ARG . 6.9 m120 -88.56 -0.79 57.61 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.355 -0.841 . . . . 0.0 109.042 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.27 9.09 80.39 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -86.67 128.05 34.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -1.143 . . . . 0.0 108.45 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -84.22 149.49 26.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.475 -0.766 . . . . 0.0 109.851 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.0 p -150.11 131.73 14.89 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.116 -0.99 . . . . 0.0 109.632 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -94.36 140.8 29.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.08 -1.012 . . . . 0.0 110.004 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -101.94 110.72 22.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.593 -0.692 . . . . 0.0 110.218 -179.332 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.99 135.96 66.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.443 -0.786 . . . . 0.0 109.951 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -81.72 15.26 1.97 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.008 1.805 . . . . 0.0 111.621 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -86.65 -69.79 0.65 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.345 -0.847 . . . . 0.0 109.213 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.4 -18.64 14.05 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.33 6.66 58.64 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.458 ' CD ' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -76.61 -174.43 2.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.85 -1.382 . . . . 0.0 109.338 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.476 ' N ' ' CD ' ' A' ' 34' ' ' GLU . 4.5 mp0 -130.77 157.11 43.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.309 -0.869 . . . . 0.0 110.229 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -116.35 127.96 55.12 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.57 116.35 4.36 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mt -99.08 -63.8 1.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.192 -1.181 . . . . 0.0 109.238 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.29 -173.01 38.53 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -92.99 8.7 38.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 108.98 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -94.23 104.24 16.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.386 -0.821 . . . . 0.0 109.82 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -60.22 -20.76 60.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.663 -0.648 . . . . 0.0 109.721 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -77.05 -55.81 5.13 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.211 -0.931 . . . . 0.0 109.074 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.3 mt -65.81 -36.56 77.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.538 -0.727 . . . . 0.0 109.198 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.13 -56.87 9.26 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.341 -0.85 . . . . 0.0 109.274 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.441 HG23 HD12 ' A' ' 45' ' ' ILE . 38.4 mt -53.58 -37.4 30.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.171 -0.956 . . . . 0.0 108.67 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.42 -55.12 31.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.07 -1.019 . . . . 0.0 109.147 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -63.3 -43.96 96.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.347 -0.846 . . . . 0.0 109.658 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.68 75.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.526 -0.734 . . . . 0.0 109.645 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.9 mt -59.64 -40.25 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.059 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -62.11 -43.78 98.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.951 -1.093 . . . . 0.0 108.478 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.89 -33.83 76.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -64.23 -36.07 82.88 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.296 -0.877 . . . . 0.0 109.333 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.405 HD13 HG22 ' A' ' 53' ' ' ILE . 96.5 mt . . . . . 0 C--N 1.302 -1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 108.684 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.1 mt . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.61 159.29 28.69 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.675 1.584 . . . . 0.0 111.171 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 15' ' ' ASN . 59.3 Cg_endo -69.69 154.54 67.91 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.376 2.051 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.505 ' ND2' ' OD1' ' A' ' 52' ' ' ASN . 3.6 m-20 74.19 -10.49 1.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.641 -0.662 . . . . 0.0 109.326 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.1 tt -105.27 148.46 26.97 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.369 -0.832 . . . . 0.0 110.121 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -137.31 -168.85 2.38 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.452 0.644 . . . . 0.0 109.408 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.2 tt -146.53 150.95 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.268 -0.895 . . . . 0.0 109.479 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -92.71 150.39 20.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.183 -0.948 . . . . 0.0 109.363 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -59.81 -10.91 4.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.29 -0.881 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -90.5 -0.16 57.56 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.48 10.45 70.58 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -87.14 136.17 33.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.055 -1.262 . . . . 0.0 108.495 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -84.22 152.97 23.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -154.86 145.81 22.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 110.305 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -108.99 155.45 20.87 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -131.72 120.24 22.46 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.231 -0.918 . . . . 0.0 109.868 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.08 134.41 71.18 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.796 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.24 24.37 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.0 1.8 . . . . 0.0 113.055 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -88.96 -67.25 0.85 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.806 -1.184 . . . . 0.0 108.612 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.447 ' CG2' ' NZ ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -112.78 -16.25 12.79 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.77 29.58 6.14 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.461 ' H ' ' HD2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -77.81 178.9 7.03 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.273 -1.133 . . . . 0.0 109.506 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -131.38 163.93 26.81 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.316 -0.865 . . . . 0.0 110.614 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -139.36 113.22 8.6 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.52 128.07 14.92 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.8 mt -105.89 -57.75 2.0 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.379 -1.071 . . . . 0.0 109.409 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.32 -157.82 28.93 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.79 1.88 23.2 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.503 -0.998 . . . . 0.0 110.189 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.33 107.37 19.86 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.049 -1.032 . . . . 0.0 110.135 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -61.0 -15.46 32.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.126 -0.984 . . . . 0.0 109.345 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -74.31 -55.0 6.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.262 -0.899 . . . . 0.0 108.862 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.3 mt -73.31 -35.82 47.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.357 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.82 -57.09 10.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.019 -1.05 . . . . 0.0 109.244 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -51.36 -40.48 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.278 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.29 -57.31 10.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.104 -0.997 . . . . 0.0 109.668 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.94 -36.01 74.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.389 -0.819 . . . . 0.0 109.473 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.47 -44.61 76.6 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.559 -0.856 . . . . 0.0 108.808 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.85 -45.06 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.232 -0.917 . . . . 0.0 110.312 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -61.84 -40.36 95.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.145 -0.972 . . . . 0.0 108.84 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.93 88.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.505 ' OD1' ' ND2' ' A' ' 15' ' ' ASN . 85.2 m-20 -70.0 -43.58 71.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.4 -0.813 . . . . 0.0 109.996 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.8 mt . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.897 . . . . 0.0 109.351 -179.223 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 70.2 mt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.46 157.44 41.21 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.611 1.541 . . . . 0.0 111.288 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.558 ' C ' ' H ' ' A' ' 16' ' ' LEU . 45.3 Cg_endo -67.18 165.17 27.53 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.455 2.104 . . . . 0.0 111.913 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 62.58 -10.78 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.796 . . . . 0.0 110.531 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.558 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.1 tt -104.26 154.22 20.05 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.159 -0.963 . . . . 0.0 109.815 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -138.3 -178.34 5.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.548 -0.72 . . . . 0.0 110.186 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.86 137.17 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.455 ' C ' ' H ' ' A' ' 21' ' ' ASN . 9.3 mtp180 -90.59 141.33 28.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.204 -0.935 . . . . 0.0 109.422 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -50.83 -13.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.359 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.611 HD21 ' N ' ' A' ' 21' ' ' ASN . 1.0 OUTLIER -89.78 0.03 57.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.482 -0.761 . . . . 0.0 109.014 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.43 10.27 82.24 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -88.58 130.78 35.18 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.315 -1.109 . . . . 0.0 108.486 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -85.48 144.18 28.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.485 -0.759 . . . . 0.0 109.308 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 m -149.33 140.2 22.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.187 -0.945 . . . . 0.0 109.753 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -101.84 143.96 31.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.348 -0.845 . . . . 0.0 109.57 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -112.12 116.63 30.81 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.408 -0.807 . . . . 0.0 109.782 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -74.34 126.69 88.71 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 108.994 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.07 -9.1 16.66 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.986 1.791 . . . . 0.0 112.103 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -89.72 -32.49 16.99 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -110.99 -27.16 8.9 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 82.44 -10.61 54.55 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.485 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 3.0 mptp? -73.38 -174.05 1.54 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.939 -1.33 . . . . 0.0 109.885 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -120.96 169.32 10.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.578 -0.701 . . . . 0.0 110.303 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -137.37 115.61 11.76 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.55 120.69 8.39 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.7 mt -103.74 -62.87 1.25 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.504 -0.998 . . . . 0.0 108.877 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.21 -171.74 34.01 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 -93.61 8.41 40.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -1.146 . . . . 0.0 109.112 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -91.96 97.1 10.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 109.58 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -56.27 -23.13 34.35 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.455 0.645 . . . . 0.0 109.528 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -74.85 -47.55 29.72 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.341 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.19 -33.64 18.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.39 -0.819 . . . . 0.0 109.591 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.79 -58.62 5.23 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 109.326 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -54.6 -36.68 36.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.214 -0.929 . . . . 0.0 109.0 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.85 -56.89 13.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.091 -1.006 . . . . 0.0 109.12 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -60.19 -40.85 91.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.613 -0.679 . . . . 0.0 109.497 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.53 -44.51 62.64 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.0 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.435 HD13 HG23 ' A' ' 49' ' ' ILE . 91.3 mt -61.7 -45.15 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.337 -0.852 . . . . 0.0 109.619 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -64.02 -33.76 76.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.065 -1.022 . . . . 0.0 108.361 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.99 -33.36 75.4 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.35 -42.38 88.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 109.6 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.177 -0.952 . . . . 0.0 108.728 179.827 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 13' ' ' PRO . 46.3 mt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 12' ' ' LEU . 33.7 Cg_exo -34.31 158.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.709 2.273 . . . . 0.0 112.246 178.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.62 159.22 54.51 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.113 1.876 . . . . 0.0 112.067 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 53.55 19.95 1.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.458 -0.776 . . . . 0.0 110.176 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.5 tp -127.21 125.13 40.5 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 43.0 m-85 -121.63 -170.69 2.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.81 0.814 . . . . 0.0 110.487 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.77 141.61 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -91.95 144.54 25.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.061 -1.025 . . . . 0.0 109.281 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -54.15 -19.02 4.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 109.857 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -86.81 0.68 54.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.18 3.21 79.37 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.463 ' CE1' ' NE ' ' A' ' 39' ' ' ARG . 12.5 m-85 -85.15 140.08 31.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.072 -1.252 . . . . 0.0 109.055 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -84.79 146.94 27.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.434 -0.791 . . . . 0.0 108.966 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 25' ' ' CYS . 20.2 p -146.46 129.77 16.69 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.873 -1.142 . . . . 0.0 110.32 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 27' ' ' ARG . 43.2 t80 -99.37 148.73 23.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.451 -0.781 . . . . 0.0 109.007 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.406 ' O ' ' CE1' ' A' ' 26' ' ' TYR . 23.2 ttm180 -104.43 117.57 34.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.489 -0.757 . . . . 0.0 109.533 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.52 150.67 95.6 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.294 -0.878 . . . . 0.0 109.623 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -85.52 -8.14 8.53 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.623 2.216 . . . . 0.0 112.996 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -90.48 -47.09 7.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.04 -1.037 . . . . 0.0 110.671 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.2 p -109.01 -11.6 14.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 109.818 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.39 2.12 25.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -179.12 3.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -1.204 . . . . 0.0 108.915 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -109.94 168.92 9.06 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.564 -0.71 . . . . 0.0 109.56 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -140.54 119.07 12.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.442 -0.786 . . . . 0.0 109.269 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.79 122.88 12.36 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.2 mt -107.06 -44.3 4.42 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -1.052 . . . . 0.0 109.069 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 147.18 -179.8 23.82 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.463 ' NE ' ' CE1' ' A' ' 23' ' ' TYR . 18.6 mtt180 -92.78 10.71 29.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -1.088 . . . . 0.0 108.403 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -95.96 105.47 17.5 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.453 0.645 . . . . 0.0 110.116 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -60.74 -19.36 58.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -71.4 -58.78 3.2 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.388 -0.82 . . . . 0.0 109.234 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 94.1 mt -68.94 -37.3 77.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.676 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.12 -56.72 11.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.031 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 79.3 mt -54.63 -33.38 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.806 -1.184 . . . . 0.0 109.372 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -58.3 -51.59 69.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.653 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -61.92 -44.91 95.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.278 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.51 -43.33 79.67 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.49 -0.756 . . . . 0.0 110.85 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.9 -52.83 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.017 -1.052 . . . . 0.0 111.624 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -60.12 -29.6 68.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.83 -1.169 . . . . 0.0 109.492 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.51 -33.76 75.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.238 -0.914 . . . . 0.0 109.028 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -69.48 -38.66 77.8 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.306 -0.871 . . . . 0.0 110.897 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.158 -0.963 . . . . 0.0 109.702 -178.914 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.0 mt . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.32 158.42 48.94 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.027 1.818 . . . . 0.0 111.181 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 16' ' ' LEU . 37.4 Cg_endo -64.6 170.89 9.1 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.533 2.155 . . . . 0.0 112.308 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 52.75 9.12 0.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.847 . . . . 0.0 109.824 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 14' ' ' PRO . 9.2 tt -133.84 137.53 45.1 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.373 -0.829 . . . . 0.0 109.427 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 12.8 m-85 -138.2 -157.07 0.74 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.57 0.7 . . . . 0.0 109.647 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.6 tt -145.39 153.2 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.669 0.747 . . . . 0.0 110.335 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' A' ' 21' ' ' ASN . 34.5 ttp180 -94.22 153.55 18.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.631 -0.668 . . . . 0.0 109.708 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.479 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -56.23 -8.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.069 179.638 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 19' ' ' ARG . 19.1 m-20 -90.37 -3.14 57.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.29 -0.881 . . . . 0.0 108.988 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.77 7.09 78.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -88.02 140.06 29.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.438 -1.037 . . . . 0.0 109.291 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -85.77 152.92 22.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 109.372 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.2 p -150.91 138.24 19.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.153 -0.967 . . . . 0.0 109.976 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -100.59 146.73 26.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.304 -0.873 . . . . 0.0 109.342 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -105.06 111.84 24.75 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.467 -0.771 . . . . 0.0 109.654 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.74 125.7 90.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 108.767 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.75 -6.42 15.22 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.803 1.669 . . . . 0.0 112.819 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -89.15 -28.77 19.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.973 -1.08 . . . . 0.0 109.345 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.7 t -116.22 -28.44 6.55 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.33 -13.15 62.64 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 8.6 mptt -77.07 -178.93 5.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.041 -1.27 . . . . 0.0 109.886 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' N ' ' CD ' ' A' ' 34' ' ' GLU . 9.6 mp0 -108.88 174.62 5.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.599 -0.688 . . . . 0.0 110.184 -179.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -138.16 123.93 19.91 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.42 130.89 21.56 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.5 mt -118.45 -55.97 2.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.554 -0.968 . . . . 0.0 109.572 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.46 -171.94 27.15 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.744 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -95.14 10.49 35.7 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.164 -1.198 . . . . 0.0 109.155 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.464 ' C ' ' N ' ' A' ' 42' ' ' ARG . 93.7 m-20 -91.73 90.68 7.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.364 -0.835 . . . . 0.0 109.494 -179.153 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -54.7 -12.54 0.78 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' C ' ' A' ' 40' ' ' ASP . 5.7 mtt180 -73.42 -56.87 4.48 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.627 -0.671 . . . . 0.0 109.587 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.3 mt -75.18 -36.95 38.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.17 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.6 -57.54 9.79 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.55 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 88.5 mt -55.88 -41.09 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.542 -1.349 . . . . 0.0 108.564 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -55.98 -56.71 17.41 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.469 -0.769 . . . . 0.0 109.592 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -27.56 66.4 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.216 -0.928 . . . . 0.0 109.186 -179.322 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.87 -48.13 77.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 108.748 178.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.75 -51.17 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.573 -0.704 . . . . 0.0 110.21 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -58.65 -37.1 75.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.947 -1.096 . . . . 0.0 108.179 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.29 88.41 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.24 -40.93 81.85 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.513 -0.742 . . . . 0.0 109.256 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.0 mt . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 108.54 179.747 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.01 162.68 18.51 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.111 1.874 . . . . 0.0 111.872 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.97 168.3 20.91 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.913 2.409 . . . . 0.0 112.684 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 48.19 22.5 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.529 -0.732 . . . . 0.0 110.302 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.444 ' C ' ' CD1' ' A' ' 17' ' ' TYR . 5.1 tt -136.05 146.08 46.72 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.217 -0.927 . . . . 0.0 109.166 179.099 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 32.0 m-85 -137.34 -172.77 3.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.546 -0.721 . . . . 0.0 110.342 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.9 tt -139.14 150.91 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -91.19 164.23 13.98 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.277 -0.889 . . . . 0.0 109.926 -178.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -66.4 -16.81 64.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.051 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -89.41 0.08 57.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.366 -0.834 . . . . 0.0 108.789 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.13 14.83 63.65 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -87.2 134.65 33.51 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.117 -1.225 . . . . 0.0 108.702 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.499 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 12.9 m-85 -83.73 156.24 22.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.995 . . . . 0.0 109.671 -179.715 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 24' ' ' TYR . 94.6 m -156.14 135.31 12.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.51 -0.744 . . . . 0.0 109.636 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -100.22 141.42 33.08 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.138 -0.976 . . . . 0.0 109.364 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -107.34 113.79 27.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.501 -0.749 . . . . 0.0 109.673 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -71.44 132.91 85.38 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.42 -0.8 . . . . 0.0 109.645 -179.904 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.59 -5.51 12.49 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.198 1.932 . . . . 0.0 112.375 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -88.5 -37.79 15.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.202 -0.936 . . . . 0.0 109.628 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 t -113.11 -29.93 7.15 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.496 -0.753 . . . . 0.0 109.069 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.3 -10.08 74.95 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.168 -0.958 . . . . 0.0 110.929 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.469 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 9.7 mptt -74.73 179.36 4.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.902 -1.352 . . . . 0.0 109.61 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -117.47 171.73 7.8 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.666 0.746 . . . . 0.0 110.661 -178.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.94 122.65 18.69 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.55 122.94 8.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.5 mt -106.59 -70.09 0.8 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.478 -1.013 . . . . 0.0 109.398 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.25 -174.09 44.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -93.9 6.66 47.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -1.137 . . . . 0.0 109.522 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -95.41 98.87 10.88 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 109.489 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.526 HH11 ' CG ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -58.34 -13.14 4.61 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 108.498 179.606 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -74.38 -49.57 22.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 89.4 mt -78.54 -36.87 20.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.39 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.85 -57.51 8.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.232 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -54.38 -37.13 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.12 -0.988 . . . . 0.0 109.287 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -54.54 -58.15 8.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 108.895 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -60.9 -37.33 81.83 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.576 0.703 . . . . 0.0 109.132 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.13 -42.61 81.26 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.59 -0.694 . . . . 0.0 109.17 179.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.62 -45.87 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.203 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -58.89 -32.69 69.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.054 -1.029 . . . . 0.0 108.686 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.52 91.32 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -67.78 -41.43 83.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 0.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 1.4 mp . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -38.31 156.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.264 1.976 . . . . 0.0 111.903 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 16' ' ' LEU . 42.8 Cg_endo -66.26 147.83 83.88 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.212 1.942 . . . . 0.0 112.131 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 65.59 -1.83 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.608 -0.682 . . . . 0.0 110.38 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.9 tt -105.87 139.09 40.97 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.146 -0.972 . . . . 0.0 110.103 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -140.63 -168.44 2.57 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.72 0.772 . . . . 0.0 109.574 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tt -146.25 146.22 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.585 -0.697 . . . . 0.0 109.683 178.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.467 ' C ' ' H ' ' A' ' 21' ' ' ASN . 19.8 mtm180 -91.65 152.8 20.07 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.355 -0.841 . . . . 0.0 109.571 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -53.46 -11.15 0.3 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.236 -0.915 . . . . 0.0 109.163 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.467 ' H ' ' C ' ' A' ' 19' ' ' ARG . 47.6 m-20 -87.75 1.39 53.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 109.254 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.13 6.56 89.12 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -86.53 126.68 34.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.066 -1.255 . . . . 0.0 108.692 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -82.69 148.93 27.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 109.37 -179.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 p -148.62 144.8 27.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.201 -0.937 . . . . 0.0 109.822 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 36.6 t80 -105.98 148.23 27.93 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.46 ' NE ' ' O ' ' A' ' 32' ' ' GLY . 15.0 ttm180 -110.01 121.11 44.5 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.463 -0.773 . . . . 0.0 110.675 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -75.72 136.87 70.38 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.333 -0.854 . . . . 0.0 108.857 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.59 6.02 5.15 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.035 1.823 . . . . 0.0 112.252 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -89.8 -56.6 3.17 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 110.131 -179.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.17 1.5 13.87 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.38 -0.825 . . . . 0.0 109.474 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.46 ' O ' ' NE ' ' A' ' 27' ' ' ARG . . . 67.78 13.97 64.55 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -174.4 1.16 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.077 -1.249 . . . . 0.0 109.064 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -130.88 153.07 49.52 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 0.0 109.525 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -115.76 128.09 55.59 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.5 114.74 3.9 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.5 mt -100.56 -63.04 1.17 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.268 -1.137 . . . . 0.0 109.951 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.68 -177.15 36.3 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.451 ' H ' ' NH1' ' A' ' 39' ' ' ARG . 2.7 mtm-85 -89.1 7.37 35.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.071 -1.252 . . . . 0.0 109.997 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -95.61 107.97 20.2 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.147 -0.971 . . . . 0.0 109.361 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -65.61 -20.04 66.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 110.081 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -73.08 -48.63 34.17 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.109 -0.995 . . . . 0.0 109.598 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 93.8 mt -76.96 -37.49 26.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.266 -179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.38 -57.41 8.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 109.804 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 45' ' ' ILE . 94.1 mt -53.25 -35.59 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 0.0 109.421 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -51.65 66.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -60.76 -35.64 76.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.859 . . . . 0.0 109.304 -179.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.02 74.2 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.584 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.13 -47.11 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.833 . . . . 0.0 110.398 -179.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -62.29 -41.05 98.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.986 -1.071 . . . . 0.0 108.155 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.68 81.84 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -64.43 -34.1 77.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.098 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 108.73 179.584 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.3 mt . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.64 161.93 16.63 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.947 1.765 . . . . 0.0 111.369 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 16' ' ' LEU . 36.3 Cg_endo -64.19 153.97 73.44 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.733 2.289 . . . . 0.0 112.595 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 67.07 -8.02 0.46 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.73 -0.606 . . . . 0.0 110.826 179.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.44 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.2 tt -107.18 143.34 35.51 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.103 -0.998 . . . . 0.0 110.018 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 28.2 m-85 -137.78 -163.59 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.53 -0.731 . . . . 0.0 109.659 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.5 tt -143.08 150.84 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 121.43 0.634 . . . . 0.0 109.775 178.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -91.72 165.46 13.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.43 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -66.39 -13.01 60.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.958 . . . . 0.0 109.334 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -89.18 -0.28 57.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 109.121 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.99 11.46 73.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -87.04 132.22 33.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -1.153 . . . . 0.0 108.609 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.533 ' OH ' ' NH1' ' A' ' 41' ' ' ARG . 44.9 m-85 -83.14 145.9 28.96 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.9 m -148.5 145.2 27.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.919 -1.113 . . . . 0.0 110.804 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -99.3 153.67 18.78 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.53 HH21 ' CD ' ' A' ' 34' ' ' GLU . 20.2 ttm180 -116.51 116.68 28.09 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.278 -0.889 . . . . 0.0 110.366 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -76.34 136.6 68.41 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.56 -11.48 14.21 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.951 1.768 . . . . 0.0 113.302 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -36.37 16.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.752 -1.217 . . . . 0.0 109.284 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 33' ' ' LYS . 79.7 p -107.04 -14.78 14.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.81 -2.64 1.83 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -74.1 -169.35 0.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -1.162 . . . . 0.0 108.714 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.53 ' CD ' HH21 ' A' ' 27' ' ' ARG . 11.7 mt-10 -128.16 170.0 13.47 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.448 -0.782 . . . . 0.0 110.032 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -134.32 124.94 26.65 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.9 122.03 6.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.1 mt -105.48 -49.4 3.44 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.46 -1.023 . . . . 0.0 109.196 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.47 -170.43 31.67 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 2.28 47.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.319 -1.107 . . . . 0.0 109.245 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -97.01 98.48 10.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.294 -0.879 . . . . 0.0 110.039 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.533 ' NH1' ' OH ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -57.55 -16.14 9.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 108.958 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -69.61 -49.02 57.91 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.449 ' N ' ' CD1' ' A' ' 43' ' ' ILE . 1.8 mp -81.44 -33.05 12.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.5 -59.0 4.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.366 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.6 mt -54.14 -37.83 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.302 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -53.22 54.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.207 -0.933 . . . . 0.0 108.973 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -63.51 -44.29 94.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.481 -0.762 . . . . 0.0 109.51 -179.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.78 -41.86 71.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.579 -0.7 . . . . 0.0 109.674 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.0 mt -60.76 -43.62 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -0.897 . . . . 0.0 110.365 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -59.96 -36.45 77.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.18 . . . . 0.0 108.176 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.33 75.51 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.29 -45.48 76.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.462 -0.774 . . . . 0.0 110.213 -179.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 108.596 -179.751 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.8 mt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.38 161.96 22.02 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.743 1.629 . . . . 0.0 111.464 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.11 171.92 9.44 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.59 2.194 . . . . 0.0 111.707 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 51.01 15.65 0.28 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -0.891 . . . . 0.0 109.988 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tt -138.09 133.93 34.05 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.165 -0.959 . . . . 0.0 110.026 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 22.7 m-85 -132.73 -163.11 1.3 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.707 -0.621 . . . . 0.0 109.418 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.1 tt -141.15 151.03 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 121.629 0.728 . . . . 0.0 110.133 179.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.478 HH21 ' CB ' ' A' ' 23' ' ' TYR . 11.7 ttp180 -92.64 148.15 22.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.516 -0.74 . . . . 0.0 109.143 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -52.91 -10.83 0.19 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.0 . . . . 0.0 109.448 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 19' ' ' ARG . 85.4 m-20 -90.09 -2.88 58.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 108.846 179.561 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.13 8.7 74.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.478 ' CB ' HH21 ' A' ' 19' ' ' ARG . 4.6 m-85 -85.77 132.55 34.1 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -82.57 147.91 28.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.16 -0.963 . . . . 0.0 108.528 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 m -148.04 144.59 28.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.993 -1.067 . . . . 0.0 109.949 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -101.08 148.09 25.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.538 -0.727 . . . . 0.0 109.788 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -105.52 108.84 20.57 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.364 -0.835 . . . . 0.0 110.025 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -72.28 119.57 75.51 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 108.669 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.75 0.55 9.71 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.626 1.551 . . . . 0.0 112.152 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -90.28 -28.87 18.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.101 -0.999 . . . . 0.0 109.352 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.7 t -120.4 -27.64 5.16 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.58 -11.84 70.61 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.5 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 10.9 mptt -77.8 179.81 6.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.02 -1.282 . . . . 0.0 110.182 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.07 176.4 5.04 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.633 -0.667 . . . . 0.0 110.336 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -139.95 114.14 9.04 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.18 121.95 9.44 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.6 mt -105.36 -57.22 2.06 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.459 -1.024 . . . . 0.0 109.633 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.04 -158.6 30.95 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.473 HH11 ' CB ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -107.35 2.53 24.51 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.528 -0.983 . . . . 0.0 109.929 -179.789 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -93.91 98.26 10.93 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.098 -1.001 . . . . 0.0 110.043 -179.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -51.18 -21.1 1.82 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.274 -0.891 . . . . 0.0 108.604 179.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -71.9 -57.29 4.45 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.2 mm -67.55 -36.42 76.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.384 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.43 -58.34 4.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.603 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.35 -35.15 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 108.964 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -53.44 -54.18 40.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.155 -0.966 . . . . 0.0 108.518 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -62.08 -41.26 97.99 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.623 0.725 . . . . 0.0 109.328 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.23 -45.94 68.91 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.585 -0.697 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.26 -46.77 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.896 . . . . 0.0 110.209 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -62.12 -36.56 82.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.93 -1.106 . . . . 0.0 108.62 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.16 -35.53 81.09 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -69.83 -40.87 75.6 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.638 -0.664 . . . . 0.0 109.629 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.266 -0.896 . . . . 0.0 109.035 -179.939 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.45 149.31 71.78 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.61 158.65 31.38 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.651 1.567 . . . . 0.0 111.312 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 16' ' ' LEU . 58.2 Cg_endo -69.63 156.67 63.06 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.603 2.202 . . . . 0.0 112.713 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 70.84 -17.35 0.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.761 -0.587 . . . . 0.0 110.195 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 14' ' ' PRO . 3.9 tt -99.95 142.7 31.08 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.204 -0.935 . . . . 0.0 109.815 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -134.34 -177.79 4.75 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.476 0.655 . . . . 0.0 109.775 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 tt -140.0 148.88 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-O 121.376 0.607 . . . . 0.0 109.792 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -91.11 156.84 17.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.359 -0.838 . . . . 0.0 109.702 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -57.38 -14.39 4.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.463 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -88.67 -2.12 58.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 108.676 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.99 12.62 67.97 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -86.51 130.52 34.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.045 -1.268 . . . . 0.0 108.429 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -84.2 148.92 26.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 109.71 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.3 p -152.72 138.66 18.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.162 -0.961 . . . . 0.0 109.903 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -100.92 150.58 22.71 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.346 -0.846 . . . . 0.0 108.956 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -111.32 113.0 25.16 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.185 -0.947 . . . . 0.0 110.293 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.07 139.71 76.41 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 108.939 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -82.75 -10.77 10.51 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.042 1.828 . . . . 0.0 113.107 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -89.08 -38.82 14.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.784 -1.198 . . . . 0.0 109.769 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 33' ' ' LYS . 2.5 t -106.51 -11.08 16.01 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.75 -6.39 0.62 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -75.52 179.71 5.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.971 -1.311 . . . . 0.0 109.315 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 68.4 mt-10 -107.89 173.03 6.5 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.539 -0.726 . . . . 0.0 109.985 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -136.6 116.55 13.25 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.82 125.79 16.8 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 28.3 mt -110.44 -59.73 1.9 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.501 -0.999 . . . . 0.0 109.207 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.91 -176.06 35.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -93.13 7.79 42.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.15 -1.206 . . . . 0.0 109.477 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.02 101.99 13.73 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -58.77 -12.88 4.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.157 -0.964 . . . . 0.0 108.764 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -75.63 -56.8 4.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.458 -0.777 . . . . 0.0 108.97 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 89.0 mt -73.27 -34.71 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.526 -0.734 . . . . 0.0 109.596 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.57 -57.71 7.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.035 -1.041 . . . . 0.0 109.437 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 92.1 mt -54.51 -36.82 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 109.211 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -53.7 -56.81 14.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 108.938 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -62.11 -42.99 99.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.651 -0.656 . . . . 0.0 110.027 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.65 67.68 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.387 -0.82 . . . . 0.0 109.147 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.31 -48.34 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.336 -0.852 . . . . 0.0 109.919 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -61.37 -39.68 91.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.989 -1.069 . . . . 0.0 108.241 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.14 75.13 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -67.92 -33.62 75.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.421 -0.799 . . . . 0.0 109.695 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.4 mt -67.22 -32.14 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 108.824 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -71.27 -29.65 65.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.377 -0.827 . . . . 0.0 109.504 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 mt -63.67 -9.28 13.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 0.0 108.792 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.67 -21.95 12.89 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 t -99.4 -19.76 16.83 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.29 -0.881 . . . . 0.0 109.358 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.74 163.33 16.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 59' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.249 -1.148 . . . . 0.0 109.481 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.2 t0 . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.5 mt -83.11 146.73 52.2 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.545 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -35.59 145.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.738 2.292 . . . . 0.0 112.52 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.523 ' C ' HD21 ' A' ' 15' ' ' ASN . 83.1 Cg_exo -44.43 138.5 7.45 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.079 1.852 . . . . 0.0 113.429 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.523 HD21 ' C ' ' A' ' 14' ' ' PRO . 1.4 m-80 61.04 43.38 11.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.446 -0.784 . . . . 0.0 111.63 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.5 tp -139.95 119.42 13.07 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -113.39 179.87 3.84 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.583 0.706 . . . . 0.0 110.413 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.0 tt -138.73 147.1 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-O 121.538 0.685 . . . . 0.0 109.243 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -91.48 160.12 15.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.533 -0.73 . . . . 0.0 110.352 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -61.36 -11.49 10.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.58 -0.7 . . . . 0.0 109.125 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -88.87 -1.2 57.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.029 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.77 4.99 86.92 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -86.65 135.29 33.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.11 -1.23 . . . . 0.0 108.367 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -84.37 152.53 24.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.166 -0.959 . . . . 0.0 110.16 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.437 ' SG ' ' O ' ' A' ' 25' ' ' CYS . 30.2 p -150.77 126.4 10.23 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.424 -0.797 . . . . 0.0 109.455 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -94.96 150.27 20.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.195 -0.94 . . . . 0.0 109.333 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -115.05 115.67 27.2 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.485 -0.759 . . . . 0.0 110.627 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -76.01 131.43 75.95 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 108.989 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.86 -7.69 13.33 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.022 1.815 . . . . 0.0 113.42 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -86.13 -18.16 33.05 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.646 -1.284 . . . . 0.0 108.977 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 t -130.67 -27.46 2.13 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.46 -3.52 84.63 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -75.21 -176.32 3.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.953 -1.322 . . . . 0.0 109.304 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -115.99 170.2 8.67 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.484 -0.76 . . . . 0.0 110.266 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -137.27 121.7 18.27 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.28 123.5 6.32 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.7 mt -104.79 -69.56 0.81 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.417 -1.049 . . . . 0.0 109.572 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.57 -177.92 37.67 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.413 ' HG3' HH11 ' A' ' 39' ' ' ARG . 6.9 mtm-85 -90.52 7.19 40.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.169 -1.195 . . . . 0.0 110.035 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -95.18 111.31 23.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.253 -0.904 . . . . 0.0 110.216 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.5 ' HG3' HH11 ' A' ' 41' ' ' ARG . 0.7 OUTLIER -62.63 -15.57 52.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 108.99 179.119 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -74.43 -46.67 38.48 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.85 -39.6 16.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.44 -58.16 7.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.667 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 98.7 mt -55.88 -37.56 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.942 -1.099 . . . . 0.0 109.343 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -55.97 -57.96 9.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 109.542 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -61.47 -42.71 99.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.475 -0.766 . . . . 0.0 109.911 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.32 64.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.491 -0.755 . . . . 0.0 109.542 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.47 -42.99 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.242 -0.911 . . . . 0.0 110.36 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -59.94 -32.47 70.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.039 -1.038 . . . . 0.0 108.804 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.28 -36.5 84.29 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -67.18 -37.49 83.79 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.28 -0.888 . . . . 0.0 109.873 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.66 -25.75 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.131 -0.981 . . . . 0.0 109.011 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 58' ' ' GLY . 48.7 mt-10 -69.9 -33.71 72.55 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.283 -0.886 . . . . 0.0 108.687 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.94 -39.98 90.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.123 -0.985 . . . . 0.0 109.604 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -81.43 0.65 36.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.141 -0.974 . . . . 0.0 109.34 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.0 m -165.28 53.63 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.254 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . -73.21 120.72 7.27 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.5 m170 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.295 -1.12 . . . . 0.0 109.47 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.5 t70 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.0 mt -82.8 148.63 58.03 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.295 -0.878 . . . . 0.0 109.453 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.91 161.91 43.71 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.34 2.027 . . . . 0.0 111.094 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.56 ' C ' ' H ' ' A' ' 16' ' ' LEU . 32.4 Cg_endo -62.58 165.03 16.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.35 2.034 . . . . 0.0 112.052 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 61.7 -9.35 0.08 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.654 -0.654 . . . . 0.0 110.698 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.56 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.9 tp -108.08 143.0 37.43 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.091 -1.005 . . . . 0.0 109.335 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 46.5 m-85 -136.78 -165.33 1.72 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.769 0.795 . . . . 0.0 110.052 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.5 tp -138.47 138.05 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.464 ' HE ' ' CB ' ' A' ' 23' ' ' TYR . 44.1 mtm180 -89.71 173.04 8.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.258 -0.901 . . . . 0.0 109.28 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.565 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -64.51 -20.04 65.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.113 -0.992 . . . . 0.0 109.699 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.85 3.1 55.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.001 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.93 19.82 74.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.464 ' CB ' ' HE ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -84.92 132.76 34.33 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -82.2 141.99 32.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.925 -1.109 . . . . 0.0 109.638 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.9 m -144.13 135.23 25.43 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 38.5 t80 -96.86 157.49 15.88 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.565 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 27.6 ttm180 -127.52 120.53 28.48 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.498 -0.751 . . . . 0.0 110.539 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -76.47 144.94 74.9 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.128 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.18 -13.0 7.85 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.997 1.798 . . . . 0.0 111.902 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -91.59 -36.3 13.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.282 -0.886 . . . . 0.0 110.078 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.517 ' C ' ' H ' ' A' ' 33' ' ' LYS . 27.6 p -106.2 -17.83 14.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.37 -0.831 . . . . 0.0 109.503 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.1 -8.99 0.81 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' A' ' 31' ' ' THR . 6.6 tmtt? -73.6 -174.17 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.983 -1.304 . . . . 0.0 108.232 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -128.99 161.38 30.07 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.39 -0.819 . . . . 0.0 110.51 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -119.48 137.17 53.97 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.8 120.58 5.25 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mt -102.53 -61.27 1.42 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.409 -1.054 . . . . 0.0 108.838 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.18 -170.18 32.69 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.572 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 1.2 mtm180 -95.85 11.37 33.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -1.194 . . . . 0.0 109.13 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -93.06 98.51 11.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.476 -0.765 . . . . 0.0 110.031 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -61.78 -13.13 20.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.572 -0.705 . . . . 0.0 109.163 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.408 HH11 ' HG3' ' A' ' 42' ' ' ARG . 17.3 mmm-85 -77.04 -57.12 4.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.48 -0.762 . . . . 0.0 109.591 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.5 ' N ' ' CD1' ' A' ' 43' ' ' ILE . 1.7 mp -74.42 -35.95 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.22 -0.925 . . . . 0.0 109.537 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.6 -52.98 62.16 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.162 -0.961 . . . . 0.0 109.346 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.5 mt -57.2 -41.67 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.684 -1.26 . . . . 0.0 108.554 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.9 m -57.76 -51.25 70.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 110.614 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -32.77 74.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.035 -1.041 . . . . 0.0 109.768 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.5 90.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.168 -0.957 . . . . 0.0 110.051 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.18 -56.31 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.353 -0.842 . . . . 0.0 111.007 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -56.19 -31.11 63.14 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.943 -1.098 . . . . 0.0 108.489 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.94 -38.0 82.3 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -65.6 -45.28 83.79 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.5 mt -69.53 -42.37 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.353 -0.842 . . . . 0.0 108.748 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -70.89 -15.07 62.59 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.575 -0.703 . . . . 0.0 109.349 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 tp -56.16 -16.63 5.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.474 -0.766 . . . . 0.0 109.266 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -100.69 -2.26 33.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.366 -0.834 . . . . 0.0 109.122 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.6 p -154.44 80.39 1.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.845 . . . . 0.0 109.313 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.552 ' O ' ' CG ' ' A' ' 59' ' ' HIS . . . -46.6 162.61 0.18 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.552 ' CG ' ' O ' ' A' ' 58' ' ' GLY . 34.1 p80 . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.661 -0.906 . . . . 0.0 110.222 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 23.6 p-10 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 13' ' ' PRO . 40.6 mt -80.99 149.55 66.98 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 109.114 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 12' ' ' LEU . 90.7 Cg_exo -35.41 158.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.617 2.212 . . . . 0.0 111.814 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.08 143.88 50.63 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.059 1.839 . . . . 0.0 111.265 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 65.85 29.17 10.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.602 -0.686 . . . . 0.0 109.939 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.0 tp -138.91 123.66 18.64 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 11.9 m-85 -131.1 -163.95 1.38 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.172 0.987 . . . . 0.0 111.11 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 tp -126.82 142.21 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.411 HH11 ' HG3' ' A' ' 19' ' ' ARG . 14.5 ttm-85 -88.48 161.53 16.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.162 -0.962 . . . . 0.0 109.036 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -59.26 -18.35 36.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.038 -1.039 . . . . 0.0 109.423 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -89.36 -0.33 57.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.093 -1.005 . . . . 0.0 108.722 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.36 8.41 74.57 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -86.22 142.61 28.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -1.174 . . . . 0.0 108.943 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -81.48 149.71 28.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.967 -1.083 . . . . 0.0 108.938 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 p -148.57 135.44 19.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.983 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -97.83 154.81 17.38 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -118.12 110.84 18.11 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.451 -0.781 . . . . 0.0 109.472 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.95 151.02 86.28 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.223 -0.923 . . . . 0.0 109.645 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -90.46 -23.18 0.64 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.624 2.216 . . . . 0.0 113.146 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -90.14 -26.35 20.22 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.933 -1.105 . . . . 0.0 110.346 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.543 ' C ' ' H ' ' A' ' 33' ' ' LYS . 68.1 p -105.92 -19.24 13.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.0 -1.062 . . . . 0.0 108.421 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.74 -11.23 0.63 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -75.99 -161.97 0.2 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.202 -1.176 . . . . 0.0 109.032 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 44.1 mt-10 -129.82 179.52 5.8 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.573 -0.705 . . . . 0.0 109.935 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -143.94 117.45 9.14 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.09 126.3 10.2 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt -105.97 -52.47 2.8 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.362 -1.081 . . . . 0.0 109.622 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.92 -173.07 30.52 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -97.72 8.95 43.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -1.129 . . . . 0.0 109.292 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -94.43 99.52 11.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.325 -0.859 . . . . 0.0 110.422 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -55.47 -19.61 10.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' A' ' 42' ' ' ARG . 1.1 mmt-85 -75.46 -54.09 7.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 109.237 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 78.9 mt -76.25 -36.84 30.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.688 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -58.52 8.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 50.8 mt -50.84 -39.43 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.8 -1.187 . . . . 0.0 109.176 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.06 -51.5 66.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.008 . . . . 0.0 109.499 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -62.37 -41.25 98.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 109.151 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.38 93.4 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.434 -0.792 . . . . 0.0 110.229 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.1 mt -60.46 -52.66 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.137 -0.977 . . . . 0.0 110.593 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -59.12 -30.87 68.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.875 -1.141 . . . . 0.0 108.712 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.31 93.18 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -68.05 -39.32 83.05 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.466 -0.771 . . . . 0.0 109.392 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.8 mt -68.81 -30.08 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.243 -0.911 . . . . 0.0 108.831 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -70.43 -21.7 62.79 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.409 -0.807 . . . . 0.0 108.831 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -36.88 79.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 108.861 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -104.33 -28.37 11.42 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.43 -0.794 . . . . 0.0 109.081 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.1 m -95.04 47.75 1.16 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.118 -0.989 . . . . 0.0 109.166 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.26 10.47 74.8 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.4 m80 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.325 -1.103 . . . . 0.0 109.547 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.1 mt -82.18 151.47 66.45 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.337 -0.852 . . . . 0.0 109.368 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.53 160.44 39.7 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.752 1.634 . . . . 0.0 110.354 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.519 ' C ' ' H ' ' A' ' 16' ' ' LEU . 57.2 Cg_endo -67.7 171.6 11.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.31 2.007 . . . . 0.0 112.201 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 57.05 4.21 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.555 -0.716 . . . . 0.0 109.422 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' PRO . 26.1 tp -129.74 132.39 46.57 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -134.46 -163.47 1.38 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.366 -0.834 . . . . 0.0 110.339 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 tp -132.04 141.11 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -88.77 158.91 18.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.968 . . . . 0.0 109.115 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.621 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -57.4 -19.91 26.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.465 -0.772 . . . . 0.0 109.043 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.81 -2.93 58.96 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.72 10.99 71.79 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -86.61 140.23 30.04 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.231 -1.158 . . . . 0.0 108.588 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.438 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 68.4 m-85 -81.84 151.24 27.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.85 -1.156 . . . . 0.0 109.432 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.447 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 17.2 p -146.68 133.36 19.93 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.397 -0.814 . . . . 0.0 110.156 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -96.94 137.33 36.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.331 -0.855 . . . . 0.0 108.812 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -108.81 115.33 29.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.591 -0.693 . . . . 0.0 110.104 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.34 142.66 89.77 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -84.17 -8.8 9.76 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.393 2.062 . . . . 0.0 113.323 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -89.78 -24.45 21.48 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.842 -1.161 . . . . 0.0 109.987 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 -22.33 3.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.368 -0.832 . . . . 0.0 109.49 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.41 0.9 68.34 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.407 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 3.6 tmtt? -73.94 179.68 4.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.959 -1.318 . . . . 0.0 108.494 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 25.9 mt-10 -131.72 160.25 36.04 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.375 -0.828 . . . . 0.0 110.605 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -138.04 125.48 21.94 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.16 132.46 33.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.428 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.6 mt -105.09 -47.79 3.9 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.413 -1.051 . . . . 0.0 108.869 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.39 -178.98 22.8 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.181 -1.967 . . . . 0.0 108.181 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -91.55 11.03 25.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.021 -1.282 . . . . 0.0 109.371 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.34 100.72 13.25 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.933 0.873 . . . . 0.0 109.835 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.438 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 43.0 ttm180 -59.25 -20.06 51.04 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.4 0.619 . . . . 0.0 109.9 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.542 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -77.08 -49.27 15.68 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.714 0.768 . . . . 0.0 109.2 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.5 mt -75.76 -36.89 34.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.8 -55.41 26.71 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.348 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.53 -40.34 74.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.418 -0.801 . . . . 0.0 109.78 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -50.63 -51.74 46.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 108.914 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -62.53 -37.76 87.34 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.551 -0.718 . . . . 0.0 109.333 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.25 -51.91 67.81 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.497 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.61 -48.87 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.361 -0.837 . . . . 0.0 110.641 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -58.07 -44.07 87.3 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.839 -1.163 . . . . 0.0 108.145 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.54 74.05 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -69.94 -45.74 66.81 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.333 -0.855 . . . . 0.0 109.521 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.7 mt -69.68 -37.68 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.085 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.61 -22.67 64.42 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.326 -0.859 . . . . 0.0 109.305 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.18 -12.84 30.97 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.121 -0.987 . . . . 0.0 108.474 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.499 ' CD1' ' C ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -117.52 -32.72 4.81 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.4 m -99.85 59.58 1.07 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.321 -0.862 . . . . 0.0 109.737 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 59' ' ' HIS . . . -166.39 177.15 41.43 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.525 ' CG ' ' O ' ' A' ' 58' ' ' GLY . 32.5 m80 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.298 -1.119 . . . . 0.0 109.264 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 mt -80.57 150.34 69.85 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 121.331 -0.856 . . . . 0.0 108.89 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -40.21 157.27 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.115 1.876 . . . . 0.0 111.85 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 16' ' ' LEU . 50.5 Cg_endo -69.61 153.03 70.15 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.093 1.862 . . . . 0.0 111.767 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 69.0 -11.27 0.45 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.535 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.5 tt -97.56 142.28 29.58 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.926 -1.109 . . . . 0.0 109.664 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -136.03 -178.83 5.32 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.551 -0.718 . . . . 0.0 109.393 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.21 147.77 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.662 0.744 . . . . 0.0 109.631 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.483 HH21 ' CB ' ' A' ' 23' ' ' TYR . 15.1 ttp180 -91.31 156.32 17.88 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -59.71 -10.33 3.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.057 -1.027 . . . . 0.0 109.604 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -88.69 1.41 55.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.259 -0.901 . . . . 0.0 108.755 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.88 6.16 88.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CB ' HH21 ' A' ' 19' ' ' ARG . 3.6 m-85 -84.36 138.06 33.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.313 -1.11 . . . . 0.0 108.488 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -83.0 154.67 24.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.034 -1.041 . . . . 0.0 109.307 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 p -150.88 132.24 14.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.818 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -101.98 143.64 31.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.378 -0.826 . . . . 0.0 109.097 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -101.86 118.66 37.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.49 -0.756 . . . . 0.0 109.5 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 35' ' ' PHE . 1.9 m-20 -74.35 149.12 86.53 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.977 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.24 3.06 7.09 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.771 2.314 . . . . 0.0 113.015 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -86.48 -55.12 4.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.951 -1.093 . . . . 0.0 110.243 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.17 -18.93 9.21 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.457 -0.777 . . . . 0.0 109.807 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.32 6.76 59.78 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.051 -1.031 . . . . 0.0 110.635 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -72.25 -175.23 1.48 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.847 -1.384 . . . . 0.0 109.325 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -119.1 166.86 12.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.646 -0.659 . . . . 0.0 109.822 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.469 ' CE1' ' OD2' ' A' ' 28' ' ' ASP . 8.0 m-85 -134.77 119.2 17.9 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.14 121.75 16.83 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -104.22 -53.49 2.72 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.526 -0.985 . . . . 0.0 109.302 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.46 -177.45 28.53 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.509 -1.837 . . . . 0.0 108.509 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.408 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 1.8 mtm180 -93.92 8.47 41.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.13 -1.218 . . . . 0.0 109.422 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -94.19 102.73 14.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -60.5 -11.77 7.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.349 -0.845 . . . . 0.0 109.018 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.575 HH11 ' CG ' ' A' ' 42' ' ' ARG . 0.2 OUTLIER -75.8 -54.72 6.49 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.467 -0.771 . . . . 0.0 109.216 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.44 ' N ' ' CD1' ' A' ' 43' ' ' ILE . 1.7 mp -74.92 -37.91 42.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.614 -0.679 . . . . 0.0 109.183 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.11 -56.74 14.3 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.65 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.7 mt -55.99 -40.88 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.043 -1.036 . . . . 0.0 109.329 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.7 m -59.96 -50.73 72.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 110.477 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -32.86 74.52 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.306 -0.871 . . . . 0.0 110.018 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.97 92.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.105 -0.997 . . . . 0.0 108.961 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.1 mt -56.86 -42.2 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.441 -0.787 . . . . 0.0 110.207 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -58.19 -39.53 79.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.053 -1.029 . . . . 0.0 108.991 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.35 84.01 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -67.8 -39.26 84.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.531 -0.731 . . . . 0.0 110.419 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 81.4 mt -68.39 -36.87 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.004 -1.06 . . . . 0.0 109.572 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -70.07 -19.35 63.27 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.31 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.83 -43.63 98.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.862 . . . . 0.0 109.199 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.413 ' C ' ' N ' ' A' ' 58' ' ' GLY . 76.3 m-85 -81.1 7.25 11.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -0.872 . . . . 0.0 109.32 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 59' ' ' HIS . 13.4 t 49.78 18.07 0.31 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.25 -0.906 . . . . 0.0 108.881 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' A' ' 56' ' ' PHE . . . 70.76 -49.06 0.81 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.412 ' H ' ' C ' ' A' ' 57' ' ' SER . 8.2 p80 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.298 -1.119 . . . . 0.0 109.386 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.7 t0 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.196 0.522 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 76.9 mt -81.22 150.64 68.33 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.952 . . . . 0.0 109.163 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -37.87 154.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.29 1.993 . . . . 0.0 111.892 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 16' ' ' LEU . 41.4 Cg_endo -66.68 153.61 77.37 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.377 2.051 . . . . 0.0 112.554 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 54.71 6.5 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.482 -0.761 . . . . 0.0 110.42 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.462 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.6 tt -104.61 148.01 27.0 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.19 -0.944 . . . . 0.0 109.25 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -139.1 -177.58 4.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.879 0.847 . . . . 0.0 110.331 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 tt -141.31 145.45 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.403 HH21 ' CB ' ' A' ' 23' ' ' TYR . 8.9 ttp180 -90.32 151.64 21.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.418 -0.801 . . . . 0.0 109.667 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.52 HD21 ' H ' ' A' ' 20' ' ' ASN . 1.5 m-80 -51.07 -15.86 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.444 -0.785 . . . . 0.0 109.973 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -88.69 0.89 56.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.178 -0.951 . . . . 0.0 108.845 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.69 12.18 78.19 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.403 ' CB ' HH21 ' A' ' 19' ' ' ARG . 8.0 m-85 -84.07 127.71 34.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.951 -1.323 . . . . 0.0 107.76 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -82.82 147.53 28.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.2 m -150.32 141.84 23.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.029 -1.045 . . . . 0.0 110.308 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 36.6 t80 -110.99 150.09 29.76 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.418 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 33.8 mtt180 -109.92 117.36 33.59 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.5 ' OD1' ' CD1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -75.06 131.73 78.2 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -75.22 -6.25 17.68 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.776 1.651 . . . . 0.0 112.622 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -89.1 -44.0 10.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.923 -1.11 . . . . 0.0 109.163 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.527 ' C ' ' H ' ' A' ' 33' ' ' LYS . 1.4 t -108.34 -7.4 15.9 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.289 -0.882 . . . . 0.0 108.913 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.6 -2.42 0.85 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.527 ' H ' ' C ' ' A' ' 31' ' ' THR . 3.4 mmtp -73.14 -179.94 3.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.068 -1.254 . . . . 0.0 108.857 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -105.75 171.72 7.19 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.537 -0.727 . . . . 0.0 109.951 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.5 ' CD1' ' OD1' ' A' ' 28' ' ' ASP . 14.8 m-85 -140.53 109.87 6.24 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.33 125.55 21.15 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.02 -31.37 7.65 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.55 -0.97 . . . . 0.0 109.93 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.15 -174.36 18.33 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -97.61 10.77 39.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.215 -1.168 . . . . 0.0 109.823 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -92.43 100.46 13.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.371 -0.831 . . . . 0.0 110.084 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -59.03 -16.39 18.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.515 -0.74 . . . . 0.0 109.628 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.515 HH11 ' CG ' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -76.49 -58.68 3.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.184 -0.948 . . . . 0.0 109.326 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.461 ' N ' ' CD1' ' A' ' 43' ' ' ILE . 1.7 mp -74.89 -33.1 29.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.654 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.44 77.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.765 -1.21 . . . . 0.0 109.928 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 45' ' ' ILE . 74.7 mt -59.1 -38.79 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.733 -1.23 . . . . 0.0 108.976 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.87 -63.92 0.99 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.239 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -53.05 -38.54 62.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.628 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.3 80.88 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.298 -0.877 . . . . 0.0 108.896 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.25 -44.83 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.425 -0.797 . . . . 0.0 110.8 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -57.41 -39.03 75.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 108.173 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.43 -35.77 81.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -66.86 -40.83 88.0 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.349 -0.845 . . . . 0.0 109.714 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.1 -28.24 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.041 -1.037 . . . . 0.0 108.477 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -70.84 -24.86 62.61 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.59 -0.694 . . . . 0.0 109.834 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.37 -16.09 59.44 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.031 -1.043 . . . . 0.0 108.62 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -109.03 11.96 25.49 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t 66.94 12.78 9.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.591 -0.693 . . . . 0.0 109.502 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.79 102.72 1.68 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.415 ' CD2' ' H ' ' A' ' 59' ' ' HIS . 8.3 p80 . . . . . 0 C--N 1.303 -1.431 0 O-C-N 121.194 -1.18 . . . . 0.0 109.269 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.6 mt -82.09 150.92 65.84 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.333 -0.855 . . . . 0.0 108.728 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -40.6 156.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.848 1.699 . . . . 0.0 111.336 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.75 165.2 16.57 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.946 1.764 . . . . 0.0 111.384 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.502 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 3.1 m-80 51.16 30.21 5.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.193 -0.942 . . . . 0.0 109.415 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 tt -138.28 127.51 24.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.349 -0.845 . . . . 0.0 108.793 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -124.11 -179.01 4.26 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.578 -0.701 . . . . 0.0 109.423 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.1 tt -140.39 150.53 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.561 -0.712 . . . . 0.0 109.299 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -91.65 152.53 20.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.168 -0.958 . . . . 0.0 109.602 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.9 -15.63 13.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 0.0 109.447 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -88.2 -1.73 58.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 108.642 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.82 9.58 65.97 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.65 129.28 34.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -1.224 . . . . 0.0 108.216 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -81.5 152.23 27.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.982 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.2 m -152.06 136.42 16.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.418 -0.801 . . . . 0.0 109.58 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 15' ' ' ASN . 81.5 t80 -105.03 137.4 42.84 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.383 -0.823 . . . . 0.0 109.083 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -103.23 113.07 26.26 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.392 -0.817 . . . . 0.0 109.682 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.13 139.9 85.25 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.275 -0.891 . . . . 0.0 110.347 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -83.5 1.4 8.98 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.479 2.12 . . . . 0.0 112.248 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -86.89 -37.0 18.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.082 -1.011 . . . . 0.0 109.88 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.1 -23.07 3.65 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.488 -0.757 . . . . 0.0 109.102 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.81 2.04 72.69 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -74.76 -164.97 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.875 -1.368 . . . . 0.0 109.777 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -129.52 171.87 12.14 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.755 0.788 . . . . 0.0 110.889 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -139.58 124.65 18.77 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.26 119.26 6.19 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.9 mt -103.8 -52.22 3.01 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.32 -1.106 . . . . 0.0 109.022 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.3 -169.09 26.46 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -97.47 11.87 35.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.288 -1.125 . . . . 0.0 109.269 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.94 106.5 18.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.367 -0.833 . . . . 0.0 110.142 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -64.43 -18.52 64.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.532 -0.73 . . . . 0.0 109.18 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.401 HH11 ' HG3' ' A' ' 42' ' ' ARG . 11.4 mmm-85 -76.84 -50.52 13.23 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.478 -0.763 . . . . 0.0 109.076 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 92.4 mt -76.12 -36.35 30.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.606 -0.684 . . . . 0.0 109.806 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.99 -52.65 58.62 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.183 -0.948 . . . . 0.0 109.823 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 45' ' ' ILE . 54.7 mt -56.14 -39.28 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.001 -1.062 . . . . 0.0 109.426 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.99 -50.87 65.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.0 109.715 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' O ' ' OE1' ' A' ' 50' ' ' GLN . 66.3 mm-40 -62.5 -39.78 94.58 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.512 -0.743 . . . . 0.0 109.656 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.43 -44.84 95.45 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.478 -0.764 . . . . 0.0 109.977 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.28 -58.41 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.217 -0.927 . . . . 0.0 111.23 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.402 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -55.73 -24.44 34.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.989 -1.069 . . . . 0.0 109.167 -178.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.57 81.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -70.58 -40.42 73.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.738 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.6 mt -67.27 -31.55 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.12 -0.987 . . . . 0.0 109.236 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -72.0 -24.47 61.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -0.866 . . . . 0.0 108.791 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -41.25 99.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.491 -0.756 . . . . 0.0 109.351 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -83.47 9.08 12.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.893 . . . . 0.0 109.318 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 t -137.71 25.42 2.84 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.358 -0.839 . . . . 0.0 109.144 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.19 -71.56 0.81 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 28.1 p80 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.26 -1.141 . . . . 0.0 109.368 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.79 148.12 60.48 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.122 -0.987 . . . . 0.0 109.34 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -37.59 158.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.447 2.098 . . . . 0.0 111.886 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.1 166.09 30.32 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.312 2.008 . . . . 0.0 111.948 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 49.48 20.94 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.919 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 tp -128.0 125.99 40.49 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -121.68 173.53 7.39 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.624 -0.672 . . . . 0.0 110.249 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.24 134.53 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.502 ' C ' ' H ' ' A' ' 21' ' ' ASN . 18.4 mtm180 -89.92 149.48 22.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.095 -1.003 . . . . 0.0 109.887 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -54.05 -8.85 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.136 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.502 ' H ' ' C ' ' A' ' 19' ' ' ARG . 88.0 m-20 -89.65 0.26 57.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.394 -0.816 . . . . 0.0 109.218 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.79 3.92 90.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -88.07 129.92 35.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.173 -1.192 . . . . 0.0 109.073 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.437 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 13.4 m-85 -84.82 156.9 21.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.461 -0.774 . . . . 0.0 108.987 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.437 ' SG ' ' O ' ' A' ' 24' ' ' TYR . 98.9 m -152.83 129.34 10.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.298 -0.877 . . . . 0.0 109.464 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -95.6 145.43 25.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.248 -0.908 . . . . 0.0 108.953 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -120.41 118.63 30.82 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.59 -0.694 . . . . 0.0 110.139 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -76.02 138.79 68.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.319 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.12 16.41 1.65 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.556 2.171 . . . . 0.0 112.896 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 -68.44 0.75 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.8 -1.188 . . . . 0.0 109.042 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.32 -19.56 13.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.307 -0.871 . . . . 0.0 109.36 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.68 17.52 23.37 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 178.84 5.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.765 -1.432 . . . . 0.0 108.977 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -126.49 164.14 21.81 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.423 -0.798 . . . . 0.0 110.443 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -134.78 133.08 39.48 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.21 131.57 10.73 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.34 -54.68 2.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.485 -1.009 . . . . 0.0 109.643 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.27 -171.46 31.54 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.91 7.66 46.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -1.201 . . . . 0.0 109.683 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -95.29 103.96 15.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.256 -0.902 . . . . 0.0 110.098 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -58.13 -18.64 26.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 108.738 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.472 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -73.46 -49.69 25.51 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.7 mt -76.89 -37.06 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.543 -0.723 . . . . 0.0 109.238 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.14 -56.56 12.21 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.854 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 88.8 mt -54.15 -35.74 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.098 -1.001 . . . . 0.0 109.351 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -56.82 -59.53 4.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.096 -1.003 . . . . 0.0 109.033 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -59.53 -42.24 91.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.37 -0.831 . . . . 0.0 109.807 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.6 -42.15 61.75 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.96 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.09 -52.49 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -60.58 -29.7 69.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.947 -1.096 . . . . 0.0 108.199 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.16 86.35 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -64.79 -36.78 85.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.412 -0.805 . . . . 0.0 109.377 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.0 mm -69.25 -29.38 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 108.876 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -70.69 -23.99 62.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.433 -0.792 . . . . 0.0 109.426 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.51 -8.47 4.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 109.127 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -130.27 4.52 4.78 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 t 53.93 19.17 1.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 109.383 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.93 26.87 19.8 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.308 -1.113 . . . . 0.0 109.401 -179.875 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.7 mt -81.72 150.64 66.56 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.28 -0.888 . . . . 0.0 109.391 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -40.78 157.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.049 1.833 . . . . 0.0 111.491 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.42 162.39 40.87 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.257 1.971 . . . . 0.0 112.143 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 52.72 27.35 5.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.469 -0.769 . . . . 0.0 110.25 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.64 148.47 47.44 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.221 -0.925 . . . . 0.0 108.81 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 22.6 m-85 -138.16 -166.85 2.05 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.115 0.96 . . . . 0.0 110.753 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.42 136.01 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 21' ' ' ASN . 26.8 ttp180 -88.62 142.25 27.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.921 -1.112 . . . . 0.0 109.424 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -50.45 -10.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.497 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.504 ' H ' ' C ' ' A' ' 19' ' ' ARG . 8.6 m120 -89.75 -0.04 57.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 109.169 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.57 5.11 87.12 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.448 ' CB ' HH21 ' A' ' 19' ' ' ARG . 3.0 m-85 -88.61 134.92 33.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.273 -1.134 . . . . 0.0 108.977 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.405 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 60.5 m-85 -84.18 147.94 27.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.927 . . . . 0.0 108.699 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 24' ' ' TYR . 83.8 m -150.62 143.03 24.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.037 -1.04 . . . . 0.0 110.044 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.436 ' CZ ' ' CB ' ' A' ' 51' ' ' ALA . 43.8 t80 -105.01 159.05 16.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.495 -0.753 . . . . 0.0 109.102 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.519 HH21 ' CD ' ' A' ' 34' ' ' GLU . 27.8 ttm180 -130.5 113.9 14.84 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.358 -0.839 . . . . 0.0 109.78 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.58 141.33 79.5 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.509 -0.744 . . . . 0.0 109.176 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -83.57 -19.82 5.04 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 121.931 1.754 . . . . 0.0 112.388 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -89.14 -26.01 21.55 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.126 -0.984 . . . . 0.0 109.491 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.551 ' C ' ' H ' ' A' ' 33' ' ' LYS . 1.9 p -107.33 -21.02 13.09 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.36 -10.43 0.66 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.551 ' H ' ' C ' ' A' ' 31' ' ' THR . 5.5 tmtt? -75.99 -179.21 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -1.232 . . . . 0.0 109.6 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.519 ' CD ' HH21 ' A' ' 27' ' ' ARG . 36.5 mt-10 -115.89 168.13 10.33 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.546 0.688 . . . . 0.0 110.291 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -135.77 121.22 19.3 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.54 124.58 6.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -105.09 -73.87 0.67 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.417 -1.049 . . . . 0.0 109.226 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 172.08 -168.55 41.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.29 0.16 45.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.269 -1.136 . . . . 0.0 109.593 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -98.36 100.1 11.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.308 -0.87 . . . . 0.0 109.748 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -54.63 -20.23 7.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.267 -0.896 . . . . 0.0 109.527 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -50.48 52.94 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.406 ' N ' ' CD1' ' A' ' 43' ' ' ILE . 1.9 mp -77.57 -34.87 20.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.82 -53.84 34.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.847 . . . . 0.0 109.781 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 73.1 mt -54.9 -35.92 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 109.232 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.22 -54.88 37.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 0.0 108.958 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.8 -39.73 95.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.529 -0.732 . . . . 0.0 109.756 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.45 81.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.486 -0.759 . . . . 0.0 109.577 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.84 -44.69 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 110.155 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -58.33 -28.9 65.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.862 -1.149 . . . . 0.0 108.519 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.436 ' CB ' ' CZ ' ' A' ' 26' ' ' TYR . . . -65.53 -35.06 79.75 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -66.89 -35.09 79.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.835 . . . . 0.0 109.473 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.85 -35.25 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -27.75 66.87 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.55 -30.91 55.46 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' A' ' 57' ' ' SER . 50.3 m-85 -87.5 9.21 21.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.071 -1.018 . . . . 0.0 109.37 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER 74.12 -43.29 0.53 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.521 -0.737 . . . . 0.0 109.719 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 56' ' ' PHE . . . 81.7 154.36 12.57 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.439 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.182 -1.187 . . . . 0.0 109.414 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.287 0.565 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.7 mt -83.24 150.52 61.0 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.266 -0.896 . . . . 0.0 108.905 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -35.29 154.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 122.556 2.171 . . . . 0.0 112.441 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 16' ' ' LEU . 49.6 Cg_endo -67.89 151.87 77.77 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.387 2.058 . . . . 0.0 111.75 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 62.73 -4.39 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.517 -0.739 . . . . 0.0 110.007 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.7 tt -100.15 153.61 19.11 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.172 -0.955 . . . . 0.0 109.221 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -138.03 -169.42 2.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.339 -0.85 . . . . 0.0 110.604 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.15 137.68 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.456 ' NE ' HD21 ' A' ' 21' ' ' ASN . 40.1 ttp180 -89.58 151.55 21.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.153 -0.967 . . . . 0.0 109.205 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 1.5 p30 -61.9 -9.28 6.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.107 -0.995 . . . . 0.0 109.665 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.456 HD21 ' NE ' ' A' ' 19' ' ' ARG . 74.0 m-80 -91.03 -1.51 57.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.337 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.74 3.03 77.84 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -87.87 140.17 29.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.207 -1.172 . . . . 0.0 109.106 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.494 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 55.0 m-85 -84.78 150.79 24.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 0.0 109.075 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.7 p -150.45 138.92 20.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.213 -0.93 . . . . 0.0 110.057 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -102.35 150.66 23.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.94 112.82 15.1 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.371 -0.831 . . . . 0.0 108.795 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.454 ' CB ' ' NZ ' ' A' ' 33' ' ' LYS . 11.2 t70 -73.29 129.73 85.49 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.891 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.02 17.99 0.95 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.049 1.833 . . . . 0.0 113.093 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -88.79 -65.47 1.01 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.732 -1.23 . . . . 0.0 109.294 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.04 -20.07 13.43 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.196 -0.94 . . . . 0.0 108.794 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.11 13.8 32.68 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.502 ' HD3' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -73.77 177.67 5.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.65 -1.5 . . . . 0.0 109.532 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -131.64 167.52 19.29 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.388 -0.82 . . . . 0.0 110.288 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -139.43 117.73 11.99 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.505 -0.747 . . . . 0.0 109.051 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.54 124.27 8.02 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.77 -71.48 0.72 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.312 -1.111 . . . . 0.0 109.653 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.67 -173.84 39.8 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -95.0 10.5 35.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.037 -1.272 . . . . 0.0 109.707 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.96 103.3 15.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.194 -0.941 . . . . 0.0 110.717 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.494 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 79.5 mtt180 -54.3 -19.81 6.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.362 -0.836 . . . . 0.0 108.822 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -74.04 -55.07 6.57 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.401 -0.812 . . . . 0.0 109.462 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.4 mt -80.65 -32.43 13.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.529 -0.732 . . . . 0.0 109.801 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.43 -58.46 5.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.827 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 97.9 mt -55.71 -37.21 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.302 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -53.81 -57.4 11.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.092 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -54.07 -43.85 70.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.615 -0.678 . . . . 0.0 109.6 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.31 -43.63 79.15 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.753 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.24 -41.09 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.204 -0.935 . . . . 0.0 110.646 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.65 -39.0 82.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.811 -1.181 . . . . 0.0 108.643 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.74 -35.48 80.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.573 -0.705 . . . . 0.0 109.364 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -68.38 -40.52 81.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.513 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.1 mt -68.79 -33.61 60.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -40.8 75.35 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.57 -10.38 34.8 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.911 -0.715 . . . . 0.0 109.106 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.48 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -100.7 -3.19 30.7 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 57' ' ' SER . 1.9 t -163.68 69.61 0.21 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.435 -0.791 . . . . 0.0 109.139 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.99 9.71 61.72 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 28.6 m170 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.188 -1.184 . . . . 0.0 109.548 -179.88 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 13' ' ' PRO . 73.8 mt -83.68 149.65 57.65 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.883 . . . . 0.0 109.598 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 12' ' ' LEU . 95.4 Cg_exo -36.14 158.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 122.508 2.138 . . . . 0.0 111.779 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' A' ' 16' ' ' LEU . 56.1 Cg_endo -69.12 166.83 25.46 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.115 1.877 . . . . 0.0 111.843 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 52.27 10.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.886 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.464 ' H ' ' C ' ' A' ' 14' ' ' PRO . 34.6 tp -124.13 140.04 53.35 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -133.19 -164.81 1.53 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 122.12 0.962 . . . . 0.0 110.766 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.47 139.27 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -91.0 151.47 21.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.012 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -13.12 6.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 109.324 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -91.13 0.3 57.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.368 -0.832 . . . . 0.0 109.262 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.63 4.89 79.22 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -88.62 138.46 31.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -1.119 . . . . 0.0 109.476 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -81.24 153.81 26.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 108.752 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -149.97 124.59 9.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.056 -1.028 . . . . 0.0 110.223 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 44.1 t80 -98.23 151.03 20.89 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.437 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 59.3 mtt180 -115.88 122.54 45.66 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.995 0.902 . . . . 0.0 110.322 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.77 129.85 77.9 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.5 -6.99 16.68 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.966 1.777 . . . . 0.0 113.537 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -89.03 -29.04 19.76 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.639 -1.288 . . . . 0.0 109.12 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.7 t -118.66 -15.49 9.5 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.9 -1.8 7.54 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -74.16 179.54 4.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.015 -1.285 . . . . 0.0 109.12 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -108.44 170.67 7.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.507 -0.746 . . . . 0.0 109.806 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -140.37 118.34 11.84 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.73 123.98 14.26 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.0 mt -106.46 -55.91 2.26 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.426 -1.044 . . . . 0.0 109.527 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.24 -175.14 25.86 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -94.3 11.03 31.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.005 -1.291 . . . . 0.0 108.672 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.78 98.65 11.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.473 -0.767 . . . . 0.0 109.711 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -61.68 -13.51 23.29 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.231 -0.918 . . . . 0.0 108.985 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -72.5 -53.27 12.55 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.338 -0.851 . . . . 0.0 109.354 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 87.8 mt -79.07 -36.81 18.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.509 -0.744 . . . . 0.0 109.631 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.46 -55.97 22.61 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.231 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.2 mt -56.45 -43.54 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.782 -1.199 . . . . 0.0 108.989 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.0 m -57.61 -51.34 69.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.982 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -32.97 74.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -0.854 . . . . 0.0 109.584 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.94 -47.91 70.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.182 -0.949 . . . . 0.0 110.399 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.4 mt -57.81 -49.68 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.275 -0.891 . . . . 0.0 111.127 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -58.74 -31.25 68.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.875 -1.14 . . . . 0.0 108.862 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.56 83.27 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -68.1 -38.79 82.68 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.416 -0.802 . . . . 0.0 109.368 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.81 -43.12 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.84 . . . . 0.0 108.988 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -70.57 -20.42 62.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.42 -0.8 . . . . 0.0 109.403 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.12 -14.91 54.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 109.267 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -83.97 -4.46 58.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 109.14 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -167.97 61.61 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 109.595 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -49.16 -90.5 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.282 -1.128 . . . . 0.0 109.664 179.889 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.385 0.612 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.2 mt -83.54 149.9 58.65 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.293 -0.88 . . . . 0.0 108.984 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.33 162.04 28.54 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.239 1.959 . . . . 0.0 111.602 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 16' ' ' LEU . 38.4 Cg_endo -65.15 169.62 11.85 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.684 2.256 . . . . 0.0 112.259 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 55.64 8.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.799 . . . . 0.0 110.07 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.0 tt -129.29 137.65 51.16 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.343 -0.848 . . . . 0.0 108.782 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -127.38 -166.59 1.62 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.678 0.751 . . . . 0.0 110.193 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -134.48 132.96 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -86.75 150.61 24.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.207 -0.933 . . . . 0.0 109.199 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.682 HD21 ' N ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -59.23 -10.6 3.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 110.014 -179.237 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.682 ' N ' HD21 ' A' ' 20' ' ' ASN . 93.8 m-20 -91.51 0.54 57.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.109 -0.994 . . . . 0.0 109.167 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.84 4.29 84.99 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -86.2 138.81 31.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -1.165 . . . . 0.0 108.725 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -83.43 150.14 26.23 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.6 p -148.85 137.14 21.01 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.847 -1.158 . . . . 0.0 110.526 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -102.09 152.49 20.93 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -127.22 116.34 20.45 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.424 -0.798 . . . . 0.0 108.88 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.81 139.61 73.82 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.03 -1.044 . . . . 0.0 109.549 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -83.34 25.31 0.69 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.121 1.88 . . . . 0.0 112.63 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -88.63 -68.13 0.79 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.919 -1.113 . . . . 0.0 108.709 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.466 ' HG1' ' N ' ' A' ' 32' ' ' GLY . 1.5 p -116.19 -25.28 7.65 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.466 ' N ' ' HG1' ' A' ' 31' ' ' THR . . . 115.88 23.0 4.44 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.469 ' H ' ' HD2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -75.45 177.96 6.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.031 -1.276 . . . . 0.0 109.103 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.44 165.3 23.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.395 -0.815 . . . . 0.0 109.621 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -135.74 115.07 12.52 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.95 119.53 6.42 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.15 -68.87 0.78 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.269 -1.136 . . . . 0.0 109.142 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.78 -165.97 38.78 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.814 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -100.7 6.27 43.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.468 -1.019 . . . . 0.0 109.312 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -94.99 98.63 10.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.343 -0.848 . . . . 0.0 110.271 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -54.9 -14.9 1.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.529 0.68 . . . . 0.0 109.291 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.527 HH11 ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -77.33 -54.77 6.06 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.355 -0.84 . . . . 0.0 109.509 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.7 mt -76.99 -32.89 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.342 -0.849 . . . . 0.0 109.658 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.71 -55.68 24.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.078 -1.014 . . . . 0.0 109.38 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mt -55.72 -39.44 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.059 -1.026 . . . . 0.0 109.254 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -51.15 -54.4 25.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.096 -1.003 . . . . 0.0 109.172 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -63.95 -41.63 97.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 0.0 109.605 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.9 -42.68 76.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.618 -0.676 . . . . 0.0 110.191 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.04 -58.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.079 -1.013 . . . . 0.0 110.911 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -58.82 -24.28 61.75 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.984 -1.073 . . . . 0.0 109.098 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.07 -35.34 80.26 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.166 -0.959 . . . . 0.0 108.445 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -67.18 -38.66 85.77 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.395 -0.816 . . . . 0.0 109.372 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.7 mt -70.47 -31.48 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.155 -0.965 . . . . 0.0 108.935 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -69.65 -21.6 63.53 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.36 -32.83 67.15 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -75.79 5.87 5.74 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.4 t 52.15 17.31 0.68 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.415 -0.803 . . . . 0.0 109.681 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.25 -158.23 25.45 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.4 p80 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.297 -1.119 . . . . 0.0 109.307 -179.823 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' PRO . 72.4 mt -82.32 150.76 64.7 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 109.079 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 12' ' ' LEU . 75.8 Cg_exo -34.94 157.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 122.555 2.17 . . . . 0.0 111.844 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.22 148.33 84.74 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.104 1.869 . . . . 0.0 111.582 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 61.88 32.63 17.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 109.929 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.0 tp -140.23 130.09 24.6 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.354 -0.841 . . . . 0.0 108.818 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -129.63 -172.32 2.73 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.717 0.77 . . . . 0.0 110.059 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.9 tt -142.94 152.04 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.398 0.618 . . . . 0.0 109.617 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 19' ' ' ARG . 19.3 ttm-85 -90.84 160.3 15.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.542 -0.724 . . . . 0.0 109.527 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -64.28 -14.75 57.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 108.994 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -90.12 -0.47 57.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.329 -0.857 . . . . 0.0 108.997 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.57 11.94 65.41 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -87.06 129.72 34.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.096 -1.237 . . . . 0.0 108.476 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.687 ' HH ' ' HE ' ' A' ' 41' ' ' ARG . 54.2 m-85 -83.11 147.91 27.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.456 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 18.7 p -150.49 131.46 14.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.099 -1.001 . . . . 0.0 109.861 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -97.21 149.35 22.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.294 -0.878 . . . . 0.0 109.286 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' A' ' 34' ' ' GLU . 25.8 ttm180 -115.93 116.58 28.21 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.341 -0.85 . . . . 0.0 110.224 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -74.27 138.28 75.17 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.455 -0.778 . . . . 0.0 108.988 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.92 -2.51 12.17 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.136 1.891 . . . . 0.0 112.516 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -88.18 -55.12 3.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.084 -1.01 . . . . 0.0 109.704 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -102.82 -1.06 30.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.41 -0.806 . . . . 0.0 109.124 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.3 4.96 2.97 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.496 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.96 179.4 3.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.157 -1.202 . . . . 0.0 109.124 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 20.8 mp0 -114.94 168.39 9.95 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.47 -0.769 . . . . 0.0 109.926 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -138.96 114.39 9.71 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.69 125.14 9.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.6 mt -105.17 -50.17 3.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.384 -1.068 . . . . 0.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.91 -155.37 26.22 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.718 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -110.53 7.08 22.43 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.435 -1.038 . . . . 0.0 109.411 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -93.09 101.86 14.17 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.345 -0.847 . . . . 0.0 110.252 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.687 ' HE ' ' HH ' ' A' ' 24' ' ' TYR . 38.1 ttm180 -58.6 -20.08 44.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.685 -0.634 . . . . 0.0 109.477 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -75.38 -52.19 11.34 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.12 -33.33 24.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.517 -0.739 . . . . 0.0 109.621 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.32 -58.82 5.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.187 -0.945 . . . . 0.0 109.517 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 50.5 mt -53.94 -36.73 31.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.075 -1.015 . . . . 0.0 109.13 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.54 -50.95 66.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 109.345 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -61.28 -40.36 93.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.482 -0.761 . . . . 0.0 109.601 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.99 -43.95 74.03 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.413 -0.804 . . . . 0.0 109.117 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.16 -46.07 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.09 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -59.1 -38.65 80.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.929 -1.107 . . . . 0.0 108.584 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.71 92.26 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -69.06 -39.08 79.33 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.45 -0.781 . . . . 0.0 109.385 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.7 mt -70.93 -26.66 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.54 -33.4 74.98 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.25 -29.06 65.48 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -108.03 8.04 28.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.41 -0.807 . . . . 0.0 109.409 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.6 p -151.89 75.01 1.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.921 . . . . 0.0 109.376 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.1 95.37 0.11 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 68.8 m80 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.247 -1.149 . . . . 0.0 109.51 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 13' ' ' PRO . 39.4 mt -83.4 148.22 55.0 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.31 -0.868 . . . . 0.0 109.567 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 12' ' ' LEU . 98.7 Cg_exo -35.92 158.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.656 2.237 . . . . 0.0 111.737 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 16' ' ' LEU . 65.8 Cg_endo -72.63 158.87 49.99 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.352 2.035 . . . . 0.0 112.214 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 59.71 1.25 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.794 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 14' ' ' PRO . 41.5 tp -108.34 136.91 47.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -132.56 -178.49 4.95 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.961 0.886 . . . . 0.0 110.511 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.5 tt -143.09 143.59 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 -89.58 169.16 11.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.409 -0.807 . . . . 0.0 109.852 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.511 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -66.86 -12.48 59.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.573 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -88.25 -1.56 58.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.092 -1.005 . . . . 0.0 108.989 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.31 10.04 78.36 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -88.22 130.72 35.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.06 -1.259 . . . . 0.0 108.732 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.21 148.31 26.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.885 . . . . 0.0 109.789 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.432 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 20.5 p -151.32 130.02 12.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.208 -0.933 . . . . 0.0 109.547 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 48.1 t80 -95.09 162.02 13.89 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.264 -0.897 . . . . 0.0 109.218 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.531 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 28.9 ttm180 -125.78 117.69 23.94 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.518 -0.739 . . . . 0.0 109.437 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -73.22 148.73 88.88 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.381 -0.824 . . . . 0.0 109.673 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -84.6 -16.52 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.405 2.07 . . . . 0.0 112.14 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -92.18 -40.66 10.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.334 -0.854 . . . . 0.0 110.092 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.587 ' C ' ' H ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -100.49 -13.35 18.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.158 -0.964 . . . . 0.0 109.349 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.48 -7.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -75.25 -166.09 0.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.885 -1.362 . . . . 0.0 108.734 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 27' ' ' ARG . 68.1 mt-10 -129.64 169.98 14.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.438 -0.789 . . . . 0.0 110.507 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -136.55 122.03 19.51 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.13 122.73 8.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 mt -104.85 -55.52 2.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.384 -1.068 . . . . 0.0 109.632 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.1 179.45 25.91 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' A' ' 39' ' ' ARG . 2.2 mtm-85 -88.04 4.87 43.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.447 -1.031 . . . . 0.0 109.494 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 42' ' ' ARG . 7.4 m-20 -94.38 99.19 11.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 109.545 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.508 ' NH1' ' NE ' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -62.17 -8.56 5.78 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.508 ' NE ' ' NH1' ' A' ' 41' ' ' ARG . 19.6 mmt180 -72.88 -56.98 4.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 95.4 mt -77.32 -34.0 20.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.326 0.584 . . . . 0.0 109.572 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -56.81 12.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.657 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.9 mt -56.1 -37.16 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.39 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.17 -52.64 62.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.01 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -63.11 -45.8 90.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.548 -0.72 . . . . 0.0 109.742 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.18 65.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.601 -0.687 . . . . 0.0 109.806 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.3 mt -61.78 -42.34 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.068 -1.02 . . . . 0.0 110.024 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.05 -35.08 74.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.906 -1.121 . . . . 0.0 109.012 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.77 -34.43 77.89 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -69.31 -35.65 76.19 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.463 -0.773 . . . . 0.0 109.62 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.7 mt -69.72 -34.13 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -33.92 75.93 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.86 -30.28 67.59 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.497 ' CG ' ' O ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -94.1 -2.47 52.73 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 m -153.61 70.36 0.84 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 109.058 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.476 ' H ' ' HD1' ' A' ' 59' ' ' HIS . . . 178.98 40.13 0.07 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.527 ' N ' ' HD1' ' A' ' 59' ' ' HIS . 4.2 p-80 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.267 -1.137 . . . . 0.0 109.521 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 121.722 0.772 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 49.0 mt -80.83 148.69 65.61 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.28 161.54 23.01 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.819 1.679 . . . . 0.0 111.273 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 16' ' ' LEU . 49.6 Cg_endo -67.35 155.12 71.77 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.626 2.218 . . . . 0.0 112.252 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.517 ' ND2' ' OD1' ' A' ' 52' ' ' ASN . 2.7 m-20 73.34 -15.83 0.52 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.652 -0.655 . . . . 0.0 110.193 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 14' ' ' PRO . 11.6 tp -102.21 139.52 37.71 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.098 -1.001 . . . . 0.0 109.009 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -123.68 -170.27 2.1 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.714 0.769 . . . . 0.0 109.948 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.97 133.99 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.4 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 13.1 mtm180 -91.11 152.41 20.62 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.0 -1.062 . . . . 0.0 109.906 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -58.21 -11.2 2.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 108.926 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -89.76 0.82 56.76 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.66 4.67 90.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.4 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 5.3 m-85 -86.68 131.13 34.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.259 -1.142 . . . . 0.0 108.715 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.525 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 78.4 m-85 -82.53 154.13 25.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 108.959 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -150.72 135.63 17.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.022 -1.048 . . . . 0.0 110.088 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 37.6 t80 -106.98 146.99 30.43 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.622 -0.674 . . . . 0.0 109.571 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.42 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 4.8 mtt180 -110.14 125.18 52.75 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.637 -0.664 . . . . 0.0 109.879 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 30' ' ' ARG . 44.2 t0 -79.0 112.3 26.61 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.929 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.41 0.82 0.31 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 121.399 1.399 . . . . 0.0 112.687 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.417 ' H ' ' C ' ' A' ' 28' ' ' ASP . 35.1 ttp180 -88.66 -52.04 5.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.894 -1.129 . . . . 0.0 109.741 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.94 -11.74 15.62 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.48 -0.762 . . . . 0.0 109.391 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.83 0.06 58.7 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -179.9 3.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.057 -1.261 . . . . 0.0 108.728 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -111.34 168.22 9.69 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.504 -0.748 . . . . 0.0 109.701 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -138.56 114.27 9.85 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.02 127.54 18.52 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.5 mt -107.8 -49.73 3.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.588 -0.948 . . . . 0.0 109.249 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.9 -174.28 23.22 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -91.01 11.38 23.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -1.228 . . . . 0.0 108.879 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -91.21 95.91 10.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.432 -0.792 . . . . 0.0 110.327 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 38.8 ttm180 -57.01 -19.04 16.19 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -77.0 -51.99 10.14 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.523 -0.736 . . . . 0.0 109.34 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -77.13 -31.62 18.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.64 -0.663 . . . . 0.0 109.682 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.52 -58.74 4.59 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.098 -1.001 . . . . 0.0 109.49 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.1 mt -54.22 -35.12 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.095 -1.003 . . . . 0.0 109.003 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.08 -50.77 66.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 0.0 108.968 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -61.07 -41.07 95.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.2 87.3 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.441 0.639 . . . . 0.0 109.751 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.81 -62.46 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.39 -0.819 . . . . 0.0 110.78 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -56.93 -30.01 63.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 108.683 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.61 -41.59 83.78 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.517 ' OD1' ' ND2' ' A' ' 15' ' ' ASN . 84.0 m-20 -68.97 -39.96 79.11 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.423 -0.798 . . . . 0.0 109.775 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.34 -36.99 78.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.207 -0.933 . . . . 0.0 108.494 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 58' ' ' GLY . 84.2 mt-10 -70.84 -34.85 72.1 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.1 mt -67.86 -13.28 62.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.128 -0.983 . . . . 0.0 109.008 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -104.34 -4.43 22.91 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.6 t -164.54 39.13 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.937 . . . . 0.0 109.271 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . -84.08 3.27 86.3 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 26.6 m80 . . . . . 0 N--CA 1.488 1.463 0 O-C-N 121.17 -1.194 . . . . 0.0 109.508 179.957 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 121.368 0.604 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.6 mt -85.2 149.01 51.64 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.411 -0.805 . . . . 0.0 109.275 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.99 164.15 5.17 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.592 1.528 . . . . 0.0 110.986 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.93 160.95 46.22 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.526 2.151 . . . . 0.0 112.286 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 59.96 19.61 8.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 110.088 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.9 tp -133.83 118.04 17.53 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -114.71 178.44 4.28 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.383 0.611 . . . . 0.0 109.824 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 tt -141.48 148.06 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.59 -0.694 . . . . 0.0 109.552 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' A' ' 21' ' ' ASN . 22.9 ttp180 -91.01 153.35 20.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.595 -0.69 . . . . 0.0 109.58 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -56.73 -11.52 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.173 -0.954 . . . . 0.0 108.989 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 19' ' ' ARG . 6.9 m120 -88.56 -0.79 57.61 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.355 -0.841 . . . . 0.0 109.042 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.27 9.09 80.39 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -86.67 128.05 34.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -1.143 . . . . 0.0 108.45 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -84.22 149.49 26.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.475 -0.766 . . . . 0.0 109.851 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.0 p -150.11 131.73 14.89 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.116 -0.99 . . . . 0.0 109.632 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -94.36 140.8 29.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.08 -1.012 . . . . 0.0 110.004 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -101.94 110.72 22.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.593 -0.692 . . . . 0.0 110.218 -179.332 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.99 135.96 66.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.443 -0.786 . . . . 0.0 109.951 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -81.72 15.26 1.97 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.008 1.805 . . . . 0.0 111.621 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -86.65 -69.79 0.65 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.345 -0.847 . . . . 0.0 109.213 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.4 -18.64 14.05 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.33 6.66 58.64 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.458 ' CD ' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -76.61 -174.43 2.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.85 -1.382 . . . . 0.0 109.338 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' N ' ' CD ' ' A' ' 34' ' ' GLU . 4.5 mp0 -130.77 157.11 43.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.309 -0.869 . . . . 0.0 110.229 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -116.35 127.96 55.12 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.57 116.35 4.36 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mt -99.08 -63.8 1.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.192 -1.181 . . . . 0.0 109.238 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.29 -173.01 38.53 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -92.99 8.7 38.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 108.98 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -94.23 104.24 16.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.386 -0.821 . . . . 0.0 109.82 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -60.22 -20.76 60.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.663 -0.648 . . . . 0.0 109.721 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -77.05 -55.81 5.13 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.211 -0.931 . . . . 0.0 109.074 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.3 mt -65.81 -36.56 77.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.538 -0.727 . . . . 0.0 109.198 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.13 -56.87 9.26 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.341 -0.85 . . . . 0.0 109.274 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.441 HG23 HD12 ' A' ' 45' ' ' ILE . 38.4 mt -53.58 -37.4 30.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.171 -0.956 . . . . 0.0 108.67 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.42 -55.12 31.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.07 -1.019 . . . . 0.0 109.147 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -63.3 -43.96 96.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.347 -0.846 . . . . 0.0 109.658 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.68 75.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.526 -0.734 . . . . 0.0 109.645 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.9 mt -59.64 -40.25 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.059 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -62.11 -43.78 98.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.951 -1.093 . . . . 0.0 108.478 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.89 -33.83 76.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -64.23 -36.07 82.88 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.296 -0.877 . . . . 0.0 109.333 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.405 HD13 HG22 ' A' ' 53' ' ' ILE . 96.5 mt -68.39 -25.96 32.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 108.684 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.573 ' O ' ' N ' ' A' ' 58' ' ' GLY . 96.8 mt-10 -70.39 -29.84 66.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.309 -0.869 . . . . 0.0 109.19 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.91 -14.72 60.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.879 -1.138 . . . . 0.0 109.046 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -99.29 6.95 46.05 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.276 -0.89 . . . . 0.0 110.329 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.7 t -170.5 -32.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.824 -1.172 . . . . 0.0 110.01 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 73.32 97.71 0.08 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.227 -1.16 . . . . 0.0 109.211 -179.83 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.1 mt -79.83 149.5 70.77 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.61 159.29 28.69 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.675 1.584 . . . . 0.0 111.171 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 15' ' ' ASN . 59.3 Cg_endo -69.69 154.54 67.91 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.376 2.051 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.505 ' ND2' ' OD1' ' A' ' 52' ' ' ASN . 3.6 m-20 74.19 -10.49 1.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.641 -0.662 . . . . 0.0 109.326 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.1 tt -105.27 148.46 26.97 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.369 -0.832 . . . . 0.0 110.121 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -137.31 -168.85 2.38 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.452 0.644 . . . . 0.0 109.408 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.2 tt -146.53 150.95 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.268 -0.895 . . . . 0.0 109.479 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -92.71 150.39 20.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.183 -0.948 . . . . 0.0 109.363 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -59.81 -10.91 4.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.29 -0.881 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -90.5 -0.16 57.56 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.48 10.45 70.58 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -87.14 136.17 33.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.055 -1.262 . . . . 0.0 108.495 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -84.22 152.97 23.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -154.86 145.81 22.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 110.305 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -108.99 155.45 20.87 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -131.72 120.24 22.46 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.231 -0.918 . . . . 0.0 109.868 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.08 134.41 71.18 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.796 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.24 24.37 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.0 1.8 . . . . 0.0 113.055 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -88.96 -67.25 0.85 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.806 -1.184 . . . . 0.0 108.612 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.447 ' CG2' ' NZ ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -112.78 -16.25 12.79 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.77 29.58 6.14 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.461 ' H ' ' HD2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -77.81 178.9 7.03 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.273 -1.133 . . . . 0.0 109.506 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -131.38 163.93 26.81 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.316 -0.865 . . . . 0.0 110.614 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -139.36 113.22 8.6 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.52 128.07 14.92 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.8 mt -105.89 -57.75 2.0 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.379 -1.071 . . . . 0.0 109.409 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.32 -157.82 28.93 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.79 1.88 23.2 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.503 -0.998 . . . . 0.0 110.189 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.33 107.37 19.86 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.049 -1.032 . . . . 0.0 110.135 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -61.0 -15.46 32.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.126 -0.984 . . . . 0.0 109.345 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -74.31 -55.0 6.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.262 -0.899 . . . . 0.0 108.862 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.3 mt -73.31 -35.82 47.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.357 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.82 -57.09 10.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.019 -1.05 . . . . 0.0 109.244 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -51.36 -40.48 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.278 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.29 -57.31 10.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.104 -0.997 . . . . 0.0 109.668 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.94 -36.01 74.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.389 -0.819 . . . . 0.0 109.473 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.47 -44.61 76.6 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.559 -0.856 . . . . 0.0 108.808 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.85 -45.06 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.232 -0.917 . . . . 0.0 110.312 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -61.84 -40.36 95.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.145 -0.972 . . . . 0.0 108.84 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.93 88.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.505 ' OD1' ' ND2' ' A' ' 15' ' ' ASN . 85.2 m-20 -70.0 -43.58 71.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.4 -0.813 . . . . 0.0 109.996 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.8 mt -68.05 -36.95 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.897 . . . . 0.0 109.351 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -70.47 -19.1 62.97 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.268 -0.895 . . . . 0.0 109.051 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.38 -44.47 97.1 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -89.48 2.72 54.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -0.915 . . . . 0.0 109.56 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.7 m -152.47 71.74 0.95 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.162 -0.961 . . . . 0.0 109.757 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.505 ' C ' ' CG ' ' A' ' 59' ' ' HIS . . . -92.91 128.36 9.4 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.505 ' CG ' ' C ' ' A' ' 58' ' ' GLY . 8.3 p-80 . . . . . 0 N--CA 1.499 1.979 0 O-C-N 121.486 -1.009 . . . . 0.0 109.841 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 70.2 mt -84.39 149.12 54.26 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 108.908 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.46 157.44 41.21 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.611 1.541 . . . . 0.0 111.288 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.558 ' C ' ' H ' ' A' ' 16' ' ' LEU . 45.3 Cg_endo -67.18 165.17 27.53 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.455 2.104 . . . . 0.0 111.913 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 62.58 -10.78 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.796 . . . . 0.0 110.531 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.558 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.1 tt -104.26 154.22 20.05 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.159 -0.963 . . . . 0.0 109.815 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -138.3 -178.34 5.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.548 -0.72 . . . . 0.0 110.186 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.86 137.17 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.455 ' C ' ' H ' ' A' ' 21' ' ' ASN . 9.3 mtp180 -90.59 141.33 28.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.204 -0.935 . . . . 0.0 109.422 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -50.83 -13.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.359 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.611 HD21 ' N ' ' A' ' 21' ' ' ASN . 1.0 OUTLIER -89.78 0.03 57.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.482 -0.761 . . . . 0.0 109.014 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.43 10.27 82.24 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -88.58 130.78 35.18 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.315 -1.109 . . . . 0.0 108.486 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -85.48 144.18 28.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.485 -0.759 . . . . 0.0 109.308 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 m -149.33 140.2 22.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.187 -0.945 . . . . 0.0 109.753 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -101.84 143.96 31.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.348 -0.845 . . . . 0.0 109.57 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -112.12 116.63 30.81 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.408 -0.807 . . . . 0.0 109.782 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -74.34 126.69 88.71 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 108.994 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.07 -9.1 16.66 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.986 1.791 . . . . 0.0 112.103 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -89.72 -32.49 16.99 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -110.99 -27.16 8.9 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 82.44 -10.61 54.55 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.485 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 3.0 mptp? -73.38 -174.05 1.54 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.939 -1.33 . . . . 0.0 109.885 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -120.96 169.32 10.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.578 -0.701 . . . . 0.0 110.303 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -137.37 115.61 11.76 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.55 120.69 8.39 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.7 mt -103.74 -62.87 1.25 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.504 -0.998 . . . . 0.0 108.877 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.21 -171.74 34.01 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 -93.61 8.41 40.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -1.146 . . . . 0.0 109.112 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -91.96 97.1 10.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 109.58 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -56.27 -23.13 34.35 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.455 0.645 . . . . 0.0 109.528 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -74.85 -47.55 29.72 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.341 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.19 -33.64 18.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.39 -0.819 . . . . 0.0 109.591 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.79 -58.62 5.23 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 109.326 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -54.6 -36.68 36.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.214 -0.929 . . . . 0.0 109.0 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.85 -56.89 13.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.091 -1.006 . . . . 0.0 109.12 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -60.19 -40.85 91.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.613 -0.679 . . . . 0.0 109.497 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.53 -44.51 62.64 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.0 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.435 HD13 HG23 ' A' ' 49' ' ' ILE . 91.3 mt -61.7 -45.15 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.337 -0.852 . . . . 0.0 109.619 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -64.02 -33.76 76.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.065 -1.022 . . . . 0.0 108.361 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.99 -33.36 75.4 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.35 -42.38 88.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 109.6 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.53 -35.91 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.177 -0.952 . . . . 0.0 108.728 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -69.22 -20.18 63.96 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.73 -47.57 82.04 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -79.55 9.12 5.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.24 -0.912 . . . . 0.0 109.041 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t 59.02 22.39 10.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.442 -0.786 . . . . 0.0 109.834 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.29 -167.2 53.36 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.329 -1.101 . . . . 0.0 109.502 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 8.4 p-10 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.239 0.542 . . . . 0.0 109.633 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 13' ' ' PRO . 46.3 mt -82.17 150.13 63.87 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 109.688 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 12' ' ' LEU . 33.7 Cg_exo -34.31 158.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.709 2.273 . . . . 0.0 112.246 178.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.62 159.22 54.51 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.113 1.876 . . . . 0.0 112.067 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 53.55 19.95 1.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.458 -0.776 . . . . 0.0 110.176 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.5 tp -127.21 125.13 40.5 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 43.0 m-85 -121.63 -170.69 2.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.81 0.814 . . . . 0.0 110.487 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.77 141.61 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -91.95 144.54 25.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.061 -1.025 . . . . 0.0 109.281 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -54.15 -19.02 4.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 109.857 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -86.81 0.68 54.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.18 3.21 79.37 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.463 ' CE1' ' NE ' ' A' ' 39' ' ' ARG . 12.5 m-85 -85.15 140.08 31.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.072 -1.252 . . . . 0.0 109.055 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -84.79 146.94 27.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.434 -0.791 . . . . 0.0 108.966 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 25' ' ' CYS . 20.2 p -146.46 129.77 16.69 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.873 -1.142 . . . . 0.0 110.32 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 27' ' ' ARG . 43.2 t80 -99.37 148.73 23.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.451 -0.781 . . . . 0.0 109.007 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.406 ' O ' ' CE1' ' A' ' 26' ' ' TYR . 23.2 ttm180 -104.43 117.57 34.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.489 -0.757 . . . . 0.0 109.533 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.52 150.67 95.6 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.294 -0.878 . . . . 0.0 109.623 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -85.52 -8.14 8.53 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.623 2.216 . . . . 0.0 112.996 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -90.48 -47.09 7.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.04 -1.037 . . . . 0.0 110.671 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.2 p -109.01 -11.6 14.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 109.818 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.39 2.12 25.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -179.12 3.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -1.204 . . . . 0.0 108.915 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -109.94 168.92 9.06 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.564 -0.71 . . . . 0.0 109.56 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -140.54 119.07 12.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.442 -0.786 . . . . 0.0 109.269 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.79 122.88 12.36 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.2 mt -107.06 -44.3 4.42 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -1.052 . . . . 0.0 109.069 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 147.18 -179.8 23.82 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.463 ' NE ' ' CE1' ' A' ' 23' ' ' TYR . 18.6 mtt180 -92.78 10.71 29.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -1.088 . . . . 0.0 108.403 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -95.96 105.47 17.5 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.453 0.645 . . . . 0.0 110.116 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -60.74 -19.36 58.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -71.4 -58.78 3.2 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.388 -0.82 . . . . 0.0 109.234 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 94.1 mt -68.94 -37.3 77.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.676 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.12 -56.72 11.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.031 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 79.3 mt -54.63 -33.38 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.806 -1.184 . . . . 0.0 109.372 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -58.3 -51.59 69.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.653 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -61.92 -44.91 95.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.278 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.51 -43.33 79.67 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.49 -0.756 . . . . 0.0 110.85 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.9 -52.83 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.017 -1.052 . . . . 0.0 111.624 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -60.12 -29.6 68.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.83 -1.169 . . . . 0.0 109.492 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.51 -33.76 75.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.238 -0.914 . . . . 0.0 109.028 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -69.48 -38.66 77.8 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.306 -0.871 . . . . 0.0 110.897 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt -67.99 -35.45 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.158 -0.963 . . . . 0.0 109.702 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 56' ' ' PHE . 98.5 mt-10 -70.1 -27.24 64.43 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.25 -0.906 . . . . 0.0 109.606 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mt -63.51 -1.82 1.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 109.179 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 54' ' ' GLU . 95.2 m-85 -142.57 4.2 1.53 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.354 -0.842 . . . . 0.0 109.319 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.1 m -144.01 46.08 1.45 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.187 -0.945 . . . . 0.0 109.539 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.52 -50.54 1.83 Allowed Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.35 -1.088 . . . . 0.0 109.578 179.966 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.302 0.572 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.84 151.44 61.03 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.243 -0.911 . . . . 0.0 109.073 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.32 158.42 48.94 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.027 1.818 . . . . 0.0 111.181 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 16' ' ' LEU . 37.4 Cg_endo -64.6 170.89 9.1 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.533 2.155 . . . . 0.0 112.308 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 52.75 9.12 0.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.847 . . . . 0.0 109.824 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 14' ' ' PRO . 9.2 tt -133.84 137.53 45.1 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.373 -0.829 . . . . 0.0 109.427 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 12.8 m-85 -138.2 -157.07 0.74 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.57 0.7 . . . . 0.0 109.647 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.6 tt -145.39 153.2 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.669 0.747 . . . . 0.0 110.335 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' A' ' 21' ' ' ASN . 34.5 ttp180 -94.22 153.55 18.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.631 -0.668 . . . . 0.0 109.708 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.479 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -56.23 -8.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.069 179.638 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 19' ' ' ARG . 19.1 m-20 -90.37 -3.14 57.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.29 -0.881 . . . . 0.0 108.988 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.77 7.09 78.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -88.02 140.06 29.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.438 -1.037 . . . . 0.0 109.291 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -85.77 152.92 22.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 109.372 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.2 p -150.91 138.24 19.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.153 -0.967 . . . . 0.0 109.976 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -100.59 146.73 26.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.304 -0.873 . . . . 0.0 109.342 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -105.06 111.84 24.75 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.467 -0.771 . . . . 0.0 109.654 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.74 125.7 90.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 108.767 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.75 -6.42 15.22 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.803 1.669 . . . . 0.0 112.819 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -89.15 -28.77 19.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.973 -1.08 . . . . 0.0 109.345 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.7 t -116.22 -28.44 6.55 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.33 -13.15 62.64 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 8.6 mptt -77.07 -178.93 5.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.041 -1.27 . . . . 0.0 109.886 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' N ' ' CD ' ' A' ' 34' ' ' GLU . 9.6 mp0 -108.88 174.62 5.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.599 -0.688 . . . . 0.0 110.184 -179.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -138.16 123.93 19.91 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.42 130.89 21.56 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.5 mt -118.45 -55.97 2.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.554 -0.968 . . . . 0.0 109.572 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.46 -171.94 27.15 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.744 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -95.14 10.49 35.7 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.164 -1.198 . . . . 0.0 109.155 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.464 ' C ' ' N ' ' A' ' 42' ' ' ARG . 93.7 m-20 -91.73 90.68 7.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.364 -0.835 . . . . 0.0 109.494 -179.153 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -54.7 -12.54 0.78 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' C ' ' A' ' 40' ' ' ASP . 5.7 mtt180 -73.42 -56.87 4.48 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.627 -0.671 . . . . 0.0 109.587 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.3 mt -75.18 -36.95 38.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.17 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.6 -57.54 9.79 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.55 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 88.5 mt -55.88 -41.09 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.542 -1.349 . . . . 0.0 108.564 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -55.98 -56.71 17.41 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.469 -0.769 . . . . 0.0 109.592 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -27.56 66.4 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.216 -0.928 . . . . 0.0 109.186 -179.322 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.87 -48.13 77.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 108.748 178.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.75 -51.17 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.573 -0.704 . . . . 0.0 110.21 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -58.65 -37.1 75.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.947 -1.096 . . . . 0.0 108.179 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.29 88.41 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.24 -40.93 81.85 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.513 -0.742 . . . . 0.0 109.256 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.0 mt -71.05 -41.56 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 108.54 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -71.85 -19.25 61.99 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.634 -0.666 . . . . 0.0 109.435 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.7 tp -59.5 -29.4 67.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.116 -0.99 . . . . 0.0 108.782 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -85.16 8.23 18.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.821 . . . . 0.0 108.868 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.4 m 52.94 14.22 0.43 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 0.0 109.435 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.33 90.07 0.14 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.494 ' N ' ' CD2' ' A' ' 59' ' ' HIS . 4.9 m170 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.15 -1.206 . . . . 0.0 109.448 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.4 t70 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.0 mt -82.95 149.08 58.57 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.913 . . . . 0.0 109.272 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.01 162.68 18.51 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.111 1.874 . . . . 0.0 111.872 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.97 168.3 20.91 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.913 2.409 . . . . 0.0 112.684 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 48.19 22.5 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.529 -0.732 . . . . 0.0 110.302 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.444 ' C ' ' CD1' ' A' ' 17' ' ' TYR . 5.1 tt -136.05 146.08 46.72 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.217 -0.927 . . . . 0.0 109.166 179.099 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 32.0 m-85 -137.34 -172.77 3.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.546 -0.721 . . . . 0.0 110.342 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.9 tt -139.14 150.91 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -91.19 164.23 13.98 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.277 -0.889 . . . . 0.0 109.926 -178.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -66.4 -16.81 64.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.051 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -89.41 0.08 57.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.366 -0.834 . . . . 0.0 108.789 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.13 14.83 63.65 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -87.2 134.65 33.51 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.117 -1.225 . . . . 0.0 108.702 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.499 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 12.9 m-85 -83.73 156.24 22.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.995 . . . . 0.0 109.671 -179.715 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 24' ' ' TYR . 94.6 m -156.14 135.31 12.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.51 -0.744 . . . . 0.0 109.636 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -100.22 141.42 33.08 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.138 -0.976 . . . . 0.0 109.364 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -107.34 113.79 27.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.501 -0.749 . . . . 0.0 109.673 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -71.44 132.91 85.38 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.42 -0.8 . . . . 0.0 109.645 -179.904 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.59 -5.51 12.49 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.198 1.932 . . . . 0.0 112.375 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -88.5 -37.79 15.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.202 -0.936 . . . . 0.0 109.628 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.5 t -113.11 -29.93 7.15 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.496 -0.753 . . . . 0.0 109.069 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.3 -10.08 74.95 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.168 -0.958 . . . . 0.0 110.929 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.469 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 9.7 mptt -74.73 179.36 4.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.902 -1.352 . . . . 0.0 109.61 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -117.47 171.73 7.8 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.666 0.746 . . . . 0.0 110.661 -178.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.94 122.65 18.69 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.55 122.94 8.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.5 mt -106.59 -70.09 0.8 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.478 -1.013 . . . . 0.0 109.398 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.25 -174.09 44.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -93.9 6.66 47.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -1.137 . . . . 0.0 109.522 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -95.41 98.87 10.88 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 109.489 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.526 HH11 ' CG ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -58.34 -13.14 4.61 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 108.498 179.606 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -74.38 -49.57 22.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 89.4 mt -78.54 -36.87 20.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.39 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.85 -57.51 8.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.232 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -54.38 -37.13 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.12 -0.988 . . . . 0.0 109.287 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -54.54 -58.15 8.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 108.895 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -60.9 -37.33 81.83 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.576 0.703 . . . . 0.0 109.132 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.13 -42.61 81.26 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.59 -0.694 . . . . 0.0 109.17 179.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.62 -45.87 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.203 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -58.89 -32.69 69.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.054 -1.029 . . . . 0.0 108.686 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.52 91.32 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -67.78 -41.43 83.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 0.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 1.4 mp -70.81 -37.5 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -73.15 -20.52 60.89 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.378 -0.826 . . . . 0.0 109.416 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 40.8 tp -60.1 -18.63 48.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 0.0 109.258 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.528 ' O ' ' CD1' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -89.04 0.9 56.29 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.794 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 59' ' ' HIS . 7.4 t -173.68 52.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.449 -0.782 . . . . 0.0 109.198 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.87 -1.52 3.83 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.453 ' H ' ' C ' ' A' ' 57' ' ' SER . 11.7 m170 . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.244 -1.151 . . . . 0.0 109.479 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.07 151.09 56.63 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.399 -0.813 . . . . 0.0 109.299 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -38.31 156.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.264 1.976 . . . . 0.0 111.903 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 16' ' ' LEU . 42.8 Cg_endo -66.26 147.83 83.88 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.212 1.942 . . . . 0.0 112.131 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 65.59 -1.83 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.608 -0.682 . . . . 0.0 110.38 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.9 tt -105.87 139.09 40.97 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.146 -0.972 . . . . 0.0 110.103 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -140.63 -168.44 2.57 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.72 0.772 . . . . 0.0 109.574 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tt -146.25 146.22 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.585 -0.697 . . . . 0.0 109.683 178.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.467 ' C ' ' H ' ' A' ' 21' ' ' ASN . 19.8 mtm180 -91.65 152.8 20.07 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.355 -0.841 . . . . 0.0 109.571 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -53.46 -11.15 0.3 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.236 -0.915 . . . . 0.0 109.163 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.467 ' H ' ' C ' ' A' ' 19' ' ' ARG . 47.6 m-20 -87.75 1.39 53.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 109.254 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.13 6.56 89.12 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -86.53 126.68 34.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.066 -1.255 . . . . 0.0 108.692 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -82.69 148.93 27.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 109.37 -179.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 p -148.62 144.8 27.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.201 -0.937 . . . . 0.0 109.822 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 36.6 t80 -105.98 148.23 27.93 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.46 ' NE ' ' O ' ' A' ' 32' ' ' GLY . 15.0 ttm180 -110.01 121.11 44.5 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.463 -0.773 . . . . 0.0 110.675 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -75.72 136.87 70.38 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.333 -0.854 . . . . 0.0 108.857 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.59 6.02 5.15 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.035 1.823 . . . . 0.0 112.252 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -89.8 -56.6 3.17 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 110.131 -179.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.17 1.5 13.87 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.38 -0.825 . . . . 0.0 109.474 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.46 ' O ' ' NE ' ' A' ' 27' ' ' ARG . . . 67.78 13.97 64.55 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -174.4 1.16 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.077 -1.249 . . . . 0.0 109.064 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -130.88 153.07 49.52 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 0.0 109.525 179.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -115.76 128.09 55.59 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.5 114.74 3.9 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.5 mt -100.56 -63.04 1.17 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.268 -1.137 . . . . 0.0 109.951 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.68 -177.15 36.3 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.451 ' H ' ' NH1' ' A' ' 39' ' ' ARG . 2.7 mtm-85 -89.1 7.37 35.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.071 -1.252 . . . . 0.0 109.997 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -95.61 107.97 20.2 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.147 -0.971 . . . . 0.0 109.361 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -65.61 -20.04 66.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 110.081 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -73.08 -48.63 34.17 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.109 -0.995 . . . . 0.0 109.598 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 93.8 mt -76.96 -37.49 26.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.266 -179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.38 -57.41 8.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 109.804 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 45' ' ' ILE . 94.1 mt -53.25 -35.59 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 0.0 109.421 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -51.65 66.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -60.76 -35.64 76.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.859 . . . . 0.0 109.304 -179.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.02 74.2 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.584 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.13 -47.11 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.833 . . . . 0.0 110.398 -179.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -62.29 -41.05 98.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.986 -1.071 . . . . 0.0 108.155 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.68 81.84 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -64.43 -34.1 77.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.098 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.3 mt -70.37 -27.83 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 108.73 179.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 58' ' ' GLY . 63.3 mt-10 -68.13 -28.37 67.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.228 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.1 mp -62.45 -15.41 49.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 109.202 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -103.65 -6.55 21.5 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.342 -0.849 . . . . 0.0 109.745 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -163.01 35.84 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.015 -1.053 . . . . 0.0 109.81 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . -84.33 146.05 22.5 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.576 ' CD2' ' H ' ' A' ' 59' ' ' HIS . 6.4 p80 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.214 -1.168 . . . . 0.0 109.45 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 121.73 0.776 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.3 mt -81.19 150.18 67.51 Favored Pre-proline 0 C--N 1.299 -1.601 0 O-C-N 121.496 -0.753 . . . . 0.0 109.108 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.64 161.93 16.63 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.947 1.765 . . . . 0.0 111.369 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 16' ' ' LEU . 36.3 Cg_endo -64.19 153.97 73.44 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.733 2.289 . . . . 0.0 112.595 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 67.07 -8.02 0.46 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.73 -0.606 . . . . 0.0 110.826 179.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.44 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.2 tt -107.18 143.34 35.51 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.103 -0.998 . . . . 0.0 110.018 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 28.2 m-85 -137.78 -163.59 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.53 -0.731 . . . . 0.0 109.659 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.5 tt -143.08 150.84 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 121.43 0.634 . . . . 0.0 109.775 178.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -91.72 165.46 13.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.43 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -66.39 -13.01 60.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.958 . . . . 0.0 109.334 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -89.18 -0.28 57.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 109.121 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.99 11.46 73.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -87.04 132.22 33.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -1.153 . . . . 0.0 108.609 179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.533 ' OH ' ' NH1' ' A' ' 41' ' ' ARG . 44.9 m-85 -83.14 145.9 28.96 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.9 m -148.5 145.2 27.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.919 -1.113 . . . . 0.0 110.804 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -99.3 153.67 18.78 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.53 HH21 ' CD ' ' A' ' 34' ' ' GLU . 20.2 ttm180 -116.51 116.68 28.09 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.278 -0.889 . . . . 0.0 110.366 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -76.34 136.6 68.41 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.56 -11.48 14.21 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.951 1.768 . . . . 0.0 113.302 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -36.37 16.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.752 -1.217 . . . . 0.0 109.284 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 33' ' ' LYS . 79.7 p -107.04 -14.78 14.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.81 -2.64 1.83 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -74.1 -169.35 0.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -1.162 . . . . 0.0 108.714 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.53 ' CD ' HH21 ' A' ' 27' ' ' ARG . 11.7 mt-10 -128.16 170.0 13.47 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.448 -0.782 . . . . 0.0 110.032 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -134.32 124.94 26.65 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.9 122.03 6.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.1 mt -105.48 -49.4 3.44 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.46 -1.023 . . . . 0.0 109.196 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.47 -170.43 31.67 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 2.28 47.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.319 -1.107 . . . . 0.0 109.245 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -97.01 98.48 10.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.294 -0.879 . . . . 0.0 110.039 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.533 ' NH1' ' OH ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -57.55 -16.14 9.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 108.958 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -69.61 -49.02 57.91 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.449 ' N ' ' CD1' ' A' ' 43' ' ' ILE . 1.8 mp -81.44 -33.05 12.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.5 -59.0 4.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.366 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.6 mt -54.14 -37.83 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.302 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -53.22 54.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.207 -0.933 . . . . 0.0 108.973 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -63.51 -44.29 94.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.481 -0.762 . . . . 0.0 109.51 -179.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.78 -41.86 71.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.579 -0.7 . . . . 0.0 109.674 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.0 mt -60.76 -43.62 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -0.897 . . . . 0.0 110.365 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -59.96 -36.45 77.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.18 . . . . 0.0 108.176 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.33 75.51 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.29 -45.48 76.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.462 -0.774 . . . . 0.0 110.213 -179.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mp -68.79 -40.2 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 108.596 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.63 -18.17 63.57 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 108.83 179.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tp -61.55 -31.31 71.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.564 -0.71 . . . . 0.0 109.305 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -93.62 7.9 42.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.282 -0.886 . . . . 0.0 109.47 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -157.74 66.91 0.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.411 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.18 -11.27 70.59 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.366 -1.079 . . . . 0.0 109.402 179.971 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.8 mt -82.05 149.01 61.84 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.955 . . . . 0.0 108.704 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.38 161.96 22.02 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.743 1.629 . . . . 0.0 111.464 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.11 171.92 9.44 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.59 2.194 . . . . 0.0 111.707 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 51.01 15.65 0.28 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -0.891 . . . . 0.0 109.988 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tt -138.09 133.93 34.05 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.165 -0.959 . . . . 0.0 110.026 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 22.7 m-85 -132.73 -163.11 1.3 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.707 -0.621 . . . . 0.0 109.418 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.1 tt -141.15 151.03 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 121.629 0.728 . . . . 0.0 110.133 179.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.478 HH21 ' CB ' ' A' ' 23' ' ' TYR . 11.7 ttp180 -92.64 148.15 22.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.516 -0.74 . . . . 0.0 109.143 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -52.91 -10.83 0.19 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.0 . . . . 0.0 109.448 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 19' ' ' ARG . 85.4 m-20 -90.09 -2.88 58.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 108.846 179.561 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.13 8.7 74.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.478 ' CB ' HH21 ' A' ' 19' ' ' ARG . 4.6 m-85 -85.77 132.55 34.1 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -82.57 147.91 28.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.16 -0.963 . . . . 0.0 108.528 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 m -148.04 144.59 28.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.993 -1.067 . . . . 0.0 109.949 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -101.08 148.09 25.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.538 -0.727 . . . . 0.0 109.788 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -105.52 108.84 20.57 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.364 -0.835 . . . . 0.0 110.025 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -72.28 119.57 75.51 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 108.669 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.75 0.55 9.71 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.626 1.551 . . . . 0.0 112.152 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -90.28 -28.87 18.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.101 -0.999 . . . . 0.0 109.352 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.7 t -120.4 -27.64 5.16 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.58 -11.84 70.61 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.5 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 10.9 mptt -77.8 179.81 6.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.02 -1.282 . . . . 0.0 110.182 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.07 176.4 5.04 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.633 -0.667 . . . . 0.0 110.336 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -139.95 114.14 9.04 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.18 121.95 9.44 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.6 mt -105.36 -57.22 2.06 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.459 -1.024 . . . . 0.0 109.633 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.04 -158.6 30.95 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.473 HH11 ' CB ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -107.35 2.53 24.51 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.528 -0.983 . . . . 0.0 109.929 -179.789 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -93.91 98.26 10.93 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.098 -1.001 . . . . 0.0 110.043 -179.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -51.18 -21.1 1.82 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.274 -0.891 . . . . 0.0 108.604 179.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -71.9 -57.29 4.45 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.2 mm -67.55 -36.42 76.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.384 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.43 -58.34 4.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.603 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.35 -35.15 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 108.964 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -53.44 -54.18 40.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.155 -0.966 . . . . 0.0 108.518 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -62.08 -41.26 97.99 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.623 0.725 . . . . 0.0 109.328 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.23 -45.94 68.91 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.585 -0.697 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.26 -46.77 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.896 . . . . 0.0 110.209 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -62.12 -36.56 82.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.93 -1.106 . . . . 0.0 108.62 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.16 -35.53 81.09 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -69.83 -40.87 75.6 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.638 -0.664 . . . . 0.0 109.629 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.27 -44.11 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.266 -0.896 . . . . 0.0 109.035 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -66.91 -19.91 65.81 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.95 -19.88 66.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.358 -0.839 . . . . 0.0 108.785 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.449 ' O ' ' CB ' ' A' ' 57' ' ' SER . 1.7 t80 -93.72 -6.78 45.4 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 56' ' ' PHE . 0.5 OUTLIER 75.16 30.59 0.87 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.631 -0.668 . . . . 0.0 110.156 179.333 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.14 -169.82 9.77 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.0 p80 . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.196 -1.179 . . . . 0.0 109.488 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.61 158.65 31.38 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.651 1.567 . . . . 0.0 111.312 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 16' ' ' LEU . 58.2 Cg_endo -69.63 156.67 63.06 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.603 2.202 . . . . 0.0 112.713 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 70.84 -17.35 0.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.761 -0.587 . . . . 0.0 110.195 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 14' ' ' PRO . 3.9 tt -99.95 142.7 31.08 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.204 -0.935 . . . . 0.0 109.815 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -134.34 -177.79 4.75 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.476 0.655 . . . . 0.0 109.775 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.571 HD12 ' CE1' ' A' ' 24' ' ' TYR . 18.6 tt -140.0 148.88 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-O 121.376 0.607 . . . . 0.0 109.792 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.428 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 13.7 mtm180 -91.11 156.84 17.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.359 -0.838 . . . . 0.0 109.702 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -57.38 -14.39 4.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.463 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -88.67 -2.12 58.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 108.676 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.99 12.62 67.97 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.428 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 2.9 m-85 -86.51 130.52 34.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.045 -1.268 . . . . 0.0 108.429 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.571 ' CE1' HD12 ' A' ' 18' ' ' ILE . 54.3 m-85 -84.2 148.92 26.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 109.71 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.3 p -152.72 138.66 18.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.162 -0.961 . . . . 0.0 109.903 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -100.92 150.58 22.71 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.346 -0.846 . . . . 0.0 108.956 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -111.32 113.0 25.16 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.185 -0.947 . . . . 0.0 110.293 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.07 139.71 76.41 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 108.939 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -82.75 -10.77 10.51 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.042 1.828 . . . . 0.0 113.107 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -89.08 -38.82 14.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.784 -1.198 . . . . 0.0 109.769 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 33' ' ' LYS . 2.5 t -106.51 -11.08 16.01 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.75 -6.39 0.62 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -75.52 179.71 5.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.971 -1.311 . . . . 0.0 109.315 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 68.4 mt-10 -107.89 173.03 6.5 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.539 -0.726 . . . . 0.0 109.985 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -136.6 116.55 13.25 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.82 125.79 16.8 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 28.3 mt -110.44 -59.73 1.9 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.501 -0.999 . . . . 0.0 109.207 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.91 -176.06 35.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -93.13 7.79 42.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.15 -1.206 . . . . 0.0 109.477 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.02 101.99 13.73 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -58.77 -12.88 4.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.157 -0.964 . . . . 0.0 108.764 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -75.63 -56.8 4.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.458 -0.777 . . . . 0.0 108.97 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 89.0 mt -73.27 -34.71 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.526 -0.734 . . . . 0.0 109.596 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.57 -57.71 7.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.035 -1.041 . . . . 0.0 109.437 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 92.1 mt -54.51 -36.82 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 109.211 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -53.7 -56.81 14.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 108.938 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -62.11 -42.99 99.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.651 -0.656 . . . . 0.0 110.027 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.65 67.68 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.387 -0.82 . . . . 0.0 109.147 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.31 -48.34 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.336 -0.852 . . . . 0.0 109.919 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -61.37 -39.68 91.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.989 -1.069 . . . . 0.0 108.241 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.14 75.13 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -67.92 -33.62 75.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.421 -0.799 . . . . 0.0 109.695 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 108.824 -179.852 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -35.59 145.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.738 2.292 . . . . 0.0 112.52 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -44.43 138.5 7.45 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.079 1.852 . . . . 0.0 113.429 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 m120 61.04 43.38 11.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.446 -0.784 . . . . 0.0 111.63 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.5 tp -139.95 119.42 13.07 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -113.39 179.87 3.84 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.583 0.706 . . . . 0.0 110.413 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.605 HD12 ' CE1' ' A' ' 24' ' ' TYR . 13.0 tt -138.73 147.1 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-O 121.538 0.685 . . . . 0.0 109.243 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -91.48 160.12 15.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.533 -0.73 . . . . 0.0 110.352 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -61.36 -11.49 10.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.58 -0.7 . . . . 0.0 109.125 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -88.87 -1.2 57.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.029 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.77 4.99 86.92 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -86.65 135.29 33.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.11 -1.23 . . . . 0.0 108.367 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.605 ' CE1' HD12 ' A' ' 18' ' ' ILE . 79.5 m-85 -84.37 152.53 24.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.166 -0.959 . . . . 0.0 110.16 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.437 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 30.2 p -150.77 126.4 10.23 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.424 -0.797 . . . . 0.0 109.455 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -94.96 150.27 20.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.195 -0.94 . . . . 0.0 109.333 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -115.05 115.67 27.2 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.485 -0.759 . . . . 0.0 110.627 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -76.01 131.43 75.95 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 108.989 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.86 -7.69 13.33 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.022 1.815 . . . . 0.0 113.42 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -86.13 -18.16 33.05 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.646 -1.284 . . . . 0.0 108.977 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 33' ' ' LYS . 1.3 t -130.67 -27.46 2.13 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.46 -3.52 84.63 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' H ' HG23 ' A' ' 31' ' ' THR . 4.3 mmtp -75.21 -176.32 3.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.953 -1.322 . . . . 0.0 109.304 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -115.99 170.2 8.67 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.484 -0.76 . . . . 0.0 110.266 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -137.27 121.7 18.27 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.28 123.5 6.32 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.7 mt -104.79 -69.56 0.81 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.417 -1.049 . . . . 0.0 109.572 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.57 -177.92 37.67 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.421 ' HG3' HH11 ' A' ' 39' ' ' ARG . 6.9 mtm-85 -90.52 7.19 40.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.169 -1.195 . . . . 0.0 110.035 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -95.18 111.31 23.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.253 -0.904 . . . . 0.0 110.216 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.519 HH11 ' HG3' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -62.63 -15.57 52.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 108.99 179.119 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -74.43 -46.67 38.48 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.85 -39.6 16.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.44 -58.16 7.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.667 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 98.7 mt -55.88 -37.56 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.942 -1.099 . . . . 0.0 109.343 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -55.97 -57.96 9.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 109.542 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -61.47 -42.71 99.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.475 -0.766 . . . . 0.0 109.911 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.32 64.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.491 -0.755 . . . . 0.0 109.542 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.47 -42.99 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.242 -0.911 . . . . 0.0 110.36 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.402 ' H ' ' HG3' ' A' ' 50' ' ' GLN . 33.7 mt-30 -59.94 -32.47 70.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.039 -1.038 . . . . 0.0 108.804 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.28 -36.5 84.29 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -67.18 -37.49 83.79 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.28 -0.888 . . . . 0.0 109.873 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.8 mt . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.131 -0.981 . . . . 0.0 109.011 -179.852 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.91 161.91 43.71 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.34 2.027 . . . . 0.0 111.094 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.52 ' C ' ' H ' ' A' ' 16' ' ' LEU . 32.4 Cg_endo -62.58 165.03 16.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.35 2.034 . . . . 0.0 112.052 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.4 m120 61.7 -9.35 0.08 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.654 -0.654 . . . . 0.0 110.698 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.9 tp -108.08 143.0 37.43 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.091 -1.005 . . . . 0.0 109.335 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 46.5 m-85 -136.78 -165.33 1.72 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.769 0.795 . . . . 0.0 110.052 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.472 HD13 ' CE1' ' A' ' 24' ' ' TYR . 10.5 tp -138.47 138.05 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.503 ' HE ' ' CB ' ' A' ' 23' ' ' TYR . 44.1 mtm180 -89.71 173.04 8.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.258 -0.901 . . . . 0.0 109.28 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -64.51 -20.04 65.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.113 -0.992 . . . . 0.0 109.699 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.85 3.1 55.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.001 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.431 ' C ' HD11 ' A' ' 18' ' ' ILE . . . 77.93 19.82 74.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.503 ' CB ' ' HE ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -84.92 132.76 34.33 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.472 ' CE1' HD13 ' A' ' 18' ' ' ILE . 65.6 m-85 -82.2 141.99 32.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.925 -1.109 . . . . 0.0 109.638 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.9 m -144.13 135.23 25.43 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 38.5 t80 -96.86 157.49 15.88 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.565 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 27.6 ttm180 -127.52 120.53 28.48 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.498 -0.751 . . . . 0.0 110.539 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -76.47 144.94 74.9 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.128 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.18 -13.0 7.85 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.997 1.798 . . . . 0.0 111.902 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -91.59 -36.3 13.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.282 -0.886 . . . . 0.0 110.078 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 33' ' ' LYS . 27.6 p -106.2 -17.83 14.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.37 -0.831 . . . . 0.0 109.503 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.1 -8.99 0.81 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 31' ' ' THR . 6.6 tmtt? -73.6 -174.17 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.983 -1.304 . . . . 0.0 108.232 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -128.99 161.38 30.07 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.39 -0.819 . . . . 0.0 110.51 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -119.48 137.17 53.97 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.8 120.58 5.25 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mt -102.53 -61.27 1.42 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.409 -1.054 . . . . 0.0 108.838 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.18 -170.18 32.69 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.63 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 1.2 mtm180 -95.85 11.37 33.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -1.194 . . . . 0.0 109.13 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -93.06 98.51 11.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.476 -0.765 . . . . 0.0 110.031 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -61.78 -13.13 20.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.572 -0.705 . . . . 0.0 109.163 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 42' ' ' ARG . 17.3 mmm-85 -77.04 -57.12 4.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.48 -0.762 . . . . 0.0 109.591 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.7 mp -74.42 -35.95 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.22 -0.925 . . . . 0.0 109.537 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.6 -52.98 62.16 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.162 -0.961 . . . . 0.0 109.346 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.5 mt -57.2 -41.67 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.684 -1.26 . . . . 0.0 108.554 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.9 m -57.76 -51.25 70.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 110.614 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -32.77 74.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.035 -1.041 . . . . 0.0 109.768 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.5 90.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.168 -0.957 . . . . 0.0 110.051 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.18 -56.31 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.353 -0.842 . . . . 0.0 111.007 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -56.19 -31.11 63.14 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.943 -1.098 . . . . 0.0 108.489 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.94 -38.0 82.3 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -65.6 -45.28 83.79 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.5 mt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.353 -0.842 . . . . 0.0 108.748 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 13' ' ' PRO . 40.6 mt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 12' ' ' LEU . 90.7 Cg_exo -35.41 158.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.617 2.212 . . . . 0.0 111.814 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.08 143.88 50.63 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.059 1.839 . . . . 0.0 111.265 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 65.85 29.17 10.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.602 -0.686 . . . . 0.0 109.939 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.0 tp -138.91 123.66 18.64 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 11.9 m-85 -131.1 -163.95 1.38 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.172 0.987 . . . . 0.0 111.11 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 tp -126.82 142.21 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' A' ' 19' ' ' ARG . 14.5 ttm-85 -88.48 161.53 16.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.162 -0.962 . . . . 0.0 109.036 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -59.26 -18.35 36.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.038 -1.039 . . . . 0.0 109.423 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -89.36 -0.33 57.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.093 -1.005 . . . . 0.0 108.722 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.36 8.41 74.57 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -86.22 142.61 28.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -1.174 . . . . 0.0 108.943 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -81.48 149.71 28.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.967 -1.083 . . . . 0.0 108.938 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 p -148.57 135.44 19.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.983 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -97.83 154.81 17.38 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -118.12 110.84 18.11 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.451 -0.781 . . . . 0.0 109.472 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.95 151.02 86.28 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.223 -0.923 . . . . 0.0 109.645 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -90.46 -23.18 0.64 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.624 2.216 . . . . 0.0 113.146 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HG3' HG23 ' A' ' 31' ' ' THR . 28.4 ptt180 -90.14 -26.35 20.22 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.933 -1.105 . . . . 0.0 110.346 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.532 ' C ' ' H ' ' A' ' 33' ' ' LYS . 68.1 p -105.92 -19.24 13.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.0 -1.062 . . . . 0.0 108.421 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.74 -11.23 0.63 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -75.99 -161.97 0.2 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.202 -1.176 . . . . 0.0 109.032 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 44.1 mt-10 -129.82 179.52 5.8 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.573 -0.705 . . . . 0.0 109.935 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -143.94 117.45 9.14 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.09 126.3 10.2 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt -105.97 -52.47 2.8 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.362 -1.081 . . . . 0.0 109.622 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.92 -173.07 30.52 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -97.72 8.95 43.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -1.129 . . . . 0.0 109.292 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -94.43 99.52 11.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.325 -0.859 . . . . 0.0 110.422 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -55.47 -19.61 10.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.538 HH11 ' HG2' ' A' ' 42' ' ' ARG . 1.1 mmt-85 -75.46 -54.09 7.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 109.237 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 78.9 mt -76.25 -36.84 30.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.688 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -58.52 8.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 50.8 mt -50.84 -39.43 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.8 -1.187 . . . . 0.0 109.176 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.06 -51.5 66.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.008 . . . . 0.0 109.499 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -62.37 -41.25 98.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 109.151 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.38 93.4 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.434 -0.792 . . . . 0.0 110.229 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.1 mt -60.46 -52.66 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.137 -0.977 . . . . 0.0 110.593 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -59.12 -30.87 68.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.875 -1.141 . . . . 0.0 108.712 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.31 93.18 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -68.05 -39.32 83.05 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.466 -0.771 . . . . 0.0 109.392 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.8 mt . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.243 -0.911 . . . . 0.0 108.831 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.1 mt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.53 160.44 39.7 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.752 1.634 . . . . 0.0 110.354 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 16' ' ' LEU . 57.2 Cg_endo -67.7 171.6 11.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.31 2.007 . . . . 0.0 112.201 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 57.05 4.21 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.555 -0.716 . . . . 0.0 109.422 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.499 ' H ' ' C ' ' A' ' 14' ' ' PRO . 26.1 tp -129.74 132.39 46.57 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -134.46 -163.47 1.38 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.366 -0.834 . . . . 0.0 110.339 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 tp -132.04 141.11 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -88.77 158.91 18.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.968 . . . . 0.0 109.115 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -57.4 -19.91 26.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.465 -0.772 . . . . 0.0 109.043 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.81 -2.93 58.96 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.72 10.99 71.79 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -86.61 140.23 30.04 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.231 -1.158 . . . . 0.0 108.588 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.438 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 68.4 m-85 -81.84 151.24 27.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.85 -1.156 . . . . 0.0 109.432 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.447 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 17.2 p -146.68 133.36 19.93 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.397 -0.814 . . . . 0.0 110.156 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -96.94 137.33 36.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.331 -0.855 . . . . 0.0 108.812 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -108.81 115.33 29.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.591 -0.693 . . . . 0.0 110.104 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.34 142.66 89.77 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -84.17 -8.8 9.76 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.393 2.062 . . . . 0.0 113.323 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -89.78 -24.45 21.48 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.842 -1.161 . . . . 0.0 109.987 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 -22.33 3.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.368 -0.832 . . . . 0.0 109.49 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.41 0.9 68.34 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.402 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 3.6 tmtt? -73.94 179.68 4.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.959 -1.318 . . . . 0.0 108.494 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 25.9 mt-10 -131.72 160.25 36.04 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.375 -0.828 . . . . 0.0 110.605 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -138.04 125.48 21.94 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.16 132.46 33.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.428 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.6 mt -105.09 -47.79 3.9 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.413 -1.051 . . . . 0.0 108.869 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.39 -178.98 22.8 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.181 -1.967 . . . . 0.0 108.181 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -91.55 11.03 25.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.021 -1.282 . . . . 0.0 109.371 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.34 100.72 13.25 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.933 0.873 . . . . 0.0 109.835 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.438 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 43.0 ttm180 -59.25 -20.06 51.04 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.4 0.619 . . . . 0.0 109.9 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.584 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -77.08 -49.27 15.68 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.714 0.768 . . . . 0.0 109.2 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.5 mt -75.76 -36.89 34.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.8 -55.41 26.71 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.348 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.53 -40.34 74.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.418 -0.801 . . . . 0.0 109.78 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -50.63 -51.74 46.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 108.914 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -62.53 -37.76 87.34 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.551 -0.718 . . . . 0.0 109.333 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.25 -51.91 67.81 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.497 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.61 -48.87 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.361 -0.837 . . . . 0.0 110.641 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -58.07 -44.07 87.3 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.839 -1.163 . . . . 0.0 108.145 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.54 74.05 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -69.94 -45.74 66.81 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.333 -0.855 . . . . 0.0 109.521 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.7 mt . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.085 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -40.21 157.27 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.115 1.876 . . . . 0.0 111.85 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 16' ' ' LEU . 50.5 Cg_endo -69.61 153.03 70.15 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.093 1.862 . . . . 0.0 111.767 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 69.0 -11.27 0.45 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.535 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.411 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.5 tt -97.56 142.28 29.58 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.926 -1.109 . . . . 0.0 109.664 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -136.03 -178.83 5.32 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.551 -0.718 . . . . 0.0 109.393 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.21 147.77 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.662 0.744 . . . . 0.0 109.631 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.504 HH21 ' CB ' ' A' ' 23' ' ' TYR . 15.1 ttp180 -91.31 156.32 17.88 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -59.71 -10.33 3.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.057 -1.027 . . . . 0.0 109.604 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -88.69 1.41 55.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.259 -0.901 . . . . 0.0 108.755 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.88 6.16 88.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.504 ' CB ' HH21 ' A' ' 19' ' ' ARG . 3.6 m-85 -84.36 138.06 33.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.313 -1.11 . . . . 0.0 108.488 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -83.0 154.67 24.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.034 -1.041 . . . . 0.0 109.307 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 p -150.88 132.24 14.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.818 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -101.98 143.64 31.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.378 -0.826 . . . . 0.0 109.097 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -101.86 118.66 37.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.49 -0.756 . . . . 0.0 109.5 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 35' ' ' PHE . 1.9 m-20 -74.35 149.12 86.53 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.977 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.24 3.06 7.09 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.771 2.314 . . . . 0.0 113.015 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -86.48 -55.12 4.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.951 -1.093 . . . . 0.0 110.243 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.42 HG23 ' H ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -118.17 -18.93 9.21 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.457 -0.777 . . . . 0.0 109.807 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.32 6.76 59.78 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.051 -1.031 . . . . 0.0 110.635 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.42 ' H ' HG23 ' A' ' 31' ' ' THR . 8.6 mptt -72.25 -175.23 1.48 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.847 -1.384 . . . . 0.0 109.325 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -119.1 166.86 12.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.646 -0.659 . . . . 0.0 109.822 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.469 ' CE1' ' OD2' ' A' ' 28' ' ' ASP . 8.0 m-85 -134.77 119.2 17.9 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.14 121.75 16.83 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -104.22 -53.49 2.72 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.526 -0.985 . . . . 0.0 109.302 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.46 -177.45 28.53 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.509 -1.837 . . . . 0.0 108.509 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.474 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 1.8 mtm180 -93.92 8.47 41.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.13 -1.218 . . . . 0.0 109.422 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -94.19 102.73 14.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -60.5 -11.77 7.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.349 -0.845 . . . . 0.0 109.018 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.2 OUTLIER -75.8 -54.72 6.49 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.467 -0.771 . . . . 0.0 109.216 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.575 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.7 mp -74.92 -37.91 42.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.614 -0.679 . . . . 0.0 109.183 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.11 -56.74 14.3 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.65 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.7 mt -55.99 -40.88 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.043 -1.036 . . . . 0.0 109.329 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.7 m -59.96 -50.73 72.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 110.477 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -32.86 74.52 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.306 -0.871 . . . . 0.0 110.018 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.97 92.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.105 -0.997 . . . . 0.0 108.961 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.1 mt -56.86 -42.2 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.441 -0.787 . . . . 0.0 110.207 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -58.19 -39.53 79.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.053 -1.029 . . . . 0.0 108.991 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.35 84.01 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -67.8 -39.26 84.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.531 -0.731 . . . . 0.0 110.419 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.004 -1.06 . . . . 0.0 109.572 -179.215 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -37.87 154.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.29 1.993 . . . . 0.0 111.892 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 16' ' ' LEU . 41.4 Cg_endo -66.68 153.61 77.37 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.377 2.051 . . . . 0.0 112.554 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 54.71 6.5 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.482 -0.761 . . . . 0.0 110.42 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.424 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.6 tt -104.61 148.01 27.0 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.19 -0.944 . . . . 0.0 109.25 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -139.1 -177.58 4.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.879 0.847 . . . . 0.0 110.331 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.66 HD12 ' CE1' ' A' ' 24' ' ' TYR . 18.6 tt -141.31 145.45 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.423 HH21 ' CB ' ' A' ' 23' ' ' TYR . 8.9 ttp180 -90.32 151.64 21.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.418 -0.801 . . . . 0.0 109.667 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -51.07 -15.86 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.444 -0.785 . . . . 0.0 109.973 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -88.69 0.89 56.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.178 -0.951 . . . . 0.0 108.845 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.69 12.18 78.19 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.423 ' CB ' HH21 ' A' ' 19' ' ' ARG . 8.0 m-85 -84.07 127.71 34.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.951 -1.323 . . . . 0.0 107.76 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.66 ' CE1' HD12 ' A' ' 18' ' ' ILE . 53.6 m-85 -82.82 147.53 28.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.2 m -150.32 141.84 23.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.029 -1.045 . . . . 0.0 110.308 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 36.6 t80 -110.99 150.09 29.76 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.418 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 33.8 mtt180 -109.92 117.36 33.59 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.5 ' OD1' ' CD1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -75.06 131.73 78.2 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -75.22 -6.25 17.68 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.776 1.651 . . . . 0.0 112.622 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -89.1 -44.0 10.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.923 -1.11 . . . . 0.0 109.163 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.488 ' C ' ' H ' ' A' ' 33' ' ' LYS . 1.4 t -108.34 -7.4 15.9 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.289 -0.882 . . . . 0.0 108.913 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.6 -2.42 0.85 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 31' ' ' THR . 3.4 mmtp -73.14 -179.94 3.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.068 -1.254 . . . . 0.0 108.857 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -105.75 171.72 7.19 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.537 -0.727 . . . . 0.0 109.951 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.5 ' CD1' ' OD1' ' A' ' 28' ' ' ASP . 14.8 m-85 -140.53 109.87 6.24 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.33 125.55 21.15 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.02 -31.37 7.65 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.55 -0.97 . . . . 0.0 109.93 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.15 -174.36 18.33 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -97.61 10.77 39.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.215 -1.168 . . . . 0.0 109.823 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -92.43 100.46 13.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.371 -0.831 . . . . 0.0 110.084 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -59.03 -16.39 18.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.515 -0.74 . . . . 0.0 109.628 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.54 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -76.49 -58.68 3.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.184 -0.948 . . . . 0.0 109.326 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.612 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.7 mp -74.89 -33.1 29.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.654 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.44 77.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.765 -1.21 . . . . 0.0 109.928 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.1 -38.79 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.733 -1.23 . . . . 0.0 108.976 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 47' ' ' GLU . 1.2 m -53.87 -63.92 0.99 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.239 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.406 ' N ' HG22 ' A' ' 46' ' ' THR . 20.0 mt-10 -53.05 -38.54 62.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.628 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.3 80.88 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.298 -0.877 . . . . 0.0 108.896 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.25 -44.83 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.425 -0.797 . . . . 0.0 110.8 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -57.41 -39.03 75.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 108.173 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.43 -35.77 81.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -66.86 -40.83 88.0 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.349 -0.845 . . . . 0.0 109.714 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.4 mt . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.041 -1.037 . . . . 0.0 108.477 179.635 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.6 mt . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -40.6 156.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.848 1.699 . . . . 0.0 111.336 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.75 165.2 16.57 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.946 1.764 . . . . 0.0 111.384 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.502 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 7.5 m120 51.16 30.21 5.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.193 -0.942 . . . . 0.0 109.415 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.698 HD23 ' N ' ' A' ' 17' ' ' TYR . 2.5 tt -138.28 127.51 24.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.349 -0.845 . . . . 0.0 108.793 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.698 ' N ' HD23 ' A' ' 16' ' ' LEU . 93.0 m-85 -124.11 -179.01 4.26 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.578 -0.701 . . . . 0.0 109.423 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.1 tt -140.39 150.53 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.561 -0.712 . . . . 0.0 109.299 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.454 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 35.0 ttp180 -91.65 152.53 20.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.168 -0.958 . . . . 0.0 109.602 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -58.9 -15.63 13.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 0.0 109.447 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -88.2 -1.73 58.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 108.642 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.82 9.58 65.97 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.454 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -84.65 129.28 34.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -1.224 . . . . 0.0 108.216 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -81.5 152.23 27.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.982 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.2 m -152.06 136.42 16.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.418 -0.801 . . . . 0.0 109.58 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 15' ' ' ASN . 81.5 t80 -105.03 137.4 42.84 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.383 -0.823 . . . . 0.0 109.083 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -103.23 113.07 26.26 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.392 -0.817 . . . . 0.0 109.682 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.13 139.9 85.25 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.275 -0.891 . . . . 0.0 110.347 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -83.5 1.4 8.98 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.479 2.12 . . . . 0.0 112.248 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -86.89 -37.0 18.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.082 -1.011 . . . . 0.0 109.88 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.1 -23.07 3.65 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.488 -0.757 . . . . 0.0 109.102 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.81 2.04 72.69 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -74.76 -164.97 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.875 -1.368 . . . . 0.0 109.777 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -129.52 171.87 12.14 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.755 0.788 . . . . 0.0 110.889 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -139.58 124.65 18.77 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.26 119.26 6.19 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.9 mt -103.8 -52.22 3.01 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.32 -1.106 . . . . 0.0 109.022 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.3 -169.09 26.46 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -97.47 11.87 35.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.288 -1.125 . . . . 0.0 109.269 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.94 106.5 18.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.367 -0.833 . . . . 0.0 110.142 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -64.43 -18.52 64.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.532 -0.73 . . . . 0.0 109.18 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 42' ' ' ARG . 11.4 mmm-85 -76.84 -50.52 13.23 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.478 -0.763 . . . . 0.0 109.076 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 92.4 mt -76.12 -36.35 30.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.606 -0.684 . . . . 0.0 109.806 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.99 -52.65 58.62 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.183 -0.948 . . . . 0.0 109.823 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.14 -39.28 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.001 -1.062 . . . . 0.0 109.426 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.99 -50.87 65.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.0 109.715 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -62.5 -39.78 94.58 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.512 -0.743 . . . . 0.0 109.656 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.514 ' CB ' HD12 ' A' ' 16' ' ' LEU . . . -62.43 -44.84 95.45 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.478 -0.764 . . . . 0.0 109.977 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.28 -58.41 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.217 -0.927 . . . . 0.0 111.23 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -55.73 -24.44 34.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.989 -1.069 . . . . 0.0 109.167 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.57 81.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -70.58 -40.42 73.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.738 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.6 mt . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.12 -0.987 . . . . 0.0 109.236 -179.36 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.2 mt . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -37.59 158.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.447 2.098 . . . . 0.0 111.886 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.1 166.09 30.32 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.312 2.008 . . . . 0.0 111.948 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 49.48 20.94 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.919 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 tp -128.0 125.99 40.49 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -121.68 173.53 7.39 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.624 -0.672 . . . . 0.0 110.249 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.24 134.53 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.468 ' C ' ' H ' ' A' ' 21' ' ' ASN . 18.4 mtm180 -89.92 149.48 22.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.095 -1.003 . . . . 0.0 109.887 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -54.05 -8.85 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.136 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 19' ' ' ARG . 88.0 m-20 -89.65 0.26 57.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.394 -0.816 . . . . 0.0 109.218 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.79 3.92 90.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.42 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 9.5 m-85 -88.07 129.92 35.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.173 -1.192 . . . . 0.0 109.073 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.437 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 13.4 m-85 -84.82 156.9 21.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.461 -0.774 . . . . 0.0 108.987 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.437 ' SG ' ' O ' ' A' ' 24' ' ' TYR . 98.9 m -152.83 129.34 10.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.298 -0.877 . . . . 0.0 109.464 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -95.6 145.43 25.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.248 -0.908 . . . . 0.0 108.953 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -120.41 118.63 30.82 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.59 -0.694 . . . . 0.0 110.139 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -76.02 138.79 68.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.319 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.12 16.41 1.65 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.556 2.171 . . . . 0.0 112.896 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 -68.44 0.75 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.8 -1.188 . . . . 0.0 109.042 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.32 -19.56 13.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.307 -0.871 . . . . 0.0 109.36 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.68 17.52 23.37 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 178.84 5.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.765 -1.432 . . . . 0.0 108.977 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -126.49 164.14 21.81 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.423 -0.798 . . . . 0.0 110.443 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -134.78 133.08 39.48 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.21 131.57 10.73 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.34 -54.68 2.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.485 -1.009 . . . . 0.0 109.643 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.27 -171.46 31.54 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.91 7.66 46.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -1.201 . . . . 0.0 109.683 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -95.29 103.96 15.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.256 -0.902 . . . . 0.0 110.098 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -58.13 -18.64 26.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 108.738 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.5 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -73.46 -49.69 25.51 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.7 mt -76.89 -37.06 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.543 -0.723 . . . . 0.0 109.238 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.14 -56.56 12.21 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.854 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 88.8 mt -54.15 -35.74 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.098 -1.001 . . . . 0.0 109.351 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -56.82 -59.53 4.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.096 -1.003 . . . . 0.0 109.033 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -59.53 -42.24 91.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.37 -0.831 . . . . 0.0 109.807 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.6 -42.15 61.75 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.96 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.09 -52.49 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -60.58 -29.7 69.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.947 -1.096 . . . . 0.0 108.199 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.16 86.35 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -64.79 -36.78 85.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.412 -0.805 . . . . 0.0 109.377 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.0 mm . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 108.876 179.784 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.7 mt . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -40.78 157.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.049 1.833 . . . . 0.0 111.491 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.42 162.39 40.87 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.257 1.971 . . . . 0.0 112.143 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 52.72 27.35 5.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.469 -0.769 . . . . 0.0 110.25 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.64 148.47 47.44 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.221 -0.925 . . . . 0.0 108.81 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 22.6 m-85 -138.16 -166.85 2.05 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.115 0.96 . . . . 0.0 110.753 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.42 136.01 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 21' ' ' ASN . 26.8 ttp180 -88.62 142.25 27.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.921 -1.112 . . . . 0.0 109.424 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -50.45 -10.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.497 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 19' ' ' ARG . 8.6 m120 -89.75 -0.04 57.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 109.169 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.57 5.11 87.12 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.467 ' CB ' HH21 ' A' ' 19' ' ' ARG . 3.0 m-85 -88.61 134.92 33.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.273 -1.134 . . . . 0.0 108.977 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -84.18 147.94 27.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.927 . . . . 0.0 108.699 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.8 m -150.62 143.03 24.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.037 -1.04 . . . . 0.0 110.044 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.448 ' CZ ' ' HB1' ' A' ' 51' ' ' ALA . 43.8 t80 -105.01 159.05 16.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.495 -0.753 . . . . 0.0 109.102 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.539 HH21 ' CD ' ' A' ' 34' ' ' GLU . 27.8 ttm180 -130.5 113.9 14.84 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.358 -0.839 . . . . 0.0 109.78 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.58 141.33 79.5 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.509 -0.744 . . . . 0.0 109.176 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -83.57 -19.82 5.04 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 121.931 1.754 . . . . 0.0 112.388 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 30' ' ' ARG . 8.6 ptm180 -89.14 -26.01 21.55 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.126 -0.984 . . . . 0.0 109.491 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 33' ' ' LYS . 1.9 p -107.33 -21.02 13.09 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.36 -10.43 0.66 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 31' ' ' THR . 5.5 tmtt? -75.99 -179.21 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -1.232 . . . . 0.0 109.6 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.539 ' CD ' HH21 ' A' ' 27' ' ' ARG . 36.5 mt-10 -115.89 168.13 10.33 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.546 0.688 . . . . 0.0 110.291 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -135.77 121.22 19.3 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.54 124.58 6.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -105.09 -73.87 0.67 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.417 -1.049 . . . . 0.0 109.226 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 172.08 -168.55 41.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.441 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -98.29 0.16 45.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.269 -1.136 . . . . 0.0 109.593 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -98.36 100.1 11.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.308 -0.87 . . . . 0.0 109.748 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 4.1 ptt180 -54.63 -20.23 7.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.267 -0.896 . . . . 0.0 109.527 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' H ' ' HD3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -68.34 -50.48 52.94 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.585 HD12 ' N ' ' A' ' 43' ' ' ILE . 1.9 mp -77.57 -34.87 20.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 41' ' ' ARG . . . -65.82 -53.84 34.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.847 . . . . 0.0 109.781 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 73.1 mt -54.9 -35.92 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 109.232 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.22 -54.88 37.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 0.0 108.958 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.8 -39.73 95.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.529 -0.732 . . . . 0.0 109.756 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -57.56 -41.45 81.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.486 -0.759 . . . . 0.0 109.577 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.84 -44.69 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 110.155 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.411 ' HG3' ' H ' ' A' ' 50' ' ' GLN . 15.3 mt-30 -58.33 -28.9 65.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.862 -1.149 . . . . 0.0 108.519 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.448 ' HB1' ' CZ ' ' A' ' 26' ' ' TYR . . . -65.53 -35.06 79.75 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -66.89 -35.09 79.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.835 . . . . 0.0 109.473 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.7 mp . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -35.29 154.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 122.556 2.171 . . . . 0.0 112.441 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 16' ' ' LEU . 49.6 Cg_endo -67.89 151.87 77.77 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.387 2.058 . . . . 0.0 111.75 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 62.73 -4.39 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.517 -0.739 . . . . 0.0 110.007 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.7 tt -100.15 153.61 19.11 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.172 -0.955 . . . . 0.0 109.221 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -138.03 -169.42 2.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.339 -0.85 . . . . 0.0 110.604 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.15 137.68 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -89.58 151.55 21.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.153 -0.967 . . . . 0.0 109.205 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -61.9 -9.28 6.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.107 -0.995 . . . . 0.0 109.665 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -91.03 -1.51 57.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.337 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.74 3.03 77.84 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -87.87 140.17 29.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.207 -1.172 . . . . 0.0 109.106 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.494 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 55.0 m-85 -84.78 150.79 24.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 0.0 109.075 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.7 p -150.45 138.92 20.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.213 -0.93 . . . . 0.0 110.057 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -102.35 150.66 23.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.94 112.82 15.1 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.371 -0.831 . . . . 0.0 108.795 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.454 ' CB ' ' NZ ' ' A' ' 33' ' ' LYS . 11.2 t70 -73.29 129.73 85.49 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.891 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.02 17.99 0.95 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.049 1.833 . . . . 0.0 113.093 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -88.79 -65.47 1.01 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.732 -1.23 . . . . 0.0 109.294 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.04 -20.07 13.43 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.196 -0.94 . . . . 0.0 108.794 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.11 13.8 32.68 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.589 ' H ' ' HD3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -73.77 177.67 5.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.65 -1.5 . . . . 0.0 109.532 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -131.64 167.52 19.29 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.388 -0.82 . . . . 0.0 110.288 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -139.43 117.73 11.99 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.505 -0.747 . . . . 0.0 109.051 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.54 124.27 8.02 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.77 -71.48 0.72 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.312 -1.111 . . . . 0.0 109.653 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.67 -173.84 39.8 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -95.0 10.5 35.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.037 -1.272 . . . . 0.0 109.707 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.96 103.3 15.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.194 -0.941 . . . . 0.0 110.717 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.494 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 79.5 mtt180 -54.3 -19.81 6.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.362 -0.836 . . . . 0.0 108.822 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -74.04 -55.07 6.57 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.401 -0.812 . . . . 0.0 109.462 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.4 mt -80.65 -32.43 13.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.529 -0.732 . . . . 0.0 109.801 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.43 -58.46 5.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.827 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 97.9 mt -55.71 -37.21 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.302 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -53.81 -57.4 11.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.092 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -54.07 -43.85 70.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.615 -0.678 . . . . 0.0 109.6 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.31 -43.63 79.15 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.753 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.24 -41.09 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.204 -0.935 . . . . 0.0 110.646 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.65 -39.0 82.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.811 -1.181 . . . . 0.0 108.643 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.74 -35.48 80.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.573 -0.705 . . . . 0.0 109.364 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -68.38 -40.52 81.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.513 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--N 1.302 -1.46 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.686 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 13' ' ' PRO . 73.8 mt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 12' ' ' LEU . 95.4 Cg_exo -36.14 158.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 122.508 2.138 . . . . 0.0 111.779 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 16' ' ' LEU . 56.1 Cg_endo -69.12 166.83 25.46 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.115 1.877 . . . . 0.0 111.843 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 52.27 10.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.886 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 14' ' ' PRO . 34.6 tp -124.13 140.04 53.35 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -133.19 -164.81 1.53 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 122.12 0.962 . . . . 0.0 110.766 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.47 139.27 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -91.0 151.47 21.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.012 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -59.09 -13.12 6.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 109.324 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -91.13 0.3 57.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.368 -0.832 . . . . 0.0 109.262 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.63 4.89 79.22 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -88.62 138.46 31.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -1.119 . . . . 0.0 109.476 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -81.24 153.81 26.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 108.752 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -149.97 124.59 9.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.056 -1.028 . . . . 0.0 110.223 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 44.1 t80 -98.23 151.03 20.89 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.437 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 59.3 mtt180 -115.88 122.54 45.66 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.995 0.902 . . . . 0.0 110.322 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.77 129.85 77.9 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.5 -6.99 16.68 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.966 1.777 . . . . 0.0 113.537 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.468 ' HG3' HH11 ' A' ' 30' ' ' ARG . 0.0 OUTLIER -89.03 -29.04 19.76 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.639 -1.288 . . . . 0.0 109.12 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.461 HG23 ' H ' ' A' ' 33' ' ' LYS . 1.7 t -118.66 -15.49 9.5 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.9 -1.8 7.54 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.461 ' H ' HG23 ' A' ' 31' ' ' THR . 6.0 tmtt? -74.16 179.54 4.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.015 -1.285 . . . . 0.0 109.12 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -108.44 170.67 7.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.507 -0.746 . . . . 0.0 109.806 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -140.37 118.34 11.84 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.73 123.98 14.26 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.0 mt -106.46 -55.91 2.26 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.426 -1.044 . . . . 0.0 109.527 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.24 -175.14 25.86 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -94.3 11.03 31.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.005 -1.291 . . . . 0.0 108.672 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.78 98.65 11.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.473 -0.767 . . . . 0.0 109.711 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -61.68 -13.51 23.29 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.231 -0.918 . . . . 0.0 108.985 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -72.5 -53.27 12.55 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.338 -0.851 . . . . 0.0 109.354 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 87.8 mt -79.07 -36.81 18.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.509 -0.744 . . . . 0.0 109.631 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.46 -55.97 22.61 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.231 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.2 mt -56.45 -43.54 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.782 -1.199 . . . . 0.0 108.989 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.0 m -57.61 -51.34 69.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.982 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -32.97 74.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -0.854 . . . . 0.0 109.584 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.94 -47.91 70.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.182 -0.949 . . . . 0.0 110.399 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.4 mt -57.81 -49.68 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.275 -0.891 . . . . 0.0 111.127 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -58.74 -31.25 68.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.875 -1.14 . . . . 0.0 108.862 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.56 83.27 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -68.1 -38.79 82.68 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.416 -0.802 . . . . 0.0 109.368 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.84 . . . . 0.0 108.988 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.2 mt . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.33 162.04 28.54 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.239 1.959 . . . . 0.0 111.602 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.15 169.62 11.85 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.684 2.256 . . . . 0.0 112.259 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 55.64 8.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.799 . . . . 0.0 110.07 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 tt -129.29 137.65 51.16 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.343 -0.848 . . . . 0.0 108.782 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -127.38 -166.59 1.62 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.678 0.751 . . . . 0.0 110.193 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -134.48 132.96 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.411 ' HG2' ' H ' ' A' ' 21' ' ' ASN . 39.9 ttp180 -86.75 150.61 24.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.207 -0.933 . . . . 0.0 109.199 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -59.23 -10.6 3.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 110.014 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.411 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 93.8 m-20 -91.51 0.54 57.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.109 -0.994 . . . . 0.0 109.167 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.84 4.29 84.99 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -86.2 138.81 31.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -1.165 . . . . 0.0 108.725 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -83.43 150.14 26.23 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.6 p -148.85 137.14 21.01 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.847 -1.158 . . . . 0.0 110.526 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -102.09 152.49 20.93 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -127.22 116.34 20.45 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.424 -0.798 . . . . 0.0 108.88 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.81 139.61 73.82 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.03 -1.044 . . . . 0.0 109.549 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -83.34 25.31 0.69 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.121 1.88 . . . . 0.0 112.63 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -88.63 -68.13 0.79 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.919 -1.113 . . . . 0.0 108.709 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 p -116.19 -25.28 7.65 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.88 23.0 4.44 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -75.45 177.96 6.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.031 -1.276 . . . . 0.0 109.103 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.44 165.3 23.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.395 -0.815 . . . . 0.0 109.621 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -135.74 115.07 12.52 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.95 119.53 6.42 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.15 -68.87 0.78 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.269 -1.136 . . . . 0.0 109.142 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.78 -165.97 38.78 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.932 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -100.7 6.27 43.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.468 -1.019 . . . . 0.0 109.312 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -94.99 98.63 10.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.343 -0.848 . . . . 0.0 110.271 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -54.9 -14.9 1.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.529 0.68 . . . . 0.0 109.291 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.54 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.0 OUTLIER -77.33 -54.77 6.06 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.355 -0.84 . . . . 0.0 109.509 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.7 mt -76.99 -32.89 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.342 -0.849 . . . . 0.0 109.658 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.71 -55.68 24.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.078 -1.014 . . . . 0.0 109.38 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mt -55.72 -39.44 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.059 -1.026 . . . . 0.0 109.254 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -51.15 -54.4 25.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.096 -1.003 . . . . 0.0 109.172 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -63.95 -41.63 97.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 0.0 109.605 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.9 -42.68 76.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.618 -0.676 . . . . 0.0 110.191 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.04 -58.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.079 -1.013 . . . . 0.0 110.911 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -58.82 -24.28 61.75 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.984 -1.073 . . . . 0.0 109.098 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.07 -35.34 80.26 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.166 -0.959 . . . . 0.0 108.445 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -67.18 -38.66 85.77 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.395 -0.816 . . . . 0.0 109.372 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.155 -0.965 . . . . 0.0 108.935 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' PRO . 72.4 mt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 12' ' ' LEU . 75.8 Cg_exo -34.94 157.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 122.555 2.17 . . . . 0.0 111.844 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.22 148.33 84.74 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.104 1.869 . . . . 0.0 111.582 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m120 61.88 32.63 17.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 109.929 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.0 tp -140.23 130.09 24.6 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.354 -0.841 . . . . 0.0 108.818 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -129.63 -172.32 2.73 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.717 0.77 . . . . 0.0 110.059 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.523 HD12 ' CE1' ' A' ' 24' ' ' TYR . 14.9 tt -142.94 152.04 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.398 0.618 . . . . 0.0 109.617 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.426 HH11 ' HG3' ' A' ' 19' ' ' ARG . 19.3 ttm-85 -90.84 160.3 15.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.542 -0.724 . . . . 0.0 109.527 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -64.28 -14.75 57.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 108.994 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -90.12 -0.47 57.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.329 -0.857 . . . . 0.0 108.997 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.57 11.94 65.41 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -87.06 129.72 34.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.096 -1.237 . . . . 0.0 108.476 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.523 ' CE1' HD12 ' A' ' 18' ' ' ILE . 54.2 m-85 -83.11 147.91 27.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.456 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 18.7 p -150.49 131.46 14.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.099 -1.001 . . . . 0.0 109.861 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -97.21 149.35 22.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.294 -0.878 . . . . 0.0 109.286 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.424 HH21 ' CG ' ' A' ' 34' ' ' GLU . 25.8 ttm180 -115.93 116.58 28.21 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.341 -0.85 . . . . 0.0 110.224 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -74.27 138.28 75.17 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.455 -0.778 . . . . 0.0 108.988 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.92 -2.51 12.17 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.136 1.891 . . . . 0.0 112.516 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -88.18 -55.12 3.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.084 -1.01 . . . . 0.0 109.704 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -102.82 -1.06 30.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.41 -0.806 . . . . 0.0 109.124 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.3 4.96 2.97 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.485 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.96 179.4 3.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.157 -1.202 . . . . 0.0 109.124 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 20.8 mp0 -114.94 168.39 9.95 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.47 -0.769 . . . . 0.0 109.926 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -138.96 114.39 9.71 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.69 125.14 9.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.6 mt -105.17 -50.17 3.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.384 -1.068 . . . . 0.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.91 -155.37 26.22 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.807 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -110.53 7.08 22.43 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.435 -1.038 . . . . 0.0 109.411 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -93.09 101.86 14.17 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.345 -0.847 . . . . 0.0 110.252 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.418 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 38.1 ttm180 -58.6 -20.08 44.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.685 -0.634 . . . . 0.0 109.477 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -75.38 -52.19 11.34 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.12 -33.33 24.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.517 -0.739 . . . . 0.0 109.621 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.32 -58.82 5.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.187 -0.945 . . . . 0.0 109.517 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 50.5 mt -53.94 -36.73 31.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.075 -1.015 . . . . 0.0 109.13 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.54 -50.95 66.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 109.345 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -61.28 -40.36 93.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.482 -0.761 . . . . 0.0 109.601 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.99 -43.95 74.03 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.413 -0.804 . . . . 0.0 109.117 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.16 -46.07 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.09 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -59.1 -38.65 80.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.929 -1.107 . . . . 0.0 108.584 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.71 92.26 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -69.06 -39.08 79.33 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.45 -0.781 . . . . 0.0 109.385 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.7 mt . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.897 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 13' ' ' PRO . 39.4 mt . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 12' ' ' LEU . 98.7 Cg_exo -35.92 158.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.656 2.237 . . . . 0.0 111.737 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.486 ' C ' ' H ' ' A' ' 16' ' ' LEU . 65.8 Cg_endo -72.63 158.87 49.99 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.352 2.035 . . . . 0.0 112.214 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 59.71 1.25 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.794 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 14' ' ' PRO . 41.5 tp -108.34 136.91 47.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -132.56 -178.49 4.95 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.961 0.886 . . . . 0.0 110.511 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.788 HD12 ' CE1' ' A' ' 24' ' ' TYR . 13.5 tt -143.09 143.59 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 -89.58 169.16 11.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.409 -0.807 . . . . 0.0 109.852 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -66.86 -12.48 59.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.573 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -88.25 -1.56 58.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.092 -1.005 . . . . 0.0 108.989 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.31 10.04 78.36 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -88.22 130.72 35.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.06 -1.259 . . . . 0.0 108.732 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.788 ' CE1' HD12 ' A' ' 18' ' ' ILE . 58.0 m-85 -85.21 148.31 26.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.885 . . . . 0.0 109.789 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.432 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 20.5 p -151.32 130.02 12.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.208 -0.933 . . . . 0.0 109.547 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 48.1 t80 -95.09 162.02 13.89 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.264 -0.897 . . . . 0.0 109.218 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.531 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 28.9 ttm180 -125.78 117.69 23.94 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.518 -0.739 . . . . 0.0 109.437 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -73.22 148.73 88.88 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.381 -0.824 . . . . 0.0 109.673 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -84.6 -16.52 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.405 2.07 . . . . 0.0 112.14 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -92.18 -40.66 10.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.334 -0.854 . . . . 0.0 110.092 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.548 ' C ' ' H ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -100.49 -13.35 18.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.158 -0.964 . . . . 0.0 109.349 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.48 -7.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -75.25 -166.09 0.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.885 -1.362 . . . . 0.0 108.734 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 27' ' ' ARG . 68.1 mt-10 -129.64 169.98 14.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.438 -0.789 . . . . 0.0 110.507 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -136.55 122.03 19.51 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.13 122.73 8.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 mt -104.85 -55.52 2.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.384 -1.068 . . . . 0.0 109.632 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.1 179.45 25.91 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 39' ' ' ARG . 2.2 mtm-85 -88.04 4.87 43.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.447 -1.031 . . . . 0.0 109.494 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -94.38 99.19 11.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 109.545 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.514 HH12 ' HE ' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -62.17 -8.56 5.78 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.514 ' HE ' HH12 ' A' ' 41' ' ' ARG . 19.6 mmt180 -72.88 -56.98 4.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 95.4 mt -77.32 -34.0 20.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.326 0.584 . . . . 0.0 109.572 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -56.81 12.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.657 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.9 mt -56.1 -37.16 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.39 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.17 -52.64 62.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.01 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -63.11 -45.8 90.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.548 -0.72 . . . . 0.0 109.742 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.18 65.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.601 -0.687 . . . . 0.0 109.806 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.3 mt -61.78 -42.34 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.068 -1.02 . . . . 0.0 110.024 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.05 -35.08 74.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.906 -1.121 . . . . 0.0 109.012 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.77 -34.43 77.89 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -69.31 -35.65 76.19 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.463 -0.773 . . . . 0.0 109.62 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.7 mt . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.35 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 49.0 mt . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.28 161.54 23.01 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.819 1.679 . . . . 0.0 111.273 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 16' ' ' LEU . 49.6 Cg_endo -67.35 155.12 71.77 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.626 2.218 . . . . 0.0 112.252 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.501 ' OD1' ' ND2' ' A' ' 52' ' ' ASN . 1.4 m120 73.34 -15.83 0.52 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.652 -0.655 . . . . 0.0 110.193 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.411 ' H ' ' C ' ' A' ' 14' ' ' PRO . 11.6 tp -102.21 139.52 37.71 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.098 -1.001 . . . . 0.0 109.009 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -123.68 -170.27 2.1 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.714 0.769 . . . . 0.0 109.948 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.97 133.99 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.467 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 13.1 mtm180 -91.11 152.41 20.62 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.0 -1.062 . . . . 0.0 109.906 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -58.21 -11.2 2.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 108.926 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -89.76 0.82 56.76 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.66 4.67 90.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.467 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 5.3 m-85 -86.68 131.13 34.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.259 -1.142 . . . . 0.0 108.715 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.525 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 78.4 m-85 -82.53 154.13 25.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 108.959 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -150.72 135.63 17.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.022 -1.048 . . . . 0.0 110.088 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 37.6 t80 -106.98 146.99 30.43 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.622 -0.674 . . . . 0.0 109.571 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.42 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 4.8 mtt180 -110.14 125.18 52.75 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.637 -0.664 . . . . 0.0 109.879 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -79.0 112.3 26.61 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.929 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.41 0.82 0.31 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 121.399 1.399 . . . . 0.0 112.687 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -88.66 -52.04 5.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.894 -1.129 . . . . 0.0 109.741 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.94 -11.74 15.62 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.48 -0.762 . . . . 0.0 109.391 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.83 0.06 58.7 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -179.9 3.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.057 -1.261 . . . . 0.0 108.728 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -111.34 168.22 9.69 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.504 -0.748 . . . . 0.0 109.701 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -138.56 114.27 9.85 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.02 127.54 18.52 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.5 mt -107.8 -49.73 3.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.588 -0.948 . . . . 0.0 109.249 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.9 -174.28 23.22 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -91.01 11.38 23.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -1.228 . . . . 0.0 108.879 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -91.21 95.91 10.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.432 -0.792 . . . . 0.0 110.327 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 38.8 ttm180 -57.01 -19.04 16.19 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -77.0 -51.99 10.14 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.523 -0.736 . . . . 0.0 109.34 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -77.13 -31.62 18.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.64 -0.663 . . . . 0.0 109.682 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.52 -58.74 4.59 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.098 -1.001 . . . . 0.0 109.49 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.1 mt -54.22 -35.12 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.095 -1.003 . . . . 0.0 109.003 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.08 -50.77 66.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 0.0 108.968 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -61.07 -41.07 95.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.2 87.3 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.441 0.639 . . . . 0.0 109.751 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.81 -62.46 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.39 -0.819 . . . . 0.0 110.78 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -56.93 -30.01 63.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 108.683 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.61 -41.59 83.78 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.501 ' ND2' ' OD1' ' A' ' 15' ' ' ASN . 10.2 m120 -68.97 -39.96 79.11 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.423 -0.798 . . . . 0.0 109.775 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--N 1.303 -1.429 0 O-C-N 121.207 -0.933 . . . . 0.0 108.494 -179.884 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.99 164.15 5.17 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.592 1.528 . . . . 0.0 110.986 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.93 160.95 46.22 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.526 2.151 . . . . 0.0 112.286 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 59.96 19.61 8.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 110.088 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.9 tp -133.83 118.04 17.53 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -114.71 178.44 4.28 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.383 0.611 . . . . 0.0 109.824 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.701 HD12 ' CE1' ' A' ' 24' ' ' TYR . 10.1 tt -141.48 148.06 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.59 -0.694 . . . . 0.0 109.552 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -91.01 153.35 20.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.595 -0.69 . . . . 0.0 109.58 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -56.73 -11.52 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.173 -0.954 . . . . 0.0 108.989 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -88.56 -0.79 57.61 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.355 -0.841 . . . . 0.0 109.042 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.27 9.09 80.39 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -86.67 128.05 34.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -1.143 . . . . 0.0 108.45 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.701 ' CE1' HD12 ' A' ' 18' ' ' ILE . 50.6 m-85 -84.22 149.49 26.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.475 -0.766 . . . . 0.0 109.851 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.0 p -150.11 131.73 14.89 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.116 -0.99 . . . . 0.0 109.632 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -94.36 140.8 29.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.08 -1.012 . . . . 0.0 110.004 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.427 HH11 ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -101.94 110.72 22.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.593 -0.692 . . . . 0.0 110.218 -179.332 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.99 135.96 66.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.443 -0.786 . . . . 0.0 109.951 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -81.72 15.26 1.97 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.008 1.805 . . . . 0.0 111.621 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -86.65 -69.79 0.65 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.345 -0.847 . . . . 0.0 109.213 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.4 -18.64 14.05 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.33 6.66 58.64 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.533 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -76.61 -174.43 2.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.85 -1.382 . . . . 0.0 109.338 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 4.5 mp0 -130.77 157.11 43.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.309 -0.869 . . . . 0.0 110.229 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -116.35 127.96 55.12 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.57 116.35 4.36 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mt -99.08 -63.8 1.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.192 -1.181 . . . . 0.0 109.238 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.29 -173.01 38.53 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -92.99 8.7 38.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 108.98 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -94.23 104.24 16.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.386 -0.821 . . . . 0.0 109.82 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -60.22 -20.76 60.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.663 -0.648 . . . . 0.0 109.721 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -77.05 -55.81 5.13 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.211 -0.931 . . . . 0.0 109.074 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 43' ' ' ILE . 27.3 mt -65.81 -36.56 77.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.538 -0.727 . . . . 0.0 109.198 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.13 -56.87 9.26 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.341 -0.85 . . . . 0.0 109.274 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mt -53.58 -37.4 30.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.171 -0.956 . . . . 0.0 108.67 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.42 -55.12 31.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.07 -1.019 . . . . 0.0 109.147 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -63.3 -43.96 96.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.347 -0.846 . . . . 0.0 109.658 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.68 75.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.526 -0.734 . . . . 0.0 109.645 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.9 mt -59.64 -40.25 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.059 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -62.11 -43.78 98.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.951 -1.093 . . . . 0.0 108.478 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.89 -33.83 76.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -64.23 -36.07 82.88 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.296 -0.877 . . . . 0.0 109.333 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.302 -1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 108.684 179.809 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.1 mt . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.61 159.29 28.69 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.675 1.584 . . . . 0.0 111.171 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 15' ' ' ASN . 59.3 Cg_endo -69.69 154.54 67.91 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.376 2.051 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.505 ' ND2' ' OD1' ' A' ' 52' ' ' ASN . 3.6 m-20 74.19 -10.49 1.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.641 -0.662 . . . . 0.0 109.326 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.1 tt -105.27 148.46 26.97 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.369 -0.832 . . . . 0.0 110.121 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -137.31 -168.85 2.38 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.452 0.644 . . . . 0.0 109.408 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.2 tt -146.53 150.95 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.268 -0.895 . . . . 0.0 109.479 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -92.71 150.39 20.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.183 -0.948 . . . . 0.0 109.363 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -59.81 -10.91 4.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.29 -0.881 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -90.5 -0.16 57.56 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.48 10.45 70.58 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -87.14 136.17 33.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.055 -1.262 . . . . 0.0 108.495 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -84.22 152.97 23.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -154.86 145.81 22.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 110.305 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -108.99 155.45 20.87 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -131.72 120.24 22.46 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.231 -0.918 . . . . 0.0 109.868 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.08 134.41 71.18 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.796 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.24 24.37 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.0 1.8 . . . . 0.0 113.055 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -88.96 -67.25 0.85 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.806 -1.184 . . . . 0.0 108.612 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.448 HG21 ' HZ1' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -112.78 -16.25 12.79 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.77 29.58 6.14 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -77.81 178.9 7.03 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.273 -1.133 . . . . 0.0 109.506 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -131.38 163.93 26.81 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.316 -0.865 . . . . 0.0 110.614 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -139.36 113.22 8.6 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.52 128.07 14.92 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.8 mt -105.89 -57.75 2.0 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.379 -1.071 . . . . 0.0 109.409 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.32 -157.82 28.93 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.412 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -107.79 1.88 23.2 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.503 -0.998 . . . . 0.0 110.189 -179.487 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.33 107.37 19.86 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.049 -1.032 . . . . 0.0 110.135 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -61.0 -15.46 32.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.126 -0.984 . . . . 0.0 109.345 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.437 ' HD2' ' H ' ' A' ' 42' ' ' ARG . 7.0 mpt_? -74.31 -55.0 6.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.262 -0.899 . . . . 0.0 108.862 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.3 mt -73.31 -35.82 47.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.357 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.82 -57.09 10.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.019 -1.05 . . . . 0.0 109.244 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -51.36 -40.48 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.278 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.29 -57.31 10.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.104 -0.997 . . . . 0.0 109.668 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.94 -36.01 74.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.389 -0.819 . . . . 0.0 109.473 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.47 -44.61 76.6 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.559 -0.856 . . . . 0.0 108.808 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.85 -45.06 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.232 -0.917 . . . . 0.0 110.312 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -61.84 -40.36 95.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.145 -0.972 . . . . 0.0 108.84 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.93 88.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.505 ' OD1' ' ND2' ' A' ' 15' ' ' ASN . 85.2 m-20 -70.0 -43.58 71.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.4 -0.813 . . . . 0.0 109.996 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.8 mt . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.897 . . . . 0.0 109.351 -179.223 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 70.2 mt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.46 157.44 41.21 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.611 1.541 . . . . 0.0 111.288 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.528 ' C ' ' H ' ' A' ' 16' ' ' LEU . 45.3 Cg_endo -67.18 165.17 27.53 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.455 2.104 . . . . 0.0 111.913 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 62.58 -10.78 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.796 . . . . 0.0 110.531 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.528 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.1 tt -104.26 154.22 20.05 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.159 -0.963 . . . . 0.0 109.815 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -138.3 -178.34 5.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.548 -0.72 . . . . 0.0 110.186 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.86 137.17 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.452 ' C ' ' N ' ' A' ' 21' ' ' ASN . 9.3 mtp180 -90.59 141.33 28.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.204 -0.935 . . . . 0.0 109.422 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -50.83 -13.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.359 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.452 ' N ' ' C ' ' A' ' 19' ' ' ARG . 2.5 m120 -89.78 0.03 57.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.482 -0.761 . . . . 0.0 109.014 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.43 10.27 82.24 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -88.58 130.78 35.18 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.315 -1.109 . . . . 0.0 108.486 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -85.48 144.18 28.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.485 -0.759 . . . . 0.0 109.308 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 m -149.33 140.2 22.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.187 -0.945 . . . . 0.0 109.753 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -101.84 143.96 31.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.348 -0.845 . . . . 0.0 109.57 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -112.12 116.63 30.81 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.408 -0.807 . . . . 0.0 109.782 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -74.34 126.69 88.71 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 108.994 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.07 -9.1 16.66 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.986 1.791 . . . . 0.0 112.103 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -89.72 -32.49 16.99 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -110.99 -27.16 8.9 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 82.44 -10.61 54.55 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.485 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 3.0 mptp? -73.38 -174.05 1.54 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.939 -1.33 . . . . 0.0 109.885 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -120.96 169.32 10.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.578 -0.701 . . . . 0.0 110.303 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -137.37 115.61 11.76 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.55 120.69 8.39 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.7 mt -103.74 -62.87 1.25 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.504 -0.998 . . . . 0.0 108.877 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.21 -171.74 34.01 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 -93.61 8.41 40.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -1.146 . . . . 0.0 109.112 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -91.96 97.1 10.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 109.58 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -56.27 -23.13 34.35 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.455 0.645 . . . . 0.0 109.528 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -74.85 -47.55 29.72 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.341 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.19 -33.64 18.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.39 -0.819 . . . . 0.0 109.591 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.79 -58.62 5.23 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 109.326 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -54.6 -36.68 36.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.214 -0.929 . . . . 0.0 109.0 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.85 -56.89 13.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.091 -1.006 . . . . 0.0 109.12 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -60.19 -40.85 91.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.613 -0.679 . . . . 0.0 109.497 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.53 -44.51 62.64 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.0 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 91.3 mt -61.7 -45.15 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.337 -0.852 . . . . 0.0 109.619 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -64.02 -33.76 76.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.065 -1.022 . . . . 0.0 108.361 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.99 -33.36 75.4 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.35 -42.38 88.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 109.6 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.177 -0.952 . . . . 0.0 108.728 179.827 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 13' ' ' PRO . 46.3 mt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 12' ' ' LEU . 33.7 Cg_exo -34.31 158.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.709 2.273 . . . . 0.0 112.246 178.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.62 159.22 54.51 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.113 1.876 . . . . 0.0 112.067 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 53.55 19.95 1.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.458 -0.776 . . . . 0.0 110.176 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.5 tp -127.21 125.13 40.5 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 43.0 m-85 -121.63 -170.69 2.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.81 0.814 . . . . 0.0 110.487 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -127.77 141.61 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.474 ' H ' HD13 ' A' ' 18' ' ' ILE . 24.9 ttm180 -91.95 144.54 25.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.061 -1.025 . . . . 0.0 109.281 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -54.15 -19.02 4.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 109.857 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -86.81 0.68 54.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.18 3.21 79.37 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.463 ' CE1' ' NE ' ' A' ' 39' ' ' ARG . 12.5 m-85 -85.15 140.08 31.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.072 -1.252 . . . . 0.0 109.055 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -84.79 146.94 27.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.434 -0.791 . . . . 0.0 108.966 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 20.2 p -146.46 129.77 16.69 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.873 -1.142 . . . . 0.0 110.32 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 27' ' ' ARG . 43.2 t80 -99.37 148.73 23.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.451 -0.781 . . . . 0.0 109.007 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.406 ' O ' ' CE1' ' A' ' 26' ' ' TYR . 23.2 ttm180 -104.43 117.57 34.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.489 -0.757 . . . . 0.0 109.533 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.52 150.67 95.6 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.294 -0.878 . . . . 0.0 109.623 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -85.52 -8.14 8.53 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.623 2.216 . . . . 0.0 112.996 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -90.48 -47.09 7.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.04 -1.037 . . . . 0.0 110.671 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.2 p -109.01 -11.6 14.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 109.818 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.39 2.12 25.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -179.12 3.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -1.204 . . . . 0.0 108.915 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -109.94 168.92 9.06 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.564 -0.71 . . . . 0.0 109.56 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -140.54 119.07 12.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.442 -0.786 . . . . 0.0 109.269 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.79 122.88 12.36 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.2 mt -107.06 -44.3 4.42 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -1.052 . . . . 0.0 109.069 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 147.18 -179.8 23.82 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.463 ' NE ' ' CE1' ' A' ' 23' ' ' TYR . 18.6 mtt180 -92.78 10.71 29.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -1.088 . . . . 0.0 108.403 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -95.96 105.47 17.5 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.453 0.645 . . . . 0.0 110.116 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -60.74 -19.36 58.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -71.4 -58.78 3.2 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.388 -0.82 . . . . 0.0 109.234 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 94.1 mt -68.94 -37.3 77.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.676 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.12 -56.72 11.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.031 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 79.3 mt -54.63 -33.38 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.806 -1.184 . . . . 0.0 109.372 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -58.3 -51.59 69.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.653 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -61.92 -44.91 95.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.278 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.51 -43.33 79.67 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.49 -0.756 . . . . 0.0 110.85 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.9 -52.83 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.017 -1.052 . . . . 0.0 111.624 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -60.12 -29.6 68.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.83 -1.169 . . . . 0.0 109.492 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.51 -33.76 75.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.238 -0.914 . . . . 0.0 109.028 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -69.48 -38.66 77.8 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.306 -0.871 . . . . 0.0 110.897 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.158 -0.963 . . . . 0.0 109.702 -178.914 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.0 mt . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.32 158.42 48.94 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.027 1.818 . . . . 0.0 111.181 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 16' ' ' LEU . 37.4 Cg_endo -64.6 170.89 9.1 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.533 2.155 . . . . 0.0 112.308 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 52.75 9.12 0.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.847 . . . . 0.0 109.824 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 14' ' ' PRO . 9.2 tt -133.84 137.53 45.1 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.373 -0.829 . . . . 0.0 109.427 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 12.8 m-85 -138.2 -157.07 0.74 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.57 0.7 . . . . 0.0 109.647 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.6 tt -145.39 153.2 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.669 0.747 . . . . 0.0 110.335 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 21' ' ' ASN . 34.5 ttp180 -94.22 153.55 18.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.631 -0.668 . . . . 0.0 109.708 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.479 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -56.23 -8.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.069 179.638 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.433 ' H ' ' C ' ' A' ' 19' ' ' ARG . 19.1 m-20 -90.37 -3.14 57.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.29 -0.881 . . . . 0.0 108.988 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.77 7.09 78.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -88.02 140.06 29.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.438 -1.037 . . . . 0.0 109.291 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -85.77 152.92 22.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 109.372 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.2 p -150.91 138.24 19.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.153 -0.967 . . . . 0.0 109.976 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -100.59 146.73 26.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.304 -0.873 . . . . 0.0 109.342 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -105.06 111.84 24.75 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.467 -0.771 . . . . 0.0 109.654 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.74 125.7 90.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 108.767 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.75 -6.42 15.22 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.803 1.669 . . . . 0.0 112.819 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 30' ' ' ARG . 6.8 ptp180 -89.15 -28.77 19.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.973 -1.08 . . . . 0.0 109.345 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.7 t -116.22 -28.44 6.55 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.33 -13.15 62.64 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.013 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 8.6 mptt -77.07 -178.93 5.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.041 -1.27 . . . . 0.0 109.886 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 9.6 mp0 -108.88 174.62 5.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.599 -0.688 . . . . 0.0 110.184 -179.306 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -138.16 123.93 19.91 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.42 130.89 21.56 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.5 mt -118.45 -55.97 2.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.554 -0.968 . . . . 0.0 109.572 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.46 -171.94 27.15 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.838 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -95.14 10.49 35.7 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.164 -1.198 . . . . 0.0 109.155 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.464 ' C ' ' N ' ' A' ' 42' ' ' ARG . 93.7 m-20 -91.73 90.68 7.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.364 -0.835 . . . . 0.0 109.494 -179.153 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -54.7 -12.54 0.78 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.13 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' C ' ' A' ' 40' ' ' ASP . 5.7 mtt180 -73.42 -56.87 4.48 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.627 -0.671 . . . . 0.0 109.587 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.3 mt -75.18 -36.95 38.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.17 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.6 -57.54 9.79 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.55 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 88.5 mt -55.88 -41.09 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.542 -1.349 . . . . 0.0 108.564 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -55.98 -56.71 17.41 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.469 -0.769 . . . . 0.0 109.592 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -27.56 66.4 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.216 -0.928 . . . . 0.0 109.186 -179.322 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 45' ' ' ILE . . . -63.87 -48.13 77.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 108.748 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.75 -51.17 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.573 -0.704 . . . . 0.0 110.21 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -58.65 -37.1 75.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.947 -1.096 . . . . 0.0 108.179 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.29 88.41 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.24 -40.93 81.85 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.513 -0.742 . . . . 0.0 109.256 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.0 mt . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 108.54 179.747 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.01 162.68 18.51 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.111 1.874 . . . . 0.0 111.872 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.97 168.3 20.91 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.913 2.409 . . . . 0.0 112.684 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 48.19 22.5 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.529 -0.732 . . . . 0.0 110.302 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.444 ' C ' ' CD1' ' A' ' 17' ' ' TYR . 5.1 tt -136.05 146.08 46.72 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.217 -0.927 . . . . 0.0 109.166 179.099 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 32.0 m-85 -137.34 -172.77 3.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.546 -0.721 . . . . 0.0 110.342 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.9 tt -139.14 150.91 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.233 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -91.19 164.23 13.98 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.277 -0.889 . . . . 0.0 109.926 -178.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -66.4 -16.81 64.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.051 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -89.41 0.08 57.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.366 -0.834 . . . . 0.0 108.789 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.13 14.83 63.65 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -87.2 134.65 33.51 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.117 -1.225 . . . . 0.0 108.702 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.495 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 12.9 m-85 -83.73 156.24 22.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.995 . . . . 0.0 109.671 -179.715 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 24' ' ' TYR . 94.6 m -156.14 135.31 12.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.51 -0.744 . . . . 0.0 109.636 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -100.22 141.42 33.08 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.138 -0.976 . . . . 0.0 109.364 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -107.34 113.79 27.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.501 -0.749 . . . . 0.0 109.673 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -71.44 132.91 85.38 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.42 -0.8 . . . . 0.0 109.645 -179.904 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.59 -5.51 12.49 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.198 1.932 . . . . 0.0 112.375 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -88.5 -37.79 15.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.202 -0.936 . . . . 0.0 109.628 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 33' ' ' LYS . 2.5 t -113.11 -29.93 7.15 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.496 -0.753 . . . . 0.0 109.069 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.3 -10.08 74.95 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.168 -0.958 . . . . 0.0 110.929 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.476 ' H ' HG23 ' A' ' 31' ' ' THR . 9.7 mptt -74.73 179.36 4.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.902 -1.352 . . . . 0.0 109.61 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -117.47 171.73 7.8 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.666 0.746 . . . . 0.0 110.661 -178.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.94 122.65 18.69 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.55 122.94 8.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.5 mt -106.59 -70.09 0.8 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.478 -1.013 . . . . 0.0 109.398 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.25 -174.09 44.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -93.9 6.66 47.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -1.137 . . . . 0.0 109.522 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -95.41 98.87 10.88 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 109.489 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.535 HH11 ' CG ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -58.34 -13.14 4.61 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 108.498 179.606 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -74.38 -49.57 22.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 89.4 mt -78.54 -36.87 20.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.39 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.85 -57.51 8.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.232 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -54.38 -37.13 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.12 -0.988 . . . . 0.0 109.287 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -54.54 -58.15 8.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 108.895 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -60.9 -37.33 81.83 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.576 0.703 . . . . 0.0 109.132 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.13 -42.61 81.26 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.59 -0.694 . . . . 0.0 109.17 179.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.62 -45.87 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.203 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -58.89 -32.69 69.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.054 -1.029 . . . . 0.0 108.686 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.52 91.32 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -67.78 -41.43 83.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 0.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.4 mp . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -38.31 156.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.264 1.976 . . . . 0.0 111.903 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.26 147.83 83.88 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.212 1.942 . . . . 0.0 112.131 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 65.59 -1.83 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.608 -0.682 . . . . 0.0 110.38 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.9 tt -105.87 139.09 40.97 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.146 -0.972 . . . . 0.0 110.103 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -140.63 -168.44 2.57 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.72 0.772 . . . . 0.0 109.574 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.727 HD12 ' CE1' ' A' ' 24' ' ' TYR . 8.4 tt -146.25 146.22 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.585 -0.697 . . . . 0.0 109.683 178.644 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 21' ' ' ASN . 19.8 mtm180 -91.65 152.8 20.07 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.355 -0.841 . . . . 0.0 109.571 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -53.46 -11.15 0.3 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.236 -0.915 . . . . 0.0 109.163 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.433 ' H ' ' C ' ' A' ' 19' ' ' ARG . 47.6 m-20 -87.75 1.39 53.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 109.254 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.13 6.56 89.12 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -86.53 126.68 34.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.066 -1.255 . . . . 0.0 108.692 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.727 ' CE1' HD12 ' A' ' 18' ' ' ILE . 57.6 m-85 -82.69 148.93 27.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 109.37 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 p -148.62 144.8 27.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.201 -0.937 . . . . 0.0 109.822 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 36.6 t80 -105.98 148.23 27.93 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.46 ' NE ' ' O ' ' A' ' 32' ' ' GLY . 15.0 ttm180 -110.01 121.11 44.5 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.463 -0.773 . . . . 0.0 110.675 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -75.72 136.87 70.38 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.333 -0.854 . . . . 0.0 108.857 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.59 6.02 5.15 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.035 1.823 . . . . 0.0 112.252 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -89.8 -56.6 3.17 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 110.131 -179.284 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.17 1.5 13.87 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.38 -0.825 . . . . 0.0 109.474 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.46 ' O ' ' NE ' ' A' ' 27' ' ' ARG . . . 67.78 13.97 64.55 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -71.79 -174.4 1.16 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.077 -1.249 . . . . 0.0 109.064 179.65 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 5.7 mp0 -130.88 153.07 49.52 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 0.0 109.525 179.186 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -115.76 128.09 55.59 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.5 114.74 3.9 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.5 mt -100.56 -63.04 1.17 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.268 -1.137 . . . . 0.0 109.951 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.68 -177.15 36.3 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.471 ' NH1' ' H ' ' A' ' 39' ' ' ARG . 2.7 mtm-85 -89.1 7.37 35.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.071 -1.252 . . . . 0.0 109.997 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -95.61 107.97 20.2 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.147 -0.971 . . . . 0.0 109.361 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -65.61 -20.04 66.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 110.081 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -73.08 -48.63 34.17 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.109 -0.995 . . . . 0.0 109.598 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 93.8 mt -76.96 -37.49 26.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.266 -179.648 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.38 -57.41 8.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 109.804 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.1 mt -53.25 -35.59 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 0.0 109.421 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -51.65 66.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -60.76 -35.64 76.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.859 . . . . 0.0 109.304 -179.365 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.02 74.2 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.584 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.13 -47.11 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.833 . . . . 0.0 110.398 -179.496 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -62.29 -41.05 98.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.986 -1.071 . . . . 0.0 108.155 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.68 81.84 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -64.43 -34.1 77.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.098 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 108.73 179.584 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.3 mt . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.64 161.93 16.63 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.947 1.765 . . . . 0.0 111.369 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.19 153.97 73.44 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.733 2.289 . . . . 0.0 112.595 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 67.07 -8.02 0.46 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.73 -0.606 . . . . 0.0 110.826 179.423 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 tt -107.18 143.34 35.51 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.103 -0.998 . . . . 0.0 110.018 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 28.2 m-85 -137.78 -163.59 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.53 -0.731 . . . . 0.0 109.659 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.46 HD12 ' CE1' ' A' ' 24' ' ' TYR . 12.5 tt -143.08 150.84 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 121.43 0.634 . . . . 0.0 109.775 178.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.41 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 16.4 ttp180 -91.72 165.46 13.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -66.39 -13.01 60.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.958 . . . . 0.0 109.334 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -89.18 -0.28 57.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 109.121 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.99 11.46 73.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.41 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 10.2 m-85 -87.04 132.22 33.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -1.153 . . . . 0.0 108.609 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.533 ' OH ' ' NH1' ' A' ' 41' ' ' ARG . 44.9 m-85 -83.14 145.9 28.96 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.9 m -148.5 145.2 27.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.919 -1.113 . . . . 0.0 110.804 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -99.3 153.67 18.78 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.191 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.54 HH21 ' CD ' ' A' ' 34' ' ' GLU . 20.2 ttm180 -116.51 116.68 28.09 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.278 -0.889 . . . . 0.0 110.366 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -76.34 136.6 68.41 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.56 -11.48 14.21 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.951 1.768 . . . . 0.0 113.302 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -36.37 16.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.752 -1.217 . . . . 0.0 109.284 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.486 ' C ' ' H ' ' A' ' 33' ' ' LYS . 79.7 p -107.04 -14.78 14.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.81 -2.64 1.83 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -74.1 -169.35 0.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -1.162 . . . . 0.0 108.714 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.54 ' CD ' HH21 ' A' ' 27' ' ' ARG . 11.7 mt-10 -128.16 170.0 13.47 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.448 -0.782 . . . . 0.0 110.032 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -134.32 124.94 26.65 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.9 122.03 6.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.1 mt -105.48 -49.4 3.44 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.46 -1.023 . . . . 0.0 109.196 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.47 -170.43 31.67 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -98.38 2.28 47.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.319 -1.107 . . . . 0.0 109.245 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -97.01 98.48 10.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.294 -0.879 . . . . 0.0 110.039 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.571 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -57.55 -16.14 9.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 108.958 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -69.61 -49.02 57.91 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.384 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.616 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.8 mp -81.44 -33.05 12.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 41' ' ' ARG . . . -65.5 -59.0 4.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.366 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.6 mt -54.14 -37.83 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.302 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -53.22 54.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.207 -0.933 . . . . 0.0 108.973 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -63.51 -44.29 94.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.481 -0.762 . . . . 0.0 109.51 -179.543 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.78 -41.86 71.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.579 -0.7 . . . . 0.0 109.674 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.0 mt -60.76 -43.62 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -0.897 . . . . 0.0 110.365 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -59.96 -36.45 77.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.18 . . . . 0.0 108.176 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.33 75.51 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.29 -45.48 76.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.462 -0.774 . . . . 0.0 110.213 -179.672 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.3 mp . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 108.596 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.8 mt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.38 161.96 22.02 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.743 1.629 . . . . 0.0 111.464 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.11 171.92 9.44 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.59 2.194 . . . . 0.0 111.707 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 51.01 15.65 0.28 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -0.891 . . . . 0.0 109.988 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tt -138.09 133.93 34.05 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.165 -0.959 . . . . 0.0 110.026 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 22.7 m-85 -132.73 -163.11 1.3 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.707 -0.621 . . . . 0.0 109.418 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.1 tt -141.15 151.03 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 121.629 0.728 . . . . 0.0 110.133 179.21 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.497 HH21 ' CB ' ' A' ' 23' ' ' TYR . 11.7 ttp180 -92.64 148.15 22.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.516 -0.74 . . . . 0.0 109.143 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -52.91 -10.83 0.19 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.0 . . . . 0.0 109.448 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 19' ' ' ARG . 85.4 m-20 -90.09 -2.88 58.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 108.846 179.561 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.13 8.7 74.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.497 ' CB ' HH21 ' A' ' 19' ' ' ARG . 4.6 m-85 -85.77 132.55 34.1 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -82.57 147.91 28.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.16 -0.963 . . . . 0.0 108.528 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 m -148.04 144.59 28.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.993 -1.067 . . . . 0.0 109.949 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -101.08 148.09 25.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.538 -0.727 . . . . 0.0 109.788 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -105.52 108.84 20.57 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.364 -0.835 . . . . 0.0 110.025 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -72.28 119.57 75.51 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 108.669 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.75 0.55 9.71 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.626 1.551 . . . . 0.0 112.152 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -90.28 -28.87 18.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.101 -0.999 . . . . 0.0 109.352 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 33' ' ' LYS . 1.7 t -120.4 -27.64 5.16 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.58 -11.84 70.61 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.111 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.5 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 10.9 mptt -77.8 179.81 6.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.02 -1.282 . . . . 0.0 110.182 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.07 176.4 5.04 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.633 -0.667 . . . . 0.0 110.336 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -139.95 114.14 9.04 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.18 121.95 9.44 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.6 mt -105.36 -57.22 2.06 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.459 -1.024 . . . . 0.0 109.633 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.04 -158.6 30.95 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.495 HH11 ' CB ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -107.35 2.53 24.51 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.528 -0.983 . . . . 0.0 109.929 -179.789 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -93.91 98.26 10.93 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.098 -1.001 . . . . 0.0 110.043 -179.04 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -51.18 -21.1 1.82 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.274 -0.891 . . . . 0.0 108.604 179.089 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -71.9 -57.29 4.45 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.2 mm -67.55 -36.42 76.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.384 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.43 -58.34 4.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.603 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.35 -35.15 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 108.964 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -53.44 -54.18 40.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.155 -0.966 . . . . 0.0 108.518 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -62.08 -41.26 97.99 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.623 0.725 . . . . 0.0 109.328 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.23 -45.94 68.91 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.585 -0.697 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.26 -46.77 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.896 . . . . 0.0 110.209 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -62.12 -36.56 82.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.93 -1.106 . . . . 0.0 108.62 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.16 -35.53 81.09 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.214 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -69.83 -40.87 75.6 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.638 -0.664 . . . . 0.0 109.629 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.266 -0.896 . . . . 0.0 109.035 -179.939 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.45 149.31 71.78 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.61 158.65 31.38 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.651 1.567 . . . . 0.0 111.312 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 16' ' ' LEU . 58.2 Cg_endo -69.63 156.67 63.06 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.603 2.202 . . . . 0.0 112.713 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 70.84 -17.35 0.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.761 -0.587 . . . . 0.0 110.195 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 14' ' ' PRO . 3.9 tt -99.95 142.7 31.08 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.204 -0.935 . . . . 0.0 109.815 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -134.34 -177.79 4.75 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.476 0.655 . . . . 0.0 109.775 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.571 HD12 ' CE1' ' A' ' 24' ' ' TYR . 18.6 tt -140.0 148.88 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-O 121.376 0.607 . . . . 0.0 109.792 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.428 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 13.7 mtm180 -91.11 156.84 17.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.359 -0.838 . . . . 0.0 109.702 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -57.38 -14.39 4.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.463 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -88.67 -2.12 58.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 108.676 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.99 12.62 67.97 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.428 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 2.9 m-85 -86.51 130.52 34.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.045 -1.268 . . . . 0.0 108.429 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.571 ' CE1' HD12 ' A' ' 18' ' ' ILE . 54.3 m-85 -84.2 148.92 26.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 109.71 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.3 p -152.72 138.66 18.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.162 -0.961 . . . . 0.0 109.903 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -100.92 150.58 22.71 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.346 -0.846 . . . . 0.0 108.956 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -111.32 113.0 25.16 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.185 -0.947 . . . . 0.0 110.293 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.07 139.71 76.41 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 108.939 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -82.75 -10.77 10.51 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.042 1.828 . . . . 0.0 113.107 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -89.08 -38.82 14.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.784 -1.198 . . . . 0.0 109.769 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 33' ' ' LYS . 2.5 t -106.51 -11.08 16.01 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.75 -6.39 0.62 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -75.52 179.71 5.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.971 -1.311 . . . . 0.0 109.315 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 68.4 mt-10 -107.89 173.03 6.5 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.539 -0.726 . . . . 0.0 109.985 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -136.6 116.55 13.25 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.82 125.79 16.8 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 28.3 mt -110.44 -59.73 1.9 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.501 -0.999 . . . . 0.0 109.207 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.91 -176.06 35.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -93.13 7.79 42.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.15 -1.206 . . . . 0.0 109.477 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.02 101.99 13.73 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -58.77 -12.88 4.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.157 -0.964 . . . . 0.0 108.764 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -75.63 -56.8 4.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.458 -0.777 . . . . 0.0 108.97 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 89.0 mt -73.27 -34.71 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.526 -0.734 . . . . 0.0 109.596 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.57 -57.71 7.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.035 -1.041 . . . . 0.0 109.437 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 92.1 mt -54.51 -36.82 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 109.211 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -53.7 -56.81 14.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 108.938 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -62.11 -42.99 99.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.651 -0.656 . . . . 0.0 110.027 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.65 67.68 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.387 -0.82 . . . . 0.0 109.147 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.31 -48.34 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.336 -0.852 . . . . 0.0 109.919 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -61.37 -39.68 91.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.989 -1.069 . . . . 0.0 108.241 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.14 75.13 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -67.92 -33.62 75.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.421 -0.799 . . . . 0.0 109.695 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.4 mt -67.22 -32.14 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 108.824 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -71.27 -29.65 65.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.377 -0.827 . . . . 0.0 109.504 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 mt -63.67 -9.28 13.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 0.0 108.792 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.67 -21.95 12.89 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 t -99.4 -19.76 16.83 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.29 -0.881 . . . . 0.0 109.358 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.74 163.33 16.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.53 ' O ' ' CG ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.249 -1.148 . . . . 0.0 109.481 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.2 t0 . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.5 mt -83.11 146.73 52.2 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.545 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -35.59 145.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.738 2.292 . . . . 0.0 112.52 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -44.43 138.5 7.45 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.079 1.852 . . . . 0.0 113.429 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 m120 61.04 43.38 11.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.446 -0.784 . . . . 0.0 111.63 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.5 tp -139.95 119.42 13.07 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -113.39 179.87 3.84 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.583 0.706 . . . . 0.0 110.413 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.605 HD12 ' CE1' ' A' ' 24' ' ' TYR . 13.0 tt -138.73 147.1 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-O 121.538 0.685 . . . . 0.0 109.243 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -91.48 160.12 15.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.533 -0.73 . . . . 0.0 110.352 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -61.36 -11.49 10.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.58 -0.7 . . . . 0.0 109.125 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -88.87 -1.2 57.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.029 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.77 4.99 86.92 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -86.65 135.29 33.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.11 -1.23 . . . . 0.0 108.367 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.605 ' CE1' HD12 ' A' ' 18' ' ' ILE . 79.5 m-85 -84.37 152.53 24.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.166 -0.959 . . . . 0.0 110.16 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.437 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 30.2 p -150.77 126.4 10.23 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.424 -0.797 . . . . 0.0 109.455 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -94.96 150.27 20.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.195 -0.94 . . . . 0.0 109.333 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -115.05 115.67 27.2 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.485 -0.759 . . . . 0.0 110.627 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -76.01 131.43 75.95 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 108.989 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.86 -7.69 13.33 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.022 1.815 . . . . 0.0 113.42 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -86.13 -18.16 33.05 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.646 -1.284 . . . . 0.0 108.977 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 33' ' ' LYS . 1.3 t -130.67 -27.46 2.13 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.46 -3.52 84.63 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' H ' HG23 ' A' ' 31' ' ' THR . 4.3 mmtp -75.21 -176.32 3.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.953 -1.322 . . . . 0.0 109.304 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -115.99 170.2 8.67 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.484 -0.76 . . . . 0.0 110.266 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -137.27 121.7 18.27 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.28 123.5 6.32 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.7 mt -104.79 -69.56 0.81 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.417 -1.049 . . . . 0.0 109.572 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.57 -177.92 37.67 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' HG3' HH11 ' A' ' 39' ' ' ARG . 6.9 mtm-85 -90.52 7.19 40.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.169 -1.195 . . . . 0.0 110.035 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -95.18 111.31 23.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.253 -0.904 . . . . 0.0 110.216 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.519 HH11 ' HG3' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -62.63 -15.57 52.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 108.99 179.119 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -74.43 -46.67 38.48 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.85 -39.6 16.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.44 -58.16 7.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.667 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 98.7 mt -55.88 -37.56 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.942 -1.099 . . . . 0.0 109.343 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -55.97 -57.96 9.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 109.542 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -61.47 -42.71 99.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.475 -0.766 . . . . 0.0 109.911 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.32 64.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.491 -0.755 . . . . 0.0 109.542 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.47 -42.99 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.242 -0.911 . . . . 0.0 110.36 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.402 ' H ' ' HG3' ' A' ' 50' ' ' GLN . 33.7 mt-30 -59.94 -32.47 70.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.039 -1.038 . . . . 0.0 108.804 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.28 -36.5 84.29 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -67.18 -37.49 83.79 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.28 -0.888 . . . . 0.0 109.873 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.66 -25.75 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.131 -0.981 . . . . 0.0 109.011 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 58' ' ' GLY . 48.7 mt-10 -69.9 -33.71 72.55 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.283 -0.886 . . . . 0.0 108.687 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.94 -39.98 90.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.123 -0.985 . . . . 0.0 109.604 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -81.43 0.65 36.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.141 -0.974 . . . . 0.0 109.34 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.0 m -165.28 53.63 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.254 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . -73.21 120.72 7.27 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.5 m170 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.295 -1.12 . . . . 0.0 109.47 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.5 t70 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.0 mt -82.8 148.63 58.03 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.295 -0.878 . . . . 0.0 109.453 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.91 161.91 43.71 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.34 2.027 . . . . 0.0 111.094 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.52 ' C ' ' H ' ' A' ' 16' ' ' LEU . 32.4 Cg_endo -62.58 165.03 16.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.35 2.034 . . . . 0.0 112.052 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.4 m120 61.7 -9.35 0.08 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.654 -0.654 . . . . 0.0 110.698 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.9 tp -108.08 143.0 37.43 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.091 -1.005 . . . . 0.0 109.335 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 46.5 m-85 -136.78 -165.33 1.72 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.769 0.795 . . . . 0.0 110.052 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.472 HD13 ' CE1' ' A' ' 24' ' ' TYR . 10.5 tp -138.47 138.05 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.503 ' HE ' ' CB ' ' A' ' 23' ' ' TYR . 44.1 mtm180 -89.71 173.04 8.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.258 -0.901 . . . . 0.0 109.28 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -64.51 -20.04 65.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.113 -0.992 . . . . 0.0 109.699 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.85 3.1 55.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.001 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.431 ' C ' HD11 ' A' ' 18' ' ' ILE . . . 77.93 19.82 74.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.503 ' CB ' ' HE ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -84.92 132.76 34.33 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.472 ' CE1' HD13 ' A' ' 18' ' ' ILE . 65.6 m-85 -82.2 141.99 32.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.925 -1.109 . . . . 0.0 109.638 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.9 m -144.13 135.23 25.43 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 38.5 t80 -96.86 157.49 15.88 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.565 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 27.6 ttm180 -127.52 120.53 28.48 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.498 -0.751 . . . . 0.0 110.539 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -76.47 144.94 74.9 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.128 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.18 -13.0 7.85 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.997 1.798 . . . . 0.0 111.902 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -91.59 -36.3 13.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.282 -0.886 . . . . 0.0 110.078 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 33' ' ' LYS . 27.6 p -106.2 -17.83 14.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.37 -0.831 . . . . 0.0 109.503 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.1 -8.99 0.81 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 31' ' ' THR . 6.6 tmtt? -73.6 -174.17 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.983 -1.304 . . . . 0.0 108.232 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -128.99 161.38 30.07 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.39 -0.819 . . . . 0.0 110.51 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -119.48 137.17 53.97 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.8 120.58 5.25 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mt -102.53 -61.27 1.42 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.409 -1.054 . . . . 0.0 108.838 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.18 -170.18 32.69 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.63 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 1.2 mtm180 -95.85 11.37 33.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -1.194 . . . . 0.0 109.13 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -93.06 98.51 11.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.476 -0.765 . . . . 0.0 110.031 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -61.78 -13.13 20.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.572 -0.705 . . . . 0.0 109.163 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 42' ' ' ARG . 17.3 mmm-85 -77.04 -57.12 4.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.48 -0.762 . . . . 0.0 109.591 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.7 mp -74.42 -35.95 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.22 -0.925 . . . . 0.0 109.537 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.6 -52.98 62.16 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.162 -0.961 . . . . 0.0 109.346 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.5 mt -57.2 -41.67 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.684 -1.26 . . . . 0.0 108.554 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.9 m -57.76 -51.25 70.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 110.614 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -32.77 74.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.035 -1.041 . . . . 0.0 109.768 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.5 90.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.168 -0.957 . . . . 0.0 110.051 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.18 -56.31 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.353 -0.842 . . . . 0.0 111.007 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -56.19 -31.11 63.14 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.943 -1.098 . . . . 0.0 108.489 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.94 -38.0 82.3 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -65.6 -45.28 83.79 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.5 mt -69.53 -42.37 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.353 -0.842 . . . . 0.0 108.748 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -70.89 -15.07 62.59 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.575 -0.703 . . . . 0.0 109.349 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 tp -56.16 -16.63 5.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.474 -0.766 . . . . 0.0 109.266 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -100.69 -2.26 33.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.366 -0.834 . . . . 0.0 109.122 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.6 p -154.44 80.39 1.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.845 . . . . 0.0 109.313 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.552 ' O ' ' CG ' ' A' ' 59' ' ' HIS . . . -46.6 162.61 0.18 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.552 ' CG ' ' O ' ' A' ' 58' ' ' GLY . 34.1 p80 . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.661 -0.906 . . . . 0.0 110.222 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 23.6 p-10 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 13' ' ' PRO . 40.6 mt -80.99 149.55 66.98 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 109.114 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 12' ' ' LEU . 90.7 Cg_exo -35.41 158.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.617 2.212 . . . . 0.0 111.814 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.08 143.88 50.63 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.059 1.839 . . . . 0.0 111.265 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 65.85 29.17 10.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.602 -0.686 . . . . 0.0 109.939 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.0 tp -138.91 123.66 18.64 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 11.9 m-85 -131.1 -163.95 1.38 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.172 0.987 . . . . 0.0 111.11 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 tp -126.82 142.21 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' A' ' 19' ' ' ARG . 14.5 ttm-85 -88.48 161.53 16.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.162 -0.962 . . . . 0.0 109.036 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -59.26 -18.35 36.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.038 -1.039 . . . . 0.0 109.423 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -89.36 -0.33 57.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.093 -1.005 . . . . 0.0 108.722 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.36 8.41 74.57 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -86.22 142.61 28.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -1.174 . . . . 0.0 108.943 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -81.48 149.71 28.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.967 -1.083 . . . . 0.0 108.938 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 p -148.57 135.44 19.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.983 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -97.83 154.81 17.38 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -118.12 110.84 18.11 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.451 -0.781 . . . . 0.0 109.472 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.95 151.02 86.28 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.223 -0.923 . . . . 0.0 109.645 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -90.46 -23.18 0.64 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.624 2.216 . . . . 0.0 113.146 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HG3' HG23 ' A' ' 31' ' ' THR . 28.4 ptt180 -90.14 -26.35 20.22 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.933 -1.105 . . . . 0.0 110.346 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.532 ' C ' ' H ' ' A' ' 33' ' ' LYS . 68.1 p -105.92 -19.24 13.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.0 -1.062 . . . . 0.0 108.421 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.74 -11.23 0.63 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -75.99 -161.97 0.2 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.202 -1.176 . . . . 0.0 109.032 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 44.1 mt-10 -129.82 179.52 5.8 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.573 -0.705 . . . . 0.0 109.935 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -143.94 117.45 9.14 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.09 126.3 10.2 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt -105.97 -52.47 2.8 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.362 -1.081 . . . . 0.0 109.622 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.92 -173.07 30.52 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -97.72 8.95 43.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -1.129 . . . . 0.0 109.292 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -94.43 99.52 11.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.325 -0.859 . . . . 0.0 110.422 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -55.47 -19.61 10.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.538 HH11 ' HG2' ' A' ' 42' ' ' ARG . 1.1 mmt-85 -75.46 -54.09 7.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 109.237 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 78.9 mt -76.25 -36.84 30.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.688 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -58.52 8.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 50.8 mt -50.84 -39.43 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.8 -1.187 . . . . 0.0 109.176 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.06 -51.5 66.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.008 . . . . 0.0 109.499 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -62.37 -41.25 98.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 109.151 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.38 93.4 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.434 -0.792 . . . . 0.0 110.229 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.1 mt -60.46 -52.66 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.137 -0.977 . . . . 0.0 110.593 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -59.12 -30.87 68.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.875 -1.141 . . . . 0.0 108.712 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.31 93.18 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -68.05 -39.32 83.05 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.466 -0.771 . . . . 0.0 109.392 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.8 mt -68.81 -30.08 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.243 -0.911 . . . . 0.0 108.831 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -70.43 -21.7 62.79 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.409 -0.807 . . . . 0.0 108.831 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.501 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.44 -36.88 79.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 108.861 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -104.33 -28.37 11.42 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.43 -0.794 . . . . 0.0 109.081 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.1 m -95.04 47.75 1.16 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.118 -0.989 . . . . 0.0 109.166 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.26 10.47 74.8 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.4 m80 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.325 -1.103 . . . . 0.0 109.547 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.1 mt -82.18 151.47 66.45 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.337 -0.852 . . . . 0.0 109.368 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.53 160.44 39.7 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.752 1.634 . . . . 0.0 110.354 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 16' ' ' LEU . 57.2 Cg_endo -67.7 171.6 11.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.31 2.007 . . . . 0.0 112.201 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 57.05 4.21 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.555 -0.716 . . . . 0.0 109.422 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.499 ' H ' ' C ' ' A' ' 14' ' ' PRO . 26.1 tp -129.74 132.39 46.57 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -134.46 -163.47 1.38 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.366 -0.834 . . . . 0.0 110.339 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 tp -132.04 141.11 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -88.77 158.91 18.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.968 . . . . 0.0 109.115 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -57.4 -19.91 26.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.465 -0.772 . . . . 0.0 109.043 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.81 -2.93 58.96 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.72 10.99 71.79 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -86.61 140.23 30.04 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.231 -1.158 . . . . 0.0 108.588 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.438 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 68.4 m-85 -81.84 151.24 27.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.85 -1.156 . . . . 0.0 109.432 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.447 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 17.2 p -146.68 133.36 19.93 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.397 -0.814 . . . . 0.0 110.156 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -96.94 137.33 36.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.331 -0.855 . . . . 0.0 108.812 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -108.81 115.33 29.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.591 -0.693 . . . . 0.0 110.104 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.34 142.66 89.77 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -84.17 -8.8 9.76 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.393 2.062 . . . . 0.0 113.323 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -89.78 -24.45 21.48 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.842 -1.161 . . . . 0.0 109.987 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 -22.33 3.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.368 -0.832 . . . . 0.0 109.49 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.41 0.9 68.34 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.402 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 3.6 tmtt? -73.94 179.68 4.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.959 -1.318 . . . . 0.0 108.494 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 25.9 mt-10 -131.72 160.25 36.04 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.375 -0.828 . . . . 0.0 110.605 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -138.04 125.48 21.94 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.16 132.46 33.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.428 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.6 mt -105.09 -47.79 3.9 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.413 -1.051 . . . . 0.0 108.869 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.39 -178.98 22.8 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.181 -1.967 . . . . 0.0 108.181 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -91.55 11.03 25.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.021 -1.282 . . . . 0.0 109.371 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.34 100.72 13.25 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.933 0.873 . . . . 0.0 109.835 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.438 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 43.0 ttm180 -59.25 -20.06 51.04 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.4 0.619 . . . . 0.0 109.9 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.584 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -77.08 -49.27 15.68 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.714 0.768 . . . . 0.0 109.2 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.5 mt -75.76 -36.89 34.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.8 -55.41 26.71 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.348 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.53 -40.34 74.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.418 -0.801 . . . . 0.0 109.78 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -50.63 -51.74 46.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 108.914 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -62.53 -37.76 87.34 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.551 -0.718 . . . . 0.0 109.333 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.25 -51.91 67.81 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.497 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.61 -48.87 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.361 -0.837 . . . . 0.0 110.641 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -58.07 -44.07 87.3 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.839 -1.163 . . . . 0.0 108.145 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.54 74.05 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -69.94 -45.74 66.81 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.333 -0.855 . . . . 0.0 109.521 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.7 mt -69.68 -37.68 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.085 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.61 -22.67 64.42 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.326 -0.859 . . . . 0.0 109.305 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.18 -12.84 30.97 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.121 -0.987 . . . . 0.0 108.474 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.499 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -117.52 -32.72 4.81 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.4 m -99.85 59.58 1.07 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.321 -0.862 . . . . 0.0 109.737 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 59' ' ' HIS . . . -166.39 177.15 41.43 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.525 ' CG ' ' O ' ' A' ' 58' ' ' GLY . 32.5 m80 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.298 -1.119 . . . . 0.0 109.264 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 mt -80.57 150.34 69.85 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 121.331 -0.856 . . . . 0.0 108.89 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -40.21 157.27 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.115 1.876 . . . . 0.0 111.85 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 16' ' ' LEU . 50.5 Cg_endo -69.61 153.03 70.15 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.093 1.862 . . . . 0.0 111.767 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 69.0 -11.27 0.45 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.535 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.411 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.5 tt -97.56 142.28 29.58 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.926 -1.109 . . . . 0.0 109.664 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -136.03 -178.83 5.32 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.551 -0.718 . . . . 0.0 109.393 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.21 147.77 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.662 0.744 . . . . 0.0 109.631 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.504 HH21 ' CB ' ' A' ' 23' ' ' TYR . 15.1 ttp180 -91.31 156.32 17.88 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -59.71 -10.33 3.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.057 -1.027 . . . . 0.0 109.604 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -88.69 1.41 55.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.259 -0.901 . . . . 0.0 108.755 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.88 6.16 88.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.504 ' CB ' HH21 ' A' ' 19' ' ' ARG . 3.6 m-85 -84.36 138.06 33.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.313 -1.11 . . . . 0.0 108.488 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -83.0 154.67 24.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.034 -1.041 . . . . 0.0 109.307 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 p -150.88 132.24 14.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.818 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -101.98 143.64 31.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.378 -0.826 . . . . 0.0 109.097 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -101.86 118.66 37.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.49 -0.756 . . . . 0.0 109.5 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 35' ' ' PHE . 1.9 m-20 -74.35 149.12 86.53 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.977 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.24 3.06 7.09 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.771 2.314 . . . . 0.0 113.015 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -86.48 -55.12 4.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.951 -1.093 . . . . 0.0 110.243 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.42 HG23 ' H ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -118.17 -18.93 9.21 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.457 -0.777 . . . . 0.0 109.807 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.32 6.76 59.78 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.051 -1.031 . . . . 0.0 110.635 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.42 ' H ' HG23 ' A' ' 31' ' ' THR . 8.6 mptt -72.25 -175.23 1.48 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.847 -1.384 . . . . 0.0 109.325 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -119.1 166.86 12.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.646 -0.659 . . . . 0.0 109.822 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.469 ' CE1' ' OD2' ' A' ' 28' ' ' ASP . 8.0 m-85 -134.77 119.2 17.9 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.14 121.75 16.83 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -104.22 -53.49 2.72 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.526 -0.985 . . . . 0.0 109.302 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.46 -177.45 28.53 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.509 -1.837 . . . . 0.0 108.509 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.474 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 1.8 mtm180 -93.92 8.47 41.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.13 -1.218 . . . . 0.0 109.422 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -94.19 102.73 14.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -60.5 -11.77 7.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.349 -0.845 . . . . 0.0 109.018 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.2 OUTLIER -75.8 -54.72 6.49 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.467 -0.771 . . . . 0.0 109.216 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.575 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.7 mp -74.92 -37.91 42.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.614 -0.679 . . . . 0.0 109.183 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.11 -56.74 14.3 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.65 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.7 mt -55.99 -40.88 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.043 -1.036 . . . . 0.0 109.329 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.7 m -59.96 -50.73 72.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 110.477 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -32.86 74.52 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.306 -0.871 . . . . 0.0 110.018 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.97 92.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.105 -0.997 . . . . 0.0 108.961 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.1 mt -56.86 -42.2 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.441 -0.787 . . . . 0.0 110.207 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -58.19 -39.53 79.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.053 -1.029 . . . . 0.0 108.991 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.35 84.01 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -67.8 -39.26 84.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.531 -0.731 . . . . 0.0 110.419 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 81.4 mt -68.39 -36.87 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.004 -1.06 . . . . 0.0 109.572 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -70.07 -19.35 63.27 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.31 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.83 -43.63 98.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.862 . . . . 0.0 109.199 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.413 ' C ' ' N ' ' A' ' 58' ' ' GLY . 76.3 m-85 -81.1 7.25 11.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -0.872 . . . . 0.0 109.32 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.4 t 49.78 18.07 0.31 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.25 -0.906 . . . . 0.0 108.881 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' A' ' 56' ' ' PHE . . . 70.76 -49.06 0.81 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 p80 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.298 -1.119 . . . . 0.0 109.386 -179.845 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.7 t0 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.196 0.522 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 76.9 mt -81.22 150.64 68.33 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.952 . . . . 0.0 109.163 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -37.87 154.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.29 1.993 . . . . 0.0 111.892 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 16' ' ' LEU . 41.4 Cg_endo -66.68 153.61 77.37 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.377 2.051 . . . . 0.0 112.554 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 54.71 6.5 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.482 -0.761 . . . . 0.0 110.42 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.424 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.6 tt -104.61 148.01 27.0 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.19 -0.944 . . . . 0.0 109.25 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -139.1 -177.58 4.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.879 0.847 . . . . 0.0 110.331 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.66 HD12 ' CE1' ' A' ' 24' ' ' TYR . 18.6 tt -141.31 145.45 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.423 HH21 ' CB ' ' A' ' 23' ' ' TYR . 8.9 ttp180 -90.32 151.64 21.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.418 -0.801 . . . . 0.0 109.667 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -51.07 -15.86 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.444 -0.785 . . . . 0.0 109.973 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -88.69 0.89 56.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.178 -0.951 . . . . 0.0 108.845 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.69 12.18 78.19 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.423 ' CB ' HH21 ' A' ' 19' ' ' ARG . 8.0 m-85 -84.07 127.71 34.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.951 -1.323 . . . . 0.0 107.76 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.66 ' CE1' HD12 ' A' ' 18' ' ' ILE . 53.6 m-85 -82.82 147.53 28.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.2 m -150.32 141.84 23.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.029 -1.045 . . . . 0.0 110.308 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 36.6 t80 -110.99 150.09 29.76 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.418 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 33.8 mtt180 -109.92 117.36 33.59 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.5 ' OD1' ' CD1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -75.06 131.73 78.2 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -75.22 -6.25 17.68 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.776 1.651 . . . . 0.0 112.622 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -89.1 -44.0 10.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.923 -1.11 . . . . 0.0 109.163 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.488 ' C ' ' H ' ' A' ' 33' ' ' LYS . 1.4 t -108.34 -7.4 15.9 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.289 -0.882 . . . . 0.0 108.913 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.6 -2.42 0.85 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 31' ' ' THR . 3.4 mmtp -73.14 -179.94 3.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.068 -1.254 . . . . 0.0 108.857 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -105.75 171.72 7.19 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.537 -0.727 . . . . 0.0 109.951 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.5 ' CD1' ' OD1' ' A' ' 28' ' ' ASP . 14.8 m-85 -140.53 109.87 6.24 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.33 125.55 21.15 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.02 -31.37 7.65 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.55 -0.97 . . . . 0.0 109.93 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.15 -174.36 18.33 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -97.61 10.77 39.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.215 -1.168 . . . . 0.0 109.823 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -92.43 100.46 13.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.371 -0.831 . . . . 0.0 110.084 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -59.03 -16.39 18.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.515 -0.74 . . . . 0.0 109.628 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.54 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -76.49 -58.68 3.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.184 -0.948 . . . . 0.0 109.326 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.612 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.7 mp -74.89 -33.1 29.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.654 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.44 77.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.765 -1.21 . . . . 0.0 109.928 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.1 -38.79 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.733 -1.23 . . . . 0.0 108.976 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 47' ' ' GLU . 1.2 m -53.87 -63.92 0.99 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.239 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.406 ' N ' HG22 ' A' ' 46' ' ' THR . 20.0 mt-10 -53.05 -38.54 62.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.628 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.3 80.88 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.298 -0.877 . . . . 0.0 108.896 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.25 -44.83 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.425 -0.797 . . . . 0.0 110.8 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -57.41 -39.03 75.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 108.173 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.43 -35.77 81.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -66.86 -40.83 88.0 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.349 -0.845 . . . . 0.0 109.714 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.1 -28.24 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.041 -1.037 . . . . 0.0 108.477 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -70.84 -24.86 62.61 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.59 -0.694 . . . . 0.0 109.834 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.37 -16.09 59.44 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.031 -1.043 . . . . 0.0 108.62 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -109.03 11.96 25.49 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t 66.94 12.78 9.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.591 -0.693 . . . . 0.0 109.502 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.79 102.72 1.68 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 . . . . . 0 C--N 1.303 -1.431 0 O-C-N 121.194 -1.18 . . . . 0.0 109.269 -179.874 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.6 mt -82.09 150.92 65.84 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.333 -0.855 . . . . 0.0 108.728 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -40.6 156.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.848 1.699 . . . . 0.0 111.336 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.75 165.2 16.57 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.946 1.764 . . . . 0.0 111.384 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.502 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 7.5 m120 51.16 30.21 5.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.193 -0.942 . . . . 0.0 109.415 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.698 HD23 ' N ' ' A' ' 17' ' ' TYR . 2.5 tt -138.28 127.51 24.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.349 -0.845 . . . . 0.0 108.793 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.698 ' N ' HD23 ' A' ' 16' ' ' LEU . 93.0 m-85 -124.11 -179.01 4.26 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.578 -0.701 . . . . 0.0 109.423 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.1 tt -140.39 150.53 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.561 -0.712 . . . . 0.0 109.299 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.454 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 35.0 ttp180 -91.65 152.53 20.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.168 -0.958 . . . . 0.0 109.602 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -58.9 -15.63 13.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 0.0 109.447 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -88.2 -1.73 58.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 108.642 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.82 9.58 65.97 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.454 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -84.65 129.28 34.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -1.224 . . . . 0.0 108.216 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -81.5 152.23 27.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.982 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.2 m -152.06 136.42 16.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.418 -0.801 . . . . 0.0 109.58 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 15' ' ' ASN . 81.5 t80 -105.03 137.4 42.84 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.383 -0.823 . . . . 0.0 109.083 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -103.23 113.07 26.26 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.392 -0.817 . . . . 0.0 109.682 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.13 139.9 85.25 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.275 -0.891 . . . . 0.0 110.347 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -83.5 1.4 8.98 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.479 2.12 . . . . 0.0 112.248 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -86.89 -37.0 18.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.082 -1.011 . . . . 0.0 109.88 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.1 -23.07 3.65 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.488 -0.757 . . . . 0.0 109.102 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.81 2.04 72.69 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -74.76 -164.97 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.875 -1.368 . . . . 0.0 109.777 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -129.52 171.87 12.14 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.755 0.788 . . . . 0.0 110.889 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -139.58 124.65 18.77 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.26 119.26 6.19 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.9 mt -103.8 -52.22 3.01 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.32 -1.106 . . . . 0.0 109.022 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.3 -169.09 26.46 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -97.47 11.87 35.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.288 -1.125 . . . . 0.0 109.269 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.94 106.5 18.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.367 -0.833 . . . . 0.0 110.142 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -64.43 -18.52 64.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.532 -0.73 . . . . 0.0 109.18 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 42' ' ' ARG . 11.4 mmm-85 -76.84 -50.52 13.23 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.478 -0.763 . . . . 0.0 109.076 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 92.4 mt -76.12 -36.35 30.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.606 -0.684 . . . . 0.0 109.806 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.99 -52.65 58.62 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.183 -0.948 . . . . 0.0 109.823 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.14 -39.28 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.001 -1.062 . . . . 0.0 109.426 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.99 -50.87 65.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.0 109.715 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -62.5 -39.78 94.58 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.512 -0.743 . . . . 0.0 109.656 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.514 ' CB ' HD12 ' A' ' 16' ' ' LEU . . . -62.43 -44.84 95.45 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.478 -0.764 . . . . 0.0 109.977 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.28 -58.41 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.217 -0.927 . . . . 0.0 111.23 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -55.73 -24.44 34.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.989 -1.069 . . . . 0.0 109.167 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.57 81.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -70.58 -40.42 73.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.738 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.6 mt -67.27 -31.55 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.12 -0.987 . . . . 0.0 109.236 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -72.0 -24.47 61.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -0.866 . . . . 0.0 108.791 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.469 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -63.11 -41.25 99.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.491 -0.756 . . . . 0.0 109.351 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -83.47 9.08 12.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.893 . . . . 0.0 109.318 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 t -137.71 25.42 2.84 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.358 -0.839 . . . . 0.0 109.144 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.19 -71.56 0.81 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 28.1 p80 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.26 -1.141 . . . . 0.0 109.368 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.79 148.12 60.48 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.122 -0.987 . . . . 0.0 109.34 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -37.59 158.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.447 2.098 . . . . 0.0 111.886 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.1 166.09 30.32 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.312 2.008 . . . . 0.0 111.948 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 49.48 20.94 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.919 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 tp -128.0 125.99 40.49 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -121.68 173.53 7.39 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.624 -0.672 . . . . 0.0 110.249 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.24 134.53 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.468 ' C ' ' H ' ' A' ' 21' ' ' ASN . 18.4 mtm180 -89.92 149.48 22.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.095 -1.003 . . . . 0.0 109.887 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -54.05 -8.85 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.136 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 19' ' ' ARG . 88.0 m-20 -89.65 0.26 57.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.394 -0.816 . . . . 0.0 109.218 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.79 3.92 90.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.42 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 9.5 m-85 -88.07 129.92 35.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.173 -1.192 . . . . 0.0 109.073 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.437 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 13.4 m-85 -84.82 156.9 21.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.461 -0.774 . . . . 0.0 108.987 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.437 ' SG ' ' O ' ' A' ' 24' ' ' TYR . 98.9 m -152.83 129.34 10.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.298 -0.877 . . . . 0.0 109.464 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -95.6 145.43 25.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.248 -0.908 . . . . 0.0 108.953 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -120.41 118.63 30.82 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.59 -0.694 . . . . 0.0 110.139 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -76.02 138.79 68.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.319 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.12 16.41 1.65 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.556 2.171 . . . . 0.0 112.896 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 -68.44 0.75 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.8 -1.188 . . . . 0.0 109.042 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.32 -19.56 13.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.307 -0.871 . . . . 0.0 109.36 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.68 17.52 23.37 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 178.84 5.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.765 -1.432 . . . . 0.0 108.977 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -126.49 164.14 21.81 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.423 -0.798 . . . . 0.0 110.443 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -134.78 133.08 39.48 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.21 131.57 10.73 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.34 -54.68 2.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.485 -1.009 . . . . 0.0 109.643 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.27 -171.46 31.54 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.91 7.66 46.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -1.201 . . . . 0.0 109.683 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -95.29 103.96 15.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.256 -0.902 . . . . 0.0 110.098 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -58.13 -18.64 26.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 108.738 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.5 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -73.46 -49.69 25.51 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.7 mt -76.89 -37.06 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.543 -0.723 . . . . 0.0 109.238 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.14 -56.56 12.21 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.854 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 88.8 mt -54.15 -35.74 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.098 -1.001 . . . . 0.0 109.351 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -56.82 -59.53 4.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.096 -1.003 . . . . 0.0 109.033 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -59.53 -42.24 91.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.37 -0.831 . . . . 0.0 109.807 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.6 -42.15 61.75 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.96 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.09 -52.49 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -60.58 -29.7 69.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.947 -1.096 . . . . 0.0 108.199 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.16 86.35 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -64.79 -36.78 85.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.412 -0.805 . . . . 0.0 109.377 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.0 mm -69.25 -29.38 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 108.876 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -70.69 -23.99 62.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.433 -0.792 . . . . 0.0 109.426 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.51 -8.47 4.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 109.127 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -130.27 4.52 4.78 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 t 53.93 19.17 1.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 109.383 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.93 26.87 19.8 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.308 -1.113 . . . . 0.0 109.401 -179.875 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.7 mt -81.72 150.64 66.56 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.28 -0.888 . . . . 0.0 109.391 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -40.78 157.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.049 1.833 . . . . 0.0 111.491 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.42 162.39 40.87 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.257 1.971 . . . . 0.0 112.143 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 52.72 27.35 5.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.469 -0.769 . . . . 0.0 110.25 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.64 148.47 47.44 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.221 -0.925 . . . . 0.0 108.81 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 22.6 m-85 -138.16 -166.85 2.05 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.115 0.96 . . . . 0.0 110.753 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.42 136.01 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 21' ' ' ASN . 26.8 ttp180 -88.62 142.25 27.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.921 -1.112 . . . . 0.0 109.424 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -50.45 -10.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.497 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 19' ' ' ARG . 8.6 m120 -89.75 -0.04 57.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 109.169 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.57 5.11 87.12 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.467 ' CB ' HH21 ' A' ' 19' ' ' ARG . 3.0 m-85 -88.61 134.92 33.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.273 -1.134 . . . . 0.0 108.977 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -84.18 147.94 27.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.927 . . . . 0.0 108.699 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.8 m -150.62 143.03 24.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.037 -1.04 . . . . 0.0 110.044 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.448 ' CZ ' ' HB1' ' A' ' 51' ' ' ALA . 43.8 t80 -105.01 159.05 16.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.495 -0.753 . . . . 0.0 109.102 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.539 HH21 ' CD ' ' A' ' 34' ' ' GLU . 27.8 ttm180 -130.5 113.9 14.84 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.358 -0.839 . . . . 0.0 109.78 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.58 141.33 79.5 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.509 -0.744 . . . . 0.0 109.176 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -83.57 -19.82 5.04 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 121.931 1.754 . . . . 0.0 112.388 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 30' ' ' ARG . 8.6 ptm180 -89.14 -26.01 21.55 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.126 -0.984 . . . . 0.0 109.491 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 33' ' ' LYS . 1.9 p -107.33 -21.02 13.09 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.36 -10.43 0.66 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 31' ' ' THR . 5.5 tmtt? -75.99 -179.21 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -1.232 . . . . 0.0 109.6 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.539 ' CD ' HH21 ' A' ' 27' ' ' ARG . 36.5 mt-10 -115.89 168.13 10.33 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.546 0.688 . . . . 0.0 110.291 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -135.77 121.22 19.3 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.54 124.58 6.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -105.09 -73.87 0.67 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.417 -1.049 . . . . 0.0 109.226 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 172.08 -168.55 41.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.441 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -98.29 0.16 45.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.269 -1.136 . . . . 0.0 109.593 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -98.36 100.1 11.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.308 -0.87 . . . . 0.0 109.748 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 4.1 ptt180 -54.63 -20.23 7.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.267 -0.896 . . . . 0.0 109.527 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' H ' ' HD3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -68.34 -50.48 52.94 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.585 HD12 ' N ' ' A' ' 43' ' ' ILE . 1.9 mp -77.57 -34.87 20.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 41' ' ' ARG . . . -65.82 -53.84 34.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.847 . . . . 0.0 109.781 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 73.1 mt -54.9 -35.92 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 109.232 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.22 -54.88 37.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 0.0 108.958 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.8 -39.73 95.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.529 -0.732 . . . . 0.0 109.756 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -57.56 -41.45 81.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.486 -0.759 . . . . 0.0 109.577 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.84 -44.69 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 110.155 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.411 ' HG3' ' H ' ' A' ' 50' ' ' GLN . 15.3 mt-30 -58.33 -28.9 65.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.862 -1.149 . . . . 0.0 108.519 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.448 ' HB1' ' CZ ' ' A' ' 26' ' ' TYR . . . -65.53 -35.06 79.75 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -66.89 -35.09 79.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.835 . . . . 0.0 109.473 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.7 mp -72.85 -35.25 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -27.75 66.87 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -54.55 -30.91 55.46 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' A' ' 57' ' ' SER . 50.3 m-85 -87.5 9.21 21.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.071 -1.018 . . . . 0.0 109.37 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER 74.12 -43.29 0.53 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.521 -0.737 . . . . 0.0 109.719 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.7 154.36 12.57 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.182 -1.187 . . . . 0.0 109.414 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.287 0.565 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.7 mt -83.24 150.52 61.0 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.266 -0.896 . . . . 0.0 108.905 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -35.29 154.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 122.556 2.171 . . . . 0.0 112.441 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 16' ' ' LEU . 49.6 Cg_endo -67.89 151.87 77.77 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.387 2.058 . . . . 0.0 111.75 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 62.73 -4.39 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.517 -0.739 . . . . 0.0 110.007 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.7 tt -100.15 153.61 19.11 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.172 -0.955 . . . . 0.0 109.221 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -138.03 -169.42 2.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.339 -0.85 . . . . 0.0 110.604 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.15 137.68 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -89.58 151.55 21.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.153 -0.967 . . . . 0.0 109.205 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -61.9 -9.28 6.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.107 -0.995 . . . . 0.0 109.665 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -91.03 -1.51 57.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.337 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.74 3.03 77.84 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -87.87 140.17 29.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.207 -1.172 . . . . 0.0 109.106 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.494 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 55.0 m-85 -84.78 150.79 24.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 0.0 109.075 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.7 p -150.45 138.92 20.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.213 -0.93 . . . . 0.0 110.057 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -102.35 150.66 23.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.94 112.82 15.1 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.371 -0.831 . . . . 0.0 108.795 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.454 ' CB ' ' NZ ' ' A' ' 33' ' ' LYS . 11.2 t70 -73.29 129.73 85.49 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.891 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.02 17.99 0.95 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.049 1.833 . . . . 0.0 113.093 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -88.79 -65.47 1.01 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.732 -1.23 . . . . 0.0 109.294 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.04 -20.07 13.43 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.196 -0.94 . . . . 0.0 108.794 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.11 13.8 32.68 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.589 ' H ' ' HD3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -73.77 177.67 5.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.65 -1.5 . . . . 0.0 109.532 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -131.64 167.52 19.29 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.388 -0.82 . . . . 0.0 110.288 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -139.43 117.73 11.99 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.505 -0.747 . . . . 0.0 109.051 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.54 124.27 8.02 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.77 -71.48 0.72 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.312 -1.111 . . . . 0.0 109.653 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.67 -173.84 39.8 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -95.0 10.5 35.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.037 -1.272 . . . . 0.0 109.707 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.96 103.3 15.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.194 -0.941 . . . . 0.0 110.717 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.494 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 79.5 mtt180 -54.3 -19.81 6.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.362 -0.836 . . . . 0.0 108.822 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -74.04 -55.07 6.57 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.401 -0.812 . . . . 0.0 109.462 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.4 mt -80.65 -32.43 13.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.529 -0.732 . . . . 0.0 109.801 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.43 -58.46 5.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.827 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 97.9 mt -55.71 -37.21 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.302 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -53.81 -57.4 11.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.092 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -54.07 -43.85 70.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.615 -0.678 . . . . 0.0 109.6 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.31 -43.63 79.15 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.753 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.24 -41.09 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.204 -0.935 . . . . 0.0 110.646 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.65 -39.0 82.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.811 -1.181 . . . . 0.0 108.643 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.74 -35.48 80.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.573 -0.705 . . . . 0.0 109.364 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -68.38 -40.52 81.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.513 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.1 mt -68.79 -33.61 60.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -40.8 75.35 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.57 -10.38 34.8 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.911 -0.715 . . . . 0.0 109.106 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.48 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -100.7 -3.19 30.7 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -163.68 69.61 0.21 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.435 -0.791 . . . . 0.0 109.139 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.99 9.71 61.72 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.188 -1.184 . . . . 0.0 109.548 -179.88 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 13' ' ' PRO . 73.8 mt -83.68 149.65 57.65 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.883 . . . . 0.0 109.598 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 12' ' ' LEU . 95.4 Cg_exo -36.14 158.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 122.508 2.138 . . . . 0.0 111.779 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 16' ' ' LEU . 56.1 Cg_endo -69.12 166.83 25.46 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.115 1.877 . . . . 0.0 111.843 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 52.27 10.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.886 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 14' ' ' PRO . 34.6 tp -124.13 140.04 53.35 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -133.19 -164.81 1.53 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 122.12 0.962 . . . . 0.0 110.766 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.47 139.27 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -91.0 151.47 21.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.012 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -59.09 -13.12 6.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 109.324 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -91.13 0.3 57.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.368 -0.832 . . . . 0.0 109.262 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.63 4.89 79.22 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -88.62 138.46 31.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -1.119 . . . . 0.0 109.476 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -81.24 153.81 26.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 108.752 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -149.97 124.59 9.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.056 -1.028 . . . . 0.0 110.223 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 44.1 t80 -98.23 151.03 20.89 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.437 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 59.3 mtt180 -115.88 122.54 45.66 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.995 0.902 . . . . 0.0 110.322 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.77 129.85 77.9 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HG3' HD13 ' A' ' 55' ' ' LEU . 86.4 Cg_endo -77.5 -6.99 16.68 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.966 1.777 . . . . 0.0 113.537 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.468 ' HG3' HH11 ' A' ' 30' ' ' ARG . 0.0 OUTLIER -89.03 -29.04 19.76 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.639 -1.288 . . . . 0.0 109.12 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.461 HG23 ' H ' ' A' ' 33' ' ' LYS . 1.7 t -118.66 -15.49 9.5 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.9 -1.8 7.54 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.461 ' H ' HG23 ' A' ' 31' ' ' THR . 6.0 tmtt? -74.16 179.54 4.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.015 -1.285 . . . . 0.0 109.12 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -108.44 170.67 7.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.507 -0.746 . . . . 0.0 109.806 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -140.37 118.34 11.84 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.73 123.98 14.26 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.0 mt -106.46 -55.91 2.26 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.426 -1.044 . . . . 0.0 109.527 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.24 -175.14 25.86 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -94.3 11.03 31.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.005 -1.291 . . . . 0.0 108.672 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.78 98.65 11.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.473 -0.767 . . . . 0.0 109.711 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -61.68 -13.51 23.29 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.231 -0.918 . . . . 0.0 108.985 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -72.5 -53.27 12.55 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.338 -0.851 . . . . 0.0 109.354 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 87.8 mt -79.07 -36.81 18.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.509 -0.744 . . . . 0.0 109.631 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.46 -55.97 22.61 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.231 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.2 mt -56.45 -43.54 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.782 -1.199 . . . . 0.0 108.989 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.0 m -57.61 -51.34 69.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.982 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -32.97 74.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -0.854 . . . . 0.0 109.584 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.94 -47.91 70.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.182 -0.949 . . . . 0.0 110.399 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.4 mt -57.81 -49.68 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.275 -0.891 . . . . 0.0 111.127 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -58.74 -31.25 68.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.875 -1.14 . . . . 0.0 108.862 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.56 83.27 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -68.1 -38.79 82.68 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.416 -0.802 . . . . 0.0 109.368 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.81 -43.12 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.84 . . . . 0.0 108.988 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -70.57 -20.42 62.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.42 -0.8 . . . . 0.0 109.403 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.417 HD13 ' HG3' ' A' ' 29' ' ' PRO . 31.0 tp -63.12 -14.91 54.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 109.267 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -83.97 -4.46 58.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 109.14 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -167.97 61.61 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 109.595 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -49.16 -90.5 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.282 -1.128 . . . . 0.0 109.664 179.889 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.385 0.612 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.2 mt -83.54 149.9 58.65 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.293 -0.88 . . . . 0.0 108.984 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.33 162.04 28.54 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.239 1.959 . . . . 0.0 111.602 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.15 169.62 11.85 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.684 2.256 . . . . 0.0 112.259 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 55.64 8.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.799 . . . . 0.0 110.07 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 tt -129.29 137.65 51.16 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.343 -0.848 . . . . 0.0 108.782 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -127.38 -166.59 1.62 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.678 0.751 . . . . 0.0 110.193 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -134.48 132.96 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.411 ' HG2' ' H ' ' A' ' 21' ' ' ASN . 39.9 ttp180 -86.75 150.61 24.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.207 -0.933 . . . . 0.0 109.199 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -59.23 -10.6 3.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 110.014 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.411 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 93.8 m-20 -91.51 0.54 57.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.109 -0.994 . . . . 0.0 109.167 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.84 4.29 84.99 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -86.2 138.81 31.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -1.165 . . . . 0.0 108.725 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -83.43 150.14 26.23 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.6 p -148.85 137.14 21.01 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.847 -1.158 . . . . 0.0 110.526 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -102.09 152.49 20.93 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -127.22 116.34 20.45 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.424 -0.798 . . . . 0.0 108.88 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.81 139.61 73.82 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.03 -1.044 . . . . 0.0 109.549 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -83.34 25.31 0.69 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.121 1.88 . . . . 0.0 112.63 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -88.63 -68.13 0.79 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.919 -1.113 . . . . 0.0 108.709 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 p -116.19 -25.28 7.65 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.88 23.0 4.44 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -75.45 177.96 6.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.031 -1.276 . . . . 0.0 109.103 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.44 165.3 23.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.395 -0.815 . . . . 0.0 109.621 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -135.74 115.07 12.52 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.95 119.53 6.42 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.15 -68.87 0.78 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.269 -1.136 . . . . 0.0 109.142 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.78 -165.97 38.78 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.932 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -100.7 6.27 43.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.468 -1.019 . . . . 0.0 109.312 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -94.99 98.63 10.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.343 -0.848 . . . . 0.0 110.271 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -54.9 -14.9 1.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.529 0.68 . . . . 0.0 109.291 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.54 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.0 OUTLIER -77.33 -54.77 6.06 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.355 -0.84 . . . . 0.0 109.509 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.7 mt -76.99 -32.89 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.342 -0.849 . . . . 0.0 109.658 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.71 -55.68 24.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.078 -1.014 . . . . 0.0 109.38 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mt -55.72 -39.44 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.059 -1.026 . . . . 0.0 109.254 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -51.15 -54.4 25.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.096 -1.003 . . . . 0.0 109.172 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -63.95 -41.63 97.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 0.0 109.605 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.9 -42.68 76.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.618 -0.676 . . . . 0.0 110.191 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.04 -58.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.079 -1.013 . . . . 0.0 110.911 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -58.82 -24.28 61.75 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.984 -1.073 . . . . 0.0 109.098 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.07 -35.34 80.26 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.166 -0.959 . . . . 0.0 108.445 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -67.18 -38.66 85.77 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.395 -0.816 . . . . 0.0 109.372 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.7 mt -70.47 -31.48 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.155 -0.965 . . . . 0.0 108.935 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -69.65 -21.6 63.53 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -57.36 -32.83 67.15 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -75.79 5.87 5.74 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.4 t 52.15 17.31 0.68 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.415 -0.803 . . . . 0.0 109.681 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.25 -158.23 25.45 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.4 p80 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.297 -1.119 . . . . 0.0 109.307 -179.823 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' PRO . 72.4 mt -82.32 150.76 64.7 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 109.079 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 12' ' ' LEU . 75.8 Cg_exo -34.94 157.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 122.555 2.17 . . . . 0.0 111.844 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.22 148.33 84.74 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.104 1.869 . . . . 0.0 111.582 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m120 61.88 32.63 17.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 109.929 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.0 tp -140.23 130.09 24.6 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.354 -0.841 . . . . 0.0 108.818 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -129.63 -172.32 2.73 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.717 0.77 . . . . 0.0 110.059 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.523 HD12 ' CE1' ' A' ' 24' ' ' TYR . 14.9 tt -142.94 152.04 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.398 0.618 . . . . 0.0 109.617 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.426 HH11 ' HG3' ' A' ' 19' ' ' ARG . 19.3 ttm-85 -90.84 160.3 15.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.542 -0.724 . . . . 0.0 109.527 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -64.28 -14.75 57.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 108.994 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -90.12 -0.47 57.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.329 -0.857 . . . . 0.0 108.997 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.57 11.94 65.41 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -87.06 129.72 34.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.096 -1.237 . . . . 0.0 108.476 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.523 ' CE1' HD12 ' A' ' 18' ' ' ILE . 54.2 m-85 -83.11 147.91 27.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.456 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 18.7 p -150.49 131.46 14.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.099 -1.001 . . . . 0.0 109.861 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -97.21 149.35 22.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.294 -0.878 . . . . 0.0 109.286 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.424 HH21 ' CG ' ' A' ' 34' ' ' GLU . 25.8 ttm180 -115.93 116.58 28.21 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.341 -0.85 . . . . 0.0 110.224 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -74.27 138.28 75.17 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.455 -0.778 . . . . 0.0 108.988 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.92 -2.51 12.17 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.136 1.891 . . . . 0.0 112.516 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -88.18 -55.12 3.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.084 -1.01 . . . . 0.0 109.704 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -102.82 -1.06 30.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.41 -0.806 . . . . 0.0 109.124 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.3 4.96 2.97 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.485 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.96 179.4 3.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.157 -1.202 . . . . 0.0 109.124 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 20.8 mp0 -114.94 168.39 9.95 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.47 -0.769 . . . . 0.0 109.926 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -138.96 114.39 9.71 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.69 125.14 9.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.6 mt -105.17 -50.17 3.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.384 -1.068 . . . . 0.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.91 -155.37 26.22 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.807 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -110.53 7.08 22.43 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.435 -1.038 . . . . 0.0 109.411 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -93.09 101.86 14.17 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.345 -0.847 . . . . 0.0 110.252 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.418 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 38.1 ttm180 -58.6 -20.08 44.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.685 -0.634 . . . . 0.0 109.477 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -75.38 -52.19 11.34 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.12 -33.33 24.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.517 -0.739 . . . . 0.0 109.621 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.32 -58.82 5.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.187 -0.945 . . . . 0.0 109.517 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 50.5 mt -53.94 -36.73 31.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.075 -1.015 . . . . 0.0 109.13 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.54 -50.95 66.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 109.345 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -61.28 -40.36 93.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.482 -0.761 . . . . 0.0 109.601 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.99 -43.95 74.03 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.413 -0.804 . . . . 0.0 109.117 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.16 -46.07 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.09 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -59.1 -38.65 80.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.929 -1.107 . . . . 0.0 108.584 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.71 92.26 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -69.06 -39.08 79.33 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.45 -0.781 . . . . 0.0 109.385 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.7 mt -70.93 -26.66 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.54 -33.4 74.98 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.25 -29.06 65.48 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -108.03 8.04 28.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.41 -0.807 . . . . 0.0 109.409 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.6 p -151.89 75.01 1.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.921 . . . . 0.0 109.376 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.1 95.37 0.11 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 68.8 m80 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.247 -1.149 . . . . 0.0 109.51 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 13' ' ' PRO . 39.4 mt -83.4 148.22 55.0 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.31 -0.868 . . . . 0.0 109.567 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 12' ' ' LEU . 98.7 Cg_exo -35.92 158.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.656 2.237 . . . . 0.0 111.737 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.486 ' C ' ' H ' ' A' ' 16' ' ' LEU . 65.8 Cg_endo -72.63 158.87 49.99 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.352 2.035 . . . . 0.0 112.214 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 59.71 1.25 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.794 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 14' ' ' PRO . 41.5 tp -108.34 136.91 47.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -132.56 -178.49 4.95 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.961 0.886 . . . . 0.0 110.511 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.788 HD12 ' CE1' ' A' ' 24' ' ' TYR . 13.5 tt -143.09 143.59 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 -89.58 169.16 11.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.409 -0.807 . . . . 0.0 109.852 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -66.86 -12.48 59.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.573 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -88.25 -1.56 58.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.092 -1.005 . . . . 0.0 108.989 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.31 10.04 78.36 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -88.22 130.72 35.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.06 -1.259 . . . . 0.0 108.732 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.788 ' CE1' HD12 ' A' ' 18' ' ' ILE . 58.0 m-85 -85.21 148.31 26.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.885 . . . . 0.0 109.789 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.432 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 20.5 p -151.32 130.02 12.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.208 -0.933 . . . . 0.0 109.547 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 48.1 t80 -95.09 162.02 13.89 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.264 -0.897 . . . . 0.0 109.218 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.531 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 28.9 ttm180 -125.78 117.69 23.94 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.518 -0.739 . . . . 0.0 109.437 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -73.22 148.73 88.88 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.381 -0.824 . . . . 0.0 109.673 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -84.6 -16.52 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.405 2.07 . . . . 0.0 112.14 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -92.18 -40.66 10.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.334 -0.854 . . . . 0.0 110.092 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.548 ' C ' ' H ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -100.49 -13.35 18.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.158 -0.964 . . . . 0.0 109.349 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.48 -7.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -75.25 -166.09 0.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.885 -1.362 . . . . 0.0 108.734 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 27' ' ' ARG . 68.1 mt-10 -129.64 169.98 14.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.438 -0.789 . . . . 0.0 110.507 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -136.55 122.03 19.51 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.13 122.73 8.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 mt -104.85 -55.52 2.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.384 -1.068 . . . . 0.0 109.632 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.1 179.45 25.91 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 39' ' ' ARG . 2.2 mtm-85 -88.04 4.87 43.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.447 -1.031 . . . . 0.0 109.494 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -94.38 99.19 11.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 109.545 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.514 HH12 ' HE ' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -62.17 -8.56 5.78 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.514 ' HE ' HH12 ' A' ' 41' ' ' ARG . 19.6 mmt180 -72.88 -56.98 4.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 95.4 mt -77.32 -34.0 20.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.326 0.584 . . . . 0.0 109.572 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -56.81 12.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.657 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.9 mt -56.1 -37.16 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.39 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.17 -52.64 62.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.01 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -63.11 -45.8 90.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.548 -0.72 . . . . 0.0 109.742 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.18 65.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.601 -0.687 . . . . 0.0 109.806 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.3 mt -61.78 -42.34 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.068 -1.02 . . . . 0.0 110.024 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.05 -35.08 74.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.906 -1.121 . . . . 0.0 109.012 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.77 -34.43 77.89 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -69.31 -35.65 76.19 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.463 -0.773 . . . . 0.0 109.62 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.7 mt -69.72 -34.13 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -33.92 75.93 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.86 -30.28 67.59 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.497 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -94.1 -2.47 52.73 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 m -153.61 70.36 0.84 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 109.058 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.98 40.13 0.07 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.452 ' ND1' ' N ' ' A' ' 59' ' ' HIS . 4.2 p-80 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.267 -1.137 . . . . 0.0 109.521 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 121.722 0.772 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 49.0 mt -80.83 148.69 65.61 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.28 161.54 23.01 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.819 1.679 . . . . 0.0 111.273 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 16' ' ' LEU . 49.6 Cg_endo -67.35 155.12 71.77 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.626 2.218 . . . . 0.0 112.252 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.501 ' OD1' ' ND2' ' A' ' 52' ' ' ASN . 1.4 m120 73.34 -15.83 0.52 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.652 -0.655 . . . . 0.0 110.193 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.411 ' H ' ' C ' ' A' ' 14' ' ' PRO . 11.6 tp -102.21 139.52 37.71 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.098 -1.001 . . . . 0.0 109.009 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -123.68 -170.27 2.1 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.714 0.769 . . . . 0.0 109.948 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.97 133.99 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.467 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 13.1 mtm180 -91.11 152.41 20.62 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.0 -1.062 . . . . 0.0 109.906 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -58.21 -11.2 2.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 108.926 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -89.76 0.82 56.76 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.66 4.67 90.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.467 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 5.3 m-85 -86.68 131.13 34.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.259 -1.142 . . . . 0.0 108.715 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.525 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 78.4 m-85 -82.53 154.13 25.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 108.959 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -150.72 135.63 17.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.022 -1.048 . . . . 0.0 110.088 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 37.6 t80 -106.98 146.99 30.43 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.622 -0.674 . . . . 0.0 109.571 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.42 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 4.8 mtt180 -110.14 125.18 52.75 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.637 -0.664 . . . . 0.0 109.879 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -79.0 112.3 26.61 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.929 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.41 0.82 0.31 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 121.399 1.399 . . . . 0.0 112.687 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -88.66 -52.04 5.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.894 -1.129 . . . . 0.0 109.741 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.94 -11.74 15.62 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.48 -0.762 . . . . 0.0 109.391 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.83 0.06 58.7 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -179.9 3.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.057 -1.261 . . . . 0.0 108.728 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -111.34 168.22 9.69 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.504 -0.748 . . . . 0.0 109.701 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -138.56 114.27 9.85 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.02 127.54 18.52 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.5 mt -107.8 -49.73 3.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.588 -0.948 . . . . 0.0 109.249 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.9 -174.28 23.22 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -91.01 11.38 23.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -1.228 . . . . 0.0 108.879 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -91.21 95.91 10.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.432 -0.792 . . . . 0.0 110.327 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 38.8 ttm180 -57.01 -19.04 16.19 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -77.0 -51.99 10.14 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.523 -0.736 . . . . 0.0 109.34 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -77.13 -31.62 18.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.64 -0.663 . . . . 0.0 109.682 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.52 -58.74 4.59 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.098 -1.001 . . . . 0.0 109.49 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.1 mt -54.22 -35.12 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.095 -1.003 . . . . 0.0 109.003 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.08 -50.77 66.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 0.0 108.968 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -61.07 -41.07 95.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.2 87.3 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.441 0.639 . . . . 0.0 109.751 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.81 -62.46 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.39 -0.819 . . . . 0.0 110.78 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -56.93 -30.01 63.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 108.683 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.61 -41.59 83.78 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.501 ' ND2' ' OD1' ' A' ' 15' ' ' ASN . 10.2 m120 -68.97 -39.96 79.11 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.423 -0.798 . . . . 0.0 109.775 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.34 -36.99 78.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.207 -0.933 . . . . 0.0 108.494 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 58' ' ' GLY . 84.2 mt-10 -70.84 -34.85 72.1 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.1 mt -67.86 -13.28 62.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.128 -0.983 . . . . 0.0 109.008 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -104.34 -4.43 22.91 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.6 t -164.54 39.13 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.937 . . . . 0.0 109.271 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . -84.08 3.27 86.3 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 26.6 m80 . . . . . 0 N--CA 1.488 1.463 0 O-C-N 121.17 -1.194 . . . . 0.0 109.508 179.957 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 121.368 0.604 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.6 mt -85.2 149.01 51.64 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.411 -0.805 . . . . 0.0 109.275 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.99 164.15 5.17 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.592 1.528 . . . . 0.0 110.986 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.93 160.95 46.22 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.526 2.151 . . . . 0.0 112.286 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 59.96 19.61 8.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 110.088 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.9 tp -133.83 118.04 17.53 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -114.71 178.44 4.28 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.383 0.611 . . . . 0.0 109.824 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.701 HD12 ' CE1' ' A' ' 24' ' ' TYR . 10.1 tt -141.48 148.06 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.59 -0.694 . . . . 0.0 109.552 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -91.01 153.35 20.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.595 -0.69 . . . . 0.0 109.58 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -56.73 -11.52 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.173 -0.954 . . . . 0.0 108.989 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -88.56 -0.79 57.61 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.355 -0.841 . . . . 0.0 109.042 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.27 9.09 80.39 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -86.67 128.05 34.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -1.143 . . . . 0.0 108.45 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.701 ' CE1' HD12 ' A' ' 18' ' ' ILE . 50.6 m-85 -84.22 149.49 26.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.475 -0.766 . . . . 0.0 109.851 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.0 p -150.11 131.73 14.89 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.116 -0.99 . . . . 0.0 109.632 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -94.36 140.8 29.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.08 -1.012 . . . . 0.0 110.004 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.427 HH11 ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -101.94 110.72 22.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.593 -0.692 . . . . 0.0 110.218 -179.332 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.99 135.96 66.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.443 -0.786 . . . . 0.0 109.951 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -81.72 15.26 1.97 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.008 1.805 . . . . 0.0 111.621 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -86.65 -69.79 0.65 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.345 -0.847 . . . . 0.0 109.213 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.4 -18.64 14.05 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.33 6.66 58.64 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.533 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -76.61 -174.43 2.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.85 -1.382 . . . . 0.0 109.338 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 4.5 mp0 -130.77 157.11 43.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.309 -0.869 . . . . 0.0 110.229 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -116.35 127.96 55.12 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.57 116.35 4.36 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mt -99.08 -63.8 1.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.192 -1.181 . . . . 0.0 109.238 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.29 -173.01 38.53 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -92.99 8.7 38.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 108.98 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -94.23 104.24 16.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.386 -0.821 . . . . 0.0 109.82 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -60.22 -20.76 60.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.663 -0.648 . . . . 0.0 109.721 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -77.05 -55.81 5.13 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.211 -0.931 . . . . 0.0 109.074 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 43' ' ' ILE . 27.3 mt -65.81 -36.56 77.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.538 -0.727 . . . . 0.0 109.198 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.13 -56.87 9.26 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.341 -0.85 . . . . 0.0 109.274 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mt -53.58 -37.4 30.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.171 -0.956 . . . . 0.0 108.67 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.42 -55.12 31.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.07 -1.019 . . . . 0.0 109.147 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -63.3 -43.96 96.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.347 -0.846 . . . . 0.0 109.658 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.68 75.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.526 -0.734 . . . . 0.0 109.645 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.9 mt -59.64 -40.25 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.059 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -62.11 -43.78 98.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.951 -1.093 . . . . 0.0 108.478 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.89 -33.83 76.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -64.23 -36.07 82.88 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.296 -0.877 . . . . 0.0 109.333 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.39 -25.96 32.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 108.684 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.573 ' O ' ' N ' ' A' ' 58' ' ' GLY . 96.8 mt-10 -70.39 -29.84 66.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.309 -0.869 . . . . 0.0 109.19 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 55' ' ' LEU . 4.0 mm? -64.91 -14.72 60.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.879 -1.138 . . . . 0.0 109.046 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -99.29 6.95 46.05 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.276 -0.89 . . . . 0.0 110.329 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.7 t -170.5 -32.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.824 -1.172 . . . . 0.0 110.01 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 73.32 97.71 0.08 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.227 -1.16 . . . . 0.0 109.211 -179.83 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.1 mt -79.83 149.5 70.77 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.61 159.29 28.69 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.675 1.584 . . . . 0.0 111.171 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 15' ' ' ASN . 59.3 Cg_endo -69.69 154.54 67.91 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.376 2.051 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.505 ' ND2' ' OD1' ' A' ' 52' ' ' ASN . 3.6 m-20 74.19 -10.49 1.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.641 -0.662 . . . . 0.0 109.326 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.1 tt -105.27 148.46 26.97 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.369 -0.832 . . . . 0.0 110.121 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -137.31 -168.85 2.38 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.452 0.644 . . . . 0.0 109.408 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.2 tt -146.53 150.95 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.268 -0.895 . . . . 0.0 109.479 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -92.71 150.39 20.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.183 -0.948 . . . . 0.0 109.363 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -59.81 -10.91 4.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.29 -0.881 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -90.5 -0.16 57.56 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.48 10.45 70.58 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -87.14 136.17 33.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.055 -1.262 . . . . 0.0 108.495 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -84.22 152.97 23.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -154.86 145.81 22.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 110.305 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -108.99 155.45 20.87 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -131.72 120.24 22.46 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.231 -0.918 . . . . 0.0 109.868 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.08 134.41 71.18 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.796 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.24 24.37 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.0 1.8 . . . . 0.0 113.055 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -88.96 -67.25 0.85 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.806 -1.184 . . . . 0.0 108.612 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.448 HG21 ' HZ1' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -112.78 -16.25 12.79 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.77 29.58 6.14 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -77.81 178.9 7.03 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.273 -1.133 . . . . 0.0 109.506 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -131.38 163.93 26.81 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.316 -0.865 . . . . 0.0 110.614 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -139.36 113.22 8.6 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.52 128.07 14.92 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.8 mt -105.89 -57.75 2.0 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.379 -1.071 . . . . 0.0 109.409 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.32 -157.82 28.93 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.412 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -107.79 1.88 23.2 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.503 -0.998 . . . . 0.0 110.189 -179.487 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.33 107.37 19.86 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.049 -1.032 . . . . 0.0 110.135 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -61.0 -15.46 32.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.126 -0.984 . . . . 0.0 109.345 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.437 ' HD2' ' H ' ' A' ' 42' ' ' ARG . 7.0 mpt_? -74.31 -55.0 6.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.262 -0.899 . . . . 0.0 108.862 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.3 mt -73.31 -35.82 47.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.357 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.82 -57.09 10.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.019 -1.05 . . . . 0.0 109.244 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -51.36 -40.48 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.278 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.29 -57.31 10.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.104 -0.997 . . . . 0.0 109.668 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.94 -36.01 74.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.389 -0.819 . . . . 0.0 109.473 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.47 -44.61 76.6 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.559 -0.856 . . . . 0.0 108.808 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.85 -45.06 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.232 -0.917 . . . . 0.0 110.312 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -61.84 -40.36 95.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.145 -0.972 . . . . 0.0 108.84 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.93 88.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.505 ' OD1' ' ND2' ' A' ' 15' ' ' ASN . 85.2 m-20 -70.0 -43.58 71.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.4 -0.813 . . . . 0.0 109.996 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.8 mt -68.05 -36.95 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.897 . . . . 0.0 109.351 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -70.47 -19.1 62.97 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.268 -0.895 . . . . 0.0 109.051 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.53 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -61.38 -44.47 97.1 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -89.48 2.72 54.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -0.915 . . . . 0.0 109.56 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.7 m -152.47 71.74 0.95 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.162 -0.961 . . . . 0.0 109.757 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.505 ' C ' ' CG ' ' A' ' 59' ' ' HIS . . . -92.91 128.36 9.4 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.505 ' CG ' ' C ' ' A' ' 58' ' ' GLY . 8.3 p-80 . . . . . 0 N--CA 1.499 1.979 0 O-C-N 121.486 -1.009 . . . . 0.0 109.841 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 70.2 mt -84.39 149.12 54.26 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 108.908 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.46 157.44 41.21 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.611 1.541 . . . . 0.0 111.288 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.528 ' C ' ' H ' ' A' ' 16' ' ' LEU . 45.3 Cg_endo -67.18 165.17 27.53 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.455 2.104 . . . . 0.0 111.913 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 62.58 -10.78 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.796 . . . . 0.0 110.531 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.528 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.1 tt -104.26 154.22 20.05 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.159 -0.963 . . . . 0.0 109.815 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -138.3 -178.34 5.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.548 -0.72 . . . . 0.0 110.186 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.86 137.17 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.452 ' C ' ' N ' ' A' ' 21' ' ' ASN . 9.3 mtp180 -90.59 141.33 28.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.204 -0.935 . . . . 0.0 109.422 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -50.83 -13.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.359 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.452 ' N ' ' C ' ' A' ' 19' ' ' ARG . 2.5 m120 -89.78 0.03 57.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.482 -0.761 . . . . 0.0 109.014 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.43 10.27 82.24 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -88.58 130.78 35.18 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.315 -1.109 . . . . 0.0 108.486 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -85.48 144.18 28.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.485 -0.759 . . . . 0.0 109.308 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 m -149.33 140.2 22.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.187 -0.945 . . . . 0.0 109.753 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -101.84 143.96 31.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.348 -0.845 . . . . 0.0 109.57 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -112.12 116.63 30.81 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.408 -0.807 . . . . 0.0 109.782 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -74.34 126.69 88.71 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 108.994 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.07 -9.1 16.66 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.986 1.791 . . . . 0.0 112.103 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -89.72 -32.49 16.99 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -110.99 -27.16 8.9 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 82.44 -10.61 54.55 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.485 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 3.0 mptp? -73.38 -174.05 1.54 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.939 -1.33 . . . . 0.0 109.885 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -120.96 169.32 10.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.578 -0.701 . . . . 0.0 110.303 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -137.37 115.61 11.76 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.55 120.69 8.39 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.7 mt -103.74 -62.87 1.25 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.504 -0.998 . . . . 0.0 108.877 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.21 -171.74 34.01 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 -93.61 8.41 40.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -1.146 . . . . 0.0 109.112 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -91.96 97.1 10.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 109.58 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -56.27 -23.13 34.35 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.455 0.645 . . . . 0.0 109.528 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -74.85 -47.55 29.72 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.341 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.19 -33.64 18.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.39 -0.819 . . . . 0.0 109.591 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.79 -58.62 5.23 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 109.326 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -54.6 -36.68 36.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.214 -0.929 . . . . 0.0 109.0 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.85 -56.89 13.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.091 -1.006 . . . . 0.0 109.12 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -60.19 -40.85 91.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.613 -0.679 . . . . 0.0 109.497 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.53 -44.51 62.64 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.0 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 91.3 mt -61.7 -45.15 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.337 -0.852 . . . . 0.0 109.619 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -64.02 -33.76 76.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.065 -1.022 . . . . 0.0 108.361 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.99 -33.36 75.4 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.35 -42.38 88.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 109.6 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.53 -35.91 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.177 -0.952 . . . . 0.0 108.728 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -69.22 -20.18 63.96 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.47 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -57.73 -47.57 82.04 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -79.55 9.12 5.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.24 -0.912 . . . . 0.0 109.041 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t 59.02 22.39 10.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.442 -0.786 . . . . 0.0 109.834 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.29 -167.2 53.36 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.329 -1.101 . . . . 0.0 109.502 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 8.4 p-10 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.239 0.542 . . . . 0.0 109.633 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 13' ' ' PRO . 46.3 mt -82.17 150.13 63.87 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 109.688 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 12' ' ' LEU . 33.7 Cg_exo -34.31 158.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.709 2.273 . . . . 0.0 112.246 178.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.62 159.22 54.51 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.113 1.876 . . . . 0.0 112.067 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 53.55 19.95 1.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.458 -0.776 . . . . 0.0 110.176 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.5 tp -127.21 125.13 40.5 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 43.0 m-85 -121.63 -170.69 2.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.81 0.814 . . . . 0.0 110.487 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -127.77 141.61 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.474 ' H ' HD13 ' A' ' 18' ' ' ILE . 24.9 ttm180 -91.95 144.54 25.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.061 -1.025 . . . . 0.0 109.281 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -54.15 -19.02 4.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 109.857 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -86.81 0.68 54.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.18 3.21 79.37 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.463 ' CE1' ' NE ' ' A' ' 39' ' ' ARG . 12.5 m-85 -85.15 140.08 31.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.072 -1.252 . . . . 0.0 109.055 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -84.79 146.94 27.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.434 -0.791 . . . . 0.0 108.966 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 20.2 p -146.46 129.77 16.69 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.873 -1.142 . . . . 0.0 110.32 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 27' ' ' ARG . 43.2 t80 -99.37 148.73 23.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.451 -0.781 . . . . 0.0 109.007 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.406 ' O ' ' CE1' ' A' ' 26' ' ' TYR . 23.2 ttm180 -104.43 117.57 34.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.489 -0.757 . . . . 0.0 109.533 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.52 150.67 95.6 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.294 -0.878 . . . . 0.0 109.623 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -85.52 -8.14 8.53 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.623 2.216 . . . . 0.0 112.996 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -90.48 -47.09 7.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.04 -1.037 . . . . 0.0 110.671 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.2 p -109.01 -11.6 14.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 109.818 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.39 2.12 25.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -179.12 3.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -1.204 . . . . 0.0 108.915 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -109.94 168.92 9.06 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.564 -0.71 . . . . 0.0 109.56 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -140.54 119.07 12.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.442 -0.786 . . . . 0.0 109.269 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.79 122.88 12.36 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.2 mt -107.06 -44.3 4.42 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -1.052 . . . . 0.0 109.069 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 147.18 -179.8 23.82 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.463 ' NE ' ' CE1' ' A' ' 23' ' ' TYR . 18.6 mtt180 -92.78 10.71 29.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -1.088 . . . . 0.0 108.403 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -95.96 105.47 17.5 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.453 0.645 . . . . 0.0 110.116 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -60.74 -19.36 58.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -71.4 -58.78 3.2 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.388 -0.82 . . . . 0.0 109.234 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 94.1 mt -68.94 -37.3 77.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.676 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.12 -56.72 11.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.031 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 79.3 mt -54.63 -33.38 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.806 -1.184 . . . . 0.0 109.372 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -58.3 -51.59 69.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.653 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -61.92 -44.91 95.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.278 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.51 -43.33 79.67 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.49 -0.756 . . . . 0.0 110.85 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.9 -52.83 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.017 -1.052 . . . . 0.0 111.624 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -60.12 -29.6 68.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.83 -1.169 . . . . 0.0 109.492 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.51 -33.76 75.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.238 -0.914 . . . . 0.0 109.028 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -69.48 -38.66 77.8 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.306 -0.871 . . . . 0.0 110.897 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt -67.99 -35.45 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.158 -0.963 . . . . 0.0 109.702 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.403 ' C ' ' H ' ' A' ' 56' ' ' PHE . 98.5 mt-10 -70.1 -27.24 64.43 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.25 -0.906 . . . . 0.0 109.606 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mt -63.51 -1.82 1.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 109.179 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.403 ' H ' ' C ' ' A' ' 54' ' ' GLU . 95.2 m-85 -142.57 4.2 1.53 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.354 -0.842 . . . . 0.0 109.319 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.1 m -144.01 46.08 1.45 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.187 -0.945 . . . . 0.0 109.539 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.52 -50.54 1.83 Allowed Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.35 -1.088 . . . . 0.0 109.578 179.966 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.302 0.572 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.84 151.44 61.03 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.243 -0.911 . . . . 0.0 109.073 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.32 158.42 48.94 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.027 1.818 . . . . 0.0 111.181 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 16' ' ' LEU . 37.4 Cg_endo -64.6 170.89 9.1 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.533 2.155 . . . . 0.0 112.308 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 52.75 9.12 0.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.847 . . . . 0.0 109.824 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 14' ' ' PRO . 9.2 tt -133.84 137.53 45.1 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.373 -0.829 . . . . 0.0 109.427 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 12.8 m-85 -138.2 -157.07 0.74 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.57 0.7 . . . . 0.0 109.647 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.6 tt -145.39 153.2 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.669 0.747 . . . . 0.0 110.335 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 21' ' ' ASN . 34.5 ttp180 -94.22 153.55 18.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.631 -0.668 . . . . 0.0 109.708 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.479 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -56.23 -8.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.069 179.638 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.433 ' H ' ' C ' ' A' ' 19' ' ' ARG . 19.1 m-20 -90.37 -3.14 57.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.29 -0.881 . . . . 0.0 108.988 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.77 7.09 78.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -88.02 140.06 29.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.438 -1.037 . . . . 0.0 109.291 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -85.77 152.92 22.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 109.372 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.2 p -150.91 138.24 19.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.153 -0.967 . . . . 0.0 109.976 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -100.59 146.73 26.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.304 -0.873 . . . . 0.0 109.342 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -105.06 111.84 24.75 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.467 -0.771 . . . . 0.0 109.654 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.74 125.7 90.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 108.767 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.75 -6.42 15.22 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.803 1.669 . . . . 0.0 112.819 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 30' ' ' ARG . 6.8 ptp180 -89.15 -28.77 19.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.973 -1.08 . . . . 0.0 109.345 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.7 t -116.22 -28.44 6.55 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.33 -13.15 62.64 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.013 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 8.6 mptt -77.07 -178.93 5.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.041 -1.27 . . . . 0.0 109.886 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 9.6 mp0 -108.88 174.62 5.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.599 -0.688 . . . . 0.0 110.184 -179.306 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -138.16 123.93 19.91 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.42 130.89 21.56 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.5 mt -118.45 -55.97 2.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.554 -0.968 . . . . 0.0 109.572 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.46 -171.94 27.15 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.838 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -95.14 10.49 35.7 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.164 -1.198 . . . . 0.0 109.155 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.464 ' C ' ' N ' ' A' ' 42' ' ' ARG . 93.7 m-20 -91.73 90.68 7.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.364 -0.835 . . . . 0.0 109.494 -179.153 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -54.7 -12.54 0.78 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.13 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' C ' ' A' ' 40' ' ' ASP . 5.7 mtt180 -73.42 -56.87 4.48 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.627 -0.671 . . . . 0.0 109.587 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.3 mt -75.18 -36.95 38.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.17 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.6 -57.54 9.79 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.55 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 88.5 mt -55.88 -41.09 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.542 -1.349 . . . . 0.0 108.564 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -55.98 -56.71 17.41 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.469 -0.769 . . . . 0.0 109.592 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -27.56 66.4 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.216 -0.928 . . . . 0.0 109.186 -179.322 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 45' ' ' ILE . . . -63.87 -48.13 77.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 108.748 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.75 -51.17 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.573 -0.704 . . . . 0.0 110.21 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -58.65 -37.1 75.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.947 -1.096 . . . . 0.0 108.179 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.29 88.41 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.24 -40.93 81.85 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.513 -0.742 . . . . 0.0 109.256 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.0 mt -71.05 -41.56 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 108.54 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -71.85 -19.25 61.99 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.634 -0.666 . . . . 0.0 109.435 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.7 tp -59.5 -29.4 67.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.116 -0.99 . . . . 0.0 108.782 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -85.16 8.23 18.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.821 . . . . 0.0 108.868 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.4 m 52.94 14.22 0.43 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 0.0 109.435 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.33 90.07 0.14 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.15 -1.206 . . . . 0.0 109.448 179.949 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.4 t70 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.0 mt -82.95 149.08 58.57 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.913 . . . . 0.0 109.272 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.01 162.68 18.51 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.111 1.874 . . . . 0.0 111.872 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.97 168.3 20.91 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.913 2.409 . . . . 0.0 112.684 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 48.19 22.5 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.529 -0.732 . . . . 0.0 110.302 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.444 ' C ' ' CD1' ' A' ' 17' ' ' TYR . 5.1 tt -136.05 146.08 46.72 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.217 -0.927 . . . . 0.0 109.166 179.099 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 32.0 m-85 -137.34 -172.77 3.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.546 -0.721 . . . . 0.0 110.342 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.9 tt -139.14 150.91 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.233 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -91.19 164.23 13.98 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.277 -0.889 . . . . 0.0 109.926 -178.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -66.4 -16.81 64.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.051 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -89.41 0.08 57.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.366 -0.834 . . . . 0.0 108.789 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.13 14.83 63.65 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -87.2 134.65 33.51 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.117 -1.225 . . . . 0.0 108.702 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.495 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 12.9 m-85 -83.73 156.24 22.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.995 . . . . 0.0 109.671 -179.715 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 24' ' ' TYR . 94.6 m -156.14 135.31 12.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.51 -0.744 . . . . 0.0 109.636 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -100.22 141.42 33.08 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.138 -0.976 . . . . 0.0 109.364 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -107.34 113.79 27.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.501 -0.749 . . . . 0.0 109.673 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -71.44 132.91 85.38 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.42 -0.8 . . . . 0.0 109.645 -179.904 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.59 -5.51 12.49 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.198 1.932 . . . . 0.0 112.375 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -88.5 -37.79 15.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.202 -0.936 . . . . 0.0 109.628 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 33' ' ' LYS . 2.5 t -113.11 -29.93 7.15 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.496 -0.753 . . . . 0.0 109.069 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.3 -10.08 74.95 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.168 -0.958 . . . . 0.0 110.929 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.476 ' H ' HG23 ' A' ' 31' ' ' THR . 9.7 mptt -74.73 179.36 4.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.902 -1.352 . . . . 0.0 109.61 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -117.47 171.73 7.8 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.666 0.746 . . . . 0.0 110.661 -178.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.94 122.65 18.69 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.55 122.94 8.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.5 mt -106.59 -70.09 0.8 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.478 -1.013 . . . . 0.0 109.398 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.25 -174.09 44.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -93.9 6.66 47.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -1.137 . . . . 0.0 109.522 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -95.41 98.87 10.88 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 109.489 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.535 HH11 ' CG ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -58.34 -13.14 4.61 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 108.498 179.606 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -74.38 -49.57 22.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 89.4 mt -78.54 -36.87 20.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.39 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.85 -57.51 8.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.232 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -54.38 -37.13 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.12 -0.988 . . . . 0.0 109.287 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -54.54 -58.15 8.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 108.895 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -60.9 -37.33 81.83 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.576 0.703 . . . . 0.0 109.132 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.13 -42.61 81.26 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.59 -0.694 . . . . 0.0 109.17 179.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.62 -45.87 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.203 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -58.89 -32.69 69.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.054 -1.029 . . . . 0.0 108.686 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.52 91.32 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -67.78 -41.43 83.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 0.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.4 mp -70.81 -37.5 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -73.15 -20.52 60.89 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.378 -0.826 . . . . 0.0 109.416 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 40.8 tp -60.1 -18.63 48.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 0.0 109.258 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -89.04 0.9 56.29 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.794 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 59' ' ' HIS . 7.4 t -173.68 52.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.449 -0.782 . . . . 0.0 109.198 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.87 -1.52 3.83 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 57' ' ' SER . 11.7 m170 . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.244 -1.151 . . . . 0.0 109.479 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.07 151.09 56.63 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.399 -0.813 . . . . 0.0 109.299 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -38.31 156.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.264 1.976 . . . . 0.0 111.903 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.26 147.83 83.88 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.212 1.942 . . . . 0.0 112.131 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 65.59 -1.83 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.608 -0.682 . . . . 0.0 110.38 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.9 tt -105.87 139.09 40.97 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.146 -0.972 . . . . 0.0 110.103 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -140.63 -168.44 2.57 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.72 0.772 . . . . 0.0 109.574 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.727 HD12 ' CE1' ' A' ' 24' ' ' TYR . 8.4 tt -146.25 146.22 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.585 -0.697 . . . . 0.0 109.683 178.644 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 21' ' ' ASN . 19.8 mtm180 -91.65 152.8 20.07 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.355 -0.841 . . . . 0.0 109.571 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -53.46 -11.15 0.3 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.236 -0.915 . . . . 0.0 109.163 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.433 ' H ' ' C ' ' A' ' 19' ' ' ARG . 47.6 m-20 -87.75 1.39 53.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 109.254 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.13 6.56 89.12 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -86.53 126.68 34.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.066 -1.255 . . . . 0.0 108.692 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.727 ' CE1' HD12 ' A' ' 18' ' ' ILE . 57.6 m-85 -82.69 148.93 27.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 109.37 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 p -148.62 144.8 27.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.201 -0.937 . . . . 0.0 109.822 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 36.6 t80 -105.98 148.23 27.93 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.46 ' NE ' ' O ' ' A' ' 32' ' ' GLY . 15.0 ttm180 -110.01 121.11 44.5 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.463 -0.773 . . . . 0.0 110.675 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -75.72 136.87 70.38 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.333 -0.854 . . . . 0.0 108.857 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.59 6.02 5.15 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.035 1.823 . . . . 0.0 112.252 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -89.8 -56.6 3.17 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 110.131 -179.284 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.17 1.5 13.87 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.38 -0.825 . . . . 0.0 109.474 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.46 ' O ' ' NE ' ' A' ' 27' ' ' ARG . . . 67.78 13.97 64.55 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -71.79 -174.4 1.16 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.077 -1.249 . . . . 0.0 109.064 179.65 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 5.7 mp0 -130.88 153.07 49.52 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 0.0 109.525 179.186 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -115.76 128.09 55.59 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.5 114.74 3.9 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.5 mt -100.56 -63.04 1.17 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.268 -1.137 . . . . 0.0 109.951 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.68 -177.15 36.3 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.471 ' NH1' ' H ' ' A' ' 39' ' ' ARG . 2.7 mtm-85 -89.1 7.37 35.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.071 -1.252 . . . . 0.0 109.997 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -95.61 107.97 20.2 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.147 -0.971 . . . . 0.0 109.361 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -65.61 -20.04 66.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 110.081 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -73.08 -48.63 34.17 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.109 -0.995 . . . . 0.0 109.598 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 93.8 mt -76.96 -37.49 26.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.266 -179.648 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.38 -57.41 8.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 109.804 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.1 mt -53.25 -35.59 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 0.0 109.421 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -51.65 66.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -60.76 -35.64 76.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.859 . . . . 0.0 109.304 -179.365 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.02 74.2 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.584 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.13 -47.11 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.833 . . . . 0.0 110.398 -179.496 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -62.29 -41.05 98.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.986 -1.071 . . . . 0.0 108.155 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.68 81.84 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -64.43 -34.1 77.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.098 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.3 mt -70.37 -27.83 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 108.73 179.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 58' ' ' GLY . 63.3 mt-10 -68.13 -28.37 67.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.228 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.1 mp -62.45 -15.41 49.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 109.202 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -103.65 -6.55 21.5 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.342 -0.849 . . . . 0.0 109.745 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -163.01 35.84 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.015 -1.053 . . . . 0.0 109.81 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . -84.33 146.05 22.5 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.214 -1.168 . . . . 0.0 109.45 179.95 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 121.73 0.776 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.3 mt -81.19 150.18 67.51 Favored Pre-proline 0 C--N 1.299 -1.601 0 O-C-N 121.496 -0.753 . . . . 0.0 109.108 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.64 161.93 16.63 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.947 1.765 . . . . 0.0 111.369 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.19 153.97 73.44 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.733 2.289 . . . . 0.0 112.595 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 67.07 -8.02 0.46 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.73 -0.606 . . . . 0.0 110.826 179.423 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 tt -107.18 143.34 35.51 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.103 -0.998 . . . . 0.0 110.018 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 28.2 m-85 -137.78 -163.59 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.53 -0.731 . . . . 0.0 109.659 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.46 HD12 ' CE1' ' A' ' 24' ' ' TYR . 12.5 tt -143.08 150.84 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 121.43 0.634 . . . . 0.0 109.775 178.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.41 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 16.4 ttp180 -91.72 165.46 13.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -66.39 -13.01 60.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.958 . . . . 0.0 109.334 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -89.18 -0.28 57.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 109.121 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.99 11.46 73.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.41 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 10.2 m-85 -87.04 132.22 33.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -1.153 . . . . 0.0 108.609 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.533 ' OH ' ' NH1' ' A' ' 41' ' ' ARG . 44.9 m-85 -83.14 145.9 28.96 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.9 m -148.5 145.2 27.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.919 -1.113 . . . . 0.0 110.804 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -99.3 153.67 18.78 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.191 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.54 HH21 ' CD ' ' A' ' 34' ' ' GLU . 20.2 ttm180 -116.51 116.68 28.09 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.278 -0.889 . . . . 0.0 110.366 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -76.34 136.6 68.41 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.56 -11.48 14.21 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.951 1.768 . . . . 0.0 113.302 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -36.37 16.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.752 -1.217 . . . . 0.0 109.284 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.486 ' C ' ' H ' ' A' ' 33' ' ' LYS . 79.7 p -107.04 -14.78 14.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.81 -2.64 1.83 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -74.1 -169.35 0.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -1.162 . . . . 0.0 108.714 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.54 ' CD ' HH21 ' A' ' 27' ' ' ARG . 11.7 mt-10 -128.16 170.0 13.47 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.448 -0.782 . . . . 0.0 110.032 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -134.32 124.94 26.65 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.9 122.03 6.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.1 mt -105.48 -49.4 3.44 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.46 -1.023 . . . . 0.0 109.196 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.47 -170.43 31.67 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -98.38 2.28 47.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.319 -1.107 . . . . 0.0 109.245 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -97.01 98.48 10.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.294 -0.879 . . . . 0.0 110.039 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.571 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -57.55 -16.14 9.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 108.958 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -69.61 -49.02 57.91 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.384 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.616 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.8 mp -81.44 -33.05 12.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 41' ' ' ARG . . . -65.5 -59.0 4.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.366 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.6 mt -54.14 -37.83 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.302 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -53.22 54.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.207 -0.933 . . . . 0.0 108.973 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -63.51 -44.29 94.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.481 -0.762 . . . . 0.0 109.51 -179.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.78 -41.86 71.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.579 -0.7 . . . . 0.0 109.674 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.0 mt -60.76 -43.62 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -0.897 . . . . 0.0 110.365 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -59.96 -36.45 77.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.18 . . . . 0.0 108.176 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.33 75.51 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.29 -45.48 76.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.462 -0.774 . . . . 0.0 110.213 -179.672 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.3 mp -68.79 -40.2 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 108.596 -179.751 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.63 -18.17 63.57 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 108.83 179.455 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tp -61.55 -31.31 71.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.564 -0.71 . . . . 0.0 109.305 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -93.62 7.9 42.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.282 -0.886 . . . . 0.0 109.47 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -157.74 66.91 0.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.411 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.18 -11.27 70.59 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.366 -1.079 . . . . 0.0 109.402 179.971 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.8 mt -82.05 149.01 61.84 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.955 . . . . 0.0 108.704 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.38 161.96 22.02 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.743 1.629 . . . . 0.0 111.464 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.11 171.92 9.44 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.59 2.194 . . . . 0.0 111.707 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 51.01 15.65 0.28 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -0.891 . . . . 0.0 109.988 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tt -138.09 133.93 34.05 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.165 -0.959 . . . . 0.0 110.026 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 22.7 m-85 -132.73 -163.11 1.3 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.707 -0.621 . . . . 0.0 109.418 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.1 tt -141.15 151.03 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 121.629 0.728 . . . . 0.0 110.133 179.21 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.497 HH21 ' CB ' ' A' ' 23' ' ' TYR . 11.7 ttp180 -92.64 148.15 22.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.516 -0.74 . . . . 0.0 109.143 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -52.91 -10.83 0.19 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.0 . . . . 0.0 109.448 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 19' ' ' ARG . 85.4 m-20 -90.09 -2.88 58.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 108.846 179.561 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.13 8.7 74.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.497 ' CB ' HH21 ' A' ' 19' ' ' ARG . 4.6 m-85 -85.77 132.55 34.1 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -82.57 147.91 28.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.16 -0.963 . . . . 0.0 108.528 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 m -148.04 144.59 28.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.993 -1.067 . . . . 0.0 109.949 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -101.08 148.09 25.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.538 -0.727 . . . . 0.0 109.788 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -105.52 108.84 20.57 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.364 -0.835 . . . . 0.0 110.025 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -72.28 119.57 75.51 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 108.669 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.75 0.55 9.71 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.626 1.551 . . . . 0.0 112.152 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -90.28 -28.87 18.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.101 -0.999 . . . . 0.0 109.352 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 33' ' ' LYS . 1.7 t -120.4 -27.64 5.16 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.58 -11.84 70.61 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.5 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 10.9 mptt -77.8 179.81 6.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.02 -1.282 . . . . 0.0 110.182 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.07 176.4 5.04 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.633 -0.667 . . . . 0.0 110.336 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -139.95 114.14 9.04 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.18 121.95 9.44 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.6 mt -105.36 -57.22 2.06 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.459 -1.024 . . . . 0.0 109.633 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.04 -158.6 30.95 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.495 HH11 ' CB ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -107.35 2.53 24.51 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.528 -0.983 . . . . 0.0 109.929 -179.789 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -93.91 98.26 10.93 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.098 -1.001 . . . . 0.0 110.043 -179.04 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -51.18 -21.1 1.82 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.274 -0.891 . . . . 0.0 108.604 179.089 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -71.9 -57.29 4.45 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.2 mm -67.55 -36.42 76.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.384 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.43 -58.34 4.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.603 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.35 -35.15 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 108.964 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -53.44 -54.18 40.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.155 -0.966 . . . . 0.0 108.518 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -62.08 -41.26 97.99 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.623 0.725 . . . . 0.0 109.328 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.23 -45.94 68.91 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.585 -0.697 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.26 -46.77 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.896 . . . . 0.0 110.209 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -62.12 -36.56 82.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.93 -1.106 . . . . 0.0 108.62 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.16 -35.53 81.09 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.214 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -69.83 -40.87 75.6 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.638 -0.664 . . . . 0.0 109.629 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.27 -44.11 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.266 -0.896 . . . . 0.0 109.035 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -66.91 -19.91 65.81 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.95 -19.88 66.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.358 -0.839 . . . . 0.0 108.785 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.449 ' O ' ' CB ' ' A' ' 57' ' ' SER . 1.7 t80 -93.72 -6.78 45.4 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 56' ' ' PHE . 0.5 OUTLIER 75.16 30.59 0.87 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.631 -0.668 . . . . 0.0 110.156 179.333 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.14 -169.82 9.77 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.0 p80 . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.196 -1.179 . . . . 0.0 109.488 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.61 158.65 31.38 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.651 1.567 . . . . 0.0 111.312 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 16' ' ' LEU . 58.2 Cg_endo -69.63 156.67 63.06 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.603 2.202 . . . . 0.0 112.713 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 70.84 -17.35 0.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.761 -0.587 . . . . 0.0 110.195 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 14' ' ' PRO . 3.9 tt -99.95 142.7 31.08 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.204 -0.935 . . . . 0.0 109.815 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -134.34 -177.79 4.75 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.476 0.655 . . . . 0.0 109.775 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.571 HD12 ' CE1' ' A' ' 24' ' ' TYR . 18.6 tt -140.0 148.88 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-O 121.376 0.607 . . . . 0.0 109.792 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.428 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 13.7 mtm180 -91.11 156.84 17.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.359 -0.838 . . . . 0.0 109.702 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -57.38 -14.39 4.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.463 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -88.67 -2.12 58.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 108.676 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.99 12.62 67.97 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.428 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 2.9 m-85 -86.51 130.52 34.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.045 -1.268 . . . . 0.0 108.429 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.571 ' CE1' HD12 ' A' ' 18' ' ' ILE . 54.3 m-85 -84.2 148.92 26.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 109.71 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.3 p -152.72 138.66 18.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.162 -0.961 . . . . 0.0 109.903 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -100.92 150.58 22.71 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.346 -0.846 . . . . 0.0 108.956 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -111.32 113.0 25.16 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.185 -0.947 . . . . 0.0 110.293 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.07 139.71 76.41 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 108.939 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -82.75 -10.77 10.51 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.042 1.828 . . . . 0.0 113.107 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -89.08 -38.82 14.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.784 -1.198 . . . . 0.0 109.769 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 33' ' ' LYS . 2.5 t -106.51 -11.08 16.01 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.75 -6.39 0.62 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -75.52 179.71 5.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.971 -1.311 . . . . 0.0 109.315 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 68.4 mt-10 -107.89 173.03 6.5 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.539 -0.726 . . . . 0.0 109.985 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -136.6 116.55 13.25 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.82 125.79 16.8 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 28.3 mt -110.44 -59.73 1.9 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.501 -0.999 . . . . 0.0 109.207 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.91 -176.06 35.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -93.13 7.79 42.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.15 -1.206 . . . . 0.0 109.477 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.02 101.99 13.73 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -58.77 -12.88 4.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.157 -0.964 . . . . 0.0 108.764 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -75.63 -56.8 4.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.458 -0.777 . . . . 0.0 108.97 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 89.0 mt -73.27 -34.71 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.526 -0.734 . . . . 0.0 109.596 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.57 -57.71 7.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.035 -1.041 . . . . 0.0 109.437 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 92.1 mt -54.51 -36.82 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 109.211 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -53.7 -56.81 14.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 108.938 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -62.11 -42.99 99.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.651 -0.656 . . . . 0.0 110.027 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.65 67.68 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.387 -0.82 . . . . 0.0 109.147 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.31 -48.34 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.336 -0.852 . . . . 0.0 109.919 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -61.37 -39.68 91.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.989 -1.069 . . . . 0.0 108.241 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.14 75.13 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -67.92 -33.62 75.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.421 -0.799 . . . . 0.0 109.695 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 108.824 -179.852 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -35.59 145.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.738 2.292 . . . . 0.0 112.52 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.543 ' C ' HD22 ' A' ' 15' ' ' ASN . 83.1 Cg_exo -44.43 138.5 7.45 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.079 1.852 . . . . 0.0 113.429 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.543 HD22 ' C ' ' A' ' 14' ' ' PRO . 1.4 m-80 61.04 43.38 11.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.446 -0.784 . . . . 0.0 111.63 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.5 tp -139.95 119.42 13.07 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -113.39 179.87 3.84 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.583 0.706 . . . . 0.0 110.413 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.605 HD12 ' CE1' ' A' ' 24' ' ' TYR . 13.0 tt -138.73 147.1 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-O 121.538 0.685 . . . . 0.0 109.243 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -91.48 160.12 15.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.533 -0.73 . . . . 0.0 110.352 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -61.36 -11.49 10.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.58 -0.7 . . . . 0.0 109.125 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -88.87 -1.2 57.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.029 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.77 4.99 86.92 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -86.65 135.29 33.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.11 -1.23 . . . . 0.0 108.367 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.605 ' CE1' HD12 ' A' ' 18' ' ' ILE . 79.5 m-85 -84.37 152.53 24.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.166 -0.959 . . . . 0.0 110.16 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.437 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 30.2 p -150.77 126.4 10.23 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.424 -0.797 . . . . 0.0 109.455 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -94.96 150.27 20.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.195 -0.94 . . . . 0.0 109.333 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -115.05 115.67 27.2 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.485 -0.759 . . . . 0.0 110.627 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -76.01 131.43 75.95 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 108.989 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.86 -7.69 13.33 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.022 1.815 . . . . 0.0 113.42 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -86.13 -18.16 33.05 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.646 -1.284 . . . . 0.0 108.977 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 33' ' ' LYS . 1.3 t -130.67 -27.46 2.13 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.46 -3.52 84.63 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' H ' HG23 ' A' ' 31' ' ' THR . 4.3 mmtp -75.21 -176.32 3.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.953 -1.322 . . . . 0.0 109.304 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -115.99 170.2 8.67 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.484 -0.76 . . . . 0.0 110.266 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -137.27 121.7 18.27 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.28 123.5 6.32 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.7 mt -104.79 -69.56 0.81 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.417 -1.049 . . . . 0.0 109.572 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.57 -177.92 37.67 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.421 ' HG3' HH11 ' A' ' 39' ' ' ARG . 6.9 mtm-85 -90.52 7.19 40.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.169 -1.195 . . . . 0.0 110.035 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -95.18 111.31 23.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.253 -0.904 . . . . 0.0 110.216 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.519 HH11 ' HG3' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -62.63 -15.57 52.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 108.99 179.119 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -74.43 -46.67 38.48 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.85 -39.6 16.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.44 -58.16 7.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.667 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 98.7 mt -55.88 -37.56 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.942 -1.099 . . . . 0.0 109.343 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -55.97 -57.96 9.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 109.542 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -61.47 -42.71 99.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.475 -0.766 . . . . 0.0 109.911 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.32 64.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.491 -0.755 . . . . 0.0 109.542 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.47 -42.99 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.242 -0.911 . . . . 0.0 110.36 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.402 ' H ' ' HG3' ' A' ' 50' ' ' GLN . 33.7 mt-30 -59.94 -32.47 70.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.039 -1.038 . . . . 0.0 108.804 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.28 -36.5 84.29 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -67.18 -37.49 83.79 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.28 -0.888 . . . . 0.0 109.873 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.8 mt . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.131 -0.981 . . . . 0.0 109.011 -179.852 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.91 161.91 43.71 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.34 2.027 . . . . 0.0 111.094 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.52 ' C ' ' H ' ' A' ' 16' ' ' LEU . 32.4 Cg_endo -62.58 165.03 16.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.35 2.034 . . . . 0.0 112.052 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 61.7 -9.35 0.08 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.654 -0.654 . . . . 0.0 110.698 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.9 tp -108.08 143.0 37.43 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.091 -1.005 . . . . 0.0 109.335 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 46.5 m-85 -136.78 -165.33 1.72 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.769 0.795 . . . . 0.0 110.052 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.472 HD13 ' CE1' ' A' ' 24' ' ' TYR . 10.5 tp -138.47 138.05 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.503 ' HE ' ' CB ' ' A' ' 23' ' ' TYR . 44.1 mtm180 -89.71 173.04 8.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.258 -0.901 . . . . 0.0 109.28 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.597 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -64.51 -20.04 65.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.113 -0.992 . . . . 0.0 109.699 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.85 3.1 55.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.001 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.431 ' C ' HD11 ' A' ' 18' ' ' ILE . . . 77.93 19.82 74.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.503 ' CB ' ' HE ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -84.92 132.76 34.33 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.472 ' CE1' HD13 ' A' ' 18' ' ' ILE . 65.6 m-85 -82.2 141.99 32.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.925 -1.109 . . . . 0.0 109.638 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.9 m -144.13 135.23 25.43 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 38.5 t80 -96.86 157.49 15.88 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.565 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 27.6 ttm180 -127.52 120.53 28.48 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.498 -0.751 . . . . 0.0 110.539 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -76.47 144.94 74.9 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.128 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.18 -13.0 7.85 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.997 1.798 . . . . 0.0 111.902 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -91.59 -36.3 13.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.282 -0.886 . . . . 0.0 110.078 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 33' ' ' LYS . 27.6 p -106.2 -17.83 14.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.37 -0.831 . . . . 0.0 109.503 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.1 -8.99 0.81 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 31' ' ' THR . 6.6 tmtt? -73.6 -174.17 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.983 -1.304 . . . . 0.0 108.232 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -128.99 161.38 30.07 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.39 -0.819 . . . . 0.0 110.51 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -119.48 137.17 53.97 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.8 120.58 5.25 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mt -102.53 -61.27 1.42 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.409 -1.054 . . . . 0.0 108.838 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.18 -170.18 32.69 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.63 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 1.2 mtm180 -95.85 11.37 33.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -1.194 . . . . 0.0 109.13 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -93.06 98.51 11.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.476 -0.765 . . . . 0.0 110.031 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -61.78 -13.13 20.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.572 -0.705 . . . . 0.0 109.163 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 42' ' ' ARG . 17.3 mmm-85 -77.04 -57.12 4.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.48 -0.762 . . . . 0.0 109.591 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.7 mp -74.42 -35.95 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.22 -0.925 . . . . 0.0 109.537 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.6 -52.98 62.16 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.162 -0.961 . . . . 0.0 109.346 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.5 mt -57.2 -41.67 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.684 -1.26 . . . . 0.0 108.554 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.9 m -57.76 -51.25 70.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 110.614 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -32.77 74.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.035 -1.041 . . . . 0.0 109.768 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.5 90.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.168 -0.957 . . . . 0.0 110.051 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.18 -56.31 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.353 -0.842 . . . . 0.0 111.007 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -56.19 -31.11 63.14 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.943 -1.098 . . . . 0.0 108.489 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.94 -38.0 82.3 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -65.6 -45.28 83.79 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.5 mt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.353 -0.842 . . . . 0.0 108.748 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 13' ' ' PRO . 40.6 mt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 12' ' ' LEU . 90.7 Cg_exo -35.41 158.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.617 2.212 . . . . 0.0 111.814 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.08 143.88 50.63 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.059 1.839 . . . . 0.0 111.265 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 65.85 29.17 10.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.602 -0.686 . . . . 0.0 109.939 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.0 tp -138.91 123.66 18.64 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 11.9 m-85 -131.1 -163.95 1.38 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.172 0.987 . . . . 0.0 111.11 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 tp -126.82 142.21 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' A' ' 19' ' ' ARG . 14.5 ttm-85 -88.48 161.53 16.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.162 -0.962 . . . . 0.0 109.036 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -59.26 -18.35 36.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.038 -1.039 . . . . 0.0 109.423 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -89.36 -0.33 57.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.093 -1.005 . . . . 0.0 108.722 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.36 8.41 74.57 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -86.22 142.61 28.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -1.174 . . . . 0.0 108.943 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -81.48 149.71 28.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.967 -1.083 . . . . 0.0 108.938 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 p -148.57 135.44 19.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.983 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -97.83 154.81 17.38 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -118.12 110.84 18.11 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.451 -0.781 . . . . 0.0 109.472 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.95 151.02 86.28 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.223 -0.923 . . . . 0.0 109.645 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -90.46 -23.18 0.64 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.624 2.216 . . . . 0.0 113.146 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HG3' HG23 ' A' ' 31' ' ' THR . 28.4 ptt180 -90.14 -26.35 20.22 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.933 -1.105 . . . . 0.0 110.346 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.532 ' C ' ' H ' ' A' ' 33' ' ' LYS . 68.1 p -105.92 -19.24 13.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.0 -1.062 . . . . 0.0 108.421 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.74 -11.23 0.63 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -75.99 -161.97 0.2 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.202 -1.176 . . . . 0.0 109.032 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 44.1 mt-10 -129.82 179.52 5.8 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.573 -0.705 . . . . 0.0 109.935 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -143.94 117.45 9.14 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.09 126.3 10.2 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt -105.97 -52.47 2.8 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.362 -1.081 . . . . 0.0 109.622 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.92 -173.07 30.52 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -97.72 8.95 43.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -1.129 . . . . 0.0 109.292 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -94.43 99.52 11.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.325 -0.859 . . . . 0.0 110.422 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -55.47 -19.61 10.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.538 HH11 ' HG2' ' A' ' 42' ' ' ARG . 1.1 mmt-85 -75.46 -54.09 7.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 109.237 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 78.9 mt -76.25 -36.84 30.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.688 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -58.52 8.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 50.8 mt -50.84 -39.43 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.8 -1.187 . . . . 0.0 109.176 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.06 -51.5 66.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.008 . . . . 0.0 109.499 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -62.37 -41.25 98.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 109.151 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.38 93.4 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.434 -0.792 . . . . 0.0 110.229 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.1 mt -60.46 -52.66 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.137 -0.977 . . . . 0.0 110.593 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -59.12 -30.87 68.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.875 -1.141 . . . . 0.0 108.712 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.31 93.18 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -68.05 -39.32 83.05 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.466 -0.771 . . . . 0.0 109.392 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.8 mt . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.243 -0.911 . . . . 0.0 108.831 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.1 mt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.53 160.44 39.7 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.752 1.634 . . . . 0.0 110.354 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 16' ' ' LEU . 57.2 Cg_endo -67.7 171.6 11.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.31 2.007 . . . . 0.0 112.201 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 57.05 4.21 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.555 -0.716 . . . . 0.0 109.422 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.499 ' H ' ' C ' ' A' ' 14' ' ' PRO . 26.1 tp -129.74 132.39 46.57 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -134.46 -163.47 1.38 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.366 -0.834 . . . . 0.0 110.339 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 tp -132.04 141.11 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -88.77 158.91 18.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.968 . . . . 0.0 109.115 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.708 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -57.4 -19.91 26.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.465 -0.772 . . . . 0.0 109.043 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.81 -2.93 58.96 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.72 10.99 71.79 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -86.61 140.23 30.04 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.231 -1.158 . . . . 0.0 108.588 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.438 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 68.4 m-85 -81.84 151.24 27.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.85 -1.156 . . . . 0.0 109.432 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.447 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 17.2 p -146.68 133.36 19.93 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.397 -0.814 . . . . 0.0 110.156 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -96.94 137.33 36.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.331 -0.855 . . . . 0.0 108.812 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -108.81 115.33 29.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.591 -0.693 . . . . 0.0 110.104 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.34 142.66 89.77 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -84.17 -8.8 9.76 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.393 2.062 . . . . 0.0 113.323 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -89.78 -24.45 21.48 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.842 -1.161 . . . . 0.0 109.987 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 -22.33 3.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.368 -0.832 . . . . 0.0 109.49 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.41 0.9 68.34 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.402 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 3.6 tmtt? -73.94 179.68 4.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.959 -1.318 . . . . 0.0 108.494 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 25.9 mt-10 -131.72 160.25 36.04 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.375 -0.828 . . . . 0.0 110.605 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -138.04 125.48 21.94 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.16 132.46 33.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.428 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.6 mt -105.09 -47.79 3.9 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.413 -1.051 . . . . 0.0 108.869 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.39 -178.98 22.8 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.181 -1.967 . . . . 0.0 108.181 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -91.55 11.03 25.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.021 -1.282 . . . . 0.0 109.371 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.34 100.72 13.25 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.933 0.873 . . . . 0.0 109.835 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.438 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 43.0 ttm180 -59.25 -20.06 51.04 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.4 0.619 . . . . 0.0 109.9 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.584 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -77.08 -49.27 15.68 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.714 0.768 . . . . 0.0 109.2 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.5 mt -75.76 -36.89 34.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.8 -55.41 26.71 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.348 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.53 -40.34 74.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.418 -0.801 . . . . 0.0 109.78 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -50.63 -51.74 46.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 108.914 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -62.53 -37.76 87.34 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.551 -0.718 . . . . 0.0 109.333 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.25 -51.91 67.81 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.497 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.61 -48.87 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.361 -0.837 . . . . 0.0 110.641 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -58.07 -44.07 87.3 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.839 -1.163 . . . . 0.0 108.145 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.54 74.05 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -69.94 -45.74 66.81 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.333 -0.855 . . . . 0.0 109.521 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.7 mt . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.085 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -40.21 157.27 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.115 1.876 . . . . 0.0 111.85 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 16' ' ' LEU . 50.5 Cg_endo -69.61 153.03 70.15 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.093 1.862 . . . . 0.0 111.767 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 69.0 -11.27 0.45 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.535 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.411 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.5 tt -97.56 142.28 29.58 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.926 -1.109 . . . . 0.0 109.664 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -136.03 -178.83 5.32 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.551 -0.718 . . . . 0.0 109.393 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.21 147.77 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.662 0.744 . . . . 0.0 109.631 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.504 HH21 ' CB ' ' A' ' 23' ' ' TYR . 15.1 ttp180 -91.31 156.32 17.88 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -59.71 -10.33 3.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.057 -1.027 . . . . 0.0 109.604 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -88.69 1.41 55.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.259 -0.901 . . . . 0.0 108.755 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.88 6.16 88.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.504 ' CB ' HH21 ' A' ' 19' ' ' ARG . 3.6 m-85 -84.36 138.06 33.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.313 -1.11 . . . . 0.0 108.488 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -83.0 154.67 24.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.034 -1.041 . . . . 0.0 109.307 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 p -150.88 132.24 14.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.818 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -101.98 143.64 31.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.378 -0.826 . . . . 0.0 109.097 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -101.86 118.66 37.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.49 -0.756 . . . . 0.0 109.5 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 35' ' ' PHE . 1.9 m-20 -74.35 149.12 86.53 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.977 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.24 3.06 7.09 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.771 2.314 . . . . 0.0 113.015 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -86.48 -55.12 4.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.951 -1.093 . . . . 0.0 110.243 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.42 HG23 ' H ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -118.17 -18.93 9.21 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.457 -0.777 . . . . 0.0 109.807 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.32 6.76 59.78 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.051 -1.031 . . . . 0.0 110.635 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.42 ' H ' HG23 ' A' ' 31' ' ' THR . 8.6 mptt -72.25 -175.23 1.48 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.847 -1.384 . . . . 0.0 109.325 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -119.1 166.86 12.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.646 -0.659 . . . . 0.0 109.822 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.469 ' CE1' ' OD2' ' A' ' 28' ' ' ASP . 8.0 m-85 -134.77 119.2 17.9 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.14 121.75 16.83 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -104.22 -53.49 2.72 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.526 -0.985 . . . . 0.0 109.302 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.46 -177.45 28.53 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.509 -1.837 . . . . 0.0 108.509 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.474 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 1.8 mtm180 -93.92 8.47 41.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.13 -1.218 . . . . 0.0 109.422 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -94.19 102.73 14.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -60.5 -11.77 7.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.349 -0.845 . . . . 0.0 109.018 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.2 OUTLIER -75.8 -54.72 6.49 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.467 -0.771 . . . . 0.0 109.216 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.575 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.7 mp -74.92 -37.91 42.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.614 -0.679 . . . . 0.0 109.183 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.11 -56.74 14.3 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.65 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.7 mt -55.99 -40.88 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.043 -1.036 . . . . 0.0 109.329 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.7 m -59.96 -50.73 72.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 110.477 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -32.86 74.52 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.306 -0.871 . . . . 0.0 110.018 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.97 92.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.105 -0.997 . . . . 0.0 108.961 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.1 mt -56.86 -42.2 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.441 -0.787 . . . . 0.0 110.207 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -58.19 -39.53 79.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.053 -1.029 . . . . 0.0 108.991 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.35 84.01 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -67.8 -39.26 84.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.531 -0.731 . . . . 0.0 110.419 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.004 -1.06 . . . . 0.0 109.572 -179.215 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -37.87 154.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.29 1.993 . . . . 0.0 111.892 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 16' ' ' LEU . 41.4 Cg_endo -66.68 153.61 77.37 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.377 2.051 . . . . 0.0 112.554 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 54.71 6.5 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.482 -0.761 . . . . 0.0 110.42 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.424 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.6 tt -104.61 148.01 27.0 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.19 -0.944 . . . . 0.0 109.25 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -139.1 -177.58 4.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.879 0.847 . . . . 0.0 110.331 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.66 HD12 ' CE1' ' A' ' 24' ' ' TYR . 18.6 tt -141.31 145.45 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.423 HH21 ' CB ' ' A' ' 23' ' ' TYR . 8.9 ttp180 -90.32 151.64 21.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.418 -0.801 . . . . 0.0 109.667 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.603 HD22 ' H ' ' A' ' 20' ' ' ASN . 1.5 m-80 -51.07 -15.86 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.444 -0.785 . . . . 0.0 109.973 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -88.69 0.89 56.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.178 -0.951 . . . . 0.0 108.845 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.69 12.18 78.19 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.423 ' CB ' HH21 ' A' ' 19' ' ' ARG . 8.0 m-85 -84.07 127.71 34.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.951 -1.323 . . . . 0.0 107.76 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.66 ' CE1' HD12 ' A' ' 18' ' ' ILE . 53.6 m-85 -82.82 147.53 28.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.2 m -150.32 141.84 23.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.029 -1.045 . . . . 0.0 110.308 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 36.6 t80 -110.99 150.09 29.76 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.418 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 33.8 mtt180 -109.92 117.36 33.59 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.5 ' OD1' ' CD1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -75.06 131.73 78.2 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -75.22 -6.25 17.68 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.776 1.651 . . . . 0.0 112.622 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -89.1 -44.0 10.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.923 -1.11 . . . . 0.0 109.163 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.488 ' C ' ' H ' ' A' ' 33' ' ' LYS . 1.4 t -108.34 -7.4 15.9 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.289 -0.882 . . . . 0.0 108.913 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.6 -2.42 0.85 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 31' ' ' THR . 3.4 mmtp -73.14 -179.94 3.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.068 -1.254 . . . . 0.0 108.857 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -105.75 171.72 7.19 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.537 -0.727 . . . . 0.0 109.951 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.5 ' CD1' ' OD1' ' A' ' 28' ' ' ASP . 14.8 m-85 -140.53 109.87 6.24 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.33 125.55 21.15 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.02 -31.37 7.65 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.55 -0.97 . . . . 0.0 109.93 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.15 -174.36 18.33 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -97.61 10.77 39.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.215 -1.168 . . . . 0.0 109.823 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -92.43 100.46 13.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.371 -0.831 . . . . 0.0 110.084 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -59.03 -16.39 18.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.515 -0.74 . . . . 0.0 109.628 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.54 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -76.49 -58.68 3.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.184 -0.948 . . . . 0.0 109.326 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.612 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.7 mp -74.89 -33.1 29.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.654 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.44 77.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.765 -1.21 . . . . 0.0 109.928 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.1 -38.79 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.733 -1.23 . . . . 0.0 108.976 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 47' ' ' GLU . 1.2 m -53.87 -63.92 0.99 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.239 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.406 ' N ' HG22 ' A' ' 46' ' ' THR . 20.0 mt-10 -53.05 -38.54 62.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.628 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.3 80.88 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.298 -0.877 . . . . 0.0 108.896 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.25 -44.83 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.425 -0.797 . . . . 0.0 110.8 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -57.41 -39.03 75.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 108.173 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.43 -35.77 81.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -66.86 -40.83 88.0 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.349 -0.845 . . . . 0.0 109.714 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.4 mt . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.041 -1.037 . . . . 0.0 108.477 179.635 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.6 mt . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -40.6 156.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.848 1.699 . . . . 0.0 111.336 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.75 165.2 16.57 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.946 1.764 . . . . 0.0 111.384 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.502 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 3.1 m-80 51.16 30.21 5.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.193 -0.942 . . . . 0.0 109.415 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.698 HD23 ' N ' ' A' ' 17' ' ' TYR . 2.5 tt -138.28 127.51 24.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.349 -0.845 . . . . 0.0 108.793 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.698 ' N ' HD23 ' A' ' 16' ' ' LEU . 93.0 m-85 -124.11 -179.01 4.26 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.578 -0.701 . . . . 0.0 109.423 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.1 tt -140.39 150.53 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.561 -0.712 . . . . 0.0 109.299 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.454 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 35.0 ttp180 -91.65 152.53 20.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.168 -0.958 . . . . 0.0 109.602 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.9 -15.63 13.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 0.0 109.447 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -88.2 -1.73 58.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 108.642 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.82 9.58 65.97 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.454 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -84.65 129.28 34.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -1.224 . . . . 0.0 108.216 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -81.5 152.23 27.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.982 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.2 m -152.06 136.42 16.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.418 -0.801 . . . . 0.0 109.58 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 15' ' ' ASN . 81.5 t80 -105.03 137.4 42.84 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.383 -0.823 . . . . 0.0 109.083 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -103.23 113.07 26.26 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.392 -0.817 . . . . 0.0 109.682 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.13 139.9 85.25 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.275 -0.891 . . . . 0.0 110.347 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -83.5 1.4 8.98 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.479 2.12 . . . . 0.0 112.248 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -86.89 -37.0 18.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.082 -1.011 . . . . 0.0 109.88 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.1 -23.07 3.65 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.488 -0.757 . . . . 0.0 109.102 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.81 2.04 72.69 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -74.76 -164.97 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.875 -1.368 . . . . 0.0 109.777 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -129.52 171.87 12.14 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.755 0.788 . . . . 0.0 110.889 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -139.58 124.65 18.77 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.26 119.26 6.19 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.9 mt -103.8 -52.22 3.01 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.32 -1.106 . . . . 0.0 109.022 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.3 -169.09 26.46 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -97.47 11.87 35.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.288 -1.125 . . . . 0.0 109.269 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.94 106.5 18.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.367 -0.833 . . . . 0.0 110.142 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -64.43 -18.52 64.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.532 -0.73 . . . . 0.0 109.18 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 42' ' ' ARG . 11.4 mmm-85 -76.84 -50.52 13.23 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.478 -0.763 . . . . 0.0 109.076 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 92.4 mt -76.12 -36.35 30.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.606 -0.684 . . . . 0.0 109.806 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.99 -52.65 58.62 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.183 -0.948 . . . . 0.0 109.823 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.14 -39.28 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.001 -1.062 . . . . 0.0 109.426 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.99 -50.87 65.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.0 109.715 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' O ' ' OE1' ' A' ' 50' ' ' GLN . 66.3 mm-40 -62.5 -39.78 94.58 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.512 -0.743 . . . . 0.0 109.656 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.514 ' CB ' HD12 ' A' ' 16' ' ' LEU . . . -62.43 -44.84 95.45 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.478 -0.764 . . . . 0.0 109.977 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.28 -58.41 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.217 -0.927 . . . . 0.0 111.23 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.402 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -55.73 -24.44 34.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.989 -1.069 . . . . 0.0 109.167 -178.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.57 81.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -70.58 -40.42 73.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.738 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.6 mt . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.12 -0.987 . . . . 0.0 109.236 -179.36 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.2 mt . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -37.59 158.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.447 2.098 . . . . 0.0 111.886 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.1 166.09 30.32 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.312 2.008 . . . . 0.0 111.948 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 49.48 20.94 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.919 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 tp -128.0 125.99 40.49 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -121.68 173.53 7.39 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.624 -0.672 . . . . 0.0 110.249 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.24 134.53 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.468 ' C ' ' H ' ' A' ' 21' ' ' ASN . 18.4 mtm180 -89.92 149.48 22.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.095 -1.003 . . . . 0.0 109.887 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -54.05 -8.85 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.136 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 19' ' ' ARG . 88.0 m-20 -89.65 0.26 57.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.394 -0.816 . . . . 0.0 109.218 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.79 3.92 90.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.42 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 9.5 m-85 -88.07 129.92 35.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.173 -1.192 . . . . 0.0 109.073 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.437 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 13.4 m-85 -84.82 156.9 21.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.461 -0.774 . . . . 0.0 108.987 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.437 ' SG ' ' O ' ' A' ' 24' ' ' TYR . 98.9 m -152.83 129.34 10.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.298 -0.877 . . . . 0.0 109.464 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -95.6 145.43 25.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.248 -0.908 . . . . 0.0 108.953 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -120.41 118.63 30.82 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.59 -0.694 . . . . 0.0 110.139 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -76.02 138.79 68.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.319 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.12 16.41 1.65 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.556 2.171 . . . . 0.0 112.896 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 -68.44 0.75 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.8 -1.188 . . . . 0.0 109.042 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.32 -19.56 13.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.307 -0.871 . . . . 0.0 109.36 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.68 17.52 23.37 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 178.84 5.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.765 -1.432 . . . . 0.0 108.977 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -126.49 164.14 21.81 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.423 -0.798 . . . . 0.0 110.443 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -134.78 133.08 39.48 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.21 131.57 10.73 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.34 -54.68 2.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.485 -1.009 . . . . 0.0 109.643 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.27 -171.46 31.54 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.91 7.66 46.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -1.201 . . . . 0.0 109.683 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -95.29 103.96 15.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.256 -0.902 . . . . 0.0 110.098 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -58.13 -18.64 26.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 108.738 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.5 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -73.46 -49.69 25.51 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.7 mt -76.89 -37.06 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.543 -0.723 . . . . 0.0 109.238 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.14 -56.56 12.21 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.854 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 88.8 mt -54.15 -35.74 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.098 -1.001 . . . . 0.0 109.351 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -56.82 -59.53 4.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.096 -1.003 . . . . 0.0 109.033 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -59.53 -42.24 91.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.37 -0.831 . . . . 0.0 109.807 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.6 -42.15 61.75 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.96 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.09 -52.49 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -60.58 -29.7 69.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.947 -1.096 . . . . 0.0 108.199 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.16 86.35 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -64.79 -36.78 85.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.412 -0.805 . . . . 0.0 109.377 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.0 mm . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 108.876 179.784 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.7 mt . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -40.78 157.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.049 1.833 . . . . 0.0 111.491 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.42 162.39 40.87 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.257 1.971 . . . . 0.0 112.143 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 52.72 27.35 5.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.469 -0.769 . . . . 0.0 110.25 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.64 148.47 47.44 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.221 -0.925 . . . . 0.0 108.81 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 22.6 m-85 -138.16 -166.85 2.05 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.115 0.96 . . . . 0.0 110.753 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.42 136.01 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 21' ' ' ASN . 26.8 ttp180 -88.62 142.25 27.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.921 -1.112 . . . . 0.0 109.424 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -50.45 -10.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.497 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 19' ' ' ARG . 8.6 m120 -89.75 -0.04 57.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 109.169 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.57 5.11 87.12 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.467 ' CB ' HH21 ' A' ' 19' ' ' ARG . 3.0 m-85 -88.61 134.92 33.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.273 -1.134 . . . . 0.0 108.977 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -84.18 147.94 27.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.927 . . . . 0.0 108.699 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.8 m -150.62 143.03 24.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.037 -1.04 . . . . 0.0 110.044 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.448 ' CZ ' ' HB1' ' A' ' 51' ' ' ALA . 43.8 t80 -105.01 159.05 16.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.495 -0.753 . . . . 0.0 109.102 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.539 HH21 ' CD ' ' A' ' 34' ' ' GLU . 27.8 ttm180 -130.5 113.9 14.84 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.358 -0.839 . . . . 0.0 109.78 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.58 141.33 79.5 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.509 -0.744 . . . . 0.0 109.176 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -83.57 -19.82 5.04 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 121.931 1.754 . . . . 0.0 112.388 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 30' ' ' ARG . 8.6 ptm180 -89.14 -26.01 21.55 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.126 -0.984 . . . . 0.0 109.491 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 33' ' ' LYS . 1.9 p -107.33 -21.02 13.09 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.36 -10.43 0.66 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 31' ' ' THR . 5.5 tmtt? -75.99 -179.21 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -1.232 . . . . 0.0 109.6 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.539 ' CD ' HH21 ' A' ' 27' ' ' ARG . 36.5 mt-10 -115.89 168.13 10.33 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.546 0.688 . . . . 0.0 110.291 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -135.77 121.22 19.3 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.54 124.58 6.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -105.09 -73.87 0.67 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.417 -1.049 . . . . 0.0 109.226 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 172.08 -168.55 41.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.441 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -98.29 0.16 45.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.269 -1.136 . . . . 0.0 109.593 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -98.36 100.1 11.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.308 -0.87 . . . . 0.0 109.748 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 4.1 ptt180 -54.63 -20.23 7.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.267 -0.896 . . . . 0.0 109.527 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' H ' ' HD3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -68.34 -50.48 52.94 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.585 HD12 ' N ' ' A' ' 43' ' ' ILE . 1.9 mp -77.57 -34.87 20.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 41' ' ' ARG . . . -65.82 -53.84 34.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.847 . . . . 0.0 109.781 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 73.1 mt -54.9 -35.92 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 109.232 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.22 -54.88 37.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 0.0 108.958 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.8 -39.73 95.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.529 -0.732 . . . . 0.0 109.756 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -57.56 -41.45 81.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.486 -0.759 . . . . 0.0 109.577 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.84 -44.69 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 110.155 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.411 ' HG3' ' H ' ' A' ' 50' ' ' GLN . 15.1 mt-30 -58.33 -28.9 65.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.862 -1.149 . . . . 0.0 108.519 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.448 ' HB1' ' CZ ' ' A' ' 26' ' ' TYR . . . -65.53 -35.06 79.75 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -66.89 -35.09 79.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.835 . . . . 0.0 109.473 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.7 mp . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -35.29 154.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 122.556 2.171 . . . . 0.0 112.441 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 16' ' ' LEU . 49.6 Cg_endo -67.89 151.87 77.77 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.387 2.058 . . . . 0.0 111.75 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 62.73 -4.39 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.517 -0.739 . . . . 0.0 110.007 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.7 tt -100.15 153.61 19.11 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.172 -0.955 . . . . 0.0 109.221 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -138.03 -169.42 2.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.339 -0.85 . . . . 0.0 110.604 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.15 137.68 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.488 ' NE ' HD22 ' A' ' 21' ' ' ASN . 40.1 ttp180 -89.58 151.55 21.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.153 -0.967 . . . . 0.0 109.205 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.538 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 1.5 p30 -61.9 -9.28 6.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.107 -0.995 . . . . 0.0 109.665 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.488 HD22 ' NE ' ' A' ' 19' ' ' ARG . 74.0 m-80 -91.03 -1.51 57.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.337 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.74 3.03 77.84 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -87.87 140.17 29.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.207 -1.172 . . . . 0.0 109.106 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.494 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 55.0 m-85 -84.78 150.79 24.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 0.0 109.075 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.7 p -150.45 138.92 20.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.213 -0.93 . . . . 0.0 110.057 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -102.35 150.66 23.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.94 112.82 15.1 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.371 -0.831 . . . . 0.0 108.795 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.454 ' CB ' ' NZ ' ' A' ' 33' ' ' LYS . 11.2 t70 -73.29 129.73 85.49 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.891 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.02 17.99 0.95 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.049 1.833 . . . . 0.0 113.093 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -88.79 -65.47 1.01 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.732 -1.23 . . . . 0.0 109.294 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.04 -20.07 13.43 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.196 -0.94 . . . . 0.0 108.794 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.11 13.8 32.68 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.589 ' H ' ' HD3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -73.77 177.67 5.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.65 -1.5 . . . . 0.0 109.532 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -131.64 167.52 19.29 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.388 -0.82 . . . . 0.0 110.288 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -139.43 117.73 11.99 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.505 -0.747 . . . . 0.0 109.051 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.54 124.27 8.02 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.77 -71.48 0.72 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.312 -1.111 . . . . 0.0 109.653 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.67 -173.84 39.8 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -95.0 10.5 35.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.037 -1.272 . . . . 0.0 109.707 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.96 103.3 15.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.194 -0.941 . . . . 0.0 110.717 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.494 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 79.5 mtt180 -54.3 -19.81 6.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.362 -0.836 . . . . 0.0 108.822 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -74.04 -55.07 6.57 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.401 -0.812 . . . . 0.0 109.462 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.4 mt -80.65 -32.43 13.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.529 -0.732 . . . . 0.0 109.801 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.43 -58.46 5.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.827 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 97.9 mt -55.71 -37.21 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.302 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -53.81 -57.4 11.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.092 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -54.07 -43.85 70.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.615 -0.678 . . . . 0.0 109.6 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.31 -43.63 79.15 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.753 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.24 -41.09 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.204 -0.935 . . . . 0.0 110.646 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.65 -39.0 82.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.811 -1.181 . . . . 0.0 108.643 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.74 -35.48 80.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.573 -0.705 . . . . 0.0 109.364 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -68.38 -40.52 81.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.513 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--N 1.302 -1.46 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.686 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 13' ' ' PRO . 73.8 mt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 12' ' ' LEU . 95.4 Cg_exo -36.14 158.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 122.508 2.138 . . . . 0.0 111.779 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 16' ' ' LEU . 56.1 Cg_endo -69.12 166.83 25.46 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.115 1.877 . . . . 0.0 111.843 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 52.27 10.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.886 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 14' ' ' PRO . 34.6 tp -124.13 140.04 53.35 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -133.19 -164.81 1.53 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 122.12 0.962 . . . . 0.0 110.766 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.47 139.27 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -91.0 151.47 21.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.012 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -13.12 6.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 109.324 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -91.13 0.3 57.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.368 -0.832 . . . . 0.0 109.262 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.63 4.89 79.22 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -88.62 138.46 31.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -1.119 . . . . 0.0 109.476 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -81.24 153.81 26.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 108.752 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -149.97 124.59 9.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.056 -1.028 . . . . 0.0 110.223 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 44.1 t80 -98.23 151.03 20.89 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.437 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 59.3 mtt180 -115.88 122.54 45.66 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.995 0.902 . . . . 0.0 110.322 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.77 129.85 77.9 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.5 -6.99 16.68 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.966 1.777 . . . . 0.0 113.537 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.468 ' HG3' HH11 ' A' ' 30' ' ' ARG . 0.0 OUTLIER -89.03 -29.04 19.76 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.639 -1.288 . . . . 0.0 109.12 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.461 HG23 ' H ' ' A' ' 33' ' ' LYS . 1.7 t -118.66 -15.49 9.5 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.9 -1.8 7.54 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.461 ' H ' HG23 ' A' ' 31' ' ' THR . 6.0 tmtt? -74.16 179.54 4.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.015 -1.285 . . . . 0.0 109.12 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -108.44 170.67 7.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.507 -0.746 . . . . 0.0 109.806 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -140.37 118.34 11.84 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.73 123.98 14.26 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.0 mt -106.46 -55.91 2.26 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.426 -1.044 . . . . 0.0 109.527 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.24 -175.14 25.86 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -94.3 11.03 31.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.005 -1.291 . . . . 0.0 108.672 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.78 98.65 11.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.473 -0.767 . . . . 0.0 109.711 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -61.68 -13.51 23.29 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.231 -0.918 . . . . 0.0 108.985 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -72.5 -53.27 12.55 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.338 -0.851 . . . . 0.0 109.354 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 87.8 mt -79.07 -36.81 18.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.509 -0.744 . . . . 0.0 109.631 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.46 -55.97 22.61 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.231 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.2 mt -56.45 -43.54 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.782 -1.199 . . . . 0.0 108.989 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.0 m -57.61 -51.34 69.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.982 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -32.97 74.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -0.854 . . . . 0.0 109.584 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.94 -47.91 70.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.182 -0.949 . . . . 0.0 110.399 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.4 mt -57.81 -49.68 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.275 -0.891 . . . . 0.0 111.127 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -58.74 -31.25 68.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.875 -1.14 . . . . 0.0 108.862 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.56 83.27 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -68.1 -38.79 82.68 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.416 -0.802 . . . . 0.0 109.368 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.84 . . . . 0.0 108.988 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.2 mt . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.33 162.04 28.54 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.239 1.959 . . . . 0.0 111.602 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.15 169.62 11.85 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.684 2.256 . . . . 0.0 112.259 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 55.64 8.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.799 . . . . 0.0 110.07 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 tt -129.29 137.65 51.16 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.343 -0.848 . . . . 0.0 108.782 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -127.38 -166.59 1.62 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.678 0.751 . . . . 0.0 110.193 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -134.48 132.96 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.411 ' HG2' ' H ' ' A' ' 21' ' ' ASN . 39.9 ttp180 -86.75 150.61 24.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.207 -0.933 . . . . 0.0 109.199 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.722 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -59.23 -10.6 3.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 110.014 -179.237 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.722 ' N ' HD22 ' A' ' 20' ' ' ASN . 93.8 m-20 -91.51 0.54 57.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.109 -0.994 . . . . 0.0 109.167 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.84 4.29 84.99 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -86.2 138.81 31.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -1.165 . . . . 0.0 108.725 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -83.43 150.14 26.23 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.6 p -148.85 137.14 21.01 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.847 -1.158 . . . . 0.0 110.526 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -102.09 152.49 20.93 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -127.22 116.34 20.45 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.424 -0.798 . . . . 0.0 108.88 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.81 139.61 73.82 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.03 -1.044 . . . . 0.0 109.549 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -83.34 25.31 0.69 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.121 1.88 . . . . 0.0 112.63 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -88.63 -68.13 0.79 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.919 -1.113 . . . . 0.0 108.709 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 p -116.19 -25.28 7.65 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.88 23.0 4.44 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -75.45 177.96 6.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.031 -1.276 . . . . 0.0 109.103 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.44 165.3 23.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.395 -0.815 . . . . 0.0 109.621 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -135.74 115.07 12.52 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.95 119.53 6.42 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.15 -68.87 0.78 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.269 -1.136 . . . . 0.0 109.142 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.78 -165.97 38.78 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.932 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -100.7 6.27 43.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.468 -1.019 . . . . 0.0 109.312 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -94.99 98.63 10.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.343 -0.848 . . . . 0.0 110.271 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -54.9 -14.9 1.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.529 0.68 . . . . 0.0 109.291 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.54 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.0 OUTLIER -77.33 -54.77 6.06 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.355 -0.84 . . . . 0.0 109.509 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.7 mt -76.99 -32.89 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.342 -0.849 . . . . 0.0 109.658 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.71 -55.68 24.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.078 -1.014 . . . . 0.0 109.38 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mt -55.72 -39.44 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.059 -1.026 . . . . 0.0 109.254 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -51.15 -54.4 25.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.096 -1.003 . . . . 0.0 109.172 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -63.95 -41.63 97.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 0.0 109.605 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.9 -42.68 76.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.618 -0.676 . . . . 0.0 110.191 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.04 -58.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.079 -1.013 . . . . 0.0 110.911 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -58.82 -24.28 61.75 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.984 -1.073 . . . . 0.0 109.098 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.07 -35.34 80.26 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.166 -0.959 . . . . 0.0 108.445 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -67.18 -38.66 85.77 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.395 -0.816 . . . . 0.0 109.372 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.155 -0.965 . . . . 0.0 108.935 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' PRO . 72.4 mt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 12' ' ' LEU . 75.8 Cg_exo -34.94 157.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 122.555 2.17 . . . . 0.0 111.844 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.22 148.33 84.74 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.104 1.869 . . . . 0.0 111.582 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 61.88 32.63 17.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 109.929 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.0 tp -140.23 130.09 24.6 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.354 -0.841 . . . . 0.0 108.818 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -129.63 -172.32 2.73 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.717 0.77 . . . . 0.0 110.059 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.523 HD12 ' CE1' ' A' ' 24' ' ' TYR . 14.9 tt -142.94 152.04 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.398 0.618 . . . . 0.0 109.617 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.426 HH11 ' HG3' ' A' ' 19' ' ' ARG . 19.3 ttm-85 -90.84 160.3 15.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.542 -0.724 . . . . 0.0 109.527 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -64.28 -14.75 57.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 108.994 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -90.12 -0.47 57.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.329 -0.857 . . . . 0.0 108.997 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.57 11.94 65.41 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -87.06 129.72 34.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.096 -1.237 . . . . 0.0 108.476 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.523 ' CE1' HD12 ' A' ' 18' ' ' ILE . 54.2 m-85 -83.11 147.91 27.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.456 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 18.7 p -150.49 131.46 14.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.099 -1.001 . . . . 0.0 109.861 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -97.21 149.35 22.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.294 -0.878 . . . . 0.0 109.286 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.424 HH21 ' CG ' ' A' ' 34' ' ' GLU . 25.8 ttm180 -115.93 116.58 28.21 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.341 -0.85 . . . . 0.0 110.224 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -74.27 138.28 75.17 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.455 -0.778 . . . . 0.0 108.988 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.92 -2.51 12.17 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.136 1.891 . . . . 0.0 112.516 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -88.18 -55.12 3.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.084 -1.01 . . . . 0.0 109.704 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -102.82 -1.06 30.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.41 -0.806 . . . . 0.0 109.124 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.3 4.96 2.97 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.485 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.96 179.4 3.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.157 -1.202 . . . . 0.0 109.124 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 20.8 mp0 -114.94 168.39 9.95 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.47 -0.769 . . . . 0.0 109.926 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -138.96 114.39 9.71 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.69 125.14 9.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.6 mt -105.17 -50.17 3.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.384 -1.068 . . . . 0.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.91 -155.37 26.22 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.807 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -110.53 7.08 22.43 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.435 -1.038 . . . . 0.0 109.411 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -93.09 101.86 14.17 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.345 -0.847 . . . . 0.0 110.252 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.418 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 38.1 ttm180 -58.6 -20.08 44.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.685 -0.634 . . . . 0.0 109.477 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -75.38 -52.19 11.34 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.12 -33.33 24.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.517 -0.739 . . . . 0.0 109.621 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.32 -58.82 5.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.187 -0.945 . . . . 0.0 109.517 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 50.5 mt -53.94 -36.73 31.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.075 -1.015 . . . . 0.0 109.13 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.54 -50.95 66.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 109.345 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -61.28 -40.36 93.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.482 -0.761 . . . . 0.0 109.601 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.99 -43.95 74.03 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.413 -0.804 . . . . 0.0 109.117 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.16 -46.07 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.09 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -59.1 -38.65 80.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.929 -1.107 . . . . 0.0 108.584 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.71 92.26 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -69.06 -39.08 79.33 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.45 -0.781 . . . . 0.0 109.385 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.7 mt . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.897 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 13' ' ' PRO . 39.4 mt . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 12' ' ' LEU . 98.7 Cg_exo -35.92 158.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.656 2.237 . . . . 0.0 111.737 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.486 ' C ' ' H ' ' A' ' 16' ' ' LEU . 65.8 Cg_endo -72.63 158.87 49.99 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.352 2.035 . . . . 0.0 112.214 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 59.71 1.25 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.794 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 14' ' ' PRO . 41.5 tp -108.34 136.91 47.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -132.56 -178.49 4.95 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.961 0.886 . . . . 0.0 110.511 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.788 HD12 ' CE1' ' A' ' 24' ' ' TYR . 13.5 tt -143.09 143.59 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 -89.58 169.16 11.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.409 -0.807 . . . . 0.0 109.852 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.592 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -66.86 -12.48 59.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.573 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -88.25 -1.56 58.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.092 -1.005 . . . . 0.0 108.989 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.31 10.04 78.36 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -88.22 130.72 35.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.06 -1.259 . . . . 0.0 108.732 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.788 ' CE1' HD12 ' A' ' 18' ' ' ILE . 58.0 m-85 -85.21 148.31 26.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.885 . . . . 0.0 109.789 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.432 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 20.5 p -151.32 130.02 12.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.208 -0.933 . . . . 0.0 109.547 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 48.1 t80 -95.09 162.02 13.89 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.264 -0.897 . . . . 0.0 109.218 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.531 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 28.9 ttm180 -125.78 117.69 23.94 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.518 -0.739 . . . . 0.0 109.437 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -73.22 148.73 88.88 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.381 -0.824 . . . . 0.0 109.673 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -84.6 -16.52 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.405 2.07 . . . . 0.0 112.14 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -92.18 -40.66 10.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.334 -0.854 . . . . 0.0 110.092 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.548 ' C ' ' H ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -100.49 -13.35 18.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.158 -0.964 . . . . 0.0 109.349 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.48 -7.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -75.25 -166.09 0.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.885 -1.362 . . . . 0.0 108.734 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 27' ' ' ARG . 68.1 mt-10 -129.64 169.98 14.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.438 -0.789 . . . . 0.0 110.507 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -136.55 122.03 19.51 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.13 122.73 8.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 mt -104.85 -55.52 2.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.384 -1.068 . . . . 0.0 109.632 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.1 179.45 25.91 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 39' ' ' ARG . 2.2 mtm-85 -88.04 4.87 43.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.447 -1.031 . . . . 0.0 109.494 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -94.38 99.19 11.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 109.545 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.514 HH12 ' HE ' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -62.17 -8.56 5.78 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.514 ' HE ' HH12 ' A' ' 41' ' ' ARG . 19.6 mmt180 -72.88 -56.98 4.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 95.4 mt -77.32 -34.0 20.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.326 0.584 . . . . 0.0 109.572 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -56.81 12.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.657 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.9 mt -56.1 -37.16 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.39 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.17 -52.64 62.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.01 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -63.11 -45.8 90.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.548 -0.72 . . . . 0.0 109.742 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.18 65.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.601 -0.687 . . . . 0.0 109.806 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.3 mt -61.78 -42.34 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.068 -1.02 . . . . 0.0 110.024 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.05 -35.08 74.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.906 -1.121 . . . . 0.0 109.012 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.77 -34.43 77.89 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -69.31 -35.65 76.19 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.463 -0.773 . . . . 0.0 109.62 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.7 mt . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.35 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 49.0 mt . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.28 161.54 23.01 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.819 1.679 . . . . 0.0 111.273 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 16' ' ' LEU . 49.6 Cg_endo -67.35 155.12 71.77 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.626 2.218 . . . . 0.0 112.252 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.517 ' ND2' ' OD1' ' A' ' 52' ' ' ASN . 2.7 m-20 73.34 -15.83 0.52 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.652 -0.655 . . . . 0.0 110.193 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.411 ' H ' ' C ' ' A' ' 14' ' ' PRO . 11.6 tp -102.21 139.52 37.71 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.098 -1.001 . . . . 0.0 109.009 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -123.68 -170.27 2.1 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.714 0.769 . . . . 0.0 109.948 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.97 133.99 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.467 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 13.1 mtm180 -91.11 152.41 20.62 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.0 -1.062 . . . . 0.0 109.906 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -58.21 -11.2 2.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 108.926 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -89.76 0.82 56.76 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.66 4.67 90.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.467 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 5.3 m-85 -86.68 131.13 34.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.259 -1.142 . . . . 0.0 108.715 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.525 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 78.4 m-85 -82.53 154.13 25.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 108.959 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -150.72 135.63 17.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.022 -1.048 . . . . 0.0 110.088 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 37.6 t80 -106.98 146.99 30.43 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.622 -0.674 . . . . 0.0 109.571 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.42 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 4.8 mtt180 -110.14 125.18 52.75 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.637 -0.664 . . . . 0.0 109.879 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -79.0 112.3 26.61 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.929 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.41 0.82 0.31 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 121.399 1.399 . . . . 0.0 112.687 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -88.66 -52.04 5.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.894 -1.129 . . . . 0.0 109.741 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.94 -11.74 15.62 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.48 -0.762 . . . . 0.0 109.391 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.83 0.06 58.7 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -179.9 3.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.057 -1.261 . . . . 0.0 108.728 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -111.34 168.22 9.69 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.504 -0.748 . . . . 0.0 109.701 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -138.56 114.27 9.85 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.02 127.54 18.52 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.5 mt -107.8 -49.73 3.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.588 -0.948 . . . . 0.0 109.249 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.9 -174.28 23.22 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -91.01 11.38 23.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -1.228 . . . . 0.0 108.879 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -91.21 95.91 10.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.432 -0.792 . . . . 0.0 110.327 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 38.8 ttm180 -57.01 -19.04 16.19 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -77.0 -51.99 10.14 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.523 -0.736 . . . . 0.0 109.34 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -77.13 -31.62 18.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.64 -0.663 . . . . 0.0 109.682 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.52 -58.74 4.59 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.098 -1.001 . . . . 0.0 109.49 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.1 mt -54.22 -35.12 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.095 -1.003 . . . . 0.0 109.003 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.08 -50.77 66.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 0.0 108.968 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -61.07 -41.07 95.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.2 87.3 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.441 0.639 . . . . 0.0 109.751 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.81 -62.46 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.39 -0.819 . . . . 0.0 110.78 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -56.93 -30.01 63.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 108.683 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.61 -41.59 83.78 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.517 ' OD1' ' ND2' ' A' ' 15' ' ' ASN . 84.0 m-20 -68.97 -39.96 79.11 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.423 -0.798 . . . . 0.0 109.775 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--N 1.303 -1.429 0 O-C-N 121.207 -0.933 . . . . 0.0 108.494 -179.884 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.99 164.15 5.17 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.592 1.528 . . . . 0.0 110.986 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.93 160.95 46.22 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.526 2.151 . . . . 0.0 112.286 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 59.96 19.61 8.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 110.088 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.9 tp -133.83 118.04 17.53 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -114.71 178.44 4.28 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.383 0.611 . . . . 0.0 109.824 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.701 HD12 ' CE1' ' A' ' 24' ' ' TYR . 10.1 tt -141.48 148.06 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.59 -0.694 . . . . 0.0 109.552 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -91.01 153.35 20.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.595 -0.69 . . . . 0.0 109.58 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -56.73 -11.52 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.173 -0.954 . . . . 0.0 108.989 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -88.56 -0.79 57.61 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.355 -0.841 . . . . 0.0 109.042 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.27 9.09 80.39 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -86.67 128.05 34.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -1.143 . . . . 0.0 108.45 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.701 ' CE1' HD12 ' A' ' 18' ' ' ILE . 50.6 m-85 -84.22 149.49 26.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.475 -0.766 . . . . 0.0 109.851 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.0 p -150.11 131.73 14.89 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.116 -0.99 . . . . 0.0 109.632 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -94.36 140.8 29.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.08 -1.012 . . . . 0.0 110.004 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.427 HH11 ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -101.94 110.72 22.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.593 -0.692 . . . . 0.0 110.218 -179.332 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.99 135.96 66.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.443 -0.786 . . . . 0.0 109.951 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -81.72 15.26 1.97 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.008 1.805 . . . . 0.0 111.621 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -86.65 -69.79 0.65 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.345 -0.847 . . . . 0.0 109.213 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.4 -18.64 14.05 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.33 6.66 58.64 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.533 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -76.61 -174.43 2.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.85 -1.382 . . . . 0.0 109.338 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 4.5 mp0 -130.77 157.11 43.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.309 -0.869 . . . . 0.0 110.229 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -116.35 127.96 55.12 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.57 116.35 4.36 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mt -99.08 -63.8 1.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.192 -1.181 . . . . 0.0 109.238 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.29 -173.01 38.53 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -92.99 8.7 38.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 108.98 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -94.23 104.24 16.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.386 -0.821 . . . . 0.0 109.82 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -60.22 -20.76 60.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.663 -0.648 . . . . 0.0 109.721 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -77.05 -55.81 5.13 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.211 -0.931 . . . . 0.0 109.074 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 43' ' ' ILE . 27.3 mt -65.81 -36.56 77.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.538 -0.727 . . . . 0.0 109.198 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.13 -56.87 9.26 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.341 -0.85 . . . . 0.0 109.274 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mt -53.58 -37.4 30.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.171 -0.956 . . . . 0.0 108.67 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.42 -55.12 31.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.07 -1.019 . . . . 0.0 109.147 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -63.3 -43.96 96.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.347 -0.846 . . . . 0.0 109.658 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.68 75.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.526 -0.734 . . . . 0.0 109.645 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.9 mt -59.64 -40.25 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.059 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -62.11 -43.78 98.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.951 -1.093 . . . . 0.0 108.478 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.89 -33.83 76.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -64.23 -36.07 82.88 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.296 -0.877 . . . . 0.0 109.333 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.302 -1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 108.684 179.809 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.1 mt . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.61 159.29 28.69 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.675 1.584 . . . . 0.0 111.171 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 15' ' ' ASN . 59.3 Cg_endo -69.69 154.54 67.91 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.376 2.051 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.505 ' ND2' ' OD1' ' A' ' 52' ' ' ASN . 3.6 m-20 74.19 -10.49 1.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.641 -0.662 . . . . 0.0 109.326 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.1 tt -105.27 148.46 26.97 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.369 -0.832 . . . . 0.0 110.121 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -137.31 -168.85 2.38 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.452 0.644 . . . . 0.0 109.408 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.2 tt -146.53 150.95 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.268 -0.895 . . . . 0.0 109.479 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -92.71 150.39 20.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.183 -0.948 . . . . 0.0 109.363 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -59.81 -10.91 4.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.29 -0.881 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -90.5 -0.16 57.56 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.48 10.45 70.58 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -87.14 136.17 33.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.055 -1.262 . . . . 0.0 108.495 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -84.22 152.97 23.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -154.86 145.81 22.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 110.305 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -108.99 155.45 20.87 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -131.72 120.24 22.46 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.231 -0.918 . . . . 0.0 109.868 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.08 134.41 71.18 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.796 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.24 24.37 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.0 1.8 . . . . 0.0 113.055 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -88.96 -67.25 0.85 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.806 -1.184 . . . . 0.0 108.612 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.448 HG21 ' HZ1' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -112.78 -16.25 12.79 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.77 29.58 6.14 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -77.81 178.9 7.03 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.273 -1.133 . . . . 0.0 109.506 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -131.38 163.93 26.81 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.316 -0.865 . . . . 0.0 110.614 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -139.36 113.22 8.6 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.52 128.07 14.92 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.8 mt -105.89 -57.75 2.0 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.379 -1.071 . . . . 0.0 109.409 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.32 -157.82 28.93 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.412 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -107.79 1.88 23.2 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.503 -0.998 . . . . 0.0 110.189 -179.487 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.33 107.37 19.86 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.049 -1.032 . . . . 0.0 110.135 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -61.0 -15.46 32.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.126 -0.984 . . . . 0.0 109.345 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.437 ' HD2' ' H ' ' A' ' 42' ' ' ARG . 7.0 mpt_? -74.31 -55.0 6.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.262 -0.899 . . . . 0.0 108.862 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.3 mt -73.31 -35.82 47.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.357 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.82 -57.09 10.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.019 -1.05 . . . . 0.0 109.244 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -51.36 -40.48 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.278 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.29 -57.31 10.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.104 -0.997 . . . . 0.0 109.668 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.94 -36.01 74.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.389 -0.819 . . . . 0.0 109.473 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.47 -44.61 76.6 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.559 -0.856 . . . . 0.0 108.808 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.85 -45.06 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.232 -0.917 . . . . 0.0 110.312 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -61.84 -40.36 95.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.145 -0.972 . . . . 0.0 108.84 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.93 88.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.505 ' OD1' ' ND2' ' A' ' 15' ' ' ASN . 85.2 m-20 -70.0 -43.58 71.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.4 -0.813 . . . . 0.0 109.996 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.8 mt . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.897 . . . . 0.0 109.351 -179.223 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 70.2 mt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.46 157.44 41.21 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.611 1.541 . . . . 0.0 111.288 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.528 ' C ' ' H ' ' A' ' 16' ' ' LEU . 45.3 Cg_endo -67.18 165.17 27.53 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.455 2.104 . . . . 0.0 111.913 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 62.58 -10.78 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.796 . . . . 0.0 110.531 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.528 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.1 tt -104.26 154.22 20.05 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.159 -0.963 . . . . 0.0 109.815 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -138.3 -178.34 5.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.548 -0.72 . . . . 0.0 110.186 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.86 137.17 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.452 ' C ' ' N ' ' A' ' 21' ' ' ASN . 9.3 mtp180 -90.59 141.33 28.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.204 -0.935 . . . . 0.0 109.422 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -50.83 -13.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.359 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.629 ' N ' HD22 ' A' ' 21' ' ' ASN . 1.0 OUTLIER -89.78 0.03 57.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.482 -0.761 . . . . 0.0 109.014 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.43 10.27 82.24 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -88.58 130.78 35.18 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.315 -1.109 . . . . 0.0 108.486 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -85.48 144.18 28.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.485 -0.759 . . . . 0.0 109.308 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 m -149.33 140.2 22.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.187 -0.945 . . . . 0.0 109.753 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -101.84 143.96 31.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.348 -0.845 . . . . 0.0 109.57 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -112.12 116.63 30.81 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.408 -0.807 . . . . 0.0 109.782 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -74.34 126.69 88.71 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 108.994 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.07 -9.1 16.66 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.986 1.791 . . . . 0.0 112.103 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -89.72 -32.49 16.99 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -110.99 -27.16 8.9 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 82.44 -10.61 54.55 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.485 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 3.0 mptp? -73.38 -174.05 1.54 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.939 -1.33 . . . . 0.0 109.885 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -120.96 169.32 10.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.578 -0.701 . . . . 0.0 110.303 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -137.37 115.61 11.76 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.55 120.69 8.39 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.7 mt -103.74 -62.87 1.25 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.504 -0.998 . . . . 0.0 108.877 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.21 -171.74 34.01 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 -93.61 8.41 40.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -1.146 . . . . 0.0 109.112 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -91.96 97.1 10.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 109.58 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -56.27 -23.13 34.35 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.455 0.645 . . . . 0.0 109.528 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -74.85 -47.55 29.72 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.341 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.19 -33.64 18.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.39 -0.819 . . . . 0.0 109.591 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.79 -58.62 5.23 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 109.326 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -54.6 -36.68 36.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.214 -0.929 . . . . 0.0 109.0 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.85 -56.89 13.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.091 -1.006 . . . . 0.0 109.12 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -60.19 -40.85 91.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.613 -0.679 . . . . 0.0 109.497 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.53 -44.51 62.64 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.0 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 91.3 mt -61.7 -45.15 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.337 -0.852 . . . . 0.0 109.619 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -64.02 -33.76 76.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.065 -1.022 . . . . 0.0 108.361 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.99 -33.36 75.4 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.35 -42.38 88.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 109.6 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.177 -0.952 . . . . 0.0 108.728 179.827 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 13' ' ' PRO . 46.3 mt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 12' ' ' LEU . 33.7 Cg_exo -34.31 158.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.709 2.273 . . . . 0.0 112.246 178.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.62 159.22 54.51 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.113 1.876 . . . . 0.0 112.067 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 53.55 19.95 1.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.458 -0.776 . . . . 0.0 110.176 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.5 tp -127.21 125.13 40.5 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 43.0 m-85 -121.63 -170.69 2.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.81 0.814 . . . . 0.0 110.487 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -127.77 141.61 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.474 ' H ' HD13 ' A' ' 18' ' ' ILE . 24.9 ttm180 -91.95 144.54 25.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.061 -1.025 . . . . 0.0 109.281 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -54.15 -19.02 4.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 109.857 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -86.81 0.68 54.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.18 3.21 79.37 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.463 ' CE1' ' NE ' ' A' ' 39' ' ' ARG . 12.5 m-85 -85.15 140.08 31.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.072 -1.252 . . . . 0.0 109.055 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -84.79 146.94 27.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.434 -0.791 . . . . 0.0 108.966 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 20.2 p -146.46 129.77 16.69 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.873 -1.142 . . . . 0.0 110.32 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 27' ' ' ARG . 43.2 t80 -99.37 148.73 23.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.451 -0.781 . . . . 0.0 109.007 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.406 ' O ' ' CE1' ' A' ' 26' ' ' TYR . 23.2 ttm180 -104.43 117.57 34.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.489 -0.757 . . . . 0.0 109.533 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.52 150.67 95.6 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.294 -0.878 . . . . 0.0 109.623 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -85.52 -8.14 8.53 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.623 2.216 . . . . 0.0 112.996 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -90.48 -47.09 7.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.04 -1.037 . . . . 0.0 110.671 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.2 p -109.01 -11.6 14.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 109.818 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.39 2.12 25.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -179.12 3.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -1.204 . . . . 0.0 108.915 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -109.94 168.92 9.06 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.564 -0.71 . . . . 0.0 109.56 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -140.54 119.07 12.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.442 -0.786 . . . . 0.0 109.269 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.79 122.88 12.36 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.2 mt -107.06 -44.3 4.42 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -1.052 . . . . 0.0 109.069 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 147.18 -179.8 23.82 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.463 ' NE ' ' CE1' ' A' ' 23' ' ' TYR . 18.6 mtt180 -92.78 10.71 29.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -1.088 . . . . 0.0 108.403 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -95.96 105.47 17.5 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.453 0.645 . . . . 0.0 110.116 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -60.74 -19.36 58.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -71.4 -58.78 3.2 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.388 -0.82 . . . . 0.0 109.234 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 94.1 mt -68.94 -37.3 77.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.676 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.12 -56.72 11.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.031 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 79.3 mt -54.63 -33.38 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.806 -1.184 . . . . 0.0 109.372 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -58.3 -51.59 69.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.653 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -61.92 -44.91 95.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.278 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.51 -43.33 79.67 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.49 -0.756 . . . . 0.0 110.85 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.9 -52.83 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.017 -1.052 . . . . 0.0 111.624 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -60.12 -29.6 68.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.83 -1.169 . . . . 0.0 109.492 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.51 -33.76 75.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.238 -0.914 . . . . 0.0 109.028 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -69.48 -38.66 77.8 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.306 -0.871 . . . . 0.0 110.897 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.158 -0.963 . . . . 0.0 109.702 -178.914 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.0 mt . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.32 158.42 48.94 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.027 1.818 . . . . 0.0 111.181 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 16' ' ' LEU . 37.4 Cg_endo -64.6 170.89 9.1 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.533 2.155 . . . . 0.0 112.308 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 52.75 9.12 0.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.847 . . . . 0.0 109.824 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 14' ' ' PRO . 9.2 tt -133.84 137.53 45.1 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.373 -0.829 . . . . 0.0 109.427 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 12.8 m-85 -138.2 -157.07 0.74 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.57 0.7 . . . . 0.0 109.647 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.6 tt -145.39 153.2 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.669 0.747 . . . . 0.0 110.335 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 21' ' ' ASN . 34.5 ttp180 -94.22 153.55 18.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.631 -0.668 . . . . 0.0 109.708 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.479 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -56.23 -8.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.069 179.638 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.433 ' H ' ' C ' ' A' ' 19' ' ' ARG . 19.1 m-20 -90.37 -3.14 57.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.29 -0.881 . . . . 0.0 108.988 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.77 7.09 78.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -88.02 140.06 29.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.438 -1.037 . . . . 0.0 109.291 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -85.77 152.92 22.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 109.372 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.2 p -150.91 138.24 19.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.153 -0.967 . . . . 0.0 109.976 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -100.59 146.73 26.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.304 -0.873 . . . . 0.0 109.342 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -105.06 111.84 24.75 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.467 -0.771 . . . . 0.0 109.654 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.74 125.7 90.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 108.767 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.75 -6.42 15.22 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.803 1.669 . . . . 0.0 112.819 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 30' ' ' ARG . 6.8 ptp180 -89.15 -28.77 19.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.973 -1.08 . . . . 0.0 109.345 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.7 t -116.22 -28.44 6.55 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.33 -13.15 62.64 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 8.6 mptt -77.07 -178.93 5.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.041 -1.27 . . . . 0.0 109.886 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 9.6 mp0 -108.88 174.62 5.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.599 -0.688 . . . . 0.0 110.184 -179.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -138.16 123.93 19.91 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.42 130.89 21.56 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.5 mt -118.45 -55.97 2.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.554 -0.968 . . . . 0.0 109.572 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.46 -171.94 27.15 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.838 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -95.14 10.49 35.7 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.164 -1.198 . . . . 0.0 109.155 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.464 ' C ' ' N ' ' A' ' 42' ' ' ARG . 93.7 m-20 -91.73 90.68 7.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.364 -0.835 . . . . 0.0 109.494 -179.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -54.7 -12.54 0.78 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' C ' ' A' ' 40' ' ' ASP . 5.7 mtt180 -73.42 -56.87 4.48 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.627 -0.671 . . . . 0.0 109.587 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.3 mt -75.18 -36.95 38.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.17 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.6 -57.54 9.79 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.55 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 88.5 mt -55.88 -41.09 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.542 -1.349 . . . . 0.0 108.564 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -55.98 -56.71 17.41 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.469 -0.769 . . . . 0.0 109.592 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -27.56 66.4 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.216 -0.928 . . . . 0.0 109.186 -179.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 45' ' ' ILE . . . -63.87 -48.13 77.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 108.748 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.75 -51.17 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.573 -0.704 . . . . 0.0 110.21 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -58.65 -37.1 75.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.947 -1.096 . . . . 0.0 108.179 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.29 88.41 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.24 -40.93 81.85 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.513 -0.742 . . . . 0.0 109.256 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.0 mt . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 108.54 179.747 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.01 162.68 18.51 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.111 1.874 . . . . 0.0 111.872 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.97 168.3 20.91 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.913 2.409 . . . . 0.0 112.684 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 48.19 22.5 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.529 -0.732 . . . . 0.0 110.302 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.444 ' C ' ' CD1' ' A' ' 17' ' ' TYR . 5.1 tt -136.05 146.08 46.72 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.217 -0.927 . . . . 0.0 109.166 179.099 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 32.0 m-85 -137.34 -172.77 3.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.546 -0.721 . . . . 0.0 110.342 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.9 tt -139.14 150.91 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -91.19 164.23 13.98 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.277 -0.889 . . . . 0.0 109.926 -178.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -66.4 -16.81 64.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.051 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -89.41 0.08 57.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.366 -0.834 . . . . 0.0 108.789 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.13 14.83 63.65 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -87.2 134.65 33.51 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.117 -1.225 . . . . 0.0 108.702 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.495 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 12.9 m-85 -83.73 156.24 22.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.995 . . . . 0.0 109.671 -179.715 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 24' ' ' TYR . 94.6 m -156.14 135.31 12.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.51 -0.744 . . . . 0.0 109.636 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -100.22 141.42 33.08 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.138 -0.976 . . . . 0.0 109.364 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -107.34 113.79 27.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.501 -0.749 . . . . 0.0 109.673 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -71.44 132.91 85.38 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.42 -0.8 . . . . 0.0 109.645 -179.904 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.59 -5.51 12.49 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.198 1.932 . . . . 0.0 112.375 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -88.5 -37.79 15.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.202 -0.936 . . . . 0.0 109.628 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 33' ' ' LYS . 2.5 t -113.11 -29.93 7.15 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.496 -0.753 . . . . 0.0 109.069 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.3 -10.08 74.95 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.168 -0.958 . . . . 0.0 110.929 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.476 ' H ' HG23 ' A' ' 31' ' ' THR . 9.7 mptt -74.73 179.36 4.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.902 -1.352 . . . . 0.0 109.61 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -117.47 171.73 7.8 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.666 0.746 . . . . 0.0 110.661 -178.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.94 122.65 18.69 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.55 122.94 8.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.5 mt -106.59 -70.09 0.8 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.478 -1.013 . . . . 0.0 109.398 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.25 -174.09 44.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -93.9 6.66 47.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -1.137 . . . . 0.0 109.522 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -95.41 98.87 10.88 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 109.489 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.535 HH11 ' CG ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -58.34 -13.14 4.61 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 108.498 179.606 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -74.38 -49.57 22.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 89.4 mt -78.54 -36.87 20.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.39 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.85 -57.51 8.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.232 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -54.38 -37.13 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.12 -0.988 . . . . 0.0 109.287 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -54.54 -58.15 8.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 108.895 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -60.9 -37.33 81.83 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.576 0.703 . . . . 0.0 109.132 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.13 -42.61 81.26 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.59 -0.694 . . . . 0.0 109.17 179.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.62 -45.87 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.203 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -58.89 -32.69 69.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.054 -1.029 . . . . 0.0 108.686 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.52 91.32 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -67.78 -41.43 83.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 0.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.4 mp . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -38.31 156.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.264 1.976 . . . . 0.0 111.903 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.26 147.83 83.88 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.212 1.942 . . . . 0.0 112.131 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 65.59 -1.83 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.608 -0.682 . . . . 0.0 110.38 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.9 tt -105.87 139.09 40.97 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.146 -0.972 . . . . 0.0 110.103 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -140.63 -168.44 2.57 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.72 0.772 . . . . 0.0 109.574 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.727 HD12 ' CE1' ' A' ' 24' ' ' TYR . 8.4 tt -146.25 146.22 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.585 -0.697 . . . . 0.0 109.683 178.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 21' ' ' ASN . 19.8 mtm180 -91.65 152.8 20.07 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.355 -0.841 . . . . 0.0 109.571 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -53.46 -11.15 0.3 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.236 -0.915 . . . . 0.0 109.163 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.433 ' H ' ' C ' ' A' ' 19' ' ' ARG . 47.6 m-20 -87.75 1.39 53.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 109.254 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.13 6.56 89.12 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -86.53 126.68 34.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.066 -1.255 . . . . 0.0 108.692 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.727 ' CE1' HD12 ' A' ' 18' ' ' ILE . 57.6 m-85 -82.69 148.93 27.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 109.37 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 p -148.62 144.8 27.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.201 -0.937 . . . . 0.0 109.822 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 36.6 t80 -105.98 148.23 27.93 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.46 ' NE ' ' O ' ' A' ' 32' ' ' GLY . 15.0 ttm180 -110.01 121.11 44.5 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.463 -0.773 . . . . 0.0 110.675 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -75.72 136.87 70.38 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.333 -0.854 . . . . 0.0 108.857 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.59 6.02 5.15 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.035 1.823 . . . . 0.0 112.252 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -89.8 -56.6 3.17 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 110.131 -179.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.17 1.5 13.87 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.38 -0.825 . . . . 0.0 109.474 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.46 ' O ' ' NE ' ' A' ' 27' ' ' ARG . . . 67.78 13.97 64.55 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -71.79 -174.4 1.16 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.077 -1.249 . . . . 0.0 109.064 179.65 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 5.7 mp0 -130.88 153.07 49.52 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 0.0 109.525 179.186 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -115.76 128.09 55.59 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.5 114.74 3.9 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.5 mt -100.56 -63.04 1.17 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.268 -1.137 . . . . 0.0 109.951 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.68 -177.15 36.3 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.471 ' NH1' ' H ' ' A' ' 39' ' ' ARG . 2.7 mtm-85 -89.1 7.37 35.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.071 -1.252 . . . . 0.0 109.997 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -95.61 107.97 20.2 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.147 -0.971 . . . . 0.0 109.361 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -65.61 -20.04 66.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 110.081 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -73.08 -48.63 34.17 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.109 -0.995 . . . . 0.0 109.598 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 93.8 mt -76.96 -37.49 26.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.266 -179.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.38 -57.41 8.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 109.804 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.1 mt -53.25 -35.59 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 0.0 109.421 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -51.65 66.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -60.76 -35.64 76.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.859 . . . . 0.0 109.304 -179.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.02 74.2 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.584 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.13 -47.11 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.833 . . . . 0.0 110.398 -179.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -62.29 -41.05 98.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.986 -1.071 . . . . 0.0 108.155 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.68 81.84 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -64.43 -34.1 77.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.098 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 108.73 179.584 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.3 mt . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.64 161.93 16.63 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.947 1.765 . . . . 0.0 111.369 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.19 153.97 73.44 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.733 2.289 . . . . 0.0 112.595 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 67.07 -8.02 0.46 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.73 -0.606 . . . . 0.0 110.826 179.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 tt -107.18 143.34 35.51 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.103 -0.998 . . . . 0.0 110.018 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 28.2 m-85 -137.78 -163.59 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.53 -0.731 . . . . 0.0 109.659 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.46 HD12 ' CE1' ' A' ' 24' ' ' TYR . 12.5 tt -143.08 150.84 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 121.43 0.634 . . . . 0.0 109.775 178.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.41 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 16.4 ttp180 -91.72 165.46 13.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -66.39 -13.01 60.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.958 . . . . 0.0 109.334 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -89.18 -0.28 57.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 109.121 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.99 11.46 73.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.41 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 10.2 m-85 -87.04 132.22 33.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -1.153 . . . . 0.0 108.609 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.533 ' OH ' ' NH1' ' A' ' 41' ' ' ARG . 44.9 m-85 -83.14 145.9 28.96 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.9 m -148.5 145.2 27.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.919 -1.113 . . . . 0.0 110.804 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -99.3 153.67 18.78 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.54 HH21 ' CD ' ' A' ' 34' ' ' GLU . 20.2 ttm180 -116.51 116.68 28.09 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.278 -0.889 . . . . 0.0 110.366 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -76.34 136.6 68.41 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.56 -11.48 14.21 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.951 1.768 . . . . 0.0 113.302 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -36.37 16.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.752 -1.217 . . . . 0.0 109.284 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.486 ' C ' ' H ' ' A' ' 33' ' ' LYS . 79.7 p -107.04 -14.78 14.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.81 -2.64 1.83 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -74.1 -169.35 0.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -1.162 . . . . 0.0 108.714 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.54 ' CD ' HH21 ' A' ' 27' ' ' ARG . 11.7 mt-10 -128.16 170.0 13.47 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.448 -0.782 . . . . 0.0 110.032 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -134.32 124.94 26.65 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.9 122.03 6.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.1 mt -105.48 -49.4 3.44 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.46 -1.023 . . . . 0.0 109.196 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.47 -170.43 31.67 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -98.38 2.28 47.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.319 -1.107 . . . . 0.0 109.245 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -97.01 98.48 10.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.294 -0.879 . . . . 0.0 110.039 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.571 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -57.55 -16.14 9.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 108.958 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -69.61 -49.02 57.91 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.616 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.8 mp -81.44 -33.05 12.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 41' ' ' ARG . . . -65.5 -59.0 4.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.366 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.6 mt -54.14 -37.83 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.302 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -53.22 54.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.207 -0.933 . . . . 0.0 108.973 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -63.51 -44.29 94.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.481 -0.762 . . . . 0.0 109.51 -179.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.78 -41.86 71.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.579 -0.7 . . . . 0.0 109.674 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.0 mt -60.76 -43.62 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -0.897 . . . . 0.0 110.365 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -59.96 -36.45 77.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.18 . . . . 0.0 108.176 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.33 75.51 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.29 -45.48 76.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.462 -0.774 . . . . 0.0 110.213 -179.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.3 mp . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 108.596 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.8 mt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.38 161.96 22.02 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.743 1.629 . . . . 0.0 111.464 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.11 171.92 9.44 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.59 2.194 . . . . 0.0 111.707 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 51.01 15.65 0.28 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -0.891 . . . . 0.0 109.988 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tt -138.09 133.93 34.05 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.165 -0.959 . . . . 0.0 110.026 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 22.7 m-85 -132.73 -163.11 1.3 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.707 -0.621 . . . . 0.0 109.418 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.1 tt -141.15 151.03 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 121.629 0.728 . . . . 0.0 110.133 179.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.497 HH21 ' CB ' ' A' ' 23' ' ' TYR . 11.7 ttp180 -92.64 148.15 22.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.516 -0.74 . . . . 0.0 109.143 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -52.91 -10.83 0.19 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.0 . . . . 0.0 109.448 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 19' ' ' ARG . 85.4 m-20 -90.09 -2.88 58.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 108.846 179.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.13 8.7 74.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.497 ' CB ' HH21 ' A' ' 19' ' ' ARG . 4.6 m-85 -85.77 132.55 34.1 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -82.57 147.91 28.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.16 -0.963 . . . . 0.0 108.528 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 m -148.04 144.59 28.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.993 -1.067 . . . . 0.0 109.949 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -101.08 148.09 25.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.538 -0.727 . . . . 0.0 109.788 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -105.52 108.84 20.57 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.364 -0.835 . . . . 0.0 110.025 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -72.28 119.57 75.51 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 108.669 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.75 0.55 9.71 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.626 1.551 . . . . 0.0 112.152 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -90.28 -28.87 18.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.101 -0.999 . . . . 0.0 109.352 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 33' ' ' LYS . 1.7 t -120.4 -27.64 5.16 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.58 -11.84 70.61 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.5 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 10.9 mptt -77.8 179.81 6.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.02 -1.282 . . . . 0.0 110.182 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.07 176.4 5.04 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.633 -0.667 . . . . 0.0 110.336 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -139.95 114.14 9.04 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.18 121.95 9.44 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.6 mt -105.36 -57.22 2.06 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.459 -1.024 . . . . 0.0 109.633 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.04 -158.6 30.95 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.495 HH11 ' CB ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -107.35 2.53 24.51 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.528 -0.983 . . . . 0.0 109.929 -179.789 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -93.91 98.26 10.93 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.098 -1.001 . . . . 0.0 110.043 -179.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -51.18 -21.1 1.82 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.274 -0.891 . . . . 0.0 108.604 179.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -71.9 -57.29 4.45 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.2 mm -67.55 -36.42 76.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.384 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.43 -58.34 4.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.603 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.35 -35.15 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 108.964 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -53.44 -54.18 40.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.155 -0.966 . . . . 0.0 108.518 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -62.08 -41.26 97.99 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.623 0.725 . . . . 0.0 109.328 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.23 -45.94 68.91 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.585 -0.697 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.26 -46.77 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.896 . . . . 0.0 110.209 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -62.12 -36.56 82.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.93 -1.106 . . . . 0.0 108.62 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.16 -35.53 81.09 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -69.83 -40.87 75.6 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.638 -0.664 . . . . 0.0 109.629 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.266 -0.896 . . . . 0.0 109.035 -179.939 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.45 149.31 71.78 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.61 158.65 31.38 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.651 1.567 . . . . 0.0 111.312 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 16' ' ' LEU . 58.2 Cg_endo -69.63 156.67 63.06 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.603 2.202 . . . . 0.0 112.713 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 70.84 -17.35 0.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.761 -0.587 . . . . 0.0 110.195 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 14' ' ' PRO . 3.9 tt -99.95 142.7 31.08 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.204 -0.935 . . . . 0.0 109.815 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -134.34 -177.79 4.75 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.476 0.655 . . . . 0.0 109.775 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.571 HD12 ' CE1' ' A' ' 24' ' ' TYR . 18.6 tt -140.0 148.88 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-O 121.376 0.607 . . . . 0.0 109.792 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.428 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 13.7 mtm180 -91.11 156.84 17.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.359 -0.838 . . . . 0.0 109.702 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -57.38 -14.39 4.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.463 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -88.67 -2.12 58.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 108.676 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.99 12.62 67.97 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.428 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 2.9 m-85 -86.51 130.52 34.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.045 -1.268 . . . . 0.0 108.429 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.571 ' CE1' HD12 ' A' ' 18' ' ' ILE . 54.3 m-85 -84.2 148.92 26.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 0.0 109.71 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.3 p -152.72 138.66 18.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.162 -0.961 . . . . 0.0 109.903 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -100.92 150.58 22.71 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.346 -0.846 . . . . 0.0 108.956 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -111.32 113.0 25.16 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.185 -0.947 . . . . 0.0 110.293 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.07 139.71 76.41 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 108.939 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -82.75 -10.77 10.51 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.042 1.828 . . . . 0.0 113.107 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -89.08 -38.82 14.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.784 -1.198 . . . . 0.0 109.769 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 33' ' ' LYS . 2.5 t -106.51 -11.08 16.01 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.75 -6.39 0.62 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -75.52 179.71 5.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.971 -1.311 . . . . 0.0 109.315 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 68.4 mt-10 -107.89 173.03 6.5 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.539 -0.726 . . . . 0.0 109.985 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -136.6 116.55 13.25 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.82 125.79 16.8 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 28.3 mt -110.44 -59.73 1.9 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.501 -0.999 . . . . 0.0 109.207 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.91 -176.06 35.04 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -93.13 7.79 42.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.15 -1.206 . . . . 0.0 109.477 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -96.02 101.99 13.73 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -58.77 -12.88 4.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.157 -0.964 . . . . 0.0 108.764 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -75.63 -56.8 4.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.458 -0.777 . . . . 0.0 108.97 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 89.0 mt -73.27 -34.71 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.526 -0.734 . . . . 0.0 109.596 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.57 -57.71 7.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.035 -1.041 . . . . 0.0 109.437 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 92.1 mt -54.51 -36.82 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 109.211 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -53.7 -56.81 14.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 108.938 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -62.11 -42.99 99.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.651 -0.656 . . . . 0.0 110.027 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.65 67.68 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.387 -0.82 . . . . 0.0 109.147 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.31 -48.34 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.336 -0.852 . . . . 0.0 109.919 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -61.37 -39.68 91.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.989 -1.069 . . . . 0.0 108.241 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.14 75.13 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -67.92 -33.62 75.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.421 -0.799 . . . . 0.0 109.695 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.4 mt -67.22 -32.14 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 108.824 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -71.27 -29.65 65.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.377 -0.827 . . . . 0.0 109.504 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 mt -63.67 -9.28 13.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 0.0 108.792 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.67 -21.95 12.89 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 t -99.4 -19.76 16.83 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.29 -0.881 . . . . 0.0 109.358 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.74 163.33 16.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.53 ' O ' ' CG ' ' A' ' 59' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.249 -1.148 . . . . 0.0 109.481 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.2 t0 . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.5 mt -83.11 146.73 52.2 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.545 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -35.59 145.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.738 2.292 . . . . 0.0 112.52 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.543 ' C ' HD22 ' A' ' 15' ' ' ASN . 83.1 Cg_exo -44.43 138.5 7.45 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.079 1.852 . . . . 0.0 113.429 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.543 HD22 ' C ' ' A' ' 14' ' ' PRO . 1.4 m-80 61.04 43.38 11.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.446 -0.784 . . . . 0.0 111.63 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.5 tp -139.95 119.42 13.07 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -113.39 179.87 3.84 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.583 0.706 . . . . 0.0 110.413 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.605 HD12 ' CE1' ' A' ' 24' ' ' TYR . 13.0 tt -138.73 147.1 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-O 121.538 0.685 . . . . 0.0 109.243 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -91.48 160.12 15.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.533 -0.73 . . . . 0.0 110.352 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -61.36 -11.49 10.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.58 -0.7 . . . . 0.0 109.125 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -88.87 -1.2 57.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.029 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.77 4.99 86.92 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -86.65 135.29 33.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.11 -1.23 . . . . 0.0 108.367 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.605 ' CE1' HD12 ' A' ' 18' ' ' ILE . 79.5 m-85 -84.37 152.53 24.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.166 -0.959 . . . . 0.0 110.16 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.437 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 30.2 p -150.77 126.4 10.23 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.424 -0.797 . . . . 0.0 109.455 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -94.96 150.27 20.35 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.195 -0.94 . . . . 0.0 109.333 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -115.05 115.67 27.2 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.485 -0.759 . . . . 0.0 110.627 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -76.01 131.43 75.95 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 108.989 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.86 -7.69 13.33 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 122.022 1.815 . . . . 0.0 113.42 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -86.13 -18.16 33.05 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.646 -1.284 . . . . 0.0 108.977 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 33' ' ' LYS . 1.3 t -130.67 -27.46 2.13 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.46 -3.52 84.63 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' H ' HG23 ' A' ' 31' ' ' THR . 4.3 mmtp -75.21 -176.32 3.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.953 -1.322 . . . . 0.0 109.304 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -115.99 170.2 8.67 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.484 -0.76 . . . . 0.0 110.266 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -137.27 121.7 18.27 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.28 123.5 6.32 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.7 mt -104.79 -69.56 0.81 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.417 -1.049 . . . . 0.0 109.572 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.57 -177.92 37.67 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' HG3' HH11 ' A' ' 39' ' ' ARG . 6.9 mtm-85 -90.52 7.19 40.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.169 -1.195 . . . . 0.0 110.035 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -95.18 111.31 23.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.253 -0.904 . . . . 0.0 110.216 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.519 HH11 ' HG3' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -62.63 -15.57 52.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 108.99 179.119 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -74.43 -46.67 38.48 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.85 -39.6 16.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.44 -58.16 7.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.667 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 98.7 mt -55.88 -37.56 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.942 -1.099 . . . . 0.0 109.343 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -55.97 -57.96 9.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 109.542 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -61.47 -42.71 99.19 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.475 -0.766 . . . . 0.0 109.911 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.32 64.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.491 -0.755 . . . . 0.0 109.542 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.2 mt -63.47 -42.99 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.242 -0.911 . . . . 0.0 110.36 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.402 ' H ' ' HG3' ' A' ' 50' ' ' GLN . 33.7 mt-30 -59.94 -32.47 70.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.039 -1.038 . . . . 0.0 108.804 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.28 -36.5 84.29 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -67.18 -37.49 83.79 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.28 -0.888 . . . . 0.0 109.873 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.66 -25.75 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.131 -0.981 . . . . 0.0 109.011 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 58' ' ' GLY . 48.7 mt-10 -69.9 -33.71 72.55 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.283 -0.886 . . . . 0.0 108.687 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.94 -39.98 90.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.123 -0.985 . . . . 0.0 109.604 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -81.43 0.65 36.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.141 -0.974 . . . . 0.0 109.34 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.0 m -165.28 53.63 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.254 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . -73.21 120.72 7.27 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.5 m170 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.295 -1.12 . . . . 0.0 109.47 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.5 t70 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 26.0 mt -82.8 148.63 58.03 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.295 -0.878 . . . . 0.0 109.453 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.91 161.91 43.71 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.34 2.027 . . . . 0.0 111.094 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.52 ' C ' ' H ' ' A' ' 16' ' ' LEU . 32.4 Cg_endo -62.58 165.03 16.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.35 2.034 . . . . 0.0 112.052 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 61.7 -9.35 0.08 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.654 -0.654 . . . . 0.0 110.698 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.9 tp -108.08 143.0 37.43 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.091 -1.005 . . . . 0.0 109.335 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 46.5 m-85 -136.78 -165.33 1.72 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.769 0.795 . . . . 0.0 110.052 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.472 HD13 ' CE1' ' A' ' 24' ' ' TYR . 10.5 tp -138.47 138.05 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.503 ' HE ' ' CB ' ' A' ' 23' ' ' TYR . 44.1 mtm180 -89.71 173.04 8.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.258 -0.901 . . . . 0.0 109.28 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.597 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -64.51 -20.04 65.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.113 -0.992 . . . . 0.0 109.699 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -90.85 3.1 55.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.001 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.431 ' C ' HD11 ' A' ' 18' ' ' ILE . . . 77.93 19.82 74.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.503 ' CB ' ' HE ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -84.92 132.76 34.33 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.472 ' CE1' HD13 ' A' ' 18' ' ' ILE . 65.6 m-85 -82.2 141.99 32.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.925 -1.109 . . . . 0.0 109.638 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.9 m -144.13 135.23 25.43 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.205 -0.934 . . . . 0.0 110.443 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 38.5 t80 -96.86 157.49 15.88 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.565 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 27.6 ttm180 -127.52 120.53 28.48 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.498 -0.751 . . . . 0.0 110.539 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -76.47 144.94 74.9 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.128 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.18 -13.0 7.85 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.997 1.798 . . . . 0.0 111.902 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -91.59 -36.3 13.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.282 -0.886 . . . . 0.0 110.078 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 33' ' ' LYS . 27.6 p -106.2 -17.83 14.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.37 -0.831 . . . . 0.0 109.503 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.1 -8.99 0.81 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 31' ' ' THR . 6.6 tmtt? -73.6 -174.17 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.983 -1.304 . . . . 0.0 108.232 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -128.99 161.38 30.07 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.39 -0.819 . . . . 0.0 110.51 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -119.48 137.17 53.97 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.8 120.58 5.25 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mt -102.53 -61.27 1.42 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.409 -1.054 . . . . 0.0 108.838 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.18 -170.18 32.69 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.63 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 1.2 mtm180 -95.85 11.37 33.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -1.194 . . . . 0.0 109.13 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -93.06 98.51 11.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.476 -0.765 . . . . 0.0 110.031 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -61.78 -13.13 20.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.572 -0.705 . . . . 0.0 109.163 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 42' ' ' ARG . 17.3 mmm-85 -77.04 -57.12 4.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.48 -0.762 . . . . 0.0 109.591 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.7 mp -74.42 -35.95 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.22 -0.925 . . . . 0.0 109.537 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.6 -52.98 62.16 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.162 -0.961 . . . . 0.0 109.346 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.5 mt -57.2 -41.67 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.684 -1.26 . . . . 0.0 108.554 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.9 m -57.76 -51.25 70.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 110.614 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.15 -32.77 74.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.035 -1.041 . . . . 0.0 109.768 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.5 90.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.168 -0.957 . . . . 0.0 110.051 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.18 -56.31 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.353 -0.842 . . . . 0.0 111.007 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -56.19 -31.11 63.14 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.943 -1.098 . . . . 0.0 108.489 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.94 -38.0 82.3 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -65.6 -45.28 83.79 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.5 mt -69.53 -42.37 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.353 -0.842 . . . . 0.0 108.748 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -70.89 -15.07 62.59 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.575 -0.703 . . . . 0.0 109.349 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 tp -56.16 -16.63 5.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.474 -0.766 . . . . 0.0 109.266 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -100.69 -2.26 33.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.366 -0.834 . . . . 0.0 109.122 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.6 p -154.44 80.39 1.11 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.845 . . . . 0.0 109.313 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.552 ' O ' ' CG ' ' A' ' 59' ' ' HIS . . . -46.6 162.61 0.18 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.552 ' CG ' ' O ' ' A' ' 58' ' ' GLY . 34.1 p80 . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.661 -0.906 . . . . 0.0 110.222 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 23.6 p-10 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 13' ' ' PRO . 40.6 mt -80.99 149.55 66.98 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 109.114 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 12' ' ' LEU . 90.7 Cg_exo -35.41 158.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.617 2.212 . . . . 0.0 111.814 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.08 143.88 50.63 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.059 1.839 . . . . 0.0 111.265 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 65.85 29.17 10.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.602 -0.686 . . . . 0.0 109.939 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.0 tp -138.91 123.66 18.64 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 11.9 m-85 -131.1 -163.95 1.38 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.172 0.987 . . . . 0.0 111.11 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 tp -126.82 142.21 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' A' ' 19' ' ' ARG . 14.5 ttm-85 -88.48 161.53 16.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.162 -0.962 . . . . 0.0 109.036 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -59.26 -18.35 36.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.038 -1.039 . . . . 0.0 109.423 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -89.36 -0.33 57.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.093 -1.005 . . . . 0.0 108.722 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.36 8.41 74.57 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -86.22 142.61 28.46 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -1.174 . . . . 0.0 108.943 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -81.48 149.71 28.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.967 -1.083 . . . . 0.0 108.938 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.9 p -148.57 135.44 19.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.983 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -97.83 154.81 17.38 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -118.12 110.84 18.11 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.451 -0.781 . . . . 0.0 109.472 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -74.95 151.02 86.28 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.223 -0.923 . . . . 0.0 109.645 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -90.46 -23.18 0.64 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.624 2.216 . . . . 0.0 113.146 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HG3' HG23 ' A' ' 31' ' ' THR . 28.4 ptt180 -90.14 -26.35 20.22 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.933 -1.105 . . . . 0.0 110.346 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.532 ' C ' ' H ' ' A' ' 33' ' ' LYS . 68.1 p -105.92 -19.24 13.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.0 -1.062 . . . . 0.0 108.421 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.74 -11.23 0.63 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.4 OUTLIER -75.99 -161.97 0.2 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.202 -1.176 . . . . 0.0 109.032 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 44.1 mt-10 -129.82 179.52 5.8 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.573 -0.705 . . . . 0.0 109.935 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -143.94 117.45 9.14 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.09 126.3 10.2 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt -105.97 -52.47 2.8 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.362 -1.081 . . . . 0.0 109.622 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.92 -173.07 30.52 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -97.72 8.95 43.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -1.129 . . . . 0.0 109.292 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -94.43 99.52 11.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.325 -0.859 . . . . 0.0 110.422 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -55.47 -19.61 10.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.538 HH11 ' HG2' ' A' ' 42' ' ' ARG . 1.1 mmt-85 -75.46 -54.09 7.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 109.237 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 78.9 mt -76.25 -36.84 30.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.688 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -58.52 8.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 110.18 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 50.8 mt -50.84 -39.43 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.8 -1.187 . . . . 0.0 109.176 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.06 -51.5 66.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.008 . . . . 0.0 109.499 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -62.37 -41.25 98.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 109.151 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.38 93.4 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.434 -0.792 . . . . 0.0 110.229 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 57.1 mt -60.46 -52.66 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.137 -0.977 . . . . 0.0 110.593 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -59.12 -30.87 68.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.875 -1.141 . . . . 0.0 108.712 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.54 -41.31 93.18 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -68.05 -39.32 83.05 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.466 -0.771 . . . . 0.0 109.392 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.8 mt -68.81 -30.08 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.243 -0.911 . . . . 0.0 108.831 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -70.43 -21.7 62.79 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.409 -0.807 . . . . 0.0 108.831 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.501 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.44 -36.88 79.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 108.861 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -104.33 -28.37 11.42 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.43 -0.794 . . . . 0.0 109.081 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.1 m -95.04 47.75 1.16 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.118 -0.989 . . . . 0.0 109.166 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.26 10.47 74.8 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.4 m80 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.325 -1.103 . . . . 0.0 109.547 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.1 mt -82.18 151.47 66.45 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.337 -0.852 . . . . 0.0 109.368 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.53 160.44 39.7 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.752 1.634 . . . . 0.0 110.354 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 16' ' ' LEU . 57.2 Cg_endo -67.7 171.6 11.83 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.31 2.007 . . . . 0.0 112.201 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 57.05 4.21 0.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.555 -0.716 . . . . 0.0 109.422 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.499 ' H ' ' C ' ' A' ' 14' ' ' PRO . 26.1 tp -129.74 132.39 46.57 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -134.46 -163.47 1.38 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.366 -0.834 . . . . 0.0 110.339 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 tp -132.04 141.11 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -88.77 158.91 18.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.968 . . . . 0.0 109.115 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.708 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -57.4 -19.91 26.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.465 -0.772 . . . . 0.0 109.043 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.81 -2.93 58.96 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.72 10.99 71.79 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -86.61 140.23 30.04 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.231 -1.158 . . . . 0.0 108.588 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.438 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 68.4 m-85 -81.84 151.24 27.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.85 -1.156 . . . . 0.0 109.432 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.447 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 17.2 p -146.68 133.36 19.93 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.397 -0.814 . . . . 0.0 110.156 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -96.94 137.33 36.19 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.331 -0.855 . . . . 0.0 108.812 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -108.81 115.33 29.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.591 -0.693 . . . . 0.0 110.104 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -70.34 142.66 89.77 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -84.17 -8.8 9.76 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.393 2.062 . . . . 0.0 113.323 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -89.78 -24.45 21.48 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.842 -1.161 . . . . 0.0 109.987 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.12 -22.33 3.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.368 -0.832 . . . . 0.0 109.49 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.41 0.9 68.34 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.402 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 3.6 tmtt? -73.94 179.68 4.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.959 -1.318 . . . . 0.0 108.494 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 25.9 mt-10 -131.72 160.25 36.04 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.375 -0.828 . . . . 0.0 110.605 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -138.04 125.48 21.94 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.16 132.46 33.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.428 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.6 mt -105.09 -47.79 3.9 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.413 -1.051 . . . . 0.0 108.869 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.39 -178.98 22.8 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.181 -1.967 . . . . 0.0 108.181 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -91.55 11.03 25.53 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.021 -1.282 . . . . 0.0 109.371 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.34 100.72 13.25 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.933 0.873 . . . . 0.0 109.835 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.438 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 43.0 ttm180 -59.25 -20.06 51.04 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.4 0.619 . . . . 0.0 109.9 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.584 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -77.08 -49.27 15.68 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.714 0.768 . . . . 0.0 109.2 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.5 mt -75.76 -36.89 34.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.8 -55.41 26.71 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.348 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.53 -40.34 74.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.418 -0.801 . . . . 0.0 109.78 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -50.63 -51.74 46.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 108.914 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -62.53 -37.76 87.34 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.551 -0.718 . . . . 0.0 109.333 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.25 -51.91 67.81 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.497 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.61 -48.87 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.361 -0.837 . . . . 0.0 110.641 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -58.07 -44.07 87.3 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.839 -1.163 . . . . 0.0 108.145 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.54 74.05 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -69.94 -45.74 66.81 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.333 -0.855 . . . . 0.0 109.521 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.7 mt -69.68 -37.68 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.085 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.61 -22.67 64.42 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.326 -0.859 . . . . 0.0 109.305 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.18 -12.84 30.97 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.121 -0.987 . . . . 0.0 108.474 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.499 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -117.52 -32.72 4.81 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.4 m -99.85 59.58 1.07 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.321 -0.862 . . . . 0.0 109.737 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 59' ' ' HIS . . . -166.39 177.15 41.43 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.525 ' CG ' ' O ' ' A' ' 58' ' ' GLY . 32.5 m80 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.298 -1.119 . . . . 0.0 109.264 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 mt -80.57 150.34 69.85 Favored Pre-proline 0 N--CA 1.486 1.359 0 O-C-N 121.331 -0.856 . . . . 0.0 108.89 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -40.21 157.27 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 122.115 1.876 . . . . 0.0 111.85 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 16' ' ' LEU . 50.5 Cg_endo -69.61 153.03 70.15 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.093 1.862 . . . . 0.0 111.767 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 69.0 -11.27 0.45 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.535 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.411 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.5 tt -97.56 142.28 29.58 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.926 -1.109 . . . . 0.0 109.664 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -136.03 -178.83 5.32 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.551 -0.718 . . . . 0.0 109.393 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.21 147.77 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.662 0.744 . . . . 0.0 109.631 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.504 HH21 ' CB ' ' A' ' 23' ' ' TYR . 15.1 ttp180 -91.31 156.32 17.88 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -59.71 -10.33 3.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.057 -1.027 . . . . 0.0 109.604 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -88.69 1.41 55.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.259 -0.901 . . . . 0.0 108.755 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.88 6.16 88.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.504 ' CB ' HH21 ' A' ' 19' ' ' ARG . 3.6 m-85 -84.36 138.06 33.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.313 -1.11 . . . . 0.0 108.488 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -83.0 154.67 24.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.034 -1.041 . . . . 0.0 109.307 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 p -150.88 132.24 14.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.818 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -101.98 143.64 31.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.378 -0.826 . . . . 0.0 109.097 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -101.86 118.66 37.39 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.49 -0.756 . . . . 0.0 109.5 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 35' ' ' PHE . 1.9 m-20 -74.35 149.12 86.53 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.977 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.24 3.06 7.09 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.771 2.314 . . . . 0.0 113.015 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -86.48 -55.12 4.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.951 -1.093 . . . . 0.0 110.243 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.42 HG23 ' H ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -118.17 -18.93 9.21 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.457 -0.777 . . . . 0.0 109.807 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.32 6.76 59.78 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.051 -1.031 . . . . 0.0 110.635 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.42 ' H ' HG23 ' A' ' 31' ' ' THR . 8.6 mptt -72.25 -175.23 1.48 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.847 -1.384 . . . . 0.0 109.325 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -119.1 166.86 12.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.646 -0.659 . . . . 0.0 109.822 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.469 ' CE1' ' OD2' ' A' ' 28' ' ' ASP . 8.0 m-85 -134.77 119.2 17.9 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.14 121.75 16.83 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -104.22 -53.49 2.72 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.526 -0.985 . . . . 0.0 109.302 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.46 -177.45 28.53 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.509 -1.837 . . . . 0.0 108.509 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.474 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 1.8 mtm180 -93.92 8.47 41.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.13 -1.218 . . . . 0.0 109.422 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -94.19 102.73 14.76 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -60.5 -11.77 7.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.349 -0.845 . . . . 0.0 109.018 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.2 OUTLIER -75.8 -54.72 6.49 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.467 -0.771 . . . . 0.0 109.216 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.575 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.7 mp -74.92 -37.91 42.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.614 -0.679 . . . . 0.0 109.183 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.11 -56.74 14.3 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.65 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.7 mt -55.99 -40.88 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.043 -1.036 . . . . 0.0 109.329 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.7 m -59.96 -50.73 72.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 110.477 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -32.86 74.52 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.306 -0.871 . . . . 0.0 110.018 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.34 -44.97 92.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.105 -0.997 . . . . 0.0 108.961 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 77.1 mt -56.86 -42.2 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.441 -0.787 . . . . 0.0 110.207 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -58.19 -39.53 79.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.053 -1.029 . . . . 0.0 108.991 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.35 84.01 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -67.8 -39.26 84.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.531 -0.731 . . . . 0.0 110.419 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 81.4 mt -68.39 -36.87 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.004 -1.06 . . . . 0.0 109.572 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -70.07 -19.35 63.27 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.31 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.83 -43.63 98.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.862 . . . . 0.0 109.199 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.413 ' C ' ' N ' ' A' ' 58' ' ' GLY . 76.3 m-85 -81.1 7.25 11.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -0.872 . . . . 0.0 109.32 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.4 t 49.78 18.07 0.31 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.25 -0.906 . . . . 0.0 108.881 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' A' ' 56' ' ' PHE . . . 70.76 -49.06 0.81 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.2 p80 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.298 -1.119 . . . . 0.0 109.386 -179.845 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.7 t0 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.196 0.522 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 76.9 mt -81.22 150.64 68.33 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.952 . . . . 0.0 109.163 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -37.87 154.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.29 1.993 . . . . 0.0 111.892 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 16' ' ' LEU . 41.4 Cg_endo -66.68 153.61 77.37 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.377 2.051 . . . . 0.0 112.554 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 54.71 6.5 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.482 -0.761 . . . . 0.0 110.42 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.424 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.6 tt -104.61 148.01 27.0 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.19 -0.944 . . . . 0.0 109.25 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -139.1 -177.58 4.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.879 0.847 . . . . 0.0 110.331 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.66 HD12 ' CE1' ' A' ' 24' ' ' TYR . 18.6 tt -141.31 145.45 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.423 HH21 ' CB ' ' A' ' 23' ' ' TYR . 8.9 ttp180 -90.32 151.64 21.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.418 -0.801 . . . . 0.0 109.667 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.603 HD22 ' H ' ' A' ' 20' ' ' ASN . 1.5 m-80 -51.07 -15.86 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.444 -0.785 . . . . 0.0 109.973 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -88.69 0.89 56.0 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.178 -0.951 . . . . 0.0 108.845 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.69 12.18 78.19 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.423 ' CB ' HH21 ' A' ' 19' ' ' ARG . 8.0 m-85 -84.07 127.71 34.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.951 -1.323 . . . . 0.0 107.76 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.66 ' CE1' HD12 ' A' ' 18' ' ' ILE . 53.6 m-85 -82.82 147.53 28.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.2 m -150.32 141.84 23.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.029 -1.045 . . . . 0.0 110.308 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 36.6 t80 -110.99 150.09 29.76 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.418 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 33.8 mtt180 -109.92 117.36 33.59 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.5 ' OD1' ' CD1' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -75.06 131.73 78.2 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -75.22 -6.25 17.68 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.776 1.651 . . . . 0.0 112.622 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -89.1 -44.0 10.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.923 -1.11 . . . . 0.0 109.163 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.488 ' C ' ' H ' ' A' ' 33' ' ' LYS . 1.4 t -108.34 -7.4 15.9 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.289 -0.882 . . . . 0.0 108.913 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.6 -2.42 0.85 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 31' ' ' THR . 3.4 mmtp -73.14 -179.94 3.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.068 -1.254 . . . . 0.0 108.857 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -105.75 171.72 7.19 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.537 -0.727 . . . . 0.0 109.951 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.5 ' CD1' ' OD1' ' A' ' 28' ' ' ASP . 14.8 m-85 -140.53 109.87 6.24 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.33 125.55 21.15 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.0 mt -109.02 -31.37 7.65 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.55 -0.97 . . . . 0.0 109.93 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.15 -174.36 18.33 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -97.61 10.77 39.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.215 -1.168 . . . . 0.0 109.823 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -92.43 100.46 13.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.371 -0.831 . . . . 0.0 110.084 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -59.03 -16.39 18.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.515 -0.74 . . . . 0.0 109.628 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.54 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -76.49 -58.68 3.14 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.184 -0.948 . . . . 0.0 109.326 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.612 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.7 mp -74.89 -33.1 29.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.654 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.74 -48.44 77.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.765 -1.21 . . . . 0.0 109.928 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.1 -38.79 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.733 -1.23 . . . . 0.0 108.976 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 47' ' ' GLU . 1.2 m -53.87 -63.92 0.99 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.239 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.406 ' N ' HG22 ' A' ' 46' ' ' THR . 20.0 mt-10 -53.05 -38.54 62.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 0.0 109.628 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.3 80.88 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.298 -0.877 . . . . 0.0 108.896 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.25 -44.83 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.425 -0.797 . . . . 0.0 110.8 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 -57.41 -39.03 75.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.874 -1.141 . . . . 0.0 108.173 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.43 -35.77 81.91 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -66.86 -40.83 88.0 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.349 -0.845 . . . . 0.0 109.714 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.4 mt -69.1 -28.24 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.041 -1.037 . . . . 0.0 108.477 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -70.84 -24.86 62.61 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.59 -0.694 . . . . 0.0 109.834 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.37 -16.09 59.44 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.031 -1.043 . . . . 0.0 108.62 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -109.03 11.96 25.49 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t 66.94 12.78 9.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.591 -0.693 . . . . 0.0 109.502 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.79 102.72 1.68 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.499 ' CD2' ' H ' ' A' ' 59' ' ' HIS . 8.3 p80 . . . . . 0 C--N 1.303 -1.431 0 O-C-N 121.194 -1.18 . . . . 0.0 109.269 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.6 mt -82.09 150.92 65.84 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.333 -0.855 . . . . 0.0 108.728 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -40.6 156.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.848 1.699 . . . . 0.0 111.336 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.75 165.2 16.57 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.946 1.764 . . . . 0.0 111.384 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.502 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 3.1 m-80 51.16 30.21 5.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.193 -0.942 . . . . 0.0 109.415 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.698 HD23 ' N ' ' A' ' 17' ' ' TYR . 2.5 tt -138.28 127.51 24.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.349 -0.845 . . . . 0.0 108.793 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.698 ' N ' HD23 ' A' ' 16' ' ' LEU . 93.0 m-85 -124.11 -179.01 4.26 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.578 -0.701 . . . . 0.0 109.423 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.1 tt -140.39 150.53 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.561 -0.712 . . . . 0.0 109.299 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.454 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 35.0 ttp180 -91.65 152.53 20.2 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.168 -0.958 . . . . 0.0 109.602 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.9 -15.63 13.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 0.0 109.447 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -88.2 -1.73 58.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 108.642 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.82 9.58 65.97 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.454 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -84.65 129.28 34.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.119 -1.224 . . . . 0.0 108.216 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -81.5 152.23 27.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.982 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.2 m -152.06 136.42 16.76 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.418 -0.801 . . . . 0.0 109.58 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 15' ' ' ASN . 81.5 t80 -105.03 137.4 42.84 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.383 -0.823 . . . . 0.0 109.083 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -103.23 113.07 26.26 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.392 -0.817 . . . . 0.0 109.682 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.13 139.9 85.25 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.275 -0.891 . . . . 0.0 110.347 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -83.5 1.4 8.98 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.479 2.12 . . . . 0.0 112.248 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -86.89 -37.0 18.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.082 -1.011 . . . . 0.0 109.88 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.1 -23.07 3.65 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.488 -0.757 . . . . 0.0 109.102 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.81 2.04 72.69 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -74.76 -164.97 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.875 -1.368 . . . . 0.0 109.777 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -129.52 171.87 12.14 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.755 0.788 . . . . 0.0 110.889 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -139.58 124.65 18.77 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.26 119.26 6.19 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.9 mt -103.8 -52.22 3.01 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.32 -1.106 . . . . 0.0 109.022 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.3 -169.09 26.46 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -97.47 11.87 35.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.288 -1.125 . . . . 0.0 109.269 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.94 106.5 18.45 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.367 -0.833 . . . . 0.0 110.142 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -64.43 -18.52 64.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.532 -0.73 . . . . 0.0 109.18 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 42' ' ' ARG . 11.4 mmm-85 -76.84 -50.52 13.23 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.478 -0.763 . . . . 0.0 109.076 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 92.4 mt -76.12 -36.35 30.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.606 -0.684 . . . . 0.0 109.806 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.99 -52.65 58.62 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.183 -0.948 . . . . 0.0 109.823 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.7 mt -56.14 -39.28 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.001 -1.062 . . . . 0.0 109.426 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.99 -50.87 65.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.0 109.715 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' O ' ' OE1' ' A' ' 50' ' ' GLN . 66.3 mm-40 -62.5 -39.78 94.58 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.512 -0.743 . . . . 0.0 109.656 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.514 ' CB ' HD12 ' A' ' 16' ' ' LEU . . . -62.43 -44.84 95.45 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.478 -0.764 . . . . 0.0 109.977 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.28 -58.41 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.217 -0.927 . . . . 0.0 111.23 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.402 ' OE1' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -55.73 -24.44 34.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.989 -1.069 . . . . 0.0 109.167 -178.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.16 -41.57 81.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -70.58 -40.42 73.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.519 -0.738 . . . . 0.0 110.159 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.6 mt -67.27 -31.55 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.12 -0.987 . . . . 0.0 109.236 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -72.0 -24.47 61.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -0.866 . . . . 0.0 108.791 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.469 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -63.11 -41.25 99.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.491 -0.756 . . . . 0.0 109.351 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -83.47 9.08 12.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.893 . . . . 0.0 109.318 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 t -137.71 25.42 2.84 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.358 -0.839 . . . . 0.0 109.144 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.19 -71.56 0.81 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 28.1 p80 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.26 -1.141 . . . . 0.0 109.368 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.79 148.12 60.48 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.122 -0.987 . . . . 0.0 109.34 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -37.59 158.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.447 2.098 . . . . 0.0 111.886 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.1 166.09 30.32 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.312 2.008 . . . . 0.0 111.948 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 49.48 20.94 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.919 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 tp -128.0 125.99 40.49 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -121.68 173.53 7.39 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.624 -0.672 . . . . 0.0 110.249 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.24 134.53 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.468 ' C ' ' H ' ' A' ' 21' ' ' ASN . 18.4 mtm180 -89.92 149.48 22.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.095 -1.003 . . . . 0.0 109.887 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -54.05 -8.85 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.136 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 19' ' ' ARG . 88.0 m-20 -89.65 0.26 57.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.394 -0.816 . . . . 0.0 109.218 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.79 3.92 90.29 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.42 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 9.5 m-85 -88.07 129.92 35.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.173 -1.192 . . . . 0.0 109.073 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.437 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 13.4 m-85 -84.82 156.9 21.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.461 -0.774 . . . . 0.0 108.987 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.437 ' SG ' ' O ' ' A' ' 24' ' ' TYR . 98.9 m -152.83 129.34 10.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.298 -0.877 . . . . 0.0 109.464 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -95.6 145.43 25.24 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.248 -0.908 . . . . 0.0 108.953 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -120.41 118.63 30.82 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.59 -0.694 . . . . 0.0 110.139 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -76.02 138.79 68.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.319 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.12 16.41 1.65 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.556 2.171 . . . . 0.0 112.896 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.57 -68.44 0.75 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.8 -1.188 . . . . 0.0 109.042 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.32 -19.56 13.55 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.307 -0.871 . . . . 0.0 109.36 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.68 17.52 23.37 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 178.84 5.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.765 -1.432 . . . . 0.0 108.977 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -126.49 164.14 21.81 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.423 -0.798 . . . . 0.0 110.443 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -134.78 133.08 39.48 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.21 131.57 10.73 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.34 -54.68 2.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.485 -1.009 . . . . 0.0 109.643 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.27 -171.46 31.54 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.91 7.66 46.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -1.201 . . . . 0.0 109.683 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -95.29 103.96 15.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.256 -0.902 . . . . 0.0 110.098 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -58.13 -18.64 26.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 108.738 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.5 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -73.46 -49.69 25.51 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.7 mt -76.89 -37.06 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.543 -0.723 . . . . 0.0 109.238 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.14 -56.56 12.21 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.854 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 88.8 mt -54.15 -35.74 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.098 -1.001 . . . . 0.0 109.351 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -56.82 -59.53 4.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.096 -1.003 . . . . 0.0 109.033 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -59.53 -42.24 91.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.37 -0.831 . . . . 0.0 109.807 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.6 -42.15 61.75 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.96 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.09 -52.49 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -60.58 -29.7 69.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.947 -1.096 . . . . 0.0 108.199 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.16 86.35 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -64.79 -36.78 85.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.412 -0.805 . . . . 0.0 109.377 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.0 mm -69.25 -29.38 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 108.876 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -70.69 -23.99 62.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.433 -0.792 . . . . 0.0 109.426 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.51 -8.47 4.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 109.127 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -130.27 4.52 4.78 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 t 53.93 19.17 1.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 109.383 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.93 26.87 19.8 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.308 -1.113 . . . . 0.0 109.401 -179.875 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.7 mt -81.72 150.64 66.56 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.28 -0.888 . . . . 0.0 109.391 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -40.78 157.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.049 1.833 . . . . 0.0 111.491 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.42 162.39 40.87 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.257 1.971 . . . . 0.0 112.143 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 52.72 27.35 5.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.469 -0.769 . . . . 0.0 110.25 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.0 tt -136.64 148.47 47.44 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.221 -0.925 . . . . 0.0 108.81 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 22.6 m-85 -138.16 -166.85 2.05 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.115 0.96 . . . . 0.0 110.753 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.42 136.01 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 21' ' ' ASN . 26.8 ttp180 -88.62 142.25 27.84 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.921 -1.112 . . . . 0.0 109.424 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -50.45 -10.59 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.497 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 19' ' ' ARG . 8.6 m120 -89.75 -0.04 57.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 109.169 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.57 5.11 87.12 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.467 ' CB ' HH21 ' A' ' 19' ' ' ARG . 3.0 m-85 -88.61 134.92 33.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.273 -1.134 . . . . 0.0 108.977 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -84.18 147.94 27.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.927 . . . . 0.0 108.699 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.8 m -150.62 143.03 24.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.037 -1.04 . . . . 0.0 110.044 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.448 ' CZ ' ' HB1' ' A' ' 51' ' ' ALA . 43.8 t80 -105.01 159.05 16.12 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.495 -0.753 . . . . 0.0 109.102 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.539 HH21 ' CD ' ' A' ' 34' ' ' GLU . 27.8 ttm180 -130.5 113.9 14.84 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.358 -0.839 . . . . 0.0 109.78 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.58 141.33 79.5 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.509 -0.744 . . . . 0.0 109.176 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -83.57 -19.82 5.04 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 121.931 1.754 . . . . 0.0 112.388 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 30' ' ' ARG . 8.6 ptm180 -89.14 -26.01 21.55 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.126 -0.984 . . . . 0.0 109.491 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 33' ' ' LYS . 1.9 p -107.33 -21.02 13.09 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.36 -10.43 0.66 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 31' ' ' THR . 5.5 tmtt? -75.99 -179.21 4.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -1.232 . . . . 0.0 109.6 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.539 ' CD ' HH21 ' A' ' 27' ' ' ARG . 36.5 mt-10 -115.89 168.13 10.33 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.546 0.688 . . . . 0.0 110.291 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -135.77 121.22 19.3 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.54 124.58 6.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -105.09 -73.87 0.67 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.417 -1.049 . . . . 0.0 109.226 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 172.08 -168.55 41.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.441 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -98.29 0.16 45.08 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.269 -1.136 . . . . 0.0 109.593 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -98.36 100.1 11.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.308 -0.87 . . . . 0.0 109.748 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 4.1 ptt180 -54.63 -20.23 7.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.267 -0.896 . . . . 0.0 109.527 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' H ' ' HD3' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -68.34 -50.48 52.94 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.585 HD12 ' N ' ' A' ' 43' ' ' ILE . 1.9 mp -77.57 -34.87 20.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 41' ' ' ARG . . . -65.82 -53.84 34.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.847 . . . . 0.0 109.781 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 73.1 mt -54.9 -35.92 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 109.232 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.22 -54.88 37.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 0.0 108.958 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.8 -39.73 95.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.529 -0.732 . . . . 0.0 109.756 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -57.56 -41.45 81.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.486 -0.759 . . . . 0.0 109.577 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.84 -44.69 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 110.155 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.411 ' HG3' ' H ' ' A' ' 50' ' ' GLN . 15.1 mt-30 -58.33 -28.9 65.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.862 -1.149 . . . . 0.0 108.519 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.448 ' HB1' ' CZ ' ' A' ' 26' ' ' TYR . . . -65.53 -35.06 79.75 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -66.89 -35.09 79.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.835 . . . . 0.0 109.473 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.7 mp -72.85 -35.25 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -27.75 66.87 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -54.55 -30.91 55.46 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' A' ' 57' ' ' SER . 50.3 m-85 -87.5 9.21 21.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.071 -1.018 . . . . 0.0 109.37 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER 74.12 -43.29 0.53 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.521 -0.737 . . . . 0.0 109.719 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.7 154.36 12.57 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.439 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.182 -1.187 . . . . 0.0 109.414 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.287 0.565 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.7 mt -83.24 150.52 61.0 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.266 -0.896 . . . . 0.0 108.905 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -35.29 154.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 122.556 2.171 . . . . 0.0 112.441 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 16' ' ' LEU . 49.6 Cg_endo -67.89 151.87 77.77 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.387 2.058 . . . . 0.0 111.75 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 62.73 -4.39 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.517 -0.739 . . . . 0.0 110.007 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.7 tt -100.15 153.61 19.11 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.172 -0.955 . . . . 0.0 109.221 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -138.03 -169.42 2.56 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.339 -0.85 . . . . 0.0 110.604 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.15 137.68 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.488 ' NE ' HD22 ' A' ' 21' ' ' ASN . 40.1 ttp180 -89.58 151.55 21.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.153 -0.967 . . . . 0.0 109.205 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.538 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 1.5 p30 -61.9 -9.28 6.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.107 -0.995 . . . . 0.0 109.665 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.488 HD22 ' NE ' ' A' ' 19' ' ' ARG . 74.0 m-80 -91.03 -1.51 57.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.891 . . . . 0.0 109.337 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.74 3.03 77.84 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -87.87 140.17 29.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.207 -1.172 . . . . 0.0 109.106 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.494 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 55.0 m-85 -84.78 150.79 24.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 0.0 109.075 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.7 p -150.45 138.92 20.51 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.213 -0.93 . . . . 0.0 110.057 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -102.35 150.66 23.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.94 112.82 15.1 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.371 -0.831 . . . . 0.0 108.795 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.454 ' CB ' ' NZ ' ' A' ' 33' ' ' LYS . 11.2 t70 -73.29 129.73 85.49 Favored Pre-proline 0 N--CA 1.489 1.511 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.891 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.02 17.99 0.95 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.049 1.833 . . . . 0.0 113.093 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -88.79 -65.47 1.01 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.732 -1.23 . . . . 0.0 109.294 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.04 -20.07 13.43 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.196 -0.94 . . . . 0.0 108.794 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.11 13.8 32.68 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.589 ' H ' ' HD3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -73.77 177.67 5.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.65 -1.5 . . . . 0.0 109.532 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -131.64 167.52 19.29 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.388 -0.82 . . . . 0.0 110.288 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -139.43 117.73 11.99 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.505 -0.747 . . . . 0.0 109.051 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.54 124.27 8.02 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.77 -71.48 0.72 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.312 -1.111 . . . . 0.0 109.653 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.67 -173.84 39.8 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -95.0 10.5 35.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.037 -1.272 . . . . 0.0 109.707 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.96 103.3 15.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.194 -0.941 . . . . 0.0 110.717 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.494 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 79.5 mtt180 -54.3 -19.81 6.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.362 -0.836 . . . . 0.0 108.822 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -74.04 -55.07 6.57 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.401 -0.812 . . . . 0.0 109.462 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.4 mt -80.65 -32.43 13.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.529 -0.732 . . . . 0.0 109.801 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.43 -58.46 5.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.827 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 97.9 mt -55.71 -37.21 45.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.946 . . . . 0.0 109.302 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -53.81 -57.4 11.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.092 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -54.07 -43.85 70.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.615 -0.678 . . . . 0.0 109.6 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.31 -43.63 79.15 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.753 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.24 -41.09 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.204 -0.935 . . . . 0.0 110.646 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.65 -39.0 82.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.811 -1.181 . . . . 0.0 108.643 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.74 -35.48 80.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.573 -0.705 . . . . 0.0 109.364 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -68.38 -40.52 81.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.513 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.1 mt -68.79 -33.61 60.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -40.8 75.35 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.57 -10.38 34.8 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.911 -0.715 . . . . 0.0 109.106 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.48 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -100.7 -3.19 30.7 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -163.68 69.61 0.21 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.435 -0.791 . . . . 0.0 109.139 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.99 9.71 61.72 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 28.6 m170 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.188 -1.184 . . . . 0.0 109.548 -179.88 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 13' ' ' PRO . 73.8 mt -83.68 149.65 57.65 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.883 . . . . 0.0 109.598 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 12' ' ' LEU . 95.4 Cg_exo -36.14 158.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 122.508 2.138 . . . . 0.0 111.779 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 16' ' ' LEU . 56.1 Cg_endo -69.12 166.83 25.46 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.115 1.877 . . . . 0.0 111.843 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 52.27 10.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.874 . . . . 0.0 109.886 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 14' ' ' PRO . 34.6 tp -124.13 140.04 53.35 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -133.19 -164.81 1.53 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 122.12 0.962 . . . . 0.0 110.766 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -134.47 139.27 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -91.0 151.47 21.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.012 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -13.12 6.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 109.324 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -91.13 0.3 57.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.368 -0.832 . . . . 0.0 109.262 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.63 4.89 79.22 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -88.62 138.46 31.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -1.119 . . . . 0.0 109.476 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -81.24 153.81 26.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.935 . . . . 0.0 108.752 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 p -149.97 124.59 9.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.056 -1.028 . . . . 0.0 110.223 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 44.1 t80 -98.23 151.03 20.89 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.437 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 59.3 mtt180 -115.88 122.54 45.66 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.995 0.902 . . . . 0.0 110.322 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.77 129.85 77.9 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HG3' HD13 ' A' ' 55' ' ' LEU . 86.4 Cg_endo -77.5 -6.99 16.68 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.966 1.777 . . . . 0.0 113.537 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.468 ' HG3' HH11 ' A' ' 30' ' ' ARG . 0.0 OUTLIER -89.03 -29.04 19.76 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.639 -1.288 . . . . 0.0 109.12 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.461 HG23 ' H ' ' A' ' 33' ' ' LYS . 1.7 t -118.66 -15.49 9.5 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.9 -1.8 7.54 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.461 ' H ' HG23 ' A' ' 31' ' ' THR . 6.0 tmtt? -74.16 179.54 4.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.015 -1.285 . . . . 0.0 109.12 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -108.44 170.67 7.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.507 -0.746 . . . . 0.0 109.806 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -140.37 118.34 11.84 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.73 123.98 14.26 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.0 mt -106.46 -55.91 2.26 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.426 -1.044 . . . . 0.0 109.527 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.24 -175.14 25.86 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -94.3 11.03 31.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.005 -1.291 . . . . 0.0 108.672 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.78 98.65 11.53 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.473 -0.767 . . . . 0.0 109.711 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -61.68 -13.51 23.29 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.231 -0.918 . . . . 0.0 108.985 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -72.5 -53.27 12.55 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.338 -0.851 . . . . 0.0 109.354 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 87.8 mt -79.07 -36.81 18.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.509 -0.744 . . . . 0.0 109.631 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.46 -55.97 22.61 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.249 -0.907 . . . . 0.0 109.231 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.2 mt -56.45 -43.54 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.782 -1.199 . . . . 0.0 108.989 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.0 m -57.61 -51.34 69.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.982 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -32.97 74.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -0.854 . . . . 0.0 109.584 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.94 -47.91 70.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.182 -0.949 . . . . 0.0 110.399 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.4 mt -57.81 -49.68 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.275 -0.891 . . . . 0.0 111.127 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -58.74 -31.25 68.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.875 -1.14 . . . . 0.0 108.862 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.56 83.27 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -68.1 -38.79 82.68 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.416 -0.802 . . . . 0.0 109.368 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.81 -43.12 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.355 -0.84 . . . . 0.0 108.988 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -70.57 -20.42 62.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.42 -0.8 . . . . 0.0 109.403 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.417 HD13 ' HG3' ' A' ' 29' ' ' PRO . 31.0 tp -63.12 -14.91 54.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 109.267 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -83.97 -4.46 58.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 109.14 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -167.97 61.61 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 109.595 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -49.16 -90.5 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.282 -1.128 . . . . 0.0 109.664 179.889 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.385 0.612 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.2 mt -83.54 149.9 58.65 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.293 -0.88 . . . . 0.0 108.984 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.33 162.04 28.54 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.239 1.959 . . . . 0.0 111.602 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.15 169.62 11.85 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.684 2.256 . . . . 0.0 112.259 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 55.64 8.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.799 . . . . 0.0 110.07 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.0 tt -129.29 137.65 51.16 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.343 -0.848 . . . . 0.0 108.782 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -127.38 -166.59 1.62 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.678 0.751 . . . . 0.0 110.193 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -134.48 132.96 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.411 ' HG2' ' H ' ' A' ' 21' ' ' ASN . 39.9 ttp180 -86.75 150.61 24.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.207 -0.933 . . . . 0.0 109.199 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.722 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -59.23 -10.6 3.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 110.014 -179.237 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.722 ' N ' HD22 ' A' ' 20' ' ' ASN . 93.8 m-20 -91.51 0.54 57.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.109 -0.994 . . . . 0.0 109.167 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.84 4.29 84.99 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -86.2 138.81 31.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.219 -1.165 . . . . 0.0 108.725 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -83.43 150.14 26.23 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.6 p -148.85 137.14 21.01 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.847 -1.158 . . . . 0.0 110.526 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -102.09 152.49 20.93 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -127.22 116.34 20.45 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.424 -0.798 . . . . 0.0 108.88 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.81 139.61 73.82 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.03 -1.044 . . . . 0.0 109.549 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -83.34 25.31 0.69 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.121 1.88 . . . . 0.0 112.63 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -88.63 -68.13 0.79 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.919 -1.113 . . . . 0.0 108.709 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 p -116.19 -25.28 7.65 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.88 23.0 4.44 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -75.45 177.96 6.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.031 -1.276 . . . . 0.0 109.103 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.44 165.3 23.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.395 -0.815 . . . . 0.0 109.621 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -135.74 115.07 12.52 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.95 119.53 6.42 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.15 -68.87 0.78 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.269 -1.136 . . . . 0.0 109.142 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 166.78 -165.97 38.78 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.932 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -100.7 6.27 43.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.468 -1.019 . . . . 0.0 109.312 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -94.99 98.63 10.82 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.343 -0.848 . . . . 0.0 110.271 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -54.9 -14.9 1.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.529 0.68 . . . . 0.0 109.291 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.54 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.0 OUTLIER -77.33 -54.77 6.06 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.355 -0.84 . . . . 0.0 109.509 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.7 mt -76.99 -32.89 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.342 -0.849 . . . . 0.0 109.658 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.71 -55.68 24.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.078 -1.014 . . . . 0.0 109.38 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mt -55.72 -39.44 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.059 -1.026 . . . . 0.0 109.254 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -51.15 -54.4 25.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.096 -1.003 . . . . 0.0 109.172 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -63.95 -41.63 97.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 0.0 109.605 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.9 -42.68 76.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.618 -0.676 . . . . 0.0 110.191 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.04 -58.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.079 -1.013 . . . . 0.0 110.911 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -58.82 -24.28 61.75 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.984 -1.073 . . . . 0.0 109.098 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.07 -35.34 80.26 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.166 -0.959 . . . . 0.0 108.445 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -67.18 -38.66 85.77 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.395 -0.816 . . . . 0.0 109.372 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.7 mt -70.47 -31.48 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.155 -0.965 . . . . 0.0 108.935 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -69.65 -21.6 63.53 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -57.36 -32.83 67.15 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -75.79 5.87 5.74 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.4 t 52.15 17.31 0.68 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.415 -0.803 . . . . 0.0 109.681 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.25 -158.23 25.45 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.4 p80 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.297 -1.119 . . . . 0.0 109.307 -179.823 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' PRO . 72.4 mt -82.32 150.76 64.7 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 109.079 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 12' ' ' LEU . 75.8 Cg_exo -34.94 157.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 122.555 2.17 . . . . 0.0 111.844 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.22 148.33 84.74 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.104 1.869 . . . . 0.0 111.582 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 61.88 32.63 17.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -0.829 . . . . 0.0 109.929 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.0 tp -140.23 130.09 24.6 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.354 -0.841 . . . . 0.0 108.818 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -129.63 -172.32 2.73 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.717 0.77 . . . . 0.0 110.059 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.523 HD12 ' CE1' ' A' ' 24' ' ' TYR . 14.9 tt -142.94 152.04 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.398 0.618 . . . . 0.0 109.617 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.426 HH11 ' HG3' ' A' ' 19' ' ' ARG . 19.3 ttm-85 -90.84 160.3 15.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.542 -0.724 . . . . 0.0 109.527 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -64.28 -14.75 57.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 108.994 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -90.12 -0.47 57.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.329 -0.857 . . . . 0.0 108.997 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.57 11.94 65.41 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -87.06 129.72 34.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.096 -1.237 . . . . 0.0 108.476 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.523 ' CE1' HD12 ' A' ' 18' ' ' ILE . 54.2 m-85 -83.11 147.91 27.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.456 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 18.7 p -150.49 131.46 14.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.099 -1.001 . . . . 0.0 109.861 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -97.21 149.35 22.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.294 -0.878 . . . . 0.0 109.286 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.424 HH21 ' CG ' ' A' ' 34' ' ' GLU . 25.8 ttm180 -115.93 116.58 28.21 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.341 -0.85 . . . . 0.0 110.224 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -74.27 138.28 75.17 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.455 -0.778 . . . . 0.0 108.988 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.92 -2.51 12.17 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.136 1.891 . . . . 0.0 112.516 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -88.18 -55.12 3.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.084 -1.01 . . . . 0.0 109.704 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -102.82 -1.06 30.44 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.41 -0.806 . . . . 0.0 109.124 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.3 4.96 2.97 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.485 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -72.96 179.4 3.75 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.157 -1.202 . . . . 0.0 109.124 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 20.8 mp0 -114.94 168.39 9.95 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.47 -0.769 . . . . 0.0 109.926 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -138.96 114.39 9.71 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.69 125.14 9.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.6 mt -105.17 -50.17 3.3 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.384 -1.068 . . . . 0.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.91 -155.37 26.22 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.807 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -110.53 7.08 22.43 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.435 -1.038 . . . . 0.0 109.411 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -93.09 101.86 14.17 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.345 -0.847 . . . . 0.0 110.252 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.418 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 38.1 ttm180 -58.6 -20.08 44.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.685 -0.634 . . . . 0.0 109.477 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -75.38 -52.19 11.34 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.12 -33.33 24.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.517 -0.739 . . . . 0.0 109.621 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.32 -58.82 5.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.187 -0.945 . . . . 0.0 109.517 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 50.5 mt -53.94 -36.73 31.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.075 -1.015 . . . . 0.0 109.13 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.54 -50.95 66.69 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 109.345 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -61.28 -40.36 93.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.482 -0.761 . . . . 0.0 109.601 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.99 -43.95 74.03 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.413 -0.804 . . . . 0.0 109.117 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.16 -46.07 95.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.09 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -59.1 -38.65 80.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.929 -1.107 . . . . 0.0 108.584 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.71 92.26 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -69.06 -39.08 79.33 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.45 -0.781 . . . . 0.0 109.385 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.7 mt -70.93 -26.66 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.54 -33.4 74.98 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.25 -29.06 65.48 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -108.03 8.04 28.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.41 -0.807 . . . . 0.0 109.409 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.6 p -151.89 75.01 1.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.921 . . . . 0.0 109.376 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.1 95.37 0.11 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 68.8 m80 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.247 -1.149 . . . . 0.0 109.51 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 13' ' ' PRO . 39.4 mt -83.4 148.22 55.0 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.31 -0.868 . . . . 0.0 109.567 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 12' ' ' LEU . 98.7 Cg_exo -35.92 158.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.656 2.237 . . . . 0.0 111.737 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.486 ' C ' ' H ' ' A' ' 16' ' ' LEU . 65.8 Cg_endo -72.63 158.87 49.99 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.352 2.035 . . . . 0.0 112.214 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 59.71 1.25 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.794 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 14' ' ' PRO . 41.5 tp -108.34 136.91 47.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -132.56 -178.49 4.95 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.961 0.886 . . . . 0.0 110.511 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.788 HD12 ' CE1' ' A' ' 24' ' ' TYR . 13.5 tt -143.09 143.59 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 -89.58 169.16 11.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.409 -0.807 . . . . 0.0 109.852 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.592 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -66.86 -12.48 59.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.352 -0.843 . . . . 0.0 109.573 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -88.25 -1.56 58.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.092 -1.005 . . . . 0.0 108.989 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.31 10.04 78.36 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -88.22 130.72 35.0 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.06 -1.259 . . . . 0.0 108.732 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.788 ' CE1' HD12 ' A' ' 18' ' ' ILE . 58.0 m-85 -85.21 148.31 26.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.885 . . . . 0.0 109.789 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.432 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 20.5 p -151.32 130.02 12.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.208 -0.933 . . . . 0.0 109.547 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 48.1 t80 -95.09 162.02 13.89 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.264 -0.897 . . . . 0.0 109.218 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.531 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 28.9 ttm180 -125.78 117.69 23.94 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.518 -0.739 . . . . 0.0 109.437 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -73.22 148.73 88.88 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.381 -0.824 . . . . 0.0 109.673 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -84.6 -16.52 5.59 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.405 2.07 . . . . 0.0 112.14 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -92.18 -40.66 10.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.334 -0.854 . . . . 0.0 110.092 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.548 ' C ' ' H ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -100.49 -13.35 18.71 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.158 -0.964 . . . . 0.0 109.349 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.48 -7.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -75.25 -166.09 0.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.885 -1.362 . . . . 0.0 108.734 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 27' ' ' ARG . 68.1 mt-10 -129.64 169.98 14.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.438 -0.789 . . . . 0.0 110.507 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -136.55 122.03 19.51 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.13 122.73 8.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 mt -104.85 -55.52 2.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.384 -1.068 . . . . 0.0 109.632 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.1 179.45 25.91 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 39' ' ' ARG . 2.2 mtm-85 -88.04 4.87 43.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.447 -1.031 . . . . 0.0 109.494 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -94.38 99.19 11.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -0.785 . . . . 0.0 109.545 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.514 HH12 ' HE ' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -62.17 -8.56 5.78 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.514 ' HE ' HH12 ' A' ' 41' ' ' ARG . 19.6 mmt180 -72.88 -56.98 4.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 95.4 mt -77.32 -34.0 20.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.326 0.584 . . . . 0.0 109.572 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -56.81 12.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.657 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.9 mt -56.1 -37.16 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.39 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.17 -52.64 62.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.01 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -63.11 -45.8 90.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.548 -0.72 . . . . 0.0 109.742 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.18 65.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.601 -0.687 . . . . 0.0 109.806 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.3 mt -61.78 -42.34 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.068 -1.02 . . . . 0.0 110.024 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.05 -35.08 74.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.906 -1.121 . . . . 0.0 109.012 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.77 -34.43 77.89 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -69.31 -35.65 76.19 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.463 -0.773 . . . . 0.0 109.62 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.7 mt -69.72 -34.13 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -33.92 75.93 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.86 -30.28 67.59 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.497 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -94.1 -2.47 52.73 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 m -153.61 70.36 0.84 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 109.058 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.98 40.13 0.07 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.452 ' ND1' ' N ' ' A' ' 59' ' ' HIS . 4.2 p-80 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.267 -1.137 . . . . 0.0 109.521 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 121.722 0.772 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 49.0 mt -80.83 148.69 65.61 Favored Pre-proline 0 C--N 1.297 -1.714 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.28 161.54 23.01 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.819 1.679 . . . . 0.0 111.273 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 16' ' ' LEU . 49.6 Cg_endo -67.35 155.12 71.77 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.626 2.218 . . . . 0.0 112.252 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.517 ' ND2' ' OD1' ' A' ' 52' ' ' ASN . 2.7 m-20 73.34 -15.83 0.52 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.652 -0.655 . . . . 0.0 110.193 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.411 ' H ' ' C ' ' A' ' 14' ' ' PRO . 11.6 tp -102.21 139.52 37.71 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.098 -1.001 . . . . 0.0 109.009 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -123.68 -170.27 2.1 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.714 0.769 . . . . 0.0 109.948 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.97 133.99 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.467 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 13.1 mtm180 -91.11 152.41 20.62 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.0 -1.062 . . . . 0.0 109.906 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -58.21 -11.2 2.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 108.926 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -89.76 0.82 56.76 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.66 4.67 90.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.467 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 5.3 m-85 -86.68 131.13 34.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.259 -1.142 . . . . 0.0 108.715 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.525 ' OH ' ' NE ' ' A' ' 41' ' ' ARG . 78.4 m-85 -82.53 154.13 25.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 108.959 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -150.72 135.63 17.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.022 -1.048 . . . . 0.0 110.088 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 37.6 t80 -106.98 146.99 30.43 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.622 -0.674 . . . . 0.0 109.571 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.42 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 4.8 mtt180 -110.14 125.18 52.75 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.637 -0.664 . . . . 0.0 109.879 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -79.0 112.3 26.61 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.929 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.41 0.82 0.31 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 121.399 1.399 . . . . 0.0 112.687 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -88.66 -52.04 5.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.894 -1.129 . . . . 0.0 109.741 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.94 -11.74 15.62 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.48 -0.762 . . . . 0.0 109.391 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.83 0.06 58.7 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -179.9 3.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.057 -1.261 . . . . 0.0 108.728 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -111.34 168.22 9.69 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.504 -0.748 . . . . 0.0 109.701 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -138.56 114.27 9.85 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.02 127.54 18.52 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.5 mt -107.8 -49.73 3.18 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.588 -0.948 . . . . 0.0 109.249 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.9 -174.28 23.22 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -91.01 11.38 23.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -1.228 . . . . 0.0 108.879 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -91.21 95.91 10.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.432 -0.792 . . . . 0.0 110.327 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' ' OH ' ' A' ' 24' ' ' TYR . 38.8 ttm180 -57.01 -19.04 16.19 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -77.0 -51.99 10.14 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.523 -0.736 . . . . 0.0 109.34 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt -77.13 -31.62 18.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.64 -0.663 . . . . 0.0 109.682 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.52 -58.74 4.59 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.098 -1.001 . . . . 0.0 109.49 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.1 mt -54.22 -35.12 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.095 -1.003 . . . . 0.0 109.003 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.08 -50.77 66.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 0.0 108.968 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -61.07 -41.07 95.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.2 87.3 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.441 0.639 . . . . 0.0 109.751 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.81 -62.46 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.39 -0.819 . . . . 0.0 110.78 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -56.93 -30.01 63.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 108.683 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.61 -41.59 83.78 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.517 ' OD1' ' ND2' ' A' ' 15' ' ' ASN . 84.0 m-20 -68.97 -39.96 79.11 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.423 -0.798 . . . . 0.0 109.775 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.34 -36.99 78.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.207 -0.933 . . . . 0.0 108.494 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 58' ' ' GLY . 84.2 mt-10 -70.84 -34.85 72.1 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.1 mt -67.86 -13.28 62.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.128 -0.983 . . . . 0.0 109.008 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -104.34 -4.43 22.91 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.6 t -164.54 39.13 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.937 . . . . 0.0 109.271 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . -84.08 3.27 86.3 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 26.6 m80 . . . . . 0 N--CA 1.488 1.463 0 O-C-N 121.17 -1.194 . . . . 0.0 109.508 179.957 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 121.368 0.604 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.6 mt -85.2 149.01 51.64 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.411 -0.805 . . . . 0.0 109.275 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.99 164.15 5.17 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.592 1.528 . . . . 0.0 110.986 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.93 160.95 46.22 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.526 2.151 . . . . 0.0 112.286 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 59.96 19.61 8.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 110.088 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.9 tp -133.83 118.04 17.53 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -114.71 178.44 4.28 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.383 0.611 . . . . 0.0 109.824 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.701 HD12 ' CE1' ' A' ' 24' ' ' TYR . 10.1 tt -141.48 148.06 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.59 -0.694 . . . . 0.0 109.552 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -91.01 153.35 20.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.595 -0.69 . . . . 0.0 109.58 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -56.73 -11.52 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.173 -0.954 . . . . 0.0 108.989 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -88.56 -0.79 57.61 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.355 -0.841 . . . . 0.0 109.042 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.27 9.09 80.39 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -86.67 128.05 34.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -1.143 . . . . 0.0 108.45 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.701 ' CE1' HD12 ' A' ' 18' ' ' ILE . 50.6 m-85 -84.22 149.49 26.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.475 -0.766 . . . . 0.0 109.851 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.0 p -150.11 131.73 14.89 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.116 -0.99 . . . . 0.0 109.632 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -94.36 140.8 29.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.08 -1.012 . . . . 0.0 110.004 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.427 HH11 ' HG2' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -101.94 110.72 22.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.593 -0.692 . . . . 0.0 110.218 -179.332 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.99 135.96 66.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.443 -0.786 . . . . 0.0 109.951 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -81.72 15.26 1.97 Allowed 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.008 1.805 . . . . 0.0 111.621 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -86.65 -69.79 0.65 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.345 -0.847 . . . . 0.0 109.213 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.4 -18.64 14.05 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.33 6.66 58.64 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.533 ' H ' ' CD ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -76.61 -174.43 2.95 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.85 -1.382 . . . . 0.0 109.338 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 4.5 mp0 -130.77 157.11 43.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.309 -0.869 . . . . 0.0 110.229 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -116.35 127.96 55.12 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.57 116.35 4.36 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 mt -99.08 -63.8 1.09 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.192 -1.181 . . . . 0.0 109.238 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.29 -173.01 38.53 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -92.99 8.7 38.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 108.98 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -94.23 104.24 16.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.386 -0.821 . . . . 0.0 109.82 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -60.22 -20.76 60.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.663 -0.648 . . . . 0.0 109.721 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -77.05 -55.81 5.13 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.211 -0.931 . . . . 0.0 109.074 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 43' ' ' ILE . 27.3 mt -65.81 -36.56 77.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.538 -0.727 . . . . 0.0 109.198 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.13 -56.87 9.26 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.341 -0.85 . . . . 0.0 109.274 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mt -53.58 -37.4 30.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.171 -0.956 . . . . 0.0 108.67 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.42 -55.12 31.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.07 -1.019 . . . . 0.0 109.147 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -63.3 -43.96 96.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.347 -0.846 . . . . 0.0 109.658 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.68 75.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.526 -0.734 . . . . 0.0 109.645 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.9 mt -59.64 -40.25 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.059 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -62.11 -43.78 98.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.951 -1.093 . . . . 0.0 108.478 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.89 -33.83 76.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -64.23 -36.07 82.88 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.296 -0.877 . . . . 0.0 109.333 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.39 -25.96 32.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 108.684 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.573 ' O ' ' N ' ' A' ' 58' ' ' GLY . 96.8 mt-10 -70.39 -29.84 66.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.309 -0.869 . . . . 0.0 109.19 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 55' ' ' LEU . 4.0 mm? -64.91 -14.72 60.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.879 -1.138 . . . . 0.0 109.046 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -99.29 6.95 46.05 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.276 -0.89 . . . . 0.0 110.329 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.7 t -170.5 -32.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.824 -1.172 . . . . 0.0 110.01 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . 73.32 97.71 0.08 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.227 -1.16 . . . . 0.0 109.211 -179.83 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.1 mt -79.83 149.5 70.77 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.61 159.29 28.69 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.675 1.584 . . . . 0.0 111.171 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 15' ' ' ASN . 59.3 Cg_endo -69.69 154.54 67.91 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.376 2.051 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.505 ' ND2' ' OD1' ' A' ' 52' ' ' ASN . 3.6 m-20 74.19 -10.49 1.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.641 -0.662 . . . . 0.0 109.326 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.1 tt -105.27 148.46 26.97 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.369 -0.832 . . . . 0.0 110.121 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -137.31 -168.85 2.38 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.452 0.644 . . . . 0.0 109.408 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.2 tt -146.53 150.95 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.268 -0.895 . . . . 0.0 109.479 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -92.71 150.39 20.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.183 -0.948 . . . . 0.0 109.363 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -59.81 -10.91 4.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.29 -0.881 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -90.5 -0.16 57.56 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.48 10.45 70.58 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -87.14 136.17 33.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.055 -1.262 . . . . 0.0 108.495 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -84.22 152.97 23.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.356 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -154.86 145.81 22.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 110.305 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -108.99 155.45 20.87 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -131.72 120.24 22.46 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.231 -0.918 . . . . 0.0 109.868 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.08 134.41 71.18 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.633 -0.827 . . . . 0.0 108.796 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.24 24.37 0.65 Allowed 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.0 1.8 . . . . 0.0 113.055 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -88.96 -67.25 0.85 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.806 -1.184 . . . . 0.0 108.612 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.448 HG21 ' HZ1' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -112.78 -16.25 12.79 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.77 29.58 6.14 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -77.81 178.9 7.03 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.273 -1.133 . . . . 0.0 109.506 179.706 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -131.38 163.93 26.81 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.316 -0.865 . . . . 0.0 110.614 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -139.36 113.22 8.6 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.52 128.07 14.92 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.8 mt -105.89 -57.75 2.0 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.379 -1.071 . . . . 0.0 109.409 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.32 -157.82 28.93 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.412 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -107.79 1.88 23.2 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.503 -0.998 . . . . 0.0 110.189 -179.487 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.33 107.37 19.86 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.049 -1.032 . . . . 0.0 110.135 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -61.0 -15.46 32.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.126 -0.984 . . . . 0.0 109.345 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.437 ' HD2' ' H ' ' A' ' 42' ' ' ARG . 7.0 mpt_? -74.31 -55.0 6.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.262 -0.899 . . . . 0.0 108.862 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.3 mt -73.31 -35.82 47.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.702 -0.799 . . . . 0.0 109.357 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.82 -57.09 10.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.019 -1.05 . . . . 0.0 109.244 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -51.36 -40.48 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 109.278 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.29 -57.31 10.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.104 -0.997 . . . . 0.0 109.668 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.94 -36.01 74.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.389 -0.819 . . . . 0.0 109.473 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.47 -44.61 76.6 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.559 -0.856 . . . . 0.0 108.808 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.85 -45.06 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.232 -0.917 . . . . 0.0 110.312 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -61.84 -40.36 95.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.145 -0.972 . . . . 0.0 108.84 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.93 88.57 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.505 ' OD1' ' ND2' ' A' ' 15' ' ' ASN . 85.2 m-20 -70.0 -43.58 71.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.4 -0.813 . . . . 0.0 109.996 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.8 mt -68.05 -36.95 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.897 . . . . 0.0 109.351 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -70.47 -19.1 62.97 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.268 -0.895 . . . . 0.0 109.051 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.53 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -61.38 -44.47 97.1 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -89.48 2.72 54.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -0.915 . . . . 0.0 109.56 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.7 m -152.47 71.74 0.95 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.162 -0.961 . . . . 0.0 109.757 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.505 ' C ' ' CG ' ' A' ' 59' ' ' HIS . . . -92.91 128.36 9.4 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.505 ' CG ' ' C ' ' A' ' 58' ' ' GLY . 8.3 p-80 . . . . . 0 N--CA 1.499 1.979 0 O-C-N 121.486 -1.009 . . . . 0.0 109.841 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 70.2 mt -84.39 149.12 54.26 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 108.908 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.46 157.44 41.21 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.611 1.541 . . . . 0.0 111.288 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.528 ' C ' ' H ' ' A' ' 16' ' ' LEU . 45.3 Cg_endo -67.18 165.17 27.53 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.455 2.104 . . . . 0.0 111.913 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 62.58 -10.78 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.796 . . . . 0.0 110.531 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.528 ' H ' ' C ' ' A' ' 14' ' ' PRO . 6.1 tt -104.26 154.22 20.05 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.159 -0.963 . . . . 0.0 109.815 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -138.3 -178.34 5.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.548 -0.72 . . . . 0.0 110.186 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.86 137.17 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.452 ' C ' ' N ' ' A' ' 21' ' ' ASN . 9.3 mtp180 -90.59 141.33 28.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.204 -0.935 . . . . 0.0 109.422 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -50.83 -13.46 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.359 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.629 ' N ' HD22 ' A' ' 21' ' ' ASN . 1.0 OUTLIER -89.78 0.03 57.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.482 -0.761 . . . . 0.0 109.014 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.43 10.27 82.24 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -88.58 130.78 35.18 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.315 -1.109 . . . . 0.0 108.486 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -85.48 144.18 28.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.485 -0.759 . . . . 0.0 109.308 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 m -149.33 140.2 22.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.187 -0.945 . . . . 0.0 109.753 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -101.84 143.96 31.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.348 -0.845 . . . . 0.0 109.57 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -112.12 116.63 30.81 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.408 -0.807 . . . . 0.0 109.782 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -74.34 126.69 88.71 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.337 -0.852 . . . . 0.0 108.994 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.07 -9.1 16.66 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.986 1.791 . . . . 0.0 112.103 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -89.72 -32.49 16.99 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.9 p -110.99 -27.16 8.9 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 82.44 -10.61 54.55 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.485 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 3.0 mptp? -73.38 -174.05 1.54 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.939 -1.33 . . . . 0.0 109.885 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -120.96 169.32 10.59 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.578 -0.701 . . . . 0.0 110.303 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -137.37 115.61 11.76 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.55 120.69 8.39 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.7 mt -103.74 -62.87 1.25 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.504 -0.998 . . . . 0.0 108.877 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.21 -171.74 34.01 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 -93.61 8.41 40.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -1.146 . . . . 0.0 109.112 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -91.96 97.1 10.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 109.58 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -56.27 -23.13 34.35 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.455 0.645 . . . . 0.0 109.528 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -74.85 -47.55 29.72 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.341 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.19 -33.64 18.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.39 -0.819 . . . . 0.0 109.591 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.79 -58.62 5.23 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 109.326 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -54.6 -36.68 36.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.214 -0.929 . . . . 0.0 109.0 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -53.85 -56.89 13.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.091 -1.006 . . . . 0.0 109.12 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -60.19 -40.85 91.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.613 -0.679 . . . . 0.0 109.497 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.53 -44.51 62.64 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.0 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 91.3 mt -61.7 -45.15 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.337 -0.852 . . . . 0.0 109.619 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -64.02 -33.76 76.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.065 -1.022 . . . . 0.0 108.361 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.99 -33.36 75.4 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.35 -42.38 88.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 109.6 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.53 -35.91 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.177 -0.952 . . . . 0.0 108.728 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -69.22 -20.18 63.96 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.47 ' O ' HD23 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -57.73 -47.57 82.04 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -79.55 9.12 5.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.24 -0.912 . . . . 0.0 109.041 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t 59.02 22.39 10.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.442 -0.786 . . . . 0.0 109.834 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.29 -167.2 53.36 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.329 -1.101 . . . . 0.0 109.502 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 8.4 p-10 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.239 0.542 . . . . 0.0 109.633 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 13' ' ' PRO . 46.3 mt -82.17 150.13 63.87 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 109.688 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 12' ' ' LEU . 33.7 Cg_exo -34.31 158.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.709 2.273 . . . . 0.0 112.246 178.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.62 159.22 54.51 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.113 1.876 . . . . 0.0 112.067 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 53.55 19.95 1.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.458 -0.776 . . . . 0.0 110.176 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.5 tp -127.21 125.13 40.5 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 43.0 m-85 -121.63 -170.69 2.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.81 0.814 . . . . 0.0 110.487 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -127.77 141.61 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.474 ' H ' HD13 ' A' ' 18' ' ' ILE . 24.9 ttm180 -91.95 144.54 25.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.061 -1.025 . . . . 0.0 109.281 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -54.15 -19.02 4.36 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 109.857 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -86.81 0.68 54.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.18 3.21 79.37 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.463 ' CE1' ' NE ' ' A' ' 39' ' ' ARG . 12.5 m-85 -85.15 140.08 31.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.072 -1.252 . . . . 0.0 109.055 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -84.79 146.94 27.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.434 -0.791 . . . . 0.0 108.966 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 20.2 p -146.46 129.77 16.69 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.873 -1.142 . . . . 0.0 110.32 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 27' ' ' ARG . 43.2 t80 -99.37 148.73 23.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.451 -0.781 . . . . 0.0 109.007 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.406 ' O ' ' CE1' ' A' ' 26' ' ' TYR . 23.2 ttm180 -104.43 117.57 34.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.489 -0.757 . . . . 0.0 109.533 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.52 150.67 95.6 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.294 -0.878 . . . . 0.0 109.623 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -85.52 -8.14 8.53 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.623 2.216 . . . . 0.0 112.996 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -90.48 -47.09 7.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.04 -1.037 . . . . 0.0 110.671 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.2 p -109.01 -11.6 14.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 109.818 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.39 2.12 25.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -179.12 3.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -1.204 . . . . 0.0 108.915 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -109.94 168.92 9.06 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.564 -0.71 . . . . 0.0 109.56 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -140.54 119.07 12.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.442 -0.786 . . . . 0.0 109.269 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.79 122.88 12.36 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.2 mt -107.06 -44.3 4.42 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.412 -1.052 . . . . 0.0 109.069 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 147.18 -179.8 23.82 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.463 ' NE ' ' CE1' ' A' ' 23' ' ' TYR . 18.6 mtt180 -92.78 10.71 29.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -1.088 . . . . 0.0 108.403 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -95.96 105.47 17.5 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.453 0.645 . . . . 0.0 110.116 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -60.74 -19.36 58.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 109.347 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -71.4 -58.78 3.2 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.388 -0.82 . . . . 0.0 109.234 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 94.1 mt -68.94 -37.3 77.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.676 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.12 -56.72 11.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.031 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 79.3 mt -54.63 -33.38 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.806 -1.184 . . . . 0.0 109.372 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -58.3 -51.59 69.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.653 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -61.92 -44.91 95.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.278 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.51 -43.33 79.67 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.49 -0.756 . . . . 0.0 110.85 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.9 -52.83 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.017 -1.052 . . . . 0.0 111.624 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -60.12 -29.6 68.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.83 -1.169 . . . . 0.0 109.492 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.51 -33.76 75.74 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.238 -0.914 . . . . 0.0 109.028 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -69.48 -38.66 77.8 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.306 -0.871 . . . . 0.0 110.897 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt -67.99 -35.45 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.158 -0.963 . . . . 0.0 109.702 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.403 ' C ' ' H ' ' A' ' 56' ' ' PHE . 98.5 mt-10 -70.1 -27.24 64.43 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.25 -0.906 . . . . 0.0 109.606 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mt -63.51 -1.82 1.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 109.179 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.403 ' H ' ' C ' ' A' ' 54' ' ' GLU . 95.2 m-85 -142.57 4.2 1.53 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.354 -0.842 . . . . 0.0 109.319 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.1 m -144.01 46.08 1.45 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.187 -0.945 . . . . 0.0 109.539 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.52 -50.54 1.83 Allowed Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.35 -1.088 . . . . 0.0 109.578 179.966 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.302 0.572 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.84 151.44 61.03 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.243 -0.911 . . . . 0.0 109.073 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.32 158.42 48.94 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.027 1.818 . . . . 0.0 111.181 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 16' ' ' LEU . 37.4 Cg_endo -64.6 170.89 9.1 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.533 2.155 . . . . 0.0 112.308 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 52.75 9.12 0.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.847 . . . . 0.0 109.824 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 14' ' ' PRO . 9.2 tt -133.84 137.53 45.1 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.373 -0.829 . . . . 0.0 109.427 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 12.8 m-85 -138.2 -157.07 0.74 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.57 0.7 . . . . 0.0 109.647 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.6 tt -145.39 153.2 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.669 0.747 . . . . 0.0 110.335 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 21' ' ' ASN . 34.5 ttp180 -94.22 153.55 18.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.631 -0.668 . . . . 0.0 109.708 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.479 ' O ' ' ND2' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -56.23 -8.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.931 . . . . 0.0 109.069 179.638 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.433 ' H ' ' C ' ' A' ' 19' ' ' ARG . 19.1 m-20 -90.37 -3.14 57.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.29 -0.881 . . . . 0.0 108.988 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.77 7.09 78.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -88.02 140.06 29.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.438 -1.037 . . . . 0.0 109.291 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -85.77 152.92 22.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 109.372 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.2 p -150.91 138.24 19.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.153 -0.967 . . . . 0.0 109.976 -179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -100.59 146.73 26.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.304 -0.873 . . . . 0.0 109.342 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -105.06 111.84 24.75 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.467 -0.771 . . . . 0.0 109.654 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.74 125.7 90.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 108.767 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.75 -6.42 15.22 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.803 1.669 . . . . 0.0 112.819 -179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 30' ' ' ARG . 6.8 ptp180 -89.15 -28.77 19.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.973 -1.08 . . . . 0.0 109.345 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.7 t -116.22 -28.44 6.55 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.33 -13.15 62.64 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 8.6 mptt -77.07 -178.93 5.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.041 -1.27 . . . . 0.0 109.886 -179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' CD ' ' N ' ' A' ' 34' ' ' GLU . 9.6 mp0 -108.88 174.62 5.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.599 -0.688 . . . . 0.0 110.184 -179.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -138.16 123.93 19.91 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.42 130.89 21.56 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.5 mt -118.45 -55.97 2.18 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.554 -0.968 . . . . 0.0 109.572 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 146.46 -171.94 27.15 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.838 ' H ' ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -95.14 10.49 35.7 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.164 -1.198 . . . . 0.0 109.155 179.971 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.464 ' C ' ' N ' ' A' ' 42' ' ' ARG . 93.7 m-20 -91.73 90.68 7.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.364 -0.835 . . . . 0.0 109.494 -179.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -54.7 -12.54 0.78 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' C ' ' A' ' 40' ' ' ASP . 5.7 mtt180 -73.42 -56.87 4.48 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.627 -0.671 . . . . 0.0 109.587 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.3 mt -75.18 -36.95 38.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.17 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.6 -57.54 9.79 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.55 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 88.5 mt -55.88 -41.09 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.542 -1.349 . . . . 0.0 108.564 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -55.98 -56.71 17.41 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.469 -0.769 . . . . 0.0 109.592 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -27.56 66.4 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.216 -0.928 . . . . 0.0 109.186 -179.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 45' ' ' ILE . . . -63.87 -48.13 77.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -0.893 . . . . 0.0 108.748 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.75 -51.17 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.573 -0.704 . . . . 0.0 110.21 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -58.65 -37.1 75.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.947 -1.096 . . . . 0.0 108.179 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -38.29 88.41 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.24 -40.93 81.85 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.513 -0.742 . . . . 0.0 109.256 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.0 mt -71.05 -41.56 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 108.54 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -71.85 -19.25 61.99 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.634 -0.666 . . . . 0.0 109.435 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.7 tp -59.5 -29.4 67.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.116 -0.99 . . . . 0.0 108.782 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -85.16 8.23 18.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.821 . . . . 0.0 108.868 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.4 m 52.94 14.22 0.43 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 0.0 109.435 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.33 90.07 0.14 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.494 ' N ' ' CD2' ' A' ' 59' ' ' HIS . 4.9 m170 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.15 -1.206 . . . . 0.0 109.448 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.4 t70 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 68.0 mt -82.95 149.08 58.57 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.913 . . . . 0.0 109.272 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.01 162.68 18.51 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.111 1.874 . . . . 0.0 111.872 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.97 168.3 20.91 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.913 2.409 . . . . 0.0 112.684 -179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 48.19 22.5 0.43 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.529 -0.732 . . . . 0.0 110.302 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.444 ' C ' ' CD1' ' A' ' 17' ' ' TYR . 5.1 tt -136.05 146.08 46.72 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.217 -0.927 . . . . 0.0 109.166 179.099 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 32.0 m-85 -137.34 -172.77 3.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.546 -0.721 . . . . 0.0 110.342 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.9 tt -139.14 150.91 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -91.19 164.23 13.98 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.277 -0.889 . . . . 0.0 109.926 -178.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -66.4 -16.81 64.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.051 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -89.41 0.08 57.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.366 -0.834 . . . . 0.0 108.789 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.13 14.83 63.65 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -87.2 134.65 33.51 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.117 -1.225 . . . . 0.0 108.702 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.495 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 12.9 m-85 -83.73 156.24 22.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.109 -0.995 . . . . 0.0 109.671 -179.715 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 24' ' ' TYR . 94.6 m -156.14 135.31 12.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.51 -0.744 . . . . 0.0 109.636 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -100.22 141.42 33.08 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.138 -0.976 . . . . 0.0 109.364 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -107.34 113.79 27.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.501 -0.749 . . . . 0.0 109.673 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -71.44 132.91 85.38 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.42 -0.8 . . . . 0.0 109.645 -179.904 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.59 -5.51 12.49 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.198 1.932 . . . . 0.0 112.375 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -88.5 -37.79 15.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.202 -0.936 . . . . 0.0 109.628 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 33' ' ' LYS . 2.5 t -113.11 -29.93 7.15 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.496 -0.753 . . . . 0.0 109.069 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.3 -10.08 74.95 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.168 -0.958 . . . . 0.0 110.929 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.476 ' H ' HG23 ' A' ' 31' ' ' THR . 9.7 mptt -74.73 179.36 4.84 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.902 -1.352 . . . . 0.0 109.61 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -117.47 171.73 7.8 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.666 0.746 . . . . 0.0 110.661 -178.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.94 122.65 18.69 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.55 122.94 8.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.5 mt -106.59 -70.09 0.8 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.478 -1.013 . . . . 0.0 109.398 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.25 -174.09 44.86 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -93.9 6.66 47.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -1.137 . . . . 0.0 109.522 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -95.41 98.87 10.88 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 109.489 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.535 HH11 ' CG ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -58.34 -13.14 4.61 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 108.498 179.606 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -74.38 -49.57 22.13 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 89.4 mt -78.54 -36.87 20.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.39 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.85 -57.51 8.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.232 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -54.38 -37.13 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.12 -0.988 . . . . 0.0 109.287 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -54.54 -58.15 8.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 108.895 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -60.9 -37.33 81.83 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.576 0.703 . . . . 0.0 109.132 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.13 -42.61 81.26 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.59 -0.694 . . . . 0.0 109.17 179.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 82.3 mt -61.62 -45.87 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.203 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -58.89 -32.69 69.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.054 -1.029 . . . . 0.0 108.686 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.52 91.32 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -67.78 -41.43 83.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.853 . . . . 0.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.4 mp -70.81 -37.5 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -73.15 -20.52 60.89 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.378 -0.826 . . . . 0.0 109.416 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 40.8 tp -60.1 -18.63 48.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 0.0 109.258 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -89.04 0.9 56.29 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.794 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 59' ' ' HIS . 7.4 t -173.68 52.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.449 -0.782 . . . . 0.0 109.198 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.87 -1.52 3.83 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 57' ' ' SER . 11.7 m170 . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.244 -1.151 . . . . 0.0 109.479 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.07 151.09 56.63 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.399 -0.813 . . . . 0.0 109.299 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -38.31 156.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.264 1.976 . . . . 0.0 111.903 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.26 147.83 83.88 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.212 1.942 . . . . 0.0 112.131 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 65.59 -1.83 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.608 -0.682 . . . . 0.0 110.38 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.9 tt -105.87 139.09 40.97 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.146 -0.972 . . . . 0.0 110.103 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -140.63 -168.44 2.57 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.72 0.772 . . . . 0.0 109.574 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.727 HD12 ' CE1' ' A' ' 24' ' ' TYR . 8.4 tt -146.25 146.22 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.585 -0.697 . . . . 0.0 109.683 178.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 21' ' ' ASN . 19.8 mtm180 -91.65 152.8 20.07 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.355 -0.841 . . . . 0.0 109.571 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -53.46 -11.15 0.3 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.236 -0.915 . . . . 0.0 109.163 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.433 ' H ' ' C ' ' A' ' 19' ' ' ARG . 47.6 m-20 -87.75 1.39 53.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 109.254 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.13 6.56 89.12 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -86.53 126.68 34.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.066 -1.255 . . . . 0.0 108.692 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.727 ' CE1' HD12 ' A' ' 18' ' ' ILE . 57.6 m-85 -82.69 148.93 27.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 109.37 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 p -148.62 144.8 27.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.201 -0.937 . . . . 0.0 109.822 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 27' ' ' ARG . 36.6 t80 -105.98 148.23 27.93 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.46 ' NE ' ' O ' ' A' ' 32' ' ' GLY . 15.0 ttm180 -110.01 121.11 44.5 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.463 -0.773 . . . . 0.0 110.675 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -75.72 136.87 70.38 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.333 -0.854 . . . . 0.0 108.857 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.59 6.02 5.15 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.035 1.823 . . . . 0.0 112.252 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -89.8 -56.6 3.17 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 0.0 110.131 -179.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.17 1.5 13.87 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.38 -0.825 . . . . 0.0 109.474 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.46 ' O ' ' NE ' ' A' ' 27' ' ' ARG . . . 67.78 13.97 64.55 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -71.79 -174.4 1.16 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.077 -1.249 . . . . 0.0 109.064 179.65 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' N ' ' HD3' ' A' ' 33' ' ' LYS . 5.7 mp0 -130.88 153.07 49.52 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 0.0 109.525 179.186 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -115.76 128.09 55.59 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.5 114.74 3.9 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.5 mt -100.56 -63.04 1.17 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.268 -1.137 . . . . 0.0 109.951 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 159.68 -177.15 36.3 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.471 ' NH1' ' H ' ' A' ' 39' ' ' ARG . 2.7 mtm-85 -89.1 7.37 35.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.071 -1.252 . . . . 0.0 109.997 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -95.61 107.97 20.2 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.147 -0.971 . . . . 0.0 109.361 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -65.61 -20.04 66.15 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 110.081 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -73.08 -48.63 34.17 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.109 -0.995 . . . . 0.0 109.598 -179.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 93.8 mt -76.96 -37.49 26.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.266 -179.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.38 -57.41 8.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 109.804 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.1 mt -53.25 -35.59 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 0.0 109.421 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -51.65 66.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -60.76 -35.64 76.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.859 . . . . 0.0 109.304 -179.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.02 74.2 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.584 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.13 -47.11 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.833 . . . . 0.0 110.398 -179.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -62.29 -41.05 98.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.986 -1.071 . . . . 0.0 108.155 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.68 81.84 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -64.43 -34.1 77.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.098 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 72.3 mt -70.37 -27.83 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 108.73 179.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 58' ' ' GLY . 63.3 mt-10 -68.13 -28.37 67.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.228 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.1 mp -62.45 -15.41 49.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 109.202 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -103.65 -6.55 21.5 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.342 -0.849 . . . . 0.0 109.745 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -163.01 35.84 0.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.015 -1.053 . . . . 0.0 109.81 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 54' ' ' GLU . . . -84.33 146.05 22.5 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.665 ' CD2' ' H ' ' A' ' 59' ' ' HIS . 6.4 p80 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.214 -1.168 . . . . 0.0 109.45 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 121.73 0.776 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.3 mt -81.19 150.18 67.51 Favored Pre-proline 0 C--N 1.299 -1.601 0 O-C-N 121.496 -0.753 . . . . 0.0 109.108 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.64 161.93 16.63 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.947 1.765 . . . . 0.0 111.369 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.19 153.97 73.44 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.733 2.289 . . . . 0.0 112.595 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 67.07 -8.02 0.46 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.73 -0.606 . . . . 0.0 110.826 179.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 tt -107.18 143.34 35.51 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.103 -0.998 . . . . 0.0 110.018 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 28.2 m-85 -137.78 -163.59 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.53 -0.731 . . . . 0.0 109.659 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.46 HD12 ' CE1' ' A' ' 24' ' ' TYR . 12.5 tt -143.08 150.84 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 121.43 0.634 . . . . 0.0 109.775 178.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.41 ' HE ' ' HB2' ' A' ' 23' ' ' TYR . 16.4 ttp180 -91.72 165.46 13.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.43 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -66.39 -13.01 60.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.958 . . . . 0.0 109.334 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -89.18 -0.28 57.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 0.0 109.121 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.99 11.46 73.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.41 ' HB2' ' HE ' ' A' ' 19' ' ' ARG . 10.2 m-85 -87.04 132.22 33.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -1.153 . . . . 0.0 108.609 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.533 ' OH ' ' NH1' ' A' ' 41' ' ' ARG . 44.9 m-85 -83.14 145.9 28.96 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.9 m -148.5 145.2 27.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.919 -1.113 . . . . 0.0 110.804 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -99.3 153.67 18.78 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.54 HH21 ' CD ' ' A' ' 34' ' ' GLU . 20.2 ttm180 -116.51 116.68 28.09 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.278 -0.889 . . . . 0.0 110.366 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -76.34 136.6 68.41 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.272 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.56 -11.48 14.21 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.951 1.768 . . . . 0.0 113.302 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -36.37 16.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.752 -1.217 . . . . 0.0 109.284 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.486 ' C ' ' H ' ' A' ' 33' ' ' LYS . 79.7 p -107.04 -14.78 14.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.81 -2.64 1.83 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -74.1 -169.35 0.76 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -1.162 . . . . 0.0 108.714 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.54 ' CD ' HH21 ' A' ' 27' ' ' ARG . 11.7 mt-10 -128.16 170.0 13.47 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.448 -0.782 . . . . 0.0 110.032 -179.608 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -134.32 124.94 26.65 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.9 122.03 6.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.1 mt -105.48 -49.4 3.44 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.46 -1.023 . . . . 0.0 109.196 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.47 -170.43 31.67 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.461 ' HD3' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -98.38 2.28 47.76 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.319 -1.107 . . . . 0.0 109.245 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -97.01 98.48 10.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.294 -0.879 . . . . 0.0 110.039 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.571 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -57.55 -16.14 9.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 108.958 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -69.61 -49.02 57.91 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.616 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.8 mp -81.44 -33.05 12.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 41' ' ' ARG . . . -65.5 -59.0 4.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.366 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.6 mt -54.14 -37.83 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.302 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -53.22 54.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.207 -0.933 . . . . 0.0 108.973 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -63.51 -44.29 94.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.481 -0.762 . . . . 0.0 109.51 -179.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.78 -41.86 71.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.579 -0.7 . . . . 0.0 109.674 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.0 mt -60.76 -43.62 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -0.897 . . . . 0.0 110.365 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -59.96 -36.45 77.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.18 . . . . 0.0 108.176 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.33 75.51 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.29 -45.48 76.44 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.462 -0.774 . . . . 0.0 110.213 -179.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.3 mp -68.79 -40.2 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.053 -1.029 . . . . 0.0 108.596 -179.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.63 -18.17 63.57 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 108.83 179.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 tp -61.55 -31.31 71.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.564 -0.71 . . . . 0.0 109.305 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -93.62 7.9 42.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.282 -0.886 . . . . 0.0 109.47 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -157.74 66.91 0.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.411 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.18 -11.27 70.59 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.366 -1.079 . . . . 0.0 109.402 179.971 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.8 mt -82.05 149.01 61.84 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.955 . . . . 0.0 108.704 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.38 161.96 22.02 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.743 1.629 . . . . 0.0 111.464 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.11 171.92 9.44 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.59 2.194 . . . . 0.0 111.707 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 51.01 15.65 0.28 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -0.891 . . . . 0.0 109.988 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tt -138.09 133.93 34.05 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.165 -0.959 . . . . 0.0 110.026 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 22.7 m-85 -132.73 -163.11 1.3 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.707 -0.621 . . . . 0.0 109.418 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.1 tt -141.15 151.03 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-O 121.629 0.728 . . . . 0.0 110.133 179.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.497 HH21 ' CB ' ' A' ' 23' ' ' TYR . 11.7 ttp180 -92.64 148.15 22.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.516 -0.74 . . . . 0.0 109.143 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -52.91 -10.83 0.19 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.0 . . . . 0.0 109.448 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 19' ' ' ARG . 85.4 m-20 -90.09 -2.88 58.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 108.846 179.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.13 8.7 74.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.497 ' CB ' HH21 ' A' ' 19' ' ' ARG . 4.6 m-85 -85.77 132.55 34.1 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -82.57 147.91 28.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.16 -0.963 . . . . 0.0 108.528 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.3 m -148.04 144.59 28.01 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.993 -1.067 . . . . 0.0 109.949 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -101.08 148.09 25.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.538 -0.727 . . . . 0.0 109.788 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -105.52 108.84 20.57 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.364 -0.835 . . . . 0.0 110.025 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -72.28 119.57 75.51 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 108.669 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.75 0.55 9.71 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.626 1.551 . . . . 0.0 112.152 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -90.28 -28.87 18.5 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.101 -0.999 . . . . 0.0 109.352 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 33' ' ' LYS . 1.7 t -120.4 -27.64 5.16 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.58 -11.84 70.61 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.5 ' CD ' ' N ' ' A' ' 33' ' ' LYS . 10.9 mptt -77.8 179.81 6.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.02 -1.282 . . . . 0.0 110.182 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.07 176.4 5.04 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.633 -0.667 . . . . 0.0 110.336 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -139.95 114.14 9.04 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.18 121.95 9.44 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.6 mt -105.36 -57.22 2.06 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.459 -1.024 . . . . 0.0 109.633 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.04 -158.6 30.95 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.495 HH11 ' CB ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -107.35 2.53 24.51 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.528 -0.983 . . . . 0.0 109.929 -179.789 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -93.91 98.26 10.93 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.098 -1.001 . . . . 0.0 110.043 -179.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -51.18 -21.1 1.82 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.274 -0.891 . . . . 0.0 108.604 179.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -71.9 -57.29 4.45 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.2 mm -67.55 -36.42 76.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.384 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.43 -58.34 4.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.603 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.35 -35.15 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 108.964 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 m -53.44 -54.18 40.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.155 -0.966 . . . . 0.0 108.518 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -62.08 -41.26 97.99 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.623 0.725 . . . . 0.0 109.328 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.23 -45.94 68.91 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.585 -0.697 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.26 -46.77 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.896 . . . . 0.0 110.209 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -62.12 -36.56 82.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.93 -1.106 . . . . 0.0 108.62 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.16 -35.53 81.09 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -69.83 -40.87 75.6 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.638 -0.664 . . . . 0.0 109.629 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.27 -44.11 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.266 -0.896 . . . . 0.0 109.035 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -66.91 -19.91 65.81 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.95 -19.88 66.18 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.358 -0.839 . . . . 0.0 108.785 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.449 ' O ' ' CB ' ' A' ' 57' ' ' SER . 1.7 t80 -93.72 -6.78 45.4 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 56' ' ' PHE . 0.5 OUTLIER 75.16 30.59 0.87 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.631 -0.668 . . . . 0.0 110.156 179.333 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.14 -169.82 9.77 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.0 p80 . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.196 -1.179 . . . . 0.0 109.488 179.994 . . . . . . . . 0 0 . 1 stop_ save_